Search Info: & ptm= & status=Reviewed
Total related records: 4775
Record | Protein | Protein id | Symbol | PTM type | Site | Species | Disease | Cell line | Drug | Regulatory | Confidence score(level) | Ref. |
---|---|---|---|---|---|---|---|---|---|---|---|---|
acc4552 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Melanoma | Selumetinib | Impairing | 5.0 (High) | 27196754 | |
acc4553 | Akt | P31750 | Akt1 | phosphorylation | Thr308 | mouse | Melanoma | Selumetinib | Impairing | 5.0 (High) | 27196754 | |
acc4554 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Melanoma | Vemurafenib | Impairing | 5.0 (High) | 27196754 | |
acc4555 | Akt | P31750 | Akt1 | phosphorylation | Thr308 | mouse | Melanoma | Vemurafenib | Impairing | 5.0 (High) | 27196754 | |
acc4599 | EGFR | P00533 | EGFR | sulfenylation | Cys797 | human | Lung Cancer | A549 | Cetuximab | Enhancing | 5.0 (High) | 30890751 |
acc4600 | EGFR | P00533 | EGFR | sulfenylation | Cys797 | human | Lung Cancer | A549 | Erlotinib | Enhancing | 5.0 (High) | 30890751 |
acc4601 | EGFR | P00533 | EGFR | S-glutathionylation | Cys797 | human | Lung Cancer | A549 | Cetuximab | Enhancing | 5.0 (High) | 30890751 |
acc4602 | EGFR | P00533 | EGFR | S-glutathionylation | Cys797 | human | Lung Cancer | A549 | Erlotinib | Enhancing | 5.0 (High) | 30890751 |
acc4609 | DR5 | O14763 | TNFRSF10B | ubiquitination | unclear | human | Renal Cancer | Caki-1 | TRAIL | Impairing | 5.0 (High) | 32825566 |
acc4610 | DR5 | O14763 | TNFRSF10B | ubiquitination | unclear | human | Renal Cancer | ACHN | TRAIL | Impairing | 5.0 (High) | 32825566 |
acc4611 | DR5 | O14763 | TNFRSF10B | ubiquitination | unclear | human | Renal Cancer | A498 | TRAIL | Impairing | 5.0 (High) | 32825566 |
acc4612 | DR5 | O14763 | TNFRSF10B | ubiquitination | unclear | human | Lung Cancer | A549 | TRAIL | Impairing | 5.0 (High) | 32825566 |
acc4613 | DR5 | O14763 | TNFRSF10B | ubiquitination | unclear | human | Breast Cancer | MCF7 | TRAIL | Impairing | 5.0 (High) | 32825566 |
acc4614 | Survivin | O15392 | BIRC5 | ubiquitination | unclear | human | Renal Cancer | Caki-1 | TRAIL | Enhancing | 5.0 (High) | 32825566 |
acc4615 | Survivin | O15392 | BIRC5 | ubiquitination | unclear | human | Renal Cancer | ACHN | TRAIL | Enhancing | 5.0 (High) | 32825566 |
acc4616 | Survivin | O15392 | BIRC5 | ubiquitination | unclear | human | Renal Cancer | A498 | TRAIL | Enhancing | 5.0 (High) | 32825566 |
acc4617 | Survivin | O15392 | BIRC5 | ubiquitination | unclear | human | Lung Cancer | A549 | TRAIL | Enhancing | 5.0 (High) | 32825566 |
acc4618 | Survivin | O15392 | BIRC5 | ubiquitination | unclear | human | Breast Cancer | MCF7 | TRAIL | Enhancing | 5.0 (High) | 32825566 |
acc4266 | ERK | P21708 | Mapk1 | phosphorylation | Tyr204 | rat | Neuropathic Pain | Oxaliplatin | Impairing | 5.0 (High) | 31765435 | |
acc4316 | Drp1 | Q8K1M6 | Dnm1l | phosphorylation | Ser616 | mouse | Cardiac Injury | NMVM | Doxorubicin | Impairing | 5.0 (High) | 32339784 |
acc4371 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreatic Cancer | MIAPaCa-2 | CUDC-907 | Impairing | 5.0 (High) | 33392641 |
acc4372 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Pancreatic Cancer | MIAPaCa-2 | CUDC-907 | Impairing | 5.0 (High) | 33392641 |
acc4373 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Pancreatic Cancer | MIAPaCa-2 | CUDC-907 | Impairing | 5.0 (High) | 33392641 |
acc4374 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreatic Cancer | MIAPaCa-2 | CUDC-907 | Impairing | 5.0 (High) | 33392641 |
acc4375 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreatic Cancer | MIAPaCa-2 | CUDC-907 | Impairing | 5.0 (High) | 33392641 |
acc4376 | S6 | P62753 | RPS6 | phosphorylation | Ser240 | human | Pancreatic Cancer | MIAPaCa-2 | CUDC-907 | Impairing | 5.0 (High) | 33392641 |
acc4377 | S6 | P62753 | RPS6 | phosphorylation | Ser244 | human | Pancreatic Cancer | MIAPaCa-2 | CUDC-907 | Impairing | 5.0 (High) | 33392641 |
acc3887 | PDGFRB | P09619 | PDGFRB | phosphorylation | Tyr857 | human | Gastric Cancer | GIST–T1 | Dasatinib | Impairing | 5.0 (High) | 25737303 |
acc3920 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Myeloma | 8226/AMY1 | Bortezomib | Impairing | 5.0 (High) | 26341959 |
acc4148 | FGFR1 | P11362 | FGFR1 | phosphorylation | Tyr654 | human | Breast Cancer | Tamoxifen | Impairing | 5.0 (High) | 30046001 | |
acc4222 | NOS3 | P29474 | NOS3 | phosphorylation | Ser1177 | human | Colorectal Cancer | DLD-1 | Oxaliplatin | Impairing | 5.0 (High) | 31195721 |
acc4223 | NOS3 | P29474 | NOS3 | phosphorylation | Ser1177 | human | Colorectal Cancer | Colo205 | Oxaliplatin | Impairing | 5.0 (High) | 31195721 |
acc1586 | Caveolin-1 | Q03135 | CAV1 | phosphorylation | Tyr14 | human | Gastric Cancer | SGC7901/Adr | adriamycin(Dox) | Impairing | 5.0 (High) | 25788263 |
acc1587 | Caveolin-1 | Q03135 | CAV1 | phosphorylation | Tyr14 | human | Breast Cancer | MCF7/Adr | adriamycin(Dox) | Impairing | 5.0 (High) | 25788263 |
acc1588 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MCF7 | Tamoxifen | Impairing | 5.0 (High) | 21170675 |
acc1603 | CYLD | Q9NQC7 | CYLD | phosphorylation | Ser418 | human | Lymphoma | HBL-1 | Rituximab | Impairing | 5.0 (High) | 33827598 |
acc1604 | CYLD | Q9NQC7 | CYLD | phosphorylation | Ser418 | human | Lymphoma | OCI-Ly10 | Rituximab | Impairing | 5.0 (High) | 33827598 |
acc1620 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | Erlotinib | Enhancing | 5.0 (High) | 26247735 | |
acc1623 | EGFR | P00533 | EGFR | ubiquitination | unclear | human | Lung Cancer | A549 | Gefitinib | Enhancing | 5.0 (High) | 21858220 |
acc1624 | EGFR | P00533 | EGFR | ubiquitination | unclear | human | Lung Cancer | H1975 | Gefitinib | Enhancing | 5.0 (High) | 21858220 |
acc1629 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | CL1-5 | Gefitinib | Impairing | 5.0 (High) | 21858220 |
acc1630 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | A549 | Gefitinib | Impairing | 5.0 (High) | 21858220 |
acc1631 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | H1975 | Gefitinib | Impairing | 5.0 (High) | 21858220 |
acc1632 | EGFR | P00533 | EGFR | ubiquitination | Tyr1068 | human | Lung Cancer | CL1-5 | Gefitinib | Enhancing | 5.0 (High) | 21858220 |
acc1643 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | H1666 | Gefitinib | Impairing | 5.0 (High) | 22777356 |
acc1644 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | H1666 | Gefitinib | Impairing | 5.0 (High) | 22777356 |
acc1645 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | H1666 | Gefitinib | Impairing | 5.0 (High) | 22777356 |
acc1646 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | H1666 | Gefitinib | Impairing | 5.0 (High) | 22777356 |
acc1647 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Lung Cancer | PC9GR | Gefitinib | Impairing | 5.0 (High) | 31671073 |
acc1648 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Lung Cancer | PC9GR | Osimertinib | Impairing | 5.0 (High) | 31671073 |
acc1651 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Lung Cancer | A549 | Doxorubicin | Impairing | 5.0 (High) | 31848319 |
acc1653 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Breast Cancer | T47D | Lapatinib | Impairing | 5.0 (High) | 32365111 |
acc1656 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Thyroid Cancer | FTC-133 | Paclitaxel | Impairing | 5.0 (High) | 28864377 |
acc1657 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Thyroid Cancer | 8505C | Paclitaxel | Impairing | 5.0 (High) | 28864377 |
acc1660 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Pancreas Cancer | PC-346C | RAD001 | Impairing | 5.0 (High) | 28745319 |
acc1661 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Pancreas Cancer | C4-2 | RAD001 | Impairing | 5.0 (High) | 28745319 |
acc1662 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Glioma | U373 | Temozolomide | Impairing | 5.0 (High) | 27289018 |
acc1663 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Glioma | LN229 | Temozolomide | Impairing | 5.0 (High) | 27289018 |
acc1665 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Hepatocellular Carcinoma | HepG2 | Sorafenib | Impairing | 5.0 (High) | 22414764 |
acc1666 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Hepatocellular Carcinoma | Hep3B | Sorafenib | Impairing | 5.0 (High) | 22414764 |
acc1667 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Hepatocellular Carcinoma | HuH6 | Sorafenib | Impairing | 5.0 (High) | 22414764 |
acc1668 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Hepatocellular Carcinoma | PLC/PRF5 | Sorafenib | Impairing | 5.0 (High) | 22414764 |
acc1669 | HER3 | P21860 | ERBB3 | phosphorylation | Tyr1289 | human | Hepatocellular Carcinoma | HepG2 | Sorafenib | Impairing | 5.0 (High) | 22414764 |
acc1670 | HER3 | P21860 | ERBB3 | phosphorylation | Tyr1068 | human | Hepatocellular Carcinoma | Hep3B | Sorafenib | Impairing | 5.0 (High) | 22414764 |
acc1671 | HER3 | P21860 | ERBB3 | phosphorylation | Tyr1068 | human | Hepatocellular Carcinoma | HuH6 | Sorafenib | Impairing | 5.0 (High) | 22414764 |
acc1672 | HER3 | P21860 | ERBB3 | phosphorylation | Tyr1068 | human | Hepatocellular Carcinoma | PLC/PRF5 | Sorafenib | Impairing | 5.0 (High) | 22414764 |
acc1677 | ERalpha | P03372 | ESR1 | phosphorylation | Ser118 | human | Breast Cancer | MCF7 | LY294002 | Impairing | 5.0 (High) | 18941890 |
acc1678 | ERalpha | P03372 | ESR1 | phosphorylation | Ser167 | human | Breast Cancer | MCF7 | LY294002 | Impairing | 5.0 (High) | 18941890 |
acc1679 | ERalpha | P03372 | ESR1 | phosphorylation | Ser118 | human | Breast Cancer | MCF7 | ICI182780 | Impairing | 5.0 (High) | 18941890 |
acc1680 | ERalpha | P03372 | ESR1 | phosphorylation | Ser167 | human | Breast Cancer | MCF7 | ICI182780 | Impairing | 5.0 (High) | 18941890 |
acc1681 | ERalpha | P19785 | Esr1 | phosphorylation | Ser118 | rat | Prolactinoma | MMQ/BRO | Bromocriptine | Impairing | 5.0 (High) | 33173437 |
acc1682 | ERalpha | P03372 | ESR1 | phosphorylation | Ser118 | human | Prolactinoma | Bromocriptine | Impairing | 5.0 (High) | 33173437 | |
acc1688 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Glioma | C6 | U0126 | Impairing | 5.0 (High) | 27878252 |
acc1689 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Glioma | C6 | U0126 | Impairing | 5.0 (High) | 27878252 |
acc1690 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Glioma | C6 | U0126 | Impairing | 5.0 (High) | 27878252 |
acc1691 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Glioma | C6 | U0126 | Impairing | 5.0 (High) | 27878252 |
acc1700 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Ovarian Cancer | A2780AD | PTX | Impairing | 5.0 (High) | 29693189 |
acc1701 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Ovarian Cancer | A2780AD | PTX | Impairing | 5.0 (High) | 29693189 |
acc1702 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Ovarian Cancer | A2780AD | PTX | Impairing | 5.0 (High) | 29693189 |
acc1703 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Ovarian Cancer | A2780AD | PTX | Impairing | 5.0 (High) | 29693189 |
acc1704 | pRB | P06400 | RB1 | phosphorylation | Ser795 | human | Lung Cancer | Ma-10 | Paclitaxel | Enhancing | 5.0 (High) | 15138593 |
acc1705 | pRB | P06400 | RB1 | phosphorylation | Ser795 | human | Lung Cancer | Ma-31 | Paclitaxel | Enhancing | 5.0 (High) | 15138593 |
acc1706 | SHP2 | Q15466 | NR0B2 | phosphorylation | Tyr62 | human | Leukemia | MOLM-13 | SHP099 | Impairing | 5.0 (High) | 35311954 |
acc1707 | SHP2 | Q15466 | NR0B2 | phosphorylation | Tyr62 | human | Leukemia | MV4-11 | SHP099 | Impairing | 5.0 (High) | 35311954 |
acc1724 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Leukemia | HL-60 | Shikonin | Impairing | 5.0 (High) | 22837689 |
acc1725 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Leukemia | HL-60 | Shikonin | Impairing | 5.0 (High) | 22837689 |
acc1726 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Leukemia | HL-60 | Shikonin | Impairing | 5.0 (High) | 22837689 |
acc1727 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Leukemia | HL-60 | Shikonin | Impairing | 5.0 (High) | 22837689 |
acc1728 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Leukemia | K562 | Shikonin | Impairing | 5.0 (High) | 22837689 |
acc1729 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Leukemia | K562 | Shikonin | Impairing | 5.0 (High) | 22837689 |
acc1730 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Leukemia | K562 | Shikonin | Impairing | 5.0 (High) | 22837689 |
acc1731 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Leukemia | K562 | Shikonin | Impairing | 5.0 (High) | 22837689 |
acc1738 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Melanoma | SK-Mel-28 | NHWD-870 | Impairing | 5.0 (High) | 35184394 |
acc1739 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Melanoma | SK-Mel-28 | NHWD-870 | Impairing | 5.0 (High) | 35184394 |
acc1740 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Melanoma | A375 | NHWD-870 | Impairing | 5.0 (High) | 35184394 |
acc1741 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Melanoma | A375 | NHWD-870 | Impairing | 5.0 (High) | 35184394 |
acc1742 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Breast Cancer | MCF7 | U0126 | Impairing | 5.0 (High) | 15231676 |
acc1743 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Breast Cancer | MCF7 | U0126 | Impairing | 5.0 (High) | 15231676 |
acc1744 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Breast Cancer | MCF7 | U0126 | Impairing | 5.0 (High) | 15231676 |
acc1745 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Breast Cancer | MCF7 | U0126 | Impairing | 5.0 (High) | 15231676 |
acc1746 | ERalpha | P03372 | ESR1 | phosphorylation | Ser118 | human | Breast Cancer | Tamoxifen | Impairing | 5.0 (High) | 19940281 | |
acc1759 | EZH2 | Q15910 | EZH2 | phosphorylation | Ser21 | human | Breast Cancer | MCF7 | Tamoxifen | Impairing | 5.0 (High) | 36356296 |
acc1775 | FOXO1 | Q12778 | FOXO1 | phosphorylation | Thr24 | human | Colorectal Cancer | HT29 | Rapamycin | Impairing | 5.0 (High) | 20392999 |
acc1776 | FOXO1 | Q12778 | FOXO1 | phosphorylation | Thr24 | human | Colorectal Cancer | LS174T | Rapamycin | Impairing | 5.0 (High) | 20392999 |
acc1777 | HER2 | P04626 | ERBB2 | phosphorylation | Tyr1248 | human | Breast Cancer | BT474 | Trastuzumab | Impairing | 5.0 (High) | 21803025 |
acc1778 | HER2 | P04626 | ERBB2 | phosphorylation | Tyr1248 | human | Breast Cancer | SK-BR-3 | Trastuzumab | Impairing | 5.0 (High) | 21803025 |
acc1785 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Head and Neck Cancer | Tu212 | Erlotinib | Impairing | 5.0 (High) | 24019973 |
acc1786 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Head and Neck Cancer | Tu686 | Erlotinib | Impairing | 5.0 (High) | 24019973 |
acc1787 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Breast Cancer | MCF7 | Rapalogues | Enhancing | 5.0 (High) | 24204783 |
acc1788 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Breast Cancer | MDA-MB-231 | Rapalogues | Enhancing | 5.0 (High) | 24204783 |
acc1798 | GSTP1 | P09211 | GSTP1 | phosphorylation | Tyr7 | human | Breast Cancer | SUM 149 | Cisplatin | Impairing | 5.0 (High) | 19254954 |
acc1799 | GSTP1 | P09211 | GSTP1 | phosphorylation | Tyr7 | human | Glioma | MGR1 | Cisplatin | Impairing | 5.0 (High) | 19254954 |
acc1800 | GSTP1 | P09211 | GSTP1 | phosphorylation | Tyr7 | human | Glioma | MGR3 | Cisplatin | Impairing | 5.0 (High) | 19254954 |
acc1801 | GSTP1 | P09211 | GSTP1 | phosphorylation | Tyr7 | human | Glioblastoma | U87-MG | Cisplatin | Impairing | 5.0 (High) | 19254954 |
acc1802 | GSTP1 | P09211 | GSTP1 | phosphorylation | Tyr198 | human | Breast Cancer | SUM 149 | Cisplatin | Impairing | 5.0 (High) | 19254954 |
acc1803 | GSTP1 | P09211 | GSTP1 | phosphorylation | Tyr198 | human | Breast Cancer | SUM 149 | Cisplatin | Impairing | 5.0 (High) | 19254954 |
acc1804 | GSTP1 | P09211 | GSTP1 | phosphorylation | Tyr198 | human | Glioma | MGR3 | Cisplatin | Impairing | 5.0 (High) | 19254954 |
acc1805 | GSTP1 | P09211 | GSTP1 | phosphorylation | Tyr198 | human | Glioma | U87-MG | Cisplatin | Impairing | 5.0 (High) | 19254954 |
acc1808 | MtCK1 | P17540 | CKMT2 | phosphorylation | Tyr153 | human | Breast Cancer | SK-BR-3 | Lapatinib | Impairing | 5.0 (High) | 30174304 |
acc1809 | MtCK1 | P17540 | CKMT2 | phosphorylation | Tyr153 | human | Breast Cancer | BT474(trastuzumab-resistant) | Lapatinib | Impairing | 5.0 (High) | 30174304 |
acc1810 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Endometrial Cancer | Ishikawa | Trastuzumab | Impairing | 5.0 (High) | 12763221 |
acc1811 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Endometrial Cancer | Ishikawa | Trastuzumab | Impairing | 5.0 (High) | 12763221 |
acc1812 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Endometrial Cancer | Ishikawa | Trastuzumab | Impairing | 5.0 (High) | 12763221 |
acc1813 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Endometrial Cancer | Ishikawa | Trastuzumab | Impairing | 5.0 (High) | 12763221 |
acc1814 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Endometrial Cancer | HEC-1A | Trastuzumab | Impairing | 5.0 (High) | 12763221 |
acc1815 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Endometrial Cancer | HEC-1A | Trastuzumab | Impairing | 5.0 (High) | 12763221 |
acc1816 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Endometrial Cancer | HEC-1A | Trastuzumab | Impairing | 5.0 (High) | 12763221 |
acc1817 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Endometrial Cancer | HEC-1A | Trastuzumab | Impairing | 5.0 (High) | 12763221 |
acc0842 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Melanoma | A375 | Trametinib | Impairing | 5.0 (High) | 29296217 |
acc0843 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Melanoma | A375 | Trametinib | Impairing | 5.0 (High) | 29296217 |
acc0844 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Melanoma | A375 | Trametinib | Impairing | 5.0 (High) | 29296217 |
acc0845 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Colorectal Cancer | COLO205 | Trametinib | Impairing | 5.0 (High) | 29296217 |
acc0846 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Colorectal Cancer | COLO205 | Trametinib | Impairing | 5.0 (High) | 29296217 |
acc0847 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Colorectal Cancer | COLO205 | Trametinib | Impairing | 5.0 (High) | 29296217 |
acc0848 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Colorectal Cancer | COLO205 | Trametinib | Impairing | 5.0 (High) | 29296217 |
acc0879 | AKT | P31749 | AKT1 | phosphorylation | Tyr705 | human | Ovarian Cancer | HEY | Cisplatin | Impairing | 5.0 (High) | 31597912 |
acc0880 | AKT | P31749 | AKT1 | phosphorylation | Tyr705 | human | Ovarian Cancer | SK-OV-3 | Cisplatin | Impairing | 5.0 (High) | 31597912 |
acc0881 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Breast Cancer | MCF7/MDR | Cisplatin | Impairing | 5.0 (High) | 31006103 |
acc0884 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Bladder Cancer | J82 | Cisplatin | Impairing | 5.0 (High) | 28178653 |
acc0885 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Bladder Cancer | BIU-87 | Cisplatin | Impairing | 5.0 (High) | 28178653 |
acc0891 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | SGC7901 | Cisplatin | Impairing | 5.0 (High) | 32058824 |
acc0915 | RPS6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Melanoma | A375 | Dabrafenib | Impairing | 5.0 (High) | 29777202 |
acc0916 | RPS6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Melanoma | A375 | Dabrafenib | Impairing | 5.0 (High) | 29777202 |
acc0917 | RPS6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Melanoma | A375 | Trametinib | Impairing | 5.0 (High) | 29777202 |
acc0918 | RPS6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Melanoma | A375 | Trametinib | Impairing | 5.0 (High) | 29777202 |
acc0920 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | H2286 | Dasatinib | Impairing | 5.0 (High) | 25348954 |
acc0921 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | HCC366 | Dasatinib | Impairing | 5.0 (High) | 25348954 |
acc0922 | MET | P08581 | MET | phosphorylation | Tyr1234 | human | Lung Cancer | H2286 | Dasatinib | Impairing | 5.0 (High) | 25348954 |
acc0923 | MET | P08581 | MET | phosphorylation | Tyr1234 | human | Lung Cancer | HCC366 | Dasatinib | Impairing | 5.0 (High) | 25348954 |
acc0924 | MET | P08581 | MET | phosphorylation | Tyr1235 | human | Lung Cancer | H2286 | Dasatinib | Impairing | 5.0 (High) | 25348954 |
acc0925 | MET | P08581 | MET | phosphorylation | Tyr1235 | human | Lung Cancer | HCC366 | Dasatinib | Impairing | 5.0 (High) | 25348954 |
acc0943 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Prostate Cancer | DU145 | Docetaxel | Impairing | 5.0 (High) | 34303965 |
acc0944 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Prostate Cancer | PC3 | Docetaxel | Impairing | 5.0 (High) | 34303965 |
acc0945 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Prostate Cancer | DU145 | Docetaxel | Impairing | 5.0 (High) | 34303965 |
acc0946 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Prostate Cancer | PC3 | Docetaxel | Impairing | 5.0 (High) | 34303965 |
acc1009 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | U1752 | Erlotinib | Impairing | 5.0 (High) | 23923067 |
acc1010 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | U1752 | Erlotinib | Impairing | 5.0 (High) | 23923067 |
acc1011 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | NCI-H292 | Erlotinib | Impairing | 5.0 (High) | 23923067 |
acc1012 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | NCI-H292 | Erlotinib | Impairing | 5.0 (High) | 23923067 |
acc1013 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | U1752 | Erlotinib | Impairing | 5.0 (High) | 23923067 |
acc1014 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | Calu-6 | Erlotinib | Impairing | 5.0 (High) | 23923067 |
acc1015 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | NCI-H292 | Erlotinib | Impairing | 5.0 (High) | 23923067 |
acc1016 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | U1752 | Erlotinib | Impairing | 5.0 (High) | 23923067 |
acc1017 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | U1752 | Erlotinib | Impairing | 5.0 (High) | 23923067 |
acc1018 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | Calu-6 | Erlotinib | Impairing | 5.0 (High) | 23923067 |
acc1019 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | Calu-6 | Erlotinib | Impairing | 5.0 (High) | 23923067 |
acc1020 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | Calu-6 | Erlotinib | Impairing | 5.0 (High) | 23923067 |
acc1021 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | Calu-6 | Erlotinib | Impairing | 5.0 (High) | 23923067 |
acc1022 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | NCI-H292 | Erlotinib | Impairing | 5.0 (High) | 23923067 |
acc1023 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | NCI-H292 | Erlotinib | Impairing | 5.0 (High) | 23923067 |
acc1024 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | PC9 | Erlotinib | Impairing | 5.0 (High) | 23872583 |
acc1025 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | 11月18日 | Erlotinib | Impairing | 5.0 (High) | 23872583 |
acc1026 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Lung Cancer | PC9 | Erlotinib | Impairing | 5.0 (High) | 23872583 |
acc1027 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Lung Cancer | 11月18日 | Erlotinib | Impairing | 5.0 (High) | 23872583 |
acc1043 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Melanoma | B16F10 | Staurosporine | Impairing | 5.0 (High) | 16707598 |
acc1045 | ERalpha | P03372 | ESR1 | phosphorylation | Ser118 | human | Endometrial Cancer | ECC1 | MPA | Impairing | 5.0 (High) | 23530112 |
acc1046 | ERalpha | P03372 | ESR1 | phosphorylation | Ser118 | human | Endometrial Cancer | USPC1 | MPA | Impairing | 5.0 (High) | 23530112 |
acc1047 | ERalpha | P03372 | ESR1 | phosphorylation | Ser167 | human | Endometrial Cancer | ECC1 | MPA | Impairing | 5.0 (High) | 23530112 |
acc1048 | ERalpha | P03372 | ESR1 | phosphorylation | Ser167 | human | Endometrial Cancer | USPC1 | MPA | Impairing | 5.0 (High) | 23530112 |
acc1049 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Endometrial Cancer | ECC1 | MPA | Impairing | 5.0 (High) | 23530112 |
acc1050 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Endometrial Cancer | USPC1 | MPA | Impairing | 5.0 (High) | 23530112 |
acc1060 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | SUM159 | Gefitinib | Impairing | 5.0 (High) | 21660955 |
acc1061 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | SUM 149 | Gefitinib | Impairing | 5.0 (High) | 21660955 |
acc1062 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | SUM229 | Gefitinib | Impairing | 5.0 (High) | 21660955 |
acc1079 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Leukemia | CML-iPSCs | Imatinib | Impairing | 5.0 (High) | 22592606 |
acc1080 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Leukemia | CML-iPSCs | Imatinib | Impairing | 5.0 (High) | 22592606 |
acc1081 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Leukemia | CML-iPSCs | Imatinib | Impairing | 5.0 (High) | 22592606 |
acc1082 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Leukemia | CML-iPSCs | Imatinib | Impairing | 5.0 (High) | 22592606 |
acc1083 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Leukemia | CML-iPSCs | Imatinib | Impairing | 5.0 (High) | 22592606 |
acc0001 | Ku70 | P12956 | XRCC6 | acetylation | unclear | human | Lung Cancer | H358 | Gefitinib | Enhancing | 5.0 (High) | 19826407 |
acc0002 | Ku70 | P12956 | XRCC6 | acetylation | unclear | human | Lung Cancer | H358 | Gefitinib + Vorinostat | Enhancing | 5.0 (High) | 19826407 |
acc0004 | p53 | P04637 | TP53 | acetylation | unclear | human | Hepatocellular Carcinoma | SMMC-7721 | Pterostilbene | Enhancing | 5.0 (High) | 29042910 |
acc0008 | alpha-tubulin | P68363 | TUBA1B | acetylation | unclear | human | Lung Cancer | A549 | Paclitaxel | Enhancing | 5.0 (High) | 32580047 |
acc0009 | alpha-tubulin | P68363 | TUBA1B | acetylation | unclear | human | Cervical Cancer | HeLa | Paclitaxel | Enhancing | 5.0 (High) | 32580047 |
acc0016 | Rb | P06400 | RB1 | phosphorylation | Ser807 | human | Pancreas Cancer | CAPAN1 | Temozolomide | Impairing | 5.0 (High) | 16170025 |
acc0017 | Rb | P06400 | RB1 | phosphorylation | Ser807 | human | Pancreas Cancer | CFPAC-1 | Temozolomide | Impairing | 5.0 (High) | 16170025 |
acc0018 | Rb | P06400 | RB1 | phosphorylation | Ser811 | human | Pancreas Cancer | CAPAN1 | Temozolomide | Impairing | 5.0 (High) | 16170025 |
acc0019 | Rb | P06400 | RB1 | phosphorylation | Ser811 | human | Pancreas Cancer | CFPAC-1 | Temozolomide | Impairing | 5.0 (High) | 16170025 |
acc0020 | Rb | P06400 | RB1 | phosphorylation | Ser795 | human | Pancreas Cancer | CAPAN1 | Temozolomide | Impairing | 5.0 (High) | 16170025 |
acc0021 | Rb | P06400 | RB1 | phosphorylation | Ser795 | human | Pancreas Cancer | CFPAC-1 | Temozolomide | Impairing | 5.0 (High) | 16170025 |
acc0022 | Rb | P06400 | RB1 | phosphorylation | Ser780 | human | Pancreas Cancer | CAPAN1 | Temozolomide | Impairing | 5.0 (High) | 16170025 |
acc0023 | Rb | P06400 | RB1 | phosphorylation | Ser780 | human | Pancreas Cancer | CFPAC-1 | Temozolomide | Impairing | 5.0 (High) | 16170025 |
acc0039 | DMAP1 | Q9NPF5 | DMAP1 | phosphorylation | Tyr246 | human | Pancreas Cancer | SW1990 | Paclitaxel | Impairing | 5.0 (High) | 30553276 |
acc0040 | DMAP1 | Q9NPF5 | DMAP1 | phosphorylation | Tyr246 | human | Pancreas Cancer | PANC-1 | Paclitaxel | Impairing | 5.0 (High) | 30553276 |
acc0045 | FLT3 | P36888 | FLT3 | methylation | Arg972 | human | Leukemia | MV4-11 | AC220 | Impairing | 5.0 (High) | 31217189 |
acc0046 | FLT3 | P36888 | FLT3 | methylation | Arg973 | human | Leukemia | MV4-11 | AC220 | Impairing | 5.0 (High) | 31217189 |
acc0081 | MARCKS | P29966 | MARCKS | phosphorylation | Ser152 | human | Myeloma | RPMI8226-R5 | Bortezomib | Impairing | 5.0 (High) | 25179733 |
acc0082 | MARCKS | P29966 | MARCKS | phosphorylation | Ser152 | human | Myeloma | MM.1R | Bortezomib | Impairing | 5.0 (High) | 25179733 |
acc0083 | MARCKS | P29966 | MARCKS | phosphorylation | Ser156 | human | Myeloma | MM.1R | Bortezomib | Impairing | 5.0 (High) | 25179733 |
acc0084 | MARCKS | P29966 | MARCKS | phosphorylation | Ser156 | human | Myeloma | RPMI8226-R5 | Dexamethasone | Impairing | 5.0 (High) | 25179733 |
acc0085 | MARCKS | P29966 | MARCKS | phosphorylation | Ser156 | human | Myeloma | MM.1R | Dexamethasone | Impairing | 5.0 (High) | 25179733 |
acc0086 | MARCKS | P29966 | MARCKS | phosphorylation | Ser156 | human | Myeloma | RPMI8226-R5 | Doxorubicin | Impairing | 5.0 (High) | 25179733 |
acc0087 | MARCKS | P29966 | MARCKS | phosphorylation | Ser156 | human | Myeloma | MM.1R | Doxorubicin | Impairing | 5.0 (High) | 25179733 |
acc0088 | MARCKS | P29966 | MARCKS | phosphorylation | Ser156 | human | Myeloma | RPMI8226-R5 | Lenalidomide | Impairing | 5.0 (High) | 25179733 |
acc0089 | MARCKS | P29966 | MARCKS | phosphorylation | Ser156 | human | Myeloma | MM.1R | Lenalidomide | Impairing | 5.0 (High) | 25179733 |
acc0090 | MARCKS | P29966 | MARCKS | phosphorylation | Ser156 | human | Myeloma | MM.1R | MG132 | Impairing | 5.0 (High) | 25179733 |
acc0091 | MARCKS | P29966 | MARCKS | phosphorylation | Ser152 | human | Myeloma | RPMI8226-R5 | Dexamethasone | Impairing | 5.0 (High) | 25179733 |
acc0092 | MARCKS | P29966 | MARCKS | phosphorylation | Ser152 | human | Myeloma | MM.1R | Dexamethasone | Impairing | 5.0 (High) | 25179733 |
acc0093 | MARCKS | P29966 | MARCKS | phosphorylation | Ser152 | human | Myeloma | RPMI8226-R5 | Doxorubicin | Impairing | 5.0 (High) | 25179733 |
acc0094 | MARCKS | P29966 | MARCKS | phosphorylation | Ser152 | human | Myeloma | MM.1R | Doxorubicin | Impairing | 5.0 (High) | 25179733 |
acc0095 | MARCKS | P29966 | MARCKS | phosphorylation | Ser152 | human | Myeloma | RPMI8226-R5 | Lenalidomide | Impairing | 5.0 (High) | 25179733 |
acc0096 | MARCKS | P29966 | MARCKS | phosphorylation | Ser152 | human | Myeloma | MM.1R | Lenalidomide | Impairing | 5.0 (High) | 25179733 |
acc0097 | MARCKS | P29966 | MARCKS | phosphorylation | Ser152 | human | Myeloma | MM.1R | MG132 | Impairing | 5.0 (High) | 25179733 |
acc0098 | MARCKS | P29966 | MARCKS | phosphorylation | Ser156 | human | Myeloma | RPMI8226-R5 | Bortezomib | Impairing | 5.0 (High) | 25179733 |
acc0104 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Gastric Cancer | MGC803 | Trametinib | Impairing | 5.0 (High) | 33035574 |
acc0123 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Prostate Cancer | BxPC3 | Erlotinib | Enhancing | 5.0 (High) | 16928826 |
acc0124 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Prostate Cancer | BxPC3 | Erlotinib | Enhancing | 5.0 (High) | 16928826 |
acc0125 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Prostate Cancer | BxPC3 | Erlotinib | Enhancing | 5.0 (High) | 16928826 |
acc0126 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Prostate Cancer | BxPC3 | Erlotinib | Enhancing | 5.0 (High) | 16928826 |
acc0128 | EGFR | P00533 | EGFR | phosphorylation | Tyr1173 | human | Breast Cancer | MDA-MB-231 | Gefitinib | Impairing | 5.0 (High) | 17363546 |
acc0129 | EGFR | P00533 | EGFR | phosphorylation | Tyr1173 | human | Breast Cancer | MDA-MB-231 | Erlotinib | Impairing | 5.0 (High) | 17363546 |
acc0136 | nNOS | P29476 | Nos1 | phosphorylation | Ser847 | rat | Pituitary Tumor | GH3 | KN93 | Enhancing | 5.0 (High) | 18271754 |
acc0137 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Leukemia | HL-60 | Imatinib | Enhancing | 5.0 (High) | 17187856 |
acc0138 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Leukemia | HL-60 | Imatinib | Enhancing | 5.0 (High) | 17187856 |
acc0139 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Leukemia | HL-60 | Imatinib | Enhancing | 5.0 (High) | 17187856 |
acc0140 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Leukemia | HL-60 | Imatinib | Enhancing | 5.0 (High) | 17187856 |
acc0141 | STAT5 | P42229 | STAT5A | phosphorylation | Tyr694 | human | Leukemia | HL-60 | Imatinib | Enhancing | 5.0 (High) | 17187856 |
acc0147 | BCL2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Leukemia | GX15-070 (Obatoclax) | Impairing | 5.0 (High) | 18596739 | |
acc0148 | BCL2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Leukemia | GX15-070 (Obatoclax) + Bortezomib | Impairing | 5.0 (High) | 18596739 | |
acc0151 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Endometrial Cancer | Ishikawa | Cisplatin | Impairing | 5.0 (High) | 18687514 |
acc0154 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Endometrial Cancer | Ishikawa | Cisplatin | Impairing | 5.0 (High) | 18687514 |
acc0159 | HER2 | P04626 | ERBB2 | phosphorylation | Tyr1221 | human | Breast Cancer | Tamoxifen | Impairing | 5.0 (High) | 19239686 | |
acc0160 | HER2 | P04626 | ERBB2 | phosphorylation | Tyr1222 | human | Breast Cancer | Tamoxifen | Impairing | 5.0 (High) | 19239686 | |
acc0161 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Schwannoma | RT4-D6P2T | Phosphatidylinositols | Impairing | 5.0 (High) | 19351837 |
acc0162 | merlin | P35240 | NF2 | phosphorylation | Ser315 | human | Schwannoma | RT4-D6P2T | Phosphatidylinositols | Impairing | 5.0 (High) | 19351837 |
acc0173 | VEGFR | P17948 | FLT1 | phosphorylation | Tyr | human | Leukemia | AML | Idarubicin | Impairing | 5.0 (High) | 19463770 |
acc0581 | EphA2 | P29317 | EPHA2 | phosphorylation | Ser897 | human | Ovarian Cancer | OVCAR4 | Platinum | Impairing | 5.0 (High) | 32115889 |
acc0582 | EphA2 | P29317 | EPHA2 | phosphorylation | Tyr558 | human | Ovarian Cancer | OVCAR4 | Platinum | Enhancing | 5.0 (High) | 32115889 |
acc0583 | EphA2 | P29317 | EPHA2 | phosphorylation | Ser897 | human | Ovarian Cancer | OVCAR8 | Platinum | Impairing | 5.0 (High) | 32115889 |
acc0584 | EphA2 | P29317 | EPHA2 | phosphorylation | Tyr558 | human | Ovarian Cancer | OVCAR8 | Platinum | Enhancing | 5.0 (High) | 32115889 |
acc0585 | PHB | P35232 | PHB1 | phosphorylation | Tyr259 | human | Ovarian Cancer | SK-OV-3 | Platinum | Impairing | 5.0 (High) | 32169072 |
acc0586 | PHB | P35232 | PHB1 | phosphorylation | Tyr259 | human | Ovarian Cancer | KURAMOCHI | Platinum | Impairing | 5.0 (High) | 32169072 |
acc0587 | DHX9 | Q08211 | DHX9 | phosphorylation | Ser321 | human | Colorectal Cancer | HCT116 | Oxaliplatin | Impairing | 5.0 (High) | 32187976 |
acc0595 | TBK1 | Q9WUN2 | Tbk1 | phosphorylation | Ser172 | mouse | Colorectal Cancer | MC38 | Ionising radiation | Enhancing | 5.0 (High) | 33496784 |
acc0596 | IRF3 | P70671 | Irf3 | phosphorylation | Ser396 | mouse | Colorectal Cancer | MC38 | Ionising radiation | Enhancing | 5.0 (High) | 33496784 |
acc0597 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | BxPC-3 | Erlotinib | Impairing | 5.0 (High) | 33614917 |
acc0598 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | PANC-1 | Erlotinib | Impairing | 5.0 (High) | 33614917 |
acc0599 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | PANC-1 | Erlotinib | Impairing | 5.0 (High) | 33614917 |
acc0600 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Pancreas Cancer | MIA PaCa-2 | Erlotinib | Impairing | 5.0 (High) | 33614917 |
acc0601 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Pancreas Cancer | MIA PaCa-2 | Erlotinib | Impairing | 5.0 (High) | 33614917 |
acc0602 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | MIA PaCa-2 | Erlotinib | Impairing | 5.0 (High) | 33614917 |
acc0603 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | MIA PaCa-2 | Erlotinib | Impairing | 5.0 (High) | 33614917 |
acc0604 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | MIA PaCa-2 | Erlotinib | Impairing | 5.0 (High) | 33614917 |
acc0605 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Pancreas Cancer | BxPC-3 | Erlotinib | Impairing | 5.0 (High) | 33614917 |
acc0606 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Pancreas Cancer | BxPC-3 | Erlotinib | Impairing | 5.0 (High) | 33614917 |
acc0607 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | BxPC-3 | Erlotinib | Impairing | 5.0 (High) | 33614917 |
acc0608 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | BxPC-3 | Erlotinib | Impairing | 5.0 (High) | 33614917 |
acc0609 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Pancreas Cancer | PANC-1 | Erlotinib | Impairing | 5.0 (High) | 33614917 |
acc0610 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Pancreas Cancer | PANC-1 | Erlotinib | Impairing | 5.0 (High) | 33614917 |
acc0611 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | PANC-1 | Erlotinib | Impairing | 5.0 (High) | 33614917 |
acc0612 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Ovarian Cancer | A2780/DDP | DDP | Impairing | 5.0 (High) | 33794187 |
acc0613 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Ovarian Cancer | COC1/DDP | DDP | Impairing | 5.0 (High) | 33794187 |
acc0632 | ATR | Q13535 | ATR | phosphorylation | Ser/Thr | human | Gastric Cancer | SUN638 | Olaparib | Impairing | 5.0 (High) | 34969765 |
acc0633 | MAPK | P28482 | MAPK1 | phosphorylation | Thr180 | human | Gastric Cancer | SUN638 | Olaparib | Impairing | 5.0 (High) | 34969765 |
acc0634 | MAPK | P28482 | MAPK1 | phosphorylation | Tyr182 | human | Gastric Cancer | SUN638 | Olaparib | Impairing | 5.0 (High) | 34969765 |
acc0635 | Rock2 | O75116 | ROCK2 | phosphorylation | Ser1366 | human | Renal Cancer | 786-O | Sunitinib | Impairing | 5.0 (High) | 34974812 |
acc0636 | Rock2 | O75116 | ROCK2 | phosphorylation | Ser1366 | human | Renal Cancer | ACHN | Sunitinib | Impairing | 5.0 (High) | 34974812 |
acc0637 | Rock2 | O75116 | ROCK2 | phosphorylation | Ser1366 | human | Renal Cancer | 786-O | Everolimus | Impairing | 5.0 (High) | 34974812 |
acc0638 | Rock2 | O75116 | ROCK2 | phosphorylation | Ser1366 | human | Renal Cancer | ACHN | Everolimus | Impairing | 5.0 (High) | 34974812 |
acc0639 | JNK | P45983 | MAPK8 | phosphorylation | unclear | human | Ovarian Cancer | A2780/DDP | Cisplatin | Enhancing | 5.0 (High) | 35179434 |
acc0640 | NT5C2 | P49902 | NT5C2 | phosphorylation | Ser502 | human | Leukemia | Jurkat | 6-MP | Impairing | 5.0 (High) | 35984649 |
acc0649 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Pancreas Cancer | Paca44 | Gemcitabine | Impairing | 5.0 (High) | 24953430 |
acc0669 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Colorectal Cancer | HT29 | FTD | Impairing | 5.0 (High) | 36734271 |
acc0670 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Colorectal Cancer | HT116 | FTD | Impairing | 5.0 (High) | 36734271 |
acc0674 | YAP | P46937 | YAP1 | phosphorylation | Ser127 | human | Ovarian Cancer | A2780 | Cisplatin | Impairing | 5.0 (High) | 37828220 |
acc0675 | YAP | P46937 | YAP1 | phosphorylation | Ser127 | human | Ovarian Cancer | ES-2 | Cisplatin | Impairing | 5.0 (High) | 37828220 |
acc0676 | RUNX1 | Q01196 | RUNX1 | phosphorylation | Ser94 | human | Leukemia | Imatinib | Enhancing | 5.0 (High) | 37903788 | |
acc0677 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Leukemia | Imatinib | Impairing | 5.0 (High) | 37903788 | |
acc0691 | KRAS | P01116 | KRAS | prenylation | Cys186 | human | Colorectal Cancer | LoVo | L-OHP | Impairing | 5.0 (High) | 37069612 |
acc0692 | KRAS | P01116 | KRAS | prenylation | Cys186 | human | Colorectal Cancer | Colon-26 | L-OHP | Impairing | 5.0 (High) | 37069612 |
acc0693 | GLI2 | P10070 | GLI2 | ubiquitination | unclear | human | Myeloma | MM.1S | Bortezomib | Enhancing | 5.0 (High) | 34546340 |
acc0694 | GLI2 | P10070 | GLI2 | ubiquitination | unclear | human | Myeloma | OPM-2 | Bortezomib | Enhancing | 5.0 (High) | 34546340 |
acc0695 | EGFR | P00533 | EGFR | ubiquitination | unclear | human | Colorectal Cancer | DiFi5 | Cetuximab | Impairing | 5.0 (High) | 17804738 |
acc0696 | EGFR | P00533 | EGFR | phosphorylation | Tyr845 | human | Colorectal Cancer | DiFi5 | Cetuximab | Impairing | 5.0 (High) | 17804738 |
acc0697 | FOXM1 | Q08050 | FOXM1 | ubiquitination | unclear | human | Pancreas Cancer | BxPC-3 | Gemcitabine | Enhancing | 5.0 (High) | 31598398 |
acc0698 | FOXM1 | Q08050 | FOXM1 | ubiquitination | unclear | human | Pancreas Cancer | SW1990 | Gemcitabine | Enhancing | 5.0 (High) | 31598398 |
acc0701 | SIRT7 | Q9NRC8 | SIRT7 | ubiquitination | unclear | human | Hepatocellular Carcinoma | Hep3B | Sorafenib | Enhancing | 5.0 (High) | 37187452 |
acc0702 | SIRT7 | Q9NRC8 | SIRT7 | ubiquitination | unclear | human | Hepatocellular Carcinoma | SNU-449 | Sorafenib | Enhancing | 5.0 (High) | 37187452 |
acc0706 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr37 | human | Lung Cancer | NCI-H196 | Olaparib | Impairing | 5.0 (High) | 30201826 |
acc0707 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr37 | human | Glioblastoma | SNB-75 | Olaparib | Impairing | 5.0 (High) | 30201826 |
acc0708 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr37 | human | Glioblastoma | SF-539 | Olaparib | Impairing | 5.0 (High) | 30201826 |
acc0709 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr37 | human | Glioblastoma | U87-MG | Olaparib | Impairing | 5.0 (High) | 30201826 |
acc0710 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr46 | human | Lung Cancer | NCI-H196 | Olaparib | Impairing | 5.0 (High) | 30201826 |
acc0711 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr46 | human | Glioblastoma | SNB-75 | Olaparib | Impairing | 5.0 (High) | 30201826 |
acc0712 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr46 | human | Glioblastoma | SF-539 | Olaparib | Impairing | 5.0 (High) | 30201826 |
acc0713 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr46 | human | Glioblastoma | U87-MG | Olaparib | Impairing | 5.0 (High) | 30201826 |
acc0725 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | HCT116 | 5-FU | Enhancing | 5.0 (High) | 28139498 |
acc0726 | HSP90 | P07900 | HSP90AA1 | acetylation | lys | human | Breast Cancer | SK-BR-3 | Trastuzumab | Enhancing | 5.0 (High) | 21082217 |
acc0727 | alpha-tubulin | P68363 | TUBA1B | acetylation | lys | human | Breast Cancer | SK-BR-3 | Geldanamycin | Enhancing | 5.0 (High) | 21082217 |
acc0736 | GD3 | Q92185 | ST8SIA1 | acetylation | unclear | human | Medulloblastoma | RES256 | Etoposide | Impairing | 5.0 (High) | 31197190 |
acc0740 | 6PGD | P52209 | PGD | methylation | Arg324 | human | Lung Cancer | Cisplatin | Impairing | 5.0 (High) | 36815049 | |
acc0741 | ENO1 | P06733 | ENO1 | methylation | Arg9 | human | Lung Cancer | Cisplatin | Impairing | 5.0 (High) | 36815049 | |
acc0742 | ENO1 | P06733 | ENO1 | methylation | Arg372 | human | Lung Cancer | Cisplatin | Impairing | 5.0 (High) | 36815049 | |
acc0745 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Cholangiocarcinoma | QBC939 | 5-FU | Enhancing | 5.0 (High) | 25933112 |
acc0746 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Cholangiocarcinoma | QBC939 | 5-FU | Enhancing | 5.0 (High) | 25933112 |
acc0747 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Cholangiocarcinoma | QBC939 | 5-FU | Enhancing | 5.0 (High) | 25933112 |
acc0748 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Cholangiocarcinoma | SK-ChA-1 | 5-FU | Enhancing | 5.0 (High) | 25933112 |
acc0749 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Cholangiocarcinoma | SK-ChA-1 | 5-FU | Enhancing | 5.0 (High) | 25933112 |
acc0750 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Cholangiocarcinoma | SK-ChA-1 | 5-FU | Enhancing | 5.0 (High) | 25933112 |
acc0751 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Cholangiocarcinoma | MZ-ChA-1 | 5-FU | Enhancing | 5.0 (High) | 25933112 |
acc0752 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Cholangiocarcinoma | MZ-ChA-1 | 5-FU | Enhancing | 5.0 (High) | 25933112 |
acc0753 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Cholangiocarcinoma | MZ-ChA-1 | 5-FU | Enhancing | 5.0 (High) | 25933112 |
acc0804 | HER2 | P04626 | ERBB2 | phosphorylation | Tyr1221 | human | Breast Cancer | BT474c | AZD5363 | Impairing | 5.0 (High) | 26095475 |
acc0805 | HER2 | P04626 | ERBB2 | phosphorylation | Tyr1221 | human | Breast Cancer | HCC1954 | AZD5363 | Impairing | 5.0 (High) | 26095475 |
acc0806 | HER2 | P04626 | ERBB2 | phosphorylation | Tyr1222 | human | Breast Cancer | BT474c | AZD5363 | Impairing | 5.0 (High) | 26095475 |
acc0807 | HER2 | P04626 | ERBB2 | phosphorylation | Tyr1222 | human | Breast Cancer | HCC1954 | AZD5363 | Impairing | 5.0 (High) | 26095475 |
acc0808 | HER3 | P21860 | ERBB3 | phosphorylation | Tyr1289 | human | Breast Cancer | BT474c | AZD5363 | Impairing | 5.0 (High) | 26095475 |
acc0809 | HER3 | P21860 | ERBB3 | phosphorylation | Tyr1289 | human | Breast Cancer | HCC1954 | AZD5363 | Impairing | 5.0 (High) | 26095475 |
acc0825 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Melanoma | A375 | Trametinib | Impairing | 5.0 (High) | 29296217 |
acc0826 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | COLO205 | Trametinib | Impairing | 5.0 (High) | 29296217 |
acc0827 | S6 | P62753 | RPS6 | phosphorylation | Thr389 | human | Colorectal Cancer | COLO205 | Trametinib | Impairing | 5.0 (High) | 29296217 |
acc0828 | S6 | P62753 | RPS6 | phosphorylation | Thr389 | human | Melanoma | A375 | Trametinib | Impairing | 5.0 (High) | 29296217 |
acc0829 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Melanoma | A375 | Dabrafenib | Impairing | 5.0 (High) | 29296217 |
acc0830 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | COLO205 | Dabrafenib | Impairing | 5.0 (High) | 29296217 |
acc0831 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Melanoma | A375 | Dabrafenib | Impairing | 5.0 (High) | 29296217 |
acc0832 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Melanoma | A375 | Dabrafenib | Impairing | 5.0 (High) | 29296217 |
acc0833 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Melanoma | A375 | Dabrafenib | Impairing | 5.0 (High) | 29296217 |
acc0834 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Melanoma | A375 | Dabrafenib | Impairing | 5.0 (High) | 29296217 |
acc0835 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Colorectal Cancer | COLO205 | Dabrafenib | Impairing | 5.0 (High) | 29296217 |
acc0836 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Colorectal Cancer | COLO205 | Dabrafenib | Impairing | 5.0 (High) | 29296217 |
acc0837 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Melanoma | A375 | Trametinib | Impairing | 5.0 (High) | 29296217 |
acc0838 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Colorectal Cancer | COLO205 | Dabrafenib | Impairing | 5.0 (High) | 29296217 |
acc0839 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Colorectal Cancer | COLO205 | Dabrafenib | Impairing | 5.0 (High) | 29296217 |
acc0840 | S6 | P62753 | RPS6 | phosphorylation | Thr389 | human | Colorectal Cancer | COLO205 | Dabrafenib | Impairing | 5.0 (High) | 29296217 |
acc0841 | S6 | P62753 | RPS6 | phosphorylation | Thr389 | human | Melanoma | A375 | Dabrafenib | Impairing | 5.0 (High) | 29296217 |
acc1342 | claudin-7 | P56704 | CLDN7 | phosphorylation | Ser204 | human | Lung Cancer | H522 | Cisplatin | Enhancing | 5.0 (High) | 23433123 |
acc1352 | ATF-2 | P16951 | Atf2 | phosphorylation | Thr71 | mouse | Melanoma | B16 | Taxol | Impairing | 5.0 (High) | 18269766 |
acc1358 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | HCC1954 | SAIT301 | Impairing | 5.0 (High) | 24662823 |
acc1366 | p38MAPK | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Glioblastoma | T98G | SB203581 | Impairing | 5.0 (High) | 37185746 |
acc1367 | p38MAPK | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Glioblastoma | T98G | SB203581 | Impairing | 5.0 (High) | 37185746 |
acc1392 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Hepatocellular Carcinoma | Bel7404 | Oxaliplatin | Impairing | 5.0 (High) | 23279642 |
acc1411 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Lung Cancer | NCI-H82 | Cisplatin | Impairing | 5.0 (High) | 15210690 |
acc1433 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Leukemia | DA1-3b/d365 | Imatinib | Impairing | 5.0 (High) | 21804606 |
acc1434 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Leukemia | DA1-3b/M1 | Imatinib | Impairing | 5.0 (High) | 21804606 |
acc1435 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Leukemia | DA1-3b/M2 | Imatinib | Impairing | 5.0 (High) | 21804606 |
acc1436 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Leukemia | DA1-3b/M2 | Staurosporine | Impairing | 5.0 (High) | 21804606 |
acc1437 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Leukemia | K562-r | Imatinib | Impairing | 5.0 (High) | 21804606 |
acc1439 | p70S6K | P23443 | RPS6KB1 | phosphorylation | Ser371 | human | Lung Cancer | Ku0063794 | Enhancing | 5.0 (High) | 23874880 | |
acc1448 | p53 | P04637 | TP53 | phosphorylation | Ser15 | human | Melanoma | A375 | TRAIL | Enhancing | 5.0 (High) | 25277183 |
acc1450 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Melanoma | A375 | TRAIL | Impairing | 5.0 (High) | 25277183 |
acc1530 | ASK-1 | Q99683 | MAP3K5 | phosphorylation | Thr845 | human | Glioma | U87 | Temozolomide | Enhancing | 5.0 (High) | 36951032 |
acc1531 | ASK-1 | Q99683 | MAP3K5 | phosphorylation | Thr845 | human | Glioma | U251 | Temozolomide | Enhancing | 5.0 (High) | 36951032 |
acc1536 | HSP27 | P04792 | HSPB1 | phosphorylation | Ser15 | human | Breast Cancer | JIMT-1 | TZMB | Impairing | 5.0 (High) | 32545363 |
acc1537 | HSP27 | P04792 | HSPB1 | phosphorylation | Ser78 | human | Breast Cancer | JIMT-1 | TZMB | Impairing | 5.0 (High) | 32545363 |
acc1559 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Esophageal Cancer | ESO26-PAC-r (paclitaxel-resistant) | Paclitaxel | Impairing | 5.0 (High) | 32579788 |
acc1560 | 70S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Esophageal Cancer | ESO26-PAC-r (paclitaxel-resistant) | Paclitaxel | Impairing | 5.0 (High) | 32579788 |
acc1561 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Esophageal Cancer | KYAE-1-PAC-r (paclitaxel-resistant) | Paclitaxel | Impairing | 5.0 (High) | 32579788 |
acc1562 | 70S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Esophageal Cancer | KYAE-1-PAC-r (paclitaxel-resistant) | Paclitaxel | Impairing | 5.0 (High) | 32579788 |
acc1569 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | MDA-MB-231 | Paclitaxel | Impairing | 5.0 (High) | 21518725 |
acc1570 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | MDA-MB-435 | Paclitaxel | Impairing | 5.0 (High) | 21518725 |
acc1571 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Breast Cancer | MDA-MB-231 | Paclitaxel | Impairing | 5.0 (High) | 21518725 |
acc1572 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Breast Cancer | MDA-MB-435 | Paclitaxel | Impairing | 5.0 (High) | 21518725 |
acc1573 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Breast Cancer | MDA-MB-231 | Paclitaxel | Impairing | 5.0 (High) | 21518725 |
acc1574 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Breast Cancer | MDA-MB-435 | Paclitaxel | Impairing | 5.0 (High) | 21518725 |
acc1578 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Esophageal Cancer | Cisplatin | Impairing | 5.0 (High) | 36525138 | |
acc0306 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | PC9 | Erlotinib | Impairing | 5.0 (High) | 23319394 |
acc0307 | p70S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Lung Cancer | PC9 | Erlotinib | Impairing | 5.0 (High) | 23319394 |
acc0308 | S6RP | P62753 | RPS6 | phosphorylation | Ser235 | human | Lung Cancer | PC9 | Erlotinib | Impairing | 5.0 (High) | 23319394 |
acc0309 | S6RP | P62753 | RPS6 | phosphorylation | Ser236 | human | Lung Cancer | PC9 | Erlotinib | Impairing | 5.0 (High) | 23319394 |
acc0340 | GSK3b | P49841 | GSK3B | phosphorylation | Ser9 | human | Hepatocellular Carcinoma | HepG2 | Sorafenib | Enhancing | 5.0 (High) | 24113128 |
acc0341 | GSK3b | P49841 | GSK3B | phosphorylation | Ser9 | human | Hepatocellular Carcinoma | HuH-7 | Sorafenib | Enhancing | 5.0 (High) | 24113128 |
acc0351 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Renal Cancer | 786-O | NVP-BEZ235 | Impairing | 5.0 (High) | 24448243 |
acc0352 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Renal Cancer | UOK101 | NVP-BEZ235 | Impairing | 5.0 (High) | 24448243 |
acc0353 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Renal Cancer | RCC4 | NVP-BEZ235 | Impairing | 5.0 (High) | 24448243 |
acc0388 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | SK-OV-3 | Bevacizumab | Impairing | 5.0 (High) | 25319392 |
acc0389 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | GOC2 | Bevacizumab | Impairing | 5.0 (High) | 25319392 |
acc0390 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | GOC-A2 | Bevacizumab | Impairing | 5.0 (High) | 25319392 |
acc0391 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | OVCAR-3 | Bevacizumab | Impairing | 5.0 (High) | 25319392 |
acc0392 | HSP27 | P04792 | HSPB1 | phosphorylation | Ser78 | human | Colorectal Cancer | HCT116 | 5-fluorouracil | Impairing | 5.0 (High) | 25364415 |
acc0393 | HSP27 | P04792 | HSPB1 | phosphorylation | Ser78 | human | Colorectal Cancer | HCT15 | 5-fluorouracil | Impairing | 5.0 (High) | 25364415 |
acc0394 | HSP27 | P04792 | HSPB1 | phosphorylation | Ser78 | human | Colorectal Cancer | HT29 | 5-fluorouracil | Impairing | 5.0 (High) | 25364415 |
acc0397 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Endometrial Cancer | Ishikawa | Cisplatin | Enhancing | 5.0 (High) | 25375375 |
acc0398 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Hepatocellular Carcinoma | HepG2 | Cisplatin | Enhancing | 5.0 (High) | 25375375 |
acc0399 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Ovarian Cancer | TOV112D | Cisplatin | Enhancing | 5.0 (High) | 25375375 |
acc0400 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Ovarian Cancer | TOV21G | Cisplatin | Enhancing | 5.0 (High) | 25375375 |
acc0401 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Endometrial Cancer | Ishikawa | Cisplatin | Enhancing | 5.0 (High) | 25375375 |
acc0402 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Hepatocellular Carcinoma | HepG2 | Cisplatin | Enhancing | 5.0 (High) | 25375375 |
acc0409 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Ovarian Cancer | TOV112D | Cisplatin | Enhancing | 5.0 (High) | 25375375 |
acc0410 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Ovarian Cancer | TOV21G | Cisplatin | Enhancing | 5.0 (High) | 25375375 |
acc0411 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Gastric Cancer | SGC7901 | Cetuximab | Impairing | 5.0 (High) | 25625229 |
acc0412 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Gastric Cancer | MGC803 | Cetuximab | Impairing | 5.0 (High) | 25625229 |
acc0413 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1131 | human | Gastric Cancer | SGC7901 | Cetuximab | Impairing | 5.0 (High) | 25625229 |
acc0414 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1131 | human | Gastric Cancer | MGC803 | Cetuximab | Impairing | 5.0 (High) | 25625229 |
acc0415 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | SGC7901 | Cetuximab | Impairing | 5.0 (High) | 25625229 |
acc0416 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | MGC803 | Cetuximab | Impairing | 5.0 (High) | 25625229 |
acc0417 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1131 | human | Gastric Cancer | SGC7901 | Cetuximab | Impairing | 5.0 (High) | 25625229 |
acc0418 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1131 | human | Gastric Cancer | MGC803 | Cetuximab | Impairing | 5.0 (High) | 25625229 |
acc0419 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Pancreas Cancer | SW1990 | Gemcitabine | Enhancing | 5.0 (High) | 30782607 |
acc0420 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Prostate Cancer | BxPC3 | Gemcitabine | Enhancing | 5.0 (High) | 30782607 |
acc0421 | MEK | Q02750 | MAP2K1 | phosphorylation | Ser217 | human | Ovarian Cancer | MCAS | Navitoclax | Enhancing | 5.0 (High) | 25968887 |
acc0422 | MEK | Q02750 | MAP2K1 | phosphorylation | Ser217 | human | Ovarian Cancer | OVCAR8 | Navitoclax | Enhancing | 5.0 (High) | 25968887 |
acc0423 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Ovarian Cancer | MCAS | Trametinib | Enhancing | 5.0 (High) | 25968887 |
acc0424 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Ovarian Cancer | MCAS | Trametinib | Enhancing | 5.0 (High) | 25968887 |
acc0425 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Ovarian Cancer | MCAS | Trametinib | Enhancing | 5.0 (High) | 25968887 |
acc0426 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Ovarian Cancer | MCAS | Trametinib | Enhancing | 5.0 (High) | 25968887 |
acc0427 | MEK | Q02750 | MAP2K1 | phosphorylation | Ser221 | human | Ovarian Cancer | MCAS | Navitoclax | Enhancing | 5.0 (High) | 25968887 |
acc0428 | MEK | Q02750 | MAP2K1 | phosphorylation | Ser221 | human | Ovarian Cancer | OVCAR8 | Navitoclax | Enhancing | 5.0 (High) | 25968887 |
acc0429 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Ovarian Cancer | MCAS | Navitoclax | Enhancing | 5.0 (High) | 25968887 |
acc0430 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Ovarian Cancer | MCAS | Navitoclax | Enhancing | 5.0 (High) | 25968887 |
acc0431 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Ovarian Cancer | MCAS | Navitoclax | Enhancing | 5.0 (High) | 25968887 |
acc0432 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Ovarian Cancer | MCAS | Navitoclax | Enhancing | 5.0 (High) | 25968887 |
acc0433 | MEK | Q02750 | MAP2K1 | phosphorylation | Ser217 | human | Ovarian Cancer | MCAS | Trametinib | Enhancing | 5.0 (High) | 25968887 |
acc0434 | MEK | Q02750 | MAP2K1 | phosphorylation | Ser221 | human | Ovarian Cancer | MCAS | Trametinib | Enhancing | 5.0 (High) | 25968887 |
acc0449 | Smad3 | P84022 | SMAD3 | phosphorylation | Ser423 | human | Hepatocellular Carcinoma | HCC | Sorafenib | Enhancing | 5.0 (High) | 26666823 |
acc0450 | Smad3 | P84022 | SMAD3 | phosphorylation | Ser425 | human | Hepatocellular Carcinoma | HCC | Sorafenib | Enhancing | 5.0 (High) | 26666823 |
acc0451 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Esophageal Cancer | EC9706 | Rapamycin | Impairing | 5.0 (High) | 26725440 |
acc0467 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Leukemia | Fludarabine | Enhancing | 5.0 (High) | 18182577 | |
acc0468 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Leukemia | Fludarabine | Enhancing | 5.0 (High) | 18182577 | |
acc0469 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Leukemia | Rituximab | Enhancing | 5.0 (High) | 18182577 | |
acc0470 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Leukemia | Rituximab | Enhancing | 5.0 (High) | 18182577 | |
acc0471 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | AGS | Cisplatin | Impairing | 5.0 (High) | 26998277 |
acc0472 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | AGS | Cisplatin | Impairing | 5.0 (High) | 26998277 |
acc0473 | YB1 | P46937 | YAP1 | phosphorylation | Ser102 | human | Gastric Cancer | MGC803 | Cisplatin | Impairing | 5.0 (High) | 27013200 |
acc0474 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Lung Cancer | A549 | RAD001 | Impairing | 5.0 (High) | 27050281 |
acc0475 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Lung Cancer | H157 | RAD001 | Impairing | 5.0 (High) | 27050281 |
acc0488 | FAK | Q05397 | PTK2 | phosphorylation | Tyr397 | human | Hepatocellular Carcinoma | HepG2 | Cabozantinib | Impairing | 5.0 (High) | 27638856 |
acc0489 | FAK | Q05397 | PTK2 | phosphorylation | Tyr397 | human | Hepatocellular Carcinoma | Bel-7402 | Cabozantinib | Impairing | 5.0 (High) | 27638856 |
acc0494 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Hepatocellular Carcinoma | HepG2 | Cisplatin | Impairing | 5.0 (High) | 27662474 |
acc0495 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Hepatocellular Carcinoma | HCC-EC | Cisplatin | Impairing | 5.0 (High) | 27662474 |
acc0503 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | KLM1-R | Gemcitabine | Impairing | 5.0 (High) | 28000865 |
acc0504 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | PK59 | Gemcitabine | Impairing | 5.0 (High) | 28000865 |
acc0505 | STAT1 | P42224 | STAT1 | phosphorylation | Ser727 | human | Ovarian Cancer | TOV112D | Bortezomib | Impairing | 5.0 (High) | 23449448 |
acc0506 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Ovarian Cancer | TOV112D | Bortezomib | Impairing | 5.0 (High) | 23449448 |
acc0507 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | SK-OV-3 | Cisplatin | Impairing | 5.0 (High) | 28685895 |
acc0508 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | A2780 | Cisplatin | Impairing | 5.0 (High) | 28685895 |
acc0510 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Pancreas Cancer | MIA PaCa-2 | Gemcitabine | Impairing | 5.0 (High) | 29048622 |
acc0516 | STAT1 | P42224 | STAT1 | ubiquitination | Tyr701 | human | Colorectal Cancer | HCT-8-7T | Alisertib | Impairing | 5.0 (High) | 34522170 |
acc0517 | STAT1 | P42224 | STAT1 | ubiquitination | Tyr701 | human | Colorectal Cancer | HCT-8-9T | Alisertib | Impairing | 5.0 (High) | 34522170 |
acc0546 | CREB | P16220 | CREB1 | phosphorylation | Ser133 | human | Ovarian Cancer | OVCAR-3 | Roflumilast | Enhancing | 5.0 (High) | 30069985 |
acc0547 | CREB | P16220 | CREB1 | phosphorylation | Ser133 | human | Ovarian Cancer | SK-OV-3 | Roflumilast | Enhancing | 5.0 (High) | 30069985 |
acc0548 | MAP4 | P27816 | MAP4 | phosphorylation | Ser696 | human | Ovarian Cancer | HeyA8 | Paclitaxel | Impairing | 5.0 (High) | 30084832 |
acc0549 | MAP4 | P27816 | MAP4 | phosphorylation | Ser696 | human | Ovarian Cancer | OVCAR5 | Paclitaxel | Impairing | 5.0 (High) | 30084832 |
acc0550 | FAK | Q05397 | PTK2 | phosphorylation | Tyr397 | human | Gastric Cancer | GIST882 | Imatinib | Impairing | 5.0 (High) | 30149002 |
acc0556 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Ovarian Cancer | A2780cp70 | Cisplatin | Impairing | 5.0 (High) | 18587580 |
acc0557 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Ovarian Cancer | A2780cp70 | Cisplatin | Impairing | 5.0 (High) | 18587580 |
acc0559 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Ovarian Cancer | OVCAR8-TR | CDDO-Me | Impairing | 5.0 (High) | 18587580 |
acc0560 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | OVCAR8-TR | Paclitaxel | Impairing | 5.0 (High) | 18587580 |
acc0561 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Ovarian Cancer | OVCAR8-TR | Paclitaxel | Impairing | 5.0 (High) | 18587580 |
acc0562 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Ovarian Cancer | OVCAR8-TR | Paclitaxel | Impairing | 5.0 (High) | 18587580 |
acc0563 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Ovarian Cancer | OVCAR8-TR | Paclitaxel | Impairing | 5.0 (High) | 18587580 |
acc0564 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | A2780cp70 | Cisplatin | Impairing | 5.0 (High) | 18587580 |
acc0565 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Ovarian Cancer | A2780cp70 | Cisplatin | Impairing | 5.0 (High) | 18587580 |
acc0575 | EGFR | P00533 | EGFR | phosphorylation | Thr654 | human | Skin Cancer | A431 | Erlotinib | Enhancing | 5.0 (High) | 31869496 |
acc0576 | EGFR | P00533 | EGFR | phosphorylation | Thr654 | human | Skin Cancer | A431 | Gefitinib | Enhancing | 5.0 (High) | 31869496 |
acc1084 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Leukemia | CML-iPSCs | Imatinib | Impairing | 5.0 (High) | 22592606 |
acc1085 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Leukemia | CML-iPSCs | Imatinib | Impairing | 5.0 (High) | 22592606 |
acc1090 | c-FLIP | O15519 | CFLAR | phosphorylation | unclear | human | Glioblastoma | LN-Z2308 | CH-11 | Impairing | 5.0 (High) | 17973862 |
acc1091 | c-FLIP | O15519 | CFLAR | phosphorylation | unclear | human | Glioblastoma | U138 | CH-11 | Impairing | 5.0 (High) | 17973862 |
acc1092 | c-FLIP | O15519 | CFLAR | phosphorylation | unclear | human | Melanoma | WM278 | CH-11 | Impairing | 5.0 (High) | 17973862 |
acc1093 | c-FLIP | O15519 | CFLAR | phosphorylation | unclear | human | Melanoma | WM35 | CH-11 | Impairing | 5.0 (High) | 17973862 |
acc1095 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Breast Cancer | BT474 | Lapatinib | Impairing | 5.0 (High) | 25590338 |
acc1096 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Breast Cancer | BT474 | Lapatinib | Impairing | 5.0 (High) | 28744398 |
acc1097 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Breast Cancer | BT474 | Lapatinib | Impairing | 5.0 (High) | 28744398 |
acc1098 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Breast Cancer | BT474 | Lapatinib | Impairing | 5.0 (High) | 28744398 |
acc1099 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Breast Cancer | BT474 | Lapatinib | Impairing | 5.0 (High) | 28744398 |
acc1100 | c-Myc | P01106 | MYC | phosphorylation | Ser62 | human | Breast Cancer | BT474 | Lapatinib | Impairing | 5.0 (High) | 28744398 |
acc1130 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | MKN45 | 5-aza | Impairing | 5.0 (High) | 18622747 |
acc1131 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | SGC7901 | 5-aza | Impairing | 5.0 (High) | 18622747 |
acc1132 | p70S6K | P23443 | RPS6KB1 | phosphorylation | Thr421 | human | Gastric Cancer | MKN45 | 5-aza | Impairing | 5.0 (High) | 18622747 |
acc1133 | p70S6K | P23443 | RPS6KB1 | phosphorylation | Thr421 | human | Gastric Cancer | SGC7901 | 5-aza | Impairing | 5.0 (High) | 18622747 |
acc1134 | p70S6K | P23443 | RPS6KB1 | phosphorylation | Ser424 | human | Gastric Cancer | MKN45 | 5-aza | Impairing | 5.0 (High) | 18622747 |
acc1135 | p70S6K | P23443 | RPS6KB1 | phosphorylation | Ser424 | human | Gastric Cancer | SGC7901 | 5-aza | Impairing | 5.0 (High) | 18622747 |
acc1136 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr70 | human | Gastric Cancer | MKN45 | 5-aza | Impairing | 5.0 (High) | 18622747 |
acc1137 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr70 | human | Gastric Cancer | SGC7901 | 5-aza | Impairing | 5.0 (High) | 18622747 |
acc1145 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Ovarian Cancer | HEY | Paclitaxel | Impairing | 5.0 (High) | 12181443 |
acc1146 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | HEY | Paclitaxel | Impairing | 5.0 (High) | 12181443 |
acc1152 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Melanoma | M-14 | Mebendazole | Enhancing | 5.0 (High) | 18667591 |
acc1153 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Melanoma | SK-Mel-19 | Mebendazole | Enhancing | 5.0 (High) | 18667591 |
acc1161 | HER2 | P04626 | ERBB2 | phosphorylation | Tyr1248 | human | Breast Cancer | MCF7 | Tamoxifen | Impairing | 5.0 (High) | 26581908 |
acc1162 | HER3 | P21860 | ERBB3 | phosphorylation | Tyr1289 | human | Breast Cancer | MCF7 | Tamoxifen | Impairing | 5.0 (High) | 26581908 |
acc1163 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MCF7 | Tamoxifen | Impairing | 5.0 (High) | 26581908 |
acc1168 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Pancreas Cancer | BxPC-3 | Gemcitabine | Impairing | 5.0 (High) | 28602977 |
acc1169 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Pancreas Cancer | T3M4 | Gemcitabine | Impairing | 5.0 (High) | 28602977 |
acc1170 | AXL | P30530 | AXL | phosphorylation | Tyr779 | human | Leukemia | K562 | TP-0903 | Impairing | 5.0 (High) | 32460059 |
acc1171 | AXL | P30530 | AXL | phosphorylation | Tyr779 | human | Leukemia | OCI/AML3 | TP-0903 | Impairing | 5.0 (High) | 32460059 |
acc1172 | AXL | P30530 | AXL | phosphorylation | Tyr779 | human | Leukemia | OCI/AML3 | Doxorubicin | Impairing | 5.0 (High) | 32460059 |
acc1173 | AXL | P30530 | AXL | phosphorylation | Tyr779 | human | Leukemia | THP-1 | Doxorubicin | Impairing | 5.0 (High) | 32460059 |
acc1174 | AXL | P30530 | AXL | phosphorylation | Tyr779 | human | Leukemia | OCI/AML2 | Doxorubicin | Impairing | 5.0 (High) | 32460059 |
acc1175 | AXL | P30530 | AXL | phosphorylation | Tyr779 | human | Leukemia | K562 | Doxorubicin | Impairing | 5.0 (High) | 32460059 |
acc1176 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | NCI-H460 | Docetaxel | Impairing | 5.0 (High) | 20571069 |
acc1177 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | A2780 | Doxorubicin | Impairing | 5.0 (High) | 20571069 |
acc1178 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | NCI-H460 | Carboplatin | Impairing | 5.0 (High) | 20571069 |
acc1179 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | A2780 | Gemcitabine | Impairing | 5.0 (High) | 20571069 |
acc1182 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Breast Cancer | MCF7 | Temozolomide | Impairing | 5.0 (High) | 21730979 |
acc1183 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Breast Cancer | MCF7 | Cisplatin | Impairing | 5.0 (High) | 21730979 |
acc1184 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Breast Cancer | MCF7 | Camptothecin | Impairing | 5.0 (High) | 21730979 |
acc1185 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Breast Cancer | MCF7 | Doxorubicin | Impairing | 5.0 (High) | 21730979 |
acc1186 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Breast Cancer | MCF7 | Hydroxyurea | Impairing | 5.0 (High) | 21730979 |
acc1210 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Ovarian Cancer | HeLa | Paclitaxel | Enhancing | 5.0 (High) | 18306930 |
acc1211 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Gastric Cancer | SNU 638 | Paclitaxel | Enhancing | 5.0 (High) | 18306930 |
acc1212 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Gastric Cancer | SNU 668 | Paclitaxel | Enhancing | 5.0 (High) | 18306930 |
acc1247 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | HT29 | Paclitaxel | Impairing | 5.0 (High) | 21594648 |
acc1248 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | HCT15 | Paclitaxel | Impairing | 5.0 (High) | 21594648 |
acc1251 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | SK-BR-3 | Pelitinib | Impairing | 5.0 (High) | 21046231 |
acc1252 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | T47D | Pelitinib | Impairing | 5.0 (High) | 21046231 |
acc1253 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | SK-BR-3 | Canertinib | Impairing | 5.0 (High) | 21046231 |
acc1254 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | T47D | Canertinib | Impairing | 5.0 (High) | 21046231 |
acc1261 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H157 | Trastuzumab | Impairing | 5.0 (High) | 11358816 |
acc1262 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H157 | Gemcitabine | Impairing | 5.0 (High) | 11358816 |
acc1263 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H1155 | Etoposide | Impairing | 5.0 (High) | 11358816 |
acc1264 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H1155 | CDDP | Impairing | 5.0 (High) | 11358816 |
acc1265 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H1155 | Paclitaxel | Impairing | 5.0 (High) | 11358816 |
acc1266 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H1155 | Trastuzumab | Impairing | 5.0 (High) | 11358816 |
acc1267 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H1155 | Gemcitabine | Impairing | 5.0 (High) | 11358816 |
acc1270 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H1703 | Etoposide | Impairing | 5.0 (High) | 11358816 |
acc1271 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H1703 | Etoposide | Impairing | 5.0 (High) | 11358816 |
acc1272 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H1703 | CDDP | Impairing | 5.0 (High) | 11358816 |
acc1273 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H1703 | Paclitaxel | Impairing | 5.0 (High) | 11358816 |
acc1274 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H1703 | Trastuzumab | Impairing | 5.0 (High) | 11358816 |
acc1275 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H1703 | Gemcitabine | Impairing | 5.0 (High) | 11358816 |
acc1276 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H157 | Etoposide | Impairing | 5.0 (High) | 11358816 |
acc1277 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H157 | CDDP | Impairing | 5.0 (High) | 11358816 |
acc1278 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H157 | Paclitaxel | Impairing | 5.0 (High) | 11358816 |
acc1279 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H157 | Trastuzumab | Impairing | 5.0 (High) | 11358816 |
acc1280 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H157 | Gemcitabine | Impairing | 5.0 (High) | 11358816 |
acc1281 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H1155 | Etoposide | Impairing | 5.0 (High) | 11358816 |
acc1282 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H1703 | CDDP | Impairing | 5.0 (High) | 11358816 |
acc1283 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H1155 | CDDP | Impairing | 5.0 (High) | 11358816 |
acc1284 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H1155 | Paclitaxel | Impairing | 5.0 (High) | 11358816 |
acc1285 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H1155 | Trastuzumab | Impairing | 5.0 (High) | 11358816 |
acc1286 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H1155 | Gemcitabine | Impairing | 5.0 (High) | 11358816 |
acc1287 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H1703 | Paclitaxel | Impairing | 5.0 (High) | 11358816 |
acc1288 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H1703 | Trastuzumab | Impairing | 5.0 (High) | 11358816 |
acc1289 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H1703 | Gemcitabine | Impairing | 5.0 (High) | 11358816 |
acc1290 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H157 | Etoposide | Impairing | 5.0 (High) | 11358816 |
acc1291 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H157 | CDDP | Impairing | 5.0 (High) | 11358816 |
acc1292 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H157 | Paclitaxel | Impairing | 5.0 (High) | 11358816 |
acc1295 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Bladder Cancer | T24 | Gemcitabine | Impairing | 5.0 (High) | 33452459 |
acc1296 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Bladder Cancer | T24 | Gemcitabine | Impairing | 5.0 (High) | 33452459 |
acc1297 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Bladder Cancer | UM-UC-3 | Gemcitabine | Impairing | 5.0 (High) | 33452459 |
acc1298 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Bladder Cancer | UM-UC-3 | Gemcitabine | Impairing | 5.0 (High) | 33452459 |
acc1299 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Thyroid Cancer | LOXIMVI | AMG655 | Enhancing | 5.0 (High) | 25867065 |
acc1300 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Thyroid Cancer | LOXIMVI | AMG655 | Enhancing | 5.0 (High) | 25867065 |
acc1301 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Thyroid Cancer | TPC-1 | AMG655 | Enhancing | 5.0 (High) | 25867065 |
acc1302 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Thyroid Cancer | TPC-1 | AMG655 | Enhancing | 5.0 (High) | 25867065 |
acc1303 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Melanoma | LOXIMVI | TRAIL | Enhancing | 5.0 (High) | 25867065 |
acc1304 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Melanoma | LOXIMVI | TRAIL | Enhancing | 5.0 (High) | 25867065 |
acc1305 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Melanoma | LOXIMVI | TRAIL | Enhancing | 5.0 (High) | 25867065 |
acc1306 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Melanoma | LOXIMVI | TRAIL | Enhancing | 5.0 (High) | 25867065 |
acc1307 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Melanoma | A375 | TRAIL | Enhancing | 5.0 (High) | 25867065 |
acc1308 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Melanoma | A375 | TRAIL | Enhancing | 5.0 (High) | 25867065 |
acc1309 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Melanoma | A375 | TRAIL | Enhancing | 5.0 (High) | 25867065 |
acc1310 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Melanoma | A375 | TRAIL | Enhancing | 5.0 (High) | 25867065 |
acc1311 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Thyroid Cancer | LOXIMVI | AMG655 | Enhancing | 5.0 (High) | 25867065 |
acc1312 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Thyroid Cancer | LOXIMVI | AMG655 | Enhancing | 5.0 (High) | 25867065 |
acc1313 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Thyroid Cancer | BCPAP | AMG655 | Enhancing | 5.0 (High) | 25867065 |
acc1314 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Thyroid Cancer | BCPAP | AMG655 | Enhancing | 5.0 (High) | 25867065 |
acc1315 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Thyroid Cancer | BCPAP | AMG655 | Enhancing | 5.0 (High) | 25867065 |
acc1316 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Thyroid Cancer | BCPAP | AMG655 | Enhancing | 5.0 (High) | 25867065 |
acc1317 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Thyroid Cancer | TPC-1 | AMG655 | Enhancing | 5.0 (High) | 25867065 |
acc1318 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Thyroid Cancer | TPC-1 | AMG655 | Enhancing | 5.0 (High) | 25867065 |
acc1335 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Osteosarcoma | OS2 | Rapamycin | Impairing | 5.0 (High) | 20486173 |
acc1336 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Osteosarcoma | OS9 | Rapamycin | Impairing | 5.0 (High) | 20486173 |
acc1337 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Osteosarcoma | OS17 | Rapamycin | Impairing | 5.0 (High) | 20486173 |
acc3460 | eNOS | P70313 | Nos3 | phosphorylation | Thr497 | mouse | Cardiac Function | MT transgenic mice | DAHP | Impairing | 5.0 (High) | 19398661 |
acc3519 | H2AX | O96017 | CHEK2 | phosphorylation | Thr68 | human | Colorectal Cancer | HT-29 | Radiation | Impairing | 5.0 (High) | 20637980 |
acc3520 | H2AX | P16104 | H2AX | phosphorylation | Ser139 | human | Colorectal Cancer | HT-29 | Radiation | Impairing | 5.0 (High) | 20637980 |
acc3544 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Diabetes Mellitus | HL-1 | Insulin | Impairing | 5.0 (High) | 21270272 |
acc3545 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Diabetes Mellitus | HL-1 | Insulin | Impairing | 5.0 (High) | 21270272 |
acc3546 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Diabetes Mellitus | Insulin | Impairing | 5.0 (High) | 21270272 | |
acc3547 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Diabetes Mellitus | Insulin | Impairing | 5.0 (High) | 21270272 | |
acc3548 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Diabetes Mellitus | HL-1 | Insulin | Impairing | 5.0 (High) | 21270272 |
acc3549 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Diabetes Mellitus | HL-1 | Insulin | Impairing | 5.0 (High) | 21270272 |
acc3550 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Diabetes Mellitus | Insulin | Impairing | 5.0 (High) | 21270272 | |
acc3551 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Diabetes Mellitus | Insulin | Impairing | 5.0 (High) | 21270272 | |
acc3605 | MLC | Q15049 | MLC1 | phosphorylation | Thr18 | human | Barrier Dysfunction | HPAEC | 2-methoxyestradiol(2-ME) | Impairing | 5.0 (High) | 22074808 |
acc3606 | MLC | Q15049 | MLC1 | phosphorylation | Ser19 | human | Barrier Dysfunction | HPAEC | 2-methoxyestradiol(2-ME) | Impairing | 5.0 (High) | 22074808 |
acc3607 | MLC | Q8VHK5 | Mlc1 | phosphorylation | Thr18 | mouse | Barrier Dysfunction | HPAEC | 2-methoxyestradiol(2-ME) | Impairing | 5.0 (High) | 22074808 |
acc3608 | MLC | Q8VHK5 | Mlc1 | phosphorylation | Ser19 | mouse | Barrier Dysfunction | HPAEC | 2-methoxyestradiol(2-ME) | Impairing | 5.0 (High) | 22074808 |
acc3609 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Barrier Dysfunction | HPAEC | 2-methoxyestradiol(2-ME) | Impairing | 5.0 (High) | 22074808 |
acc3610 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Barrier Dysfunction | HPAEC | 2-methoxyestradiol(2-ME) | Impairing | 5.0 (High) | 22074808 |
acc3611 | p38 | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | Barrier Dysfunction | HPAEC | 2-methoxyestradiol(2-ME) | Impairing | 5.0 (High) | 22074808 |
acc3612 | p38 | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | Barrier Dysfunction | HPAEC | 2-methoxyestradiol(2-ME) | Impairing | 5.0 (High) | 22074808 |
acc3642 | DOR | P33533 | Oprd1 | phosphorylation | Thr161 | rat | Inflammatory | Morphine | Impairing | 5.0 (High) | 22466129 | |
acc2590 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Breast Cancer | 4T1 | Doxorubicin | Impairing | 5.0 (High) | 32035191 |
acc2591 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Breast Cancer | T47D | Lapatinib | Enhancing | 5.0 (High) | 32365111 |
acc2592 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Breast Cancer | MCF7 | Lapatinib | Enhancing | 5.0 (High) | 32365111 |
acc2593 | AMPK | Q13131 | PRKAA1 | phosphorylation | Thr183 | human | Lung Cancer | A549 | "cis,cis,trans-[Pt(NH3)2Cl2(BEZ)(OH)] (CB)" | Impairing | 5.0 (High) | 34388483 |
acc2594 | AMPK | P54646 | PRKAA2 | phosphorylation | Thr172 | human | Lung Cancer | A549 | "cis,cis,trans-[Pt(NH3)2Cl2(BEZ)2] (CP)" | Impairing | 5.0 (High) | 34388483 |
acc2596 | RNF4 | P78317 | RNF4 | methylation | Arg164 | human | Leukemia | As2O3 | Impairing | 5.0 (High) | 35622143 | |
acc2601 | PP2A | Q15257 | PTPA | methylation | unclear | human | Glioblastoma | U87-MG | Temozolomide | Enhancing | 5.0 (High) | 37500619 |
acc2603 | PP2A | Q15257 | PTPA | methylation | unclear | human | Glioblastoma | U251MG | Temozolomide | Enhancing | 5.0 (High) | 37500619 |
acc2612 | p53 | P04637 | TP53 | acetylation | Lys382 | human | Ovarian Cancer | IGROV-1 | ST1926 | Enhancing | 5.0 (High) | 19676051 |
acc2614 | ATM | Q13315 | ATM | phosphorylation | Ser1981 | human | Ovarian Cancer | IGROV-1 | ST1926 | Associated | 5.0 (High) | 19676051 |
acc2615 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Ovarian Cancer | IGROV-1 | ST1926 | Associated | 5.0 (High) | 19676051 |
acc2616 | Chk2 | O96017 | CHEK2 | phosphorylation | Thr68 | human | Ovarian Cancer | IGROV-1 | ST1926 | Associated | 5.0 (High) | 19676051 |
acc2619 | p53 | P04637 | TP53 | phosphorylation | Ser15 | human | Ovarian Cancer | IGROV-1 | ST1926 | Associated | 5.0 (High) | 19676051 |
acc2620 | RPA-2 | Q9H9Y6 | POLR1B | phosphorylation | unclear | human | Ovarian Cancer | IGROV-1 | ST1926 | Associated | 5.0 (High) | 19676051 |
acc2646 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Cancer | BCap37 | Paclitaxel | Enhancing | 5.0 (High) | 15269161 |
acc2647 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Cancer | KB | Paclitaxel | Enhancing | 5.0 (High) | 15269161 |
acc2648 | Cdc2 | P06493 | CDK1 | phosphorylation | Tyr15 | human | Cancer | BCap37 | Paclitaxel | Enhancing | 5.0 (High) | 15269161 |
acc2649 | Cdc2 | P06493 | CDK1 | phosphorylation | Tyr15 | human | Cancer | KB | Paclitaxel | Enhancing | 5.0 (High) | 15269161 |
acc2665 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Gastric Cancer | MKN-45 | CH-11 | Impairing | 5.0 (High) | 15767780 |
acc2671 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | A549 | Rapamycin | Impairing | 5.0 (High) | 16103051 |
acc2672 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H157 | Rapamycin | Impairing | 5.0 (High) | 16103051 |
acc2673 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H358 | Rapamycin | Impairing | 5.0 (High) | 16103051 |
acc2674 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H460 | Rapamycin | Impairing | 5.0 (High) | 16103051 |
acc2675 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Lung Cancer | A549 | Rapamycin | Impairing | 5.0 (High) | 16103051 |
acc2676 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Lung Cancer | H157 | Rapamycin | Impairing | 5.0 (High) | 16103051 |
acc2677 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Lung Cancer | H358 | Rapamycin | Impairing | 5.0 (High) | 16103051 |
acc2678 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Lung Cancer | H460 | Rapamycin | Impairing | 5.0 (High) | 16103051 |
acc2777 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Lung Cancer | cancer cells from MPE | Cisplatin | Impairing | 5.0 (High) | 20814891 |
acc2778 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Lung Cancer | PC14PE6/AS2 | Cisplatin | Impairing | 5.0 (High) | 20814891 |
acc2779 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Nasopharyngeal Carcinoma | HONE1-cis6 | Cisplatin | Impairing | 5.0 (High) | 20814891 |
acc2780 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Nasopharyngeal Carcinoma | HONE1 | Cisplatin | Impairing | 5.0 (High) | 20814891 |
acc1821 | HER2 | P04626 | ERBB2 | phosphorylation | Tyr | human | Breast Cancer | MDA-MB-231 | Paclitaxel | Impairing | 5.0 (High) | 10037184 |
acc1823 | HER2 | P04626 | ERBB2 | phosphorylation | Tyr | human | Breast Cancer | MDA-MB-361 | Paclitaxel | Impairing | 5.0 (High) | 10037184 |
acc1831 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H358 | Gefitinib | Impairing | 5.0 (High) | 24374738 |
acc1832 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H322 | Gefitinib | Impairing | 5.0 (High) | 24374738 |
acc1833 | Ku70 | P12956 | XRCC6 | acetylation | unclear | human | Lung Cancer | H358 | Gefitinib | Enhancing | 5.0 (High) | 24374738 |
acc1834 | Ku70 | P12956 | XRCC6 | acetylation | unclear | human | Lung Cancer | H322 | Gefitinib | Enhancing | 5.0 (High) | 24374738 |
acc1858 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | SW480 | Cetuximab | Impairing | 5.0 (High) | 32473242 |
acc1859 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | LoVo | Cetuximab | Impairing | 5.0 (High) | 32473242 |
acc1860 | AKT | P31749 | AKT1 | phosphorylation | Tyr308 | human | Colorectal Cancer | SW480 | Cetuximab | Impairing | 5.0 (High) | 32473242 |
acc1861 | AKT | P31749 | AKT1 | phosphorylation | Tyr308 | human | Colorectal Cancer | LoVo | Cetuximab | Impairing | 5.0 (High) | 32473242 |
acc1864 | HSP70 | P0DMV8 | HSPA1A | methylation | Arg416 | human | Pancreas Cancer | MIA PaCa-2 | Gemcitabine | Impairing | 5.0 (High) | 32699135 |
acc1865 | HSP70 | P0DMV8 | HSPA1A | methylation | Arg447 | human | Pancreas Cancer | MIA PaCa-2 | Gemcitabine | Impairing | 5.0 (High) | 32699135 |
acc1866 | ULK1 | O75385 | ULK1 | methylation | Arg170 | human | Lung Cancer | A549 | Carboplatin | Impairing | 5.0 (High) | 37381616 |
acc1867 | ULK1 | O75385 | ULK1 | methylation | Arg170 | human | Lung Cancer | NCI-H1975 | Carboplatin | Impairing | 5.0 (High) | 37381616 |
acc1868 | RNF4 | P78317 | RNF4 | methylation | Arg164 | human | Leukemia | NB-4 | As2O3 | Impairing | 5.0 (High) | 35622143 |
acc1899 | CUL1 | Q13616 | CUL1 | neddylation | unclear | human | Lung Cancer | H1299 | MLN4924 | Impairing | 5.0 (High) | 31208947 |
acc1900 | CUL2 | Q13617 | CUL2 | neddylation | unclear | human | Lung Cancer | H1299 | MLN4924 | Impairing | 5.0 (High) | 31208947 |
acc1901 | CUL3 | Q13618 | CUL3 | neddylation | unclear | human | Lung Cancer | H1299 | MLN4924 | Impairing | 5.0 (High) | 31208947 |
acc1902 | CUL4A | Q13619 | CUL4A | neddylation | unclear | human | Lung Cancer | H1299 | MLN4924 | Impairing | 5.0 (High) | 31208947 |
acc1903 | CUL4B | Q13620 | CUL4B | neddylation | unclear | human | Lung Cancer | H1299 | MLN4924 | Impairing | 5.0 (High) | 31208947 |
acc1904 | CUL5 | Q93034 | CUL5 | neddylation | unclear | human | Lung Cancer | H1299 | MLN4924 | Impairing | 5.0 (High) | 31208947 |
acc1907 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Myeloma | ARP-1 | Bortezomib | Impairing | 5.0 (High) | 27924158 |
acc1908 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Myeloma | ANBL6 | Bortezomib | Impairing | 5.0 (High) | 27924158 |
acc1909 | HSP27 | P04792 | HSPB1 | phosphorylation | Ser78 | human | Leukemia | THP-1 | Apigenin | Impairing | 5.0 (High) | 21364669 |
acc1910 | HSP27 | P04792 | HSPB1 | phosphorylation | Ser82 | human | Leukemia | THP-1 | Apigenin | Impairing | 5.0 (High) | 21364669 |
acc1913 | IGF1R | P08069 | IGF1R | phosphorylation | Tyr1135 | human | Sarcoma | U2OS | Mitoxantrone | Impairing | 5.0 (High) | 34110249 |
acc1914 | IGF1R | P08069 | IGF1R | phosphorylation | Tyr1136 | human | Sarcoma | U2OS | Mitoxantrone | Impairing | 5.0 (High) | 34110249 |
acc1915 | IGF1R | Q60751 | Igf1r | phosphorylation | Tyr1135 | mouse | Sarcoma | MCA205 | Mitoxantrone | Impairing | 5.0 (High) | 34110249 |
acc1916 | IGF1R | Q60751 | Igf1r | phosphorylation | Tyr1136 | mouse | Sarcoma | MCA205 | Mitoxantrone | Impairing | 5.0 (High) | 34110249 |
acc1917 | IGF1R | Q60751 | Igf1r | phosphorylation | Tyr1135 | mouse | Sarcoma | MCA205 | Oxaliplatin | Impairing | 5.0 (High) | 34110249 |
acc1918 | IGF1R | Q60751 | Igf1r | phosphorylation | Tyr1136 | mouse | Sarcoma | MCA205 | Oxaliplatin | Impairing | 5.0 (High) | 34110249 |
acc1919 | IGF1R | Q60751 | Igf1r | phosphorylation | Tyr1135 | mouse | Breast Cancer | AT3 | Oxaliplatin | Impairing | 5.0 (High) | 34110249 |
acc1920 | IGF1R | Q60751 | Igf1r | phosphorylation | Tyr1136 | mouse | Breast Cancer | AT3 | Oxaliplatin | Impairing | 5.0 (High) | 34110249 |
acc1921 | IGF1R | Q60751 | Igf1r | phosphorylation | Tyr1135 | mouse | Lung Cancer | TC1 | Oxaliplatin | Impairing | 5.0 (High) | 34110249 |
acc1922 | IGF1R | Q60751 | Igf1r | phosphorylation | Tyr1136 | mouse | Lung Cancer | TC1 | Oxaliplatin | Impairing | 5.0 (High) | 34110249 |
acc1923 | IGFBP-3 | O00425 | IGF2BP3 | phosphorylation | Ser | human | Lung Cancer | A549 | Cisplatin | Impairing | 5.0 (High) | 36766747 |
acc1924 | IGFBP-3 | O00425 | IGF2BP3 | phosphorylation | Ser | human | Lung Cancer | H1299 | Cisplatin | Impairing | 5.0 (High) | 36766747 |
acc1926 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Breast Cancer | Bcap37 | Paclitaxel | Enhancing | 5.0 (High) | 17568189 |
acc1927 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Ovarian Cancer | OV2008 | Paclitaxel | Enhancing | 5.0 (High) | 17568189 |
acc1933 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Oral Cancer | SAS | Cisplatin | Impairing | 5.0 (High) | 33551310 |
acc1934 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Oral Cancer | GNM | Cisplatin | Impairing | 5.0 (High) | 33551310 |
acc1952 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Pancreas Cancer | Gemcitabine | Impairing | 5.0 (High) | 27003603 | |
acc2009 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Colorectal Cancer | HCT116 | Doxorubicin | Enhancing | 5.0 (High) | 20026083 |
acc2010 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | MDA-MB-231 | Doxorubicin | Enhancing | 5.0 (High) | 20026083 |
acc2011 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | HeLa | Doxorubicin | Enhancing | 5.0 (High) | 20026083 |
acc2012 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | HepG2 | Doxorubicin | Enhancing | 5.0 (High) | 20026083 |
acc2020 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | HepG2 xenografts | Sorafenib + Cucurbitacin B | Impairing | 5.0 (High) | 33176070 |
acc2024 | BIM | P55916 | BCL2L11 | phosphorylation | unclear | human | Leukemia | SUPT-1 | Prednisolone | Impairing | 5.0 (High) | 34007050 |
acc2055 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | HCC2450 | AZD6244 | Impairing | 5.0 (High) | 19783898 |
acc2056 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | HCC2450 | AZD6244 | Impairing | 5.0 (High) | 19783898 |
acc2063 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H522 | AZD6244 | Impairing | 5.0 (High) | 19783898 |
acc2064 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H522 | AZD6244 | Impairing | 5.0 (High) | 19783898 |
acc2311 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Lung Cancer | FA31 | Gefitinib | Impairing | 5.0 (High) | 19491201 |
acc2312 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Lung Cancer | H1819 | Gefitinib | Impairing | 5.0 (High) | 19491201 |
acc2313 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Lung Cancer | H1975 | Gefitinib | Impairing | 5.0 (High) | 19491201 |
acc2323 | Smad2 | Q15796 | SMAD2 | phosphorylation | Ser465 | human | Hepatocellular Carcinoma | HepG2 | NH4Cl | Enhancing | 5.0 (High) | 25342595 |
acc2324 | Smad2 | Q15796 | SMAD2 | phosphorylation | Ser467 | human | Hepatocellular Carcinoma | HepG2 | NH4Cl | Enhancing | 5.0 (High) | 25342595 |
acc2325 | CtIP | Q99708 | RBBP8 | phosphorylation | Thr847 | human | Ovarian Cancer | IGROV1 | Olaparib | Impairing | 5.0 (High) | 37333340 |
acc2326 | CtIP | Q99708 | RBBP8 | phosphorylation | Thr847 | human | Ovarian Cancer | IGROV1 | Cisplatin | Impairing | 5.0 (High) | 37333340 |
acc2345 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Myeloma | U266 | Lenalidomide | Impairing | 5.0 (High) | 21520044 |
acc2346 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Myeloma | MM1.S | Lenalidomide | Impairing | 5.0 (High) | 21520044 |
acc2397 | STAT5 | P42229 | STAT5A | phosphorylation | Tyr694 | human | Lymphoma | CRL-2105 | Romidepsin | Impairing | 5.0 (High) | 34089720 |
acc2398 | STAT5 | P42229 | STAT5A | phosphorylation | Tyr694 | human | Lymphoma | HuT78 | Romidepsin | Impairing | 5.0 (High) | 34089720 |
acc2410 | YAP | P46937 | YAP1 | phosphorylation | Ser127 | human | Pancreas Cancer | PANC-1 | Gemcitabine | Impairing | 5.0 (High) | 31627466 |
acc2411 | YAP | P46937 | YAP1 | phosphorylation | Ser127 | human | Pancreas Cancer | BxPC-3 | Gemcitabine | Impairing | 5.0 (High) | 31627466 |
acc2412 | YAP | P46937 | YAP1 | phosphorylation | Ser127 | human | Pancreas Cancer | ASPC-1 | Gemcitabine | Impairing | 5.0 (High) | 31627466 |
acc2413 | Bcl-2 | P10415 | BCL2 | phosphorylation | unclear | human | Lung Cancer | H5800 | Cisplatin | Enhancing | 5.0 (High) | 24548862 |
acc2414 | Bcl-2 | P10417 | Bcl2 | phosphorylation | unclear | mouse | Lung Cancer | LKR | Cisplatin | Enhancing | 5.0 (High) | 24548862 |
acc2415 | Beclin-1 | Q9Y243 | BECN1 | ubiquitination | Ser90 | human | Myeloma | KMS11 | BTZ | Impairing | 5.0 (High) | 31955515 |
acc2416 | Beclin-1 | Q9Y243 | BECN1 | ubiquitination | Ser90 | human | Myeloma | RPMI8226 | BTZ | Impairing | 5.0 (High) | 31955515 |
acc2417 | Beclin-1 | Q9Y243 | BECN1 | ubiquitination | Ser93 | human | Myeloma | KMS11 | BTZ | Impairing | 5.0 (High) | 31955515 |
acc2418 | Beclin-1 | Q9Y243 | BECN1 | ubiquitination | Ser93 | human | Myeloma | RPMI8226 | BTZ | Impairing | 5.0 (High) | 31955515 |
acc2419 | Beclin-1 | Q9Y243 | BECN1 | ubiquitination | Ser96 | human | Myeloma | KMS11 | BTZ | Impairing | 5.0 (High) | 31955515 |
acc2420 | Beclin-1 | Q9Y243 | BECN1 | ubiquitination | Ser96 | human | Myeloma | RPMI8226 | BTZ | Impairing | 5.0 (High) | 31955515 |
acc2421 | MRE11 | P49959 | MRE11 | ubiquitination | Lys339 | human | Breast Cancer | HCC1806 | Radiotherapy | Enhancing | 5.0 (High) | 36563124 |
acc2422 | MRE11 | P49959 | MRE11 | ubiquitination | Lys339 | human | Breast Cancer | MDA-MB-231 | Radiotherapy | Enhancing | 5.0 (High) | 36563124 |
acc2423 | MRE11 | P49959 | MRE11 | ubiquitination | Lys480 | human | Breast Cancer | HCC1806 | Radiotherapy | Enhancing | 5.0 (High) | 36563124 |
acc2424 | MRE11 | P49959 | MRE11 | ubiquitination | Lys480 | human | Breast Cancer | MDA-MB-231 | Radiotherapy | Enhancing | 5.0 (High) | 36563124 |
acc2441 | AMPK | P54646 | PRKAA2 | phosphorylation | Thr172 | human | Lung Cancer | A549 | TRAIL | Impairing | 5.0 (High) | 29929000 |
acc2442 | AMPK | Q13131 | PRKAA1 | phosphorylation | Thr183 | human | Lung Cancer | A549 | TRAIL | Impairing | 5.0 (High) | 29929000 |
acc2443 | AMPK | P54646 | PRKAA2 | phosphorylation | Thr172 | human | Lung Cancer | HCC-15 | TRAIL | Impairing | 5.0 (High) | 29929000 |
acc2444 | AMPK | Q13131 | PRKAA1 | phosphorylation | Thr183 | human | Lung Cancer | HCC-15 | TRAIL | Impairing | 5.0 (High) | 29929000 |
acc2445 | JNK2 | P45984 | MAPK9 | phosphorylation | Thr183 | human | Colorectal Cancer | HT29 | TRAIL + 5-fluorouracil (5-FU) | Enhancing | 5.0 (High) | 15837763 |
acc2446 | JNK2 | P45984 | MAPK9 | phosphorylation | Thr183 | human | Hepatocellular Carcinoma | HepG2 | TRAIL + 5-fluorouracil (5-FU) | Enhancing | 5.0 (High) | 15837763 |
acc2447 | JNK2 | P45984 | MAPK9 | phosphorylation | Tyr185 | human | Colorectal Cancer | HT29 | TRAIL + 5-fluorouracil (5-FU) | Enhancing | 5.0 (High) | 15837763 |
acc2448 | JNK2 | P45984 | MAPK9 | phosphorylation | Tyr185 | human | Hepatocellular Carcinoma | HepG2 | TRAIL + 5-fluorouracil (5-FU) | Enhancing | 5.0 (High) | 15837763 |
acc2449 | JNK2 | P45984 | MAPK9 | phosphorylation | Thr183 | human | Colorectal Cancer | HT29 | TRAIL + Cisplatin | Enhancing | 5.0 (High) | 15837763 |
acc2450 | JNK2 | P45984 | MAPK9 | phosphorylation | Thr183 | human | Hepatocellular Carcinoma | HepG2 | TRAIL + Cisplatin | Enhancing | 5.0 (High) | 15837763 |
acc2451 | JNK2 | P45984 | MAPK9 | phosphorylation | Tyr185 | human | Colorectal Cancer | HT29 | TRAIL + Cisplatin | Enhancing | 5.0 (High) | 15837763 |
acc2452 | JNK2 | P45984 | MAPK9 | phosphorylation | Tyr185 | human | Hepatocellular Carcinoma | HepG2 | TRAIL + Cisplatin | Enhancing | 5.0 (High) | 15837763 |
acc2453 | TRIP13 | Q15645 | TRIP13 | phosphorylation | Tyr56 | human | Head and Neck Cancer | UM-SCC-1 | Cetuximab | Enhancing | 5.0 (High) | 34111559 |
acc2454 | TRIP13 | Q15645 | TRIP13 | phosphorylation | Tyr56 | human | Head and Neck Cancer | UM-SCC-1 | Radiotherapy | Impairing | 5.0 (High) | 34111559 |
acc2455 | TRIP13 | Q15645 | TRIP13 | phosphorylation | Tyr56 | human | Head and Neck Cancer | UM-SCC-11A | Cetuximab | Enhancing | 5.0 (High) | 34111559 |
acc2456 | TRIP13 | Q15645 | TRIP13 | phosphorylation | Tyr56 | human | Head and Neck Cancer | UM-SCC-11A | Radiotherapy | Impairing | 5.0 (High) | 34111559 |
acc2463 | AXL | P30530 | AXL | phosphorylation | Tyr779 | human | Leukemia | K562 | DXR | Impairing | 5.0 (High) | 32460059 |
acc2464 | AXL | P30530 | AXL | phosphorylation | Tyr779 | human | Leukemia | K562 | DXR | Impairing | 5.0 (High) | 32460059 |
acc2467 | AXL | P30530 | AXL | phosphorylation | Tyr779 | human | Leukemia | OCI/AML3 | TP-0903 | Impairing | 5.0 (High) | 32460059 |
acc2468 | AXL | P30530 | AXL | phosphorylation | Tyr779 | human | Leukemia | OCI/AML3 | TP-0903 | Impairing | 5.0 (High) | 32460059 |
acc2469 | AXL | P30530 | AXL | phosphorylation | Tyr779 | human | Leukemia | K562 | TP-0903 | Impairing | 5.0 (High) | 32460059 |
acc2470 | AXL | P30530 | AXL | phosphorylation | Tyr779 | human | Leukemia | K562 | TP-0903 | Impairing | 5.0 (High) | 32460059 |
acc2471 | AXL | P30530 | AXL | phosphorylation | Tyr779 | human | Leukemia | OCI/AML3 | DXR | Impairing | 5.0 (High) | 32460059 |
acc2472 | AXL | P30530 | AXL | phosphorylation | Tyr779 | human | Leukemia | OCI/AML3 | DXR | Impairing | 5.0 (High) | 32460059 |
acc2477 | p53 | P04637 | TP53 | phosphorylation | Ser15 | human | Melanoma | DB-1 | Dacarbazine | Enhancing | 5.0 (High) | 18791269 |
acc2478 | p53 | P04637 | TP53 | phosphorylation | Ser20 | human | Melanoma | DB-1 | Dacarbazine | Enhancing | 5.0 (High) | 18791269 |
acc2479 | p53 | P04637 | TP53 | phosphorylation | Ser37 | human | Melanoma | SK-Mel-28 | Dacarbazine | Enhancing | 5.0 (High) | 18791269 |
acc2480 | p53 | P04637 | TP53 | phosphorylation | Ser392 | human | Melanoma | SK-Mel-28 | Dacarbazine | Enhancing | 5.0 (High) | 18791269 |
acc2481 | p53 | P04637 | TP53 | phosphorylation | Ser37 | human | Melanoma | DB-1 | Dacarbazine | Enhancing | 5.0 (High) | 18791269 |
acc2482 | p53 | P04637 | TP53 | phosphorylation | Ser392 | human | Melanoma | DB-1 | Dacarbazine | Enhancing | 5.0 (High) | 18791269 |
acc2483 | p53 | P04637 | TP53 | phosphorylation | Ser15 | human | Melanoma | SK-MEL-5 | Dacarbazine | Enhancing | 5.0 (High) | 18791269 |
acc2484 | p53 | P04637 | TP53 | phosphorylation | Ser20 | human | Melanoma | SK-MEL-5 | Dacarbazine | Enhancing | 5.0 (High) | 18791269 |
acc2485 | p53 | P04637 | TP53 | phosphorylation | Ser37 | human | Melanoma | SK-MEL-5 | Dacarbazine | Enhancing | 5.0 (High) | 18791269 |
acc2486 | p53 | P04637 | TP53 | phosphorylation | Ser392 | human | Melanoma | SK-MEL-5 | Dacarbazine | Enhancing | 5.0 (High) | 18791269 |
acc2487 | p53 | P04637 | TP53 | phosphorylation | Ser15 | human | Melanoma | SK-Mel-28 | Dacarbazine | Enhancing | 5.0 (High) | 18791269 |
acc2488 | p53 | P04637 | TP53 | phosphorylation | Ser20 | human | Melanoma | SK-Mel-28 | Dacarbazine | Enhancing | 5.0 (High) | 18791269 |
acc2489 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser317 | human | Lung Cancer | A549 | Cisplatin | Impairing | 5.0 (High) | 35856403 |
acc2497 | KLF4 | O43474 | KLF4 | phosphorylation | Tyr20 | human | Breast Cancer | MCF7 | Tamoxifen | Enhancing | 5.0 (High) | 32084531 |
acc2498 | KLF4 | O43474 | KLF4 | phosphorylation | Tyr20 | human | Breast Cancer | HTR | Tamoxifen | Enhancing | 5.0 (High) | 32084531 |
acc2503 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Endometrial Cancer | RL95-2 | Cisplatin | Impairing | 5.0 (High) | 33680959 |
acc2504 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Endometrial Cancer | ARK-2 | Cisplatin | Impairing | 5.0 (High) | 33680959 |
acc2517 | SOX10 | P56693 | SOX10 | sumoylation | Lys55 | human | Melanoma | Vemurafenib | Impairing | 5.0 (High) | 34087780 | |
acc2518 | LIP | P28033 | Cebpb | ubiquitination | unclear | mouse | Mesothelioma | AB1 | Cisplatin | Enhancing | 5.0 (High) | 29748013 |
acc2519 | LIP | P17676 | CEBPB | ubiquitination | unclear | human | Mesothelioma | Cisplatin | Enhancing | 5.0 (High) | 29748013 | |
acc2524 | Stathmin | P16949 | STMN1 | phosphorylation | Ser38 | human | Ovarian Cancer | RMG-1 | Paclitaxel | Impairing | 5.0 (High) | 36328498 |
acc2530 | JNK2 | P45984 | MAPK9 | phosphorylation | unclear | human | Colorectal Cancer | HT29 | TRAIL + 5-fluorouracil (5-FU) | Enhancing | 5.0 (High) | 15837763 |
acc2531 | JNK2 | P45984 | MAPK9 | phosphorylation | unclear | human | Colorectal Cancer | HepG2 | TRAIL + 5-fluorouracil (5-FU) | Enhancing | 5.0 (High) | 15837763 |
acc2535 | MRP3 | O15438 | ABCC3 | nitration | unclear | human | Colorectal Cancer | HT29 | Doxorubicin | Enhancing | 5.0 (High) | 18922976 |
acc2536 | MRP3 | O15438 | ABCC3 | nitration | unclear | human | Colorectal Cancer | HT29-dx | Doxorubicin | Enhancing | 5.0 (High) | 18922976 |
acc2546 | THOC5 | Q13769 | THOC5 | phosphorylation | Tyr225 | human | Leukemia | K562 | Dasatinib | Enhancing | 5.0 (High) | 23032722 |
acc2547 | THOC5 | Q13769 | THOC5 | phosphorylation | Tyr225 | human | Leukemia | K562 | Imatinib | Enhancing | 5.0 (High) | 23032722 |
acc2548 | THOC5 | Q13769 | THOC5 | phosphorylation | Tyr225 | human | Leukemia | K562 | Nilotinib | Enhancing | 5.0 (High) | 23032722 |
acc2549 | ITGalpha6 | P23229 | ITGA6 | S-nitrosylation | Cys86 | human | Prostate Cancer | PC3 | 1400W(iNOS inhibitors) | Enhancing | 5.0 (High) | 23106339 |
acc2557 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Myeloma | Metformin | Impairing | 5.0 (High) | 25542900 | |
acc2559 | mTORC1 | P42345 | MTOR | phosphorylation | Thr172 | human | Myeloma | Metformin | Impairing | 5.0 (High) | 25542900 | |
acc2560 | Trx1 | P10599 | TXN | oxidation | unclear | human | Breast Cancer | MDA-MB-231 | 2DG + Au | Enhancing | 5.0 (High) | 25560241 |
acc2561 | Trx1 | P10599 | TXN | oxidation | unclear | human | Breast Cancer | MDA-MB-231 | 2DG + DHEA | Enhancing | 5.0 (High) | 25560241 |
acc2562 | Trx1 | P10599 | TXN | oxidation | unclear | human | Prostate Cancer | PC3 | 2DG + Au | Enhancing | 5.0 (High) | 25560241 |
acc2563 | Trx1 | P10599 | TXN | oxidation | unclear | human | Prostate Cancer | PC3 | 2DG + DHEA | Enhancing | 5.0 (High) | 25560241 |
acc2564 | Trx1 | P10599 | TXN | oxidation | unclear | human | Prostate Cancer | DU145 | 2DG + Au | Enhancing | 5.0 (High) | 25560241 |
acc2565 | Trx1 | P10599 | TXN | oxidation | unclear | human | Prostate Cancer | DU145 | 2DG + DHEA | Enhancing | 5.0 (High) | 25560241 |
acc2570 | PKM2 | P14618 | PKM | glycosylation | Arg399 | human | Cancer | MG | Impairing | 5.0 (High) | 26911935 | |
acc2574 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Ovarian Cancer | PD98049 | Enhancing | 5.0 (High) | 29693189 | |
acc2575 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Ovarian Cancer | PD98049 | Enhancing | 5.0 (High) | 29693189 | |
acc2576 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Ovarian Cancer | PD98049 | Enhancing | 5.0 (High) | 29693189 | |
acc2577 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Ovarian Cancer | PD98049 | Enhancing | 5.0 (High) | 29693189 | |
acc2581 | c-Jun | P05412 | JUN | phosphorylation | Ser63 | human | Pancreas Cancer | PANC-1 | ActD | Enhancing | 5.0 (High) | 30295945 |
acc3128 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | A549 | PTX | Impairing | 5.0 (High) | 33321583 |
acc3129 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | A549/Taxol | PTX | Impairing | 5.0 (High) | 33321583 |
acc3130 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | A549 | PTX | Impairing | 5.0 (High) | 33321583 |
acc3131 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | A549 | PTX | Impairing | 5.0 (High) | 33321583 |
acc3132 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | A549/Taxol | PTX | Impairing | 5.0 (High) | 33321583 |
acc3133 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | A549/Taxol | PTX | Impairing | 5.0 (High) | 33321583 |
acc3134 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | A549 | PTX | Impairing | 5.0 (High) | 33321583 |
acc3135 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | A549 | PTX | Impairing | 5.0 (High) | 33321583 |
acc3136 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | A549/Taxol | PTX | Impairing | 5.0 (High) | 33321583 |
acc3137 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | A549/Taxol | PTX | Impairing | 5.0 (High) | 33321583 |
acc3201 | Raf-1 | Q99N57 | Raf1 | phosphorylation | Ser289 | mouse | Heterologous Desensitization | delta opioid receptor | Impairing | 5.0 (High) | 36525124 | |
acc3202 | Raf-1 | Q99N57 | Raf1 | phosphorylation | Ser296 | mouse | Heterologous Desensitization | delta opioid receptor | Impairing | 5.0 (High) | 36525124 | |
acc3203 | Raf-1 | Q99N57 | Raf1 | phosphorylation | Ser301 | mouse | Heterologous Desensitization | delta opioid receptor | Impairing | 5.0 (High) | 36525124 | |
acc3222 | IkappaBalpha | O15111 | CHUK | phosphorylation | Ser180 | human | Leukemia | KBM–5 | Taxol | Impairing | 5.0 (High) | 16785236 |
acc3223 | IKKbeta | O14920 | IKBKB | phosphorylation | Ser181 | human | Leukemia | KBM–5 | Taxol | Impairing | 5.0 (High) | 16785236 |
acc3224 | IkappaBalpha | P25963 | NFKBIA | phosphorylation | Ser32 | human | Leukemia | KBM–5 | Taxol | Impairing | 5.0 (High) | 16785236 |
acc3225 | p65 | Q04206 | RELA | phosphorylation | Ser536 | human | Leukemia | KBM–5 | Taxol | Impairing | 5.0 (High) | 16785236 |
acc3265 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Pancreatic Cancer | Gemcitabine | Impairing | 5.0 (High) | 11595724 | |
acc3280 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Epidermoid Carcinoma | A431/CDDP2 | Cisplatin | Impairing | 5.0 (High) | 12709826 |
acc2100 | KNL1 | Q8NG31 | KNL1 | phosphorylation | Thr875 | human | Breast Cancer | MDA-MB-231 | Paclitaxel | Impairing | 5.0 (High) | 31575759 |
acc2101 | KNL1 | Q8NG31 | KNL1 | phosphorylation | Thr875 | human | Breast Cancer | MDA-MB-468 | Paclitaxel | Impairing | 5.0 (High) | 31575759 |
acc2115 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Lung Cancer | A549 | Cisplatin | Impairing | 5.0 (High) | 34543857 |
acc2121 | p27 | P46527 | CDKN1B | phosphorylation | Ser10 | human | Breast Cancer | BT474 | Erlotinib | Impairing | 5.0 (High) | 21045138 |
acc2122 | p27 | P46527 | CDKN1B | phosphorylation | Ser10 | human | Breast Cancer | SK-BR-3 | Erlotinib | Impairing | 5.0 (High) | 21045138 |
acc2123 | Cdc2 | P06493 | CDK1 | phosphorylation | Tyr15 | human | Breast Cancer | MDA-MB-435 | Taxol | Impairing | 5.0 (High) | 12384528 |
acc2124 | Cdc2 | P06493 | CDK1 | phosphorylation | Tyr15 | human | Breast Cancer | SK-BR-3 | Taxol | Impairing | 5.0 (High) | 12384528 |
acc2125 | Cdc2 | P06493 | CDK1 | phosphorylation | Tyr15 | human | Breast Cancer | MDA-MB-453 | Taxol | Impairing | 5.0 (High) | 12384528 |
acc2126 | Cdc2 | P06493 | CDK1 | phosphorylation | Tyr15 | human | Breast Cancer | 435eB | Taxol | Impairing | 5.0 (High) | 12384528 |
acc2128 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Breast Cancer | MCF7 | SB203580 | Enhancing | 5.0 (High) | 11060298 |
acc2129 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Leukemia | NB-4 | SB203580 | Enhancing | 5.0 (High) | 11060298 |
acc2130 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Breast Cancer | MCF7 | SB202190 | Enhancing | 5.0 (High) | 11060298 |
acc2131 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Leukemia | NB-4 | SB202190 | Enhancing | 5.0 (High) | 11060298 |
acc2132 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Breast Cancer | MCF7 | SB203580 | Enhancing | 5.0 (High) | 11060298 |
acc2133 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Leukemia | NB-4 | SB203580 | Enhancing | 5.0 (High) | 11060298 |
acc2134 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Breast Cancer | MCF7 | SB202190 | Enhancing | 5.0 (High) | 11060298 |
acc2135 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Leukemia | NB-4 | SB202190 | Enhancing | 5.0 (High) | 11060298 |
acc2140 | p53 | P04637 | TP53 | phosphorylation | Ser46 | human | Colorectal Cancer | RKO | adryamicin | Impairing | 5.0 (High) | 25260780 |
acc2141 | p53 | P04637 | TP53 | phosphorylation | Ser46 | human | Colorectal Cancer | HCT116 | adryamicin | Impairing | 5.0 (High) | 25260780 |
acc2142 | p53 | P04637 | TP53 | phosphorylation | Ser46 | human | Ovarian Cancer | 2008 | adryamicin | Impairing | 5.0 (High) | 25260780 |
acc2143 | p53 | P04637 | TP53 | phosphorylation | Ser46 | human | Lung Cancer | A549 | adryamicin | Impairing | 5.0 (High) | 25260780 |
acc2144 | p53 | P04637 | TP53 | phosphorylation | Ser46 | human | Colorectal Cancer | RKO | Cisplatin | Impairing | 5.0 (High) | 25260780 |
acc2145 | p53 | P04637 | TP53 | phosphorylation | Ser46 | human | Colorectal Cancer | HCT116 | Cisplatin | Impairing | 5.0 (High) | 25260780 |
acc2146 | p53 | P04637 | TP53 | phosphorylation | Ser46 | human | Ovarian Cancer | 2008 | Cisplatin | Impairing | 5.0 (High) | 25260780 |
acc2147 | p53 | P04637 | TP53 | phosphorylation | Ser46 | human | Lung Cancer | A549 | Cisplatin | Impairing | 5.0 (High) | 25260780 |
acc2151 | p53 | P04637 | TP53 | phosphorylation | Ser15 | human | Ovarian Cancer | A2780 | Cisplatin | Enhancing | 5.0 (High) | 14513366 |
acc2152 | p53 | P04637 | TP53 | phosphorylation | Ser15 | human | Breast Cancer | MCF7 | Cisplatin | Enhancing | 5.0 (High) | 14513366 |
acc2153 | p53 | P04637 | TP53 | phosphorylation | Ser392 | human | Ovarian Cancer | A2780 | Cisplatin | Enhancing | 5.0 (High) | 14513366 |
acc2154 | p53 | P04637 | TP53 | phosphorylation | Ser392 | human | Breast Cancer | MCF7 | Cisplatin | Enhancing | 5.0 (High) | 14513366 |
acc2155 | p53 | P04637 | TP53 | phosphorylation | Ser15 | human | Ovarian Cancer | 2780CP/Cl-16 | Cisplatin | Enhancing | 5.0 (High) | 14513366 |
acc2156 | p53 | P04637 | TP53 | phosphorylation | Ser15 | human | Ovarian Cancer | HEY/C-2 | Cisplatin | Enhancing | 5.0 (High) | 14513366 |
acc2157 | p53 | P04637 | TP53 | phosphorylation | Ser392 | human | Ovarian Cancer | 2780CP/Cl-16 | Cisplatin | Enhancing | 5.0 (High) | 14513366 |
acc2158 | p53 | P04637 | TP53 | phosphorylation | Ser392 | human | Ovarian Cancer | HEY/C-2 | Cisplatin | Enhancing | 5.0 (High) | 14513366 |
acc2159 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | PC9 | Osimertinib | Impairing | 5.0 (High) | 34599981 |
acc2160 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | PC9 | Osimertinib | Impairing | 5.0 (High) | 34599981 |
acc2161 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | PC9 | Osimertinib | Impairing | 5.0 (High) | 34599981 |
acc2162 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | PC9 | Osimertinib | Impairing | 5.0 (High) | 34599981 |
acc2173 | PELP1 | Q8IZL8 | PELP1 | phosphorylation | Ser1033 | human | Breast Cancer | MCF7 | Etoposide | Enhancing | 5.0 (High) | 24786831 |
acc2174 | PELP1 | Q8IZL8 | PELP1 | phosphorylation | Ser1033 | human | Breast Cancer | ZR75 | Etoposide | Enhancing | 5.0 (High) | 24786831 |
acc2175 | PELP1 | Q8IZL8 | PELP1 | phosphorylation | Ser1033 | human | Breast Cancer | MCF7 | Camptothecin | Enhancing | 5.0 (High) | 24786831 |
acc2176 | PELP1 | Q8IZL8 | PELP1 | phosphorylation | Ser1033 | human | Breast Cancer | ZR75 | Camptothecin | Enhancing | 5.0 (High) | 24786831 |
acc2179 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Leukemia | K562 | Imatinib | Impairing | 5.0 (High) | 23095523 |
acc2180 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Leukemia | BV173 | Imatinib | Impairing | 5.0 (High) | 23095523 |
acc2183 | PKC | P17252 | PRKCA | phosphorylation | Ser660 | human | Prostate Cancer | LNCaP | Ro-31-8220 | Enhancing | 5.0 (High) | 24352647 |
acc2184 | PKC | P17252 | PRKCA | phosphorylation | Ser660 | human | Prostate Cancer | C4-2 | Ro-31-8220 | Enhancing | 5.0 (High) | 24352647 |
acc2185 | PKC | P17252 | PRKCA | phosphorylation | Ser660 | human | Prostate Cancer | 22Rv1 | Ro-31-8220 | Enhancing | 5.0 (High) | 24352647 |
acc2186 | HSP27 | P04792 | HSPB1 | phosphorylation | Ser15 | human | Leukemia | THP-1 | Apigenin | Enhancing | 5.0 (High) | 21364669 |
acc2187 | HSP27 | P04792 | HSPB1 | phosphorylation | Ser78 | human | Leukemia | THP-1 | Apigenin | Enhancing | 5.0 (High) | 21364669 |
acc2188 | HSP27 | P04792 | HSPB1 | phosphorylation | Ser82 | human | Leukemia | THP-1 | Apigenin | Enhancing | 5.0 (High) | 21364669 |
acc2211 | PLK1 | P53350 | PLK1 | phosphorylation | Thr210 | human | Prostate Cancer | PC3 | KUD773 | Enhancing | 5.0 (High) | 25563361 |
acc2212 | PLK1 | P53350 | PLK1 | phosphorylation | Thr210 | human | Prostate Cancer | DU145 | KUD773 | Enhancing | 5.0 (High) | 25563361 |
acc2230 | RB | P06400 | RB1 | phosphorylation | Ser807 | human | Esophageal Cancer | OE19 | 5-FU | Impairing | 5.0 (High) | 28734226 |
acc2231 | RB | P06400 | RB1 | phosphorylation | Ser807 | human | Esophageal Cancer | OE19 | Cisplatin | Enhancing | 5.0 (High) | 28734226 |
acc2232 | RB | P06400 | RB1 | phosphorylation | Ser811 | human | Esophageal Cancer | TE-13 | 5-FU | Impairing | 5.0 (High) | 28734226 |
acc2233 | RB | P06400 | RB1 | phosphorylation | Ser811 | human | Esophageal Cancer | TE-13 | Cisplatin | Enhancing | 5.0 (High) | 28734226 |
acc2234 | RB | P06400 | RB1 | phosphorylation | Ser807 | human | Esophageal Cancer | OE21 | 5-FU | Impairing | 5.0 (High) | 28734226 |
acc2235 | RB | P06400 | RB1 | phosphorylation | Ser807 | human | Esophageal Cancer | OE21 | Cisplatin | Enhancing | 5.0 (High) | 28734226 |
acc2236 | RB | P06400 | RB1 | phosphorylation | Ser807 | human | Esophageal Cancer | TE-13 | 5-FU | Impairing | 5.0 (High) | 28734226 |
acc2237 | RB | P06400 | RB1 | phosphorylation | Ser807 | human | Esophageal Cancer | TE-13 | Cisplatin | Enhancing | 5.0 (High) | 28734226 |
acc2238 | RB | P06400 | RB1 | phosphorylation | Ser811 | human | Esophageal Cancer | OE19 | 5-FU | Impairing | 5.0 (High) | 28734226 |
acc2239 | RB | P06400 | RB1 | phosphorylation | Ser811 | human | Esophageal Cancer | OE19 | Cisplatin | Enhancing | 5.0 (High) | 28734226 |
acc2240 | RB | P06400 | RB1 | phosphorylation | Ser811 | human | Esophageal Cancer | OE21 | 5-FU | Impairing | 5.0 (High) | 28734226 |
acc2241 | RB | P06400 | RB1 | phosphorylation | Ser811 | human | Esophageal Cancer | OE21 | Cisplatin | Enhancing | 5.0 (High) | 28734226 |
acc2242 | AXL | P30530 | AXL | phosphorylation | Tyr702 | human | Glioblastoma | Nivolumab | Impairing | 5.0 (High) | 29531161 | |
acc2243 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Hepatocellular Carcinoma | HA22T | apicidin | Enhancing | 5.0 (High) | 31261976 |
acc2244 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Hepatocellular Carcinoma | HA22T | SAHA | Impairing | 5.0 (High) | 31261976 |
acc2245 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser317 | human | Lung Cancer | HTB182 | Cisplatin | Impairing | 5.0 (High) | 25937999 |
acc2246 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Lung Cancer | HTB182 | Cisplatin | Impairing | 5.0 (High) | 25937999 |
acc2247 | ATM | Q13315 | ATM | phosphorylation | Ser1981 | human | Lung Cancer | HTB182 | Cisplatin | Enhancing | 5.0 (High) | 25937999 |
acc2248 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser317 | human | Lung Cancer | CRL5985 | Cisplatin | Impairing | 5.0 (High) | 25937999 |
acc2249 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Lung Cancer | CRL5985 | Cisplatin | Impairing | 5.0 (High) | 25937999 |
acc2250 | ATM | Q13315 | ATM | phosphorylation | Ser1981 | human | Lung Cancer | CRL5985 | Cisplatin | Enhancing | 5.0 (High) | 25937999 |
acc2253 | RelA | Q04206 | RELA | phosphorylation | Ser536 | human | Breast Cancer | MCF7 | RITA | Enhancing | 5.0 (High) | 27721021 |
acc2254 | RelA | Q04206 | RELA | phosphorylation | Ser276 | human | Breast Cancer | MCF7 | RITA | Impairing | 5.0 (High) | 27721021 |
acc2255 | RelA | Q04206 | RELA | phosphorylation | Ser468 | human | Breast Cancer | MCF7 | RITA | Impairing | 5.0 (High) | 27721021 |
acc2256 | RelA | Q04206 | RELA | phosphorylation | Ser536 | human | Colorectal Cancer | HCT116 | RITA | Enhancing | 5.0 (High) | 27721021 |
acc2257 | RelA | Q04206 | RELA | phosphorylation | Ser276 | human | Colorectal Cancer | HCT116 | RITA | Impairing | 5.0 (High) | 27721021 |
acc2258 | RelA | Q04206 | RELA | phosphorylation | Ser468 | human | Colorectal Cancer | HCT116 | RITA | Impairing | 5.0 (High) | 27721021 |
acc2303 | IRAK1 | P51617 | IRAK1 | phosphorylation | unclear | human | Nasopharyngeal Carcinoma | CNE2 R | Paclitaxel | Enhancing | 5.0 (High) | 33402387 |
acc2304 | IRAK1 | P51617 | IRAK1 | phosphorylation | unclear | human | Nasopharyngeal Carcinoma | S26 R | Paclitaxel | Enhancing | 5.0 (High) | 33402387 |
acc2305 | NDRG-1 | Q92597 | NDRG1 | phosphorylation | Thr346 | human | Myeloma | BR bortezomib-resistant 8226 | Bortezomib | Impairing | 5.0 (High) | 26869290 |
acc2848 | E2F1 | Q01094 | E2F1 | phosphorylation | Ser364 | human | Breast Cancer | MCF-7 | Vinorelbine | Impairing | 5.0 (High) | 23306062 |
acc2849 | E2F1 | Q01094 | E2F1 | phosphorylation | Ser364 | human | Breast Cancer | MCF-7 | Docetaxel | Impairing | 5.0 (High) | 23306062 |
acc2850 | E2F1 | Q01094 | E2F1 | phosphorylation | Ser364 | human | Breast Cancer | MDA-MB-231 | Vinorelbine | Impairing | 5.0 (High) | 23306062 |
acc2851 | E2F1 | Q01094 | E2F1 | phosphorylation | Ser364 | human | Breast Cancer | MDA-MB-231 | Docetaxel | Impairing | 5.0 (High) | 23306062 |
acc2852 | p53 | P04637 | TP53 | phosphorylation | Ser15 | human | Breast Cancer | MCF-7 | Auranofin | Enhancing | 5.0 (High) | 23342042 |
acc2873 | HSP27 | P04792 | SAFB | phosphorylation | Ser82 | human | Cervical Cancer | HeLa | TRAIL | Enhancing | 5.0 (High) | 24176848 |
acc2903 | ERRgamma | P62508 | ESRRG | phosphorylation | Ser57 | human | Breast Cancer | MCF-7 | Tamoxifen | Impairing | 5.0 (High) | 24684682 |
acc2904 | ERRgamma | P62508 | ESRRG | phosphorylation | Ser81 | human | Breast Cancer | MCF-7 | Tamoxifen | Impairing | 5.0 (High) | 24684682 |
acc2905 | ERRgamma | P62508 | ESRRG | phosphorylation | Ser219 | human | Breast Cancer | MCF-7 | Tamoxifen | Impairing | 5.0 (High) | 24684682 |
acc2936 | p21 | P38936 | CDKN1A | methylation | Arg156 | human | Colorectal Cancer | HCT116 | Doxorubicin | Impairing | 5.0 (High) | 26436589 |
acc2937 | p21 | P38936 | CDKN1A | methylation | Arg156 | human | Cervical Cancer | HeLa | Doxorubicin | Impairing | 5.0 (High) | 26436589 |
acc2938 | p21 | P38936 | CDKN1A | phosphorylation | Thr145 | human | Colorectal Cancer | HCT116 | Doxorubicin | Impairing | 5.0 (High) | 26436589 |
acc2939 | p21 | P38936 | CDKN1A | phosphorylation | Thr145 | human | Cervical Cancer | HeLa | Doxorubicin | Impairing | 5.0 (High) | 26436589 |
acc2946 | A20 | Q60769 | Tnfaip3 | phosphorylation | Ser381 | mouse | Inflammatory | TNF | Enhancing | 5.0 (High) | 26649818 | |
acc2947 | A20 | Q60769 | Tnfaip3 | phosphorylation | Ser480 | mouse | Inflammatory | TNF | Enhancing | 5.0 (High) | 26649818 | |
acc2948 | A20 | Q60769 | Tnfaip3 | phosphorylation | Ser565 | mouse | Inflammatory | TNF | Enhancing | 5.0 (High) | 26649818 | |
acc2949 | A20 | Q60769 | Tnfaip3 | phosphorylation | Thr625 | mouse | Inflammatory | TNF | Enhancing | 5.0 (High) | 26649818 | |
acc2996 | HSA | P02768 | ALB | glycosylation | unclear | human | Hyperglycemia | Tolbutamide | Impairing | 5.0 (High) | 29258218 | |
acc2997 | HSA | P02768 | ALB | glycosylation | unclear | human | Hyperglycemia | Losartan | Impairing | 5.0 (High) | 29258218 | |
acc2999 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | ZR-75-1 | Everolimus | Impairing | 5.0 (High) | 29476223 |
acc3000 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Breast Cancer | ZR-75-1 | Everolimus | Impairing | 5.0 (High) | 29476223 |
acc3001 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | T47D | Everolimus | Impairing | 5.0 (High) | 29476223 |
acc3002 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Breast Cancer | T47D | Everolimus | Impairing | 5.0 (High) | 29476223 |
acc3003 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Breast Cancer | ZR-75-1 | Everolimus | Impairing | 5.0 (High) | 29476223 |
acc3004 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Breast Cancer | ZR-75-1 | Everolimus | Impairing | 5.0 (High) | 29476223 |
acc3005 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Breast Cancer | T47D | Everolimus | Impairing | 5.0 (High) | 29476223 |
acc3006 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Breast Cancer | T47D | Everolimus | Impairing | 5.0 (High) | 29476223 |
acc3007 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Breast Cancer | ZR-75-1 | Everolimus | Impairing | 5.0 (High) | 29476223 |
acc3008 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Breast Cancer | ZR-75-1 | Everolimus | Impairing | 5.0 (High) | 29476223 |
acc3009 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Breast Cancer | T47D | Everolimus | Impairing | 5.0 (High) | 29476223 |
acc3010 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Breast Cancer | T47D | Everolimus | Impairing | 5.0 (High) | 29476223 |
acc3011 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Breast Cancer | ZR-75-1 | Everolimus | Impairing | 5.0 (High) | 29476223 |
acc3012 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Breast Cancer | T47D | Everolimus | Impairing | 5.0 (High) | 29476223 |
acc3015 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Breast Cancer | SK-BR-3 | Trastuzumab | Enhancing | 5.0 (High) | 29796172 |
acc3016 | STAT1 | P42224 | STAT1 | phosphorylation | Ser727 | human | Breast Cancer | SK-BR-3 | Trastuzumab | Enhancing | 5.0 (High) | 29796172 |
acc3039 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Breast Cancer | MCF-7 | TRAIL | Enhancing | 5.0 (High) | 29964331 |
acc3040 | PERK | Q9NZJ5 | EIF2AK3 | phosphorylation | Thr981 | human | Breast Cancer | MCF-7 | TRAIL | Enhancing | 5.0 (High) | 29964331 |
acc3042 | AMPK | P54646 | PRKAA2 | phosphorylation | Thr172 | human | Lung Cancer | A549 | Phenformin | Impairing | 5.0 (High) | 29991651 |
acc3043 | AMPK | Q13131 | PRKAA1 | phosphorylation | Thr183 | human | Lung Cancer | A549 | Phenformin | Impairing | 5.0 (High) | 29991651 |
acc3044 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | A549 | DTX | Impairing | 5.0 (High) | 30061946 |
acc3049 | NF-kappaB p65 | Q04206 | RELA | phosphorylation | Ser536 | human | Nephropathy | HEK293 | Cisplatin | Impairing | 5.0 (High) | 30564368 |
acc3050 | NF-kappaB p65 | Q7TQN4 | Rela | phosphorylation | Ser536 | rat | Nephropathy | Cisplatin | Impairing | 5.0 (High) | 30564368 | |
acc3056 | PFKFB3 | Q16875 | PFKFB3 | phosphorylation | Ser461 | human | Lung Cancer | H522 | Erlotinib | Impairing | 5.0 (High) | 31126985 |
acc3057 | PFKFB3 | Q16875 | PFKFB3 | phosphorylation | Ser461 | human | Lung Cancer | H1437 | Erlotinib | Impairing | 5.0 (High) | 31126985 |
acc3058 | PFKFB3 | Q16875 | PFKFB3 | phosphorylation | Ser461 | human | Lung Cancer | PC9 | Erlotinib | Impairing | 5.0 (High) | 31126985 |
acc3059 | PFKFB3 | Q16875 | PFKFB3 | phosphorylation | Ser461 | human | Lung Cancer | HCC827 | Erlotinib | Impairing | 5.0 (High) | 31126985 |
acc3084 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreatic Cancer | Mia PaCa–2 | Gemcitabine | Impairing | 5.0 (High) | 32194695 |
acc3085 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreatic Cancer | Panc–1 | Gemcitabine | Impairing | 5.0 (High) | 32194695 |
acc2854 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Cancer | HeLa | Hyperthermia | Impairing | 4.5 (High) | 23383325 |
acc2855 | Chk2 | O96017 | CHEK2 | phosphorylation | Thr68 | human | Cancer | HeLa | Hyperthermia | Impairing | 4.5 (High) | 23383325 |
acc2893 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Pain | acupuncture | Enhancing | 4.5 (High) | 24524846 | |
acc2894 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Pain | acupuncture | Enhancing | 4.5 (High) | 24524846 | |
acc2895 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Pain | acupuncture | Enhancing | 4.5 (High) | 24524846 | |
acc2896 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Pain | acupuncture | Enhancing | 4.5 (High) | 24524846 | |
acc2934 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Multiple Sclerosis | humanized mice | Treg-mediated suppression | Impairing | 4.5 (High) | 26193267 |
acc3014 | calpastatin | P20810 | CAST | phosphorylation | Ser633 | human | Glioblastoma | U87 | Radiation | Impairing | 4.5 (High) | 29581866 |
acc1824 | histone H4 | P62805 | H4C1 | acetylation | Lys5 | human | Prostate Cancer | C4-2 | Enzalutamide | Impairing | 4.5 (High) | 34323404 |
acc1825 | histone H4 | P62805 | H4C1 | acetylation | Lys5 | human | Prostate Cancer | 22Rv1 | Enzalutamide | Impairing | 4.5 (High) | 34323404 |
acc1826 | histone H4 | P62805 | H4C1 | acetylation | Lys5 | human | Prostate Cancer | LNCaP | Enzalutamide | Impairing | 4.5 (High) | 34323404 |
acc1905 | LCK | P06240 | Lck | nitration | Tyr394 | mouse | Lung Cancer | Lewis | ICB | Impairing | 4.5 (High) | 30232256 |
acc1906 | LCK | P06240 | Lck | nitration | Tyr394 | mouse | Prostate Cancer | ICB | Impairing | 4.5 (High) | 30232256 | |
acc2600 | PP2A | Q15257 | PTPA | methylation | unclear | human | Glioblastoma | U87-MG | Radiotherapy | Enhancing | 4.5 (High) | 37500619 |
acc2602 | PP2A | Q15257 | PTPA | methylation | unclear | human | Glioblastoma | U251MG | Radiotherapy | Enhancing | 4.5 (High) | 37500619 |
acc2604 | AROS | Q86WX3 | RPS19BP1 | methylation | Lys27 | human | Colorectal Cancer | LoVo | Radiotherapy | Impairing | 4.5 (High) | 37756162 |
acc2605 | AROS | Q86WX3 | RPS19BP1 | methylation | Lys27 | human | Colorectal Cancer | HCT116 | Radiotherapy | Impairing | 4.5 (High) | 37756162 |
acc2606 | NADPH | oxidation | unclear | human | Breast Cancer | Carbon monoxide | Impairing | 4.5 (High) | 4004771 | |||
acc2607 | NADPH | oxidation | unclear | human | Breast Cancer | antibody against cytochrome P-450 | Impairing | 4.5 (High) | 4004771 | |||
acc2618 | H2AX | P16104 | H2AX | phosphorylation | unclear | human | Ovarian Cancer | IGROV-1 | ST1926 | Associated | 4.5 (High) | 19676051 |
acc2691 | IkappaBalpha | O15111 | CHUK | phosphorylation | Ser180 | human | Leukemia | KBM–5 | TNF | Impairing | 4.5 (High) | 16785236 |
acc2692 | IKKbeta | O14920 | IKBKB | phosphorylation | Ser181 | human | Leukemia | KBM–5 | TNF | Impairing | 4.5 (High) | 16785236 |
acc2693 | IkappaBalpha | P25963 | NFKBIA | phosphorylation | Ser32 | human | Leukemia | KBM–5 | TNF | Impairing | 4.5 (High) | 16785236 |
acc2694 | p65 | Q04206 | RELA | phosphorylation | Ser536 | human | Leukemia | KBM–5 | TNF | Impairing | 4.5 (High) | 16785236 |
acc2112 | MYC | P01106 | MYC | phosphorylation | Thr58 | human | Prostate Cancer | PC3 | anti-PD1 immunotherapy | Enhancing | 4.5 (High) | 31679823 |
acc2113 | MYC | P01106 | MYC | phosphorylation | Thr58 | human | Prostate Cancer | MycCaP | anti-PD1 immunotherapy | Enhancing | 4.5 (High) | 31679823 |
acc2114 | MYC | P01106 | MYC | phosphorylation | Thr58 | human | Prostate Cancer | LNCaP | anti-PD1 immunotherapy | Enhancing | 4.5 (High) | 31679823 |
acc2127 | p36 | Q9D020 | Nt5c3a | phosphorylation | unclear | mouse | Lung Cancer | Butylated hydroxytoluene (BHT) | Impairing | 4.5 (High) | 4053047 | |
acc2148 | p53 | P04637 | TP53 | phosphorylation | Ser20 | human | Colorectal Cancer | HCT116 | Ionising radiation | Impairing | 4.5 (High) | 12384533 |
acc2149 | p53 | P04637 | TP53 | phosphorylation | Ser15 | human | Colorectal Cancer | HCT116 | NO + ionizing radiation | Enhancing | 4.5 (High) | 15520210 |
acc2150 | p53 | P04637 | TP53 | phosphorylation | Ser15 | human | Gastric Cancer | SNU-1040 | NO + ionizing radiation | Enhancing | 4.5 (High) | 15520210 |
acc2177 | PELP1 | Q8IZL8 | PELP1 | phosphorylation | Ser1033 | human | Breast Cancer | MCF7 | gamma-Radiation | Enhancing | 4.5 (High) | 24786831 |
acc2178 | PELP1 | Q8IZL8 | PELP1 | phosphorylation | Ser1033 | human | Breast Cancer | ZR75 | gamma-Radiation | Enhancing | 4.5 (High) | 24786831 |
acc2181 | PTEN | P60484 | PTEN | phosphorylation | Tyr240 | human | Glioma | patient-derived glioma stem cell lines | Ionising radiation | Impairing | 4.5 (High) | 31025173 |
acc2399 | STAT5 | P42229 | STAT5A | phosphorylation | Tyr694 | human | Hepatocellular Carcinoma | PD-1 therapy | Impairing | 4.5 (High) | 34036623 | |
acc2402 | H2AX | P16104 | H2AX | methylation | Lys134 | human | Breast Cancer | MDA-MB-231 | Doxorubicin | Impairing | 4.5 (High) | 30159125 |
acc2403 | H2AX | P16104 | H2AX | phosphorylation | Ser139 | human | Breast Cancer | MDA-MB-231 | Doxorubicin | Impairing | 4.5 (High) | 30159125 |
acc2404 | H2AX | P16104 | H2AX | methylation | Lys134 | human | Lung Cancer | A549 | Doxorubicin | Impairing | 4.5 (High) | 30159125 |
acc2405 | H2AX | P16104 | H2AX | phosphorylation | Ser139 | human | Lung Cancer | A549 | Doxorubicin | Impairing | 4.5 (High) | 30159125 |
acc2501 | Cdc2 | P06493 | CDK1 | phosphorylation | Tyr15 | human | Ovarian Cancer | HT29 | Radiation | Impairing | 4.5 (High) | 11719452 |
acc2502 | Cdc2 | P06493 | CDK1 | phosphorylation | Thr14 | human | Colorectal Cancer | HT29 | Radiation | Impairing | 4.5 (High) | 11719452 |
acc2544 | MKP-1 | O95147 | DUSP14 | S-nitrosylation | Cys258 | human | Head and Neck Cancer | MDA-1483 | Radiotherapy | Impairing | 4.5 (High) | 22014408 |
acc2545 | MKP-1 | O95147 | DUSP14 | S-nitrosylation | Cys258 | human | Head and Neck Cancer | UM-SCC-10A | Radiotherapy | Impairing | 4.5 (High) | 22014408 |
acc2573 | Smad3 | P84022 | SMAD3 | phosphorylation | Thr179 | human | Hepatocellular Carcinoma | TGF-beta | Impairing | 4.5 (High) | 29524413 | |
acc4131 | CaMKII | P11798 | Camk2a | phosphorylation | Met281 | mouse | Duchenne Muscular Dystrophy | genetic inhibition | Impairing | 4.5 (High) | 29654126 | |
acc4132 | CaMKII | P11798 | Camk2a | phosphorylation | Met282 | mouse | Duchenne Muscular Dystrophy | genetic inhibition | Impairing | 4.5 (High) | 29654126 | |
acc3707 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Infarction | IPost + atorvastatin | Enhancing | 4.5 (High) | 23106693 | |
acc3708 | eNOS | Q62600 | Nos3 | phosphorylation | Ser1177 | rat | Infarction | IPost + atorvastatin | Enhancing | 4.5 (High) | 23106693 | |
acc1187 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Breast Cancer | MCF7 | Ionising radiation | Impairing | 4.5 (High) | 21730979 |
acc1259 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H1155 | Radiation | Impairing | 4.5 (High) | 11358816 |
acc1260 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H157 | Radiation | Impairing | 4.5 (High) | 11358816 |
acc1268 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H1155 | Radiation | Impairing | 4.5 (High) | 11358816 |
acc1269 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H157 | Radiation | Impairing | 4.5 (High) | 11358816 |
acc0047 | cullin | Q13616 | CUL1 | neddylation | unclear | human | Pancreas Cancer | MIA PaCa-2 | Ionising radiation | Enhancing | 4.5 (High) | 22072567 |
acc0048 | cullin | Q13616 | CUL1 | neddylation | unclear | human | Pancreas Cancer | BxPC-3 | Ionising radiation | Enhancing | 4.5 (High) | 22072567 |
acc0053 | NADPH | oxidation | unclear | rat | Breast Cancer | Tamoxifen | Impairing | 4.5 (High) | 4004771 | |||
acc0054 | NADPH | oxidation | unclear | rat | Endometrial Cancer | Tamoxifen | Impairing | 4.5 (High) | 4004771 | |||
acc1782 | 53BP1 | Q12888 | TP53BP1 | phosphorylation | Ser166 | human | Glioblastoma | U87 | Ionising radiation | Impairing | 4.5 (High) | 29328365 |
acc1806 | p65 | Q04206 | RELA | acetylation | Lys310 | human | Pancreas Cancer | PANC-1 | ICB | Enhancing | 4.5 (High) | 35265200 |
acc1807 | p65 | Q04206 | RELA | acetylation | Lys310 | human | Pancreas Cancer | MIA PaCa-2 | ICB | Enhancing | 4.5 (High) | 35265200 |
acc0868 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Pancreas Cancer | PANC-1 | Radiotherapy | Impairing | 4.5 (High) | 26887043 |
acc1031 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Bladder Cancer | SQ20B | Radiation | Impairing | 4.5 (High) | 16166302 |
acc1032 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Bladder Cancer | T24 | Radiation | Impairing | 4.5 (High) | 16166302 |
acc0382 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Hepatocellular Carcinoma | HuH-7 | Radiotherapy | Impairing | 4.5 (High) | 25004403 |
acc0383 | mTOR | Q9JLN9 | Mtor | phosphorylation | Ser2448 | mouse | Hepatocellular Carcinoma | BNL | Radiotherapy | Impairing | 4.5 (High) | 25004403 |
acc0384 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | HuH-7 | Radiotherapy | Impairing | 4.5 (High) | 25004403 |
acc0385 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Hepatocellular Carcinoma | BNL | Radiotherapy | Impairing | 4.5 (High) | 25004403 |
acc0518 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Ser45 | human | Thyroid Cancer | SW1736 | I131 | Impairing | 4.5 (High) | 29344218 |
acc0519 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Tyr654 | human | Thyroid Cancer | SW1736 | I131 | Impairing | 4.5 (High) | 29344218 |
acc0520 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Thyroid Cancer | SW1736 | I131 | Impairing | 4.5 (High) | 29344218 |
acc0724 | histone H3 | P68431 | H3C1 | acetylation | Lys9 | human | Colorectal Cancer | HCT116 | 5-FU | Enhancing | 4.5 (High) | 28139498 |
acc0580 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | PA-1 | Curcumin | Associated | 4.0 (Moderate) | 19647363 |
acc0588 | PHB1 | P35232 | PHB1 | phosphorylation | Thr258 | human | Colorectal Cancer | RKO | FL3 | Associated | 4.0 (Moderate) | 32665357 |
acc0589 | PHB1 | P35232 | PHB1 | phosphorylation | Thr258 | human | Colorectal Cancer | HCT116 | FL3 | Associated | 4.0 (Moderate) | 32665357 |
acc0590 | PHB1 | P35232 | PHB1 | phosphorylation | Thr258 | human | Colorectal Cancer | SW48 | FL3 | Associated | 4.0 (Moderate) | 32665357 |
acc0591 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Pancreas Cancer | PANC-1 | Curcumin | Associated | 4.0 (Moderate) | 20121547 |
acc0592 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Pancreas Cancer | AsPC-1 | Curcumin | Associated | 4.0 (Moderate) | 20121547 |
acc0593 | MDM2 | Q00987 | MDM2 | phosphorylation | unclear | human | Pancreas Cancer | SW1990 | Sodium cantharidinate | Associated | 4.0 (Moderate) | 33165811 |
acc0594 | p53 | P04637 | TP53 | phosphorylation | Ser315 | human | Pancreas Cancer | SW1990 | Sodium cantharidinate | Associated | 4.0 (Moderate) | 33165811 |
acc0614 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | Hep3B | FLLL32 | Associated | 4.0 (Moderate) | 20818158 |
acc0615 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | SNU-398 | FLLL32 | Associated | 4.0 (Moderate) | 20818158 |
acc0616 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Hepatocellular Carcinoma | HepG2 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0617 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Hepatocellular Carcinoma | HepG2 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0618 | p38MAPK | Q16539 | MAPK14 | phosphorylation | Tyr180 | human | Hepatocellular Carcinoma | SK-HEP-1 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0619 | p38MAPK | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Hepatocellular Carcinoma | SK-HEP-1 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0620 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Hepatocellular Carcinoma | SK-HEP-1 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0621 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Hepatocellular Carcinoma | SK-HEP-1 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0622 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Hepatocellular Carcinoma | SK-HEP-1 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0623 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Hepatocellular Carcinoma | SK-HEP-1 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0624 | p38MAPK | Q16539 | MAPK14 | phosphorylation | Tyr180 | human | Hepatocellular Carcinoma | HepG2 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0625 | p38MAPK | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Hepatocellular Carcinoma | HepG2 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0626 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Hepatocellular Carcinoma | HepG2 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0627 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Hepatocellular Carcinoma | HepG2 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0628 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Hepatocellular Carcinoma | HepG2 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0629 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Hepatocellular Carcinoma | HepG2 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0630 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Hepatocellular Carcinoma | SK-HEP-1 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0631 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Hepatocellular Carcinoma | SK-HEP-1 | Sorafenib + Berbamine + Ouabain | Associated | 4.0 (Moderate) | 34233013 |
acc0641 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Renal Cancer | SK-RC-45 | FLLL32 | Associated | 4.0 (Moderate) | 22899991 |
acc0642 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Renal Cancer | SK-RC-54 | FLLL32 | Associated | 4.0 (Moderate) | 22899991 |
acc0643 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Melanoma | A375 | FLLL32 | Associated | 4.0 (Moderate) | 22899991 |
acc0644 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Melanoma | Hs294T | FLLL32 | Associated | 4.0 (Moderate) | 22899991 |
acc0645 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Renal Cancer | SK-RC-45 | FLLL62 | Associated | 4.0 (Moderate) | 22899991 |
acc0646 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Renal Cancer | SK-RC-54 | FLLL62 | Associated | 4.0 (Moderate) | 22899991 |
acc0647 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Melanoma | A375 | FLLL62 | Associated | 4.0 (Moderate) | 22899991 |
acc0648 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Melanoma | Hs294T | FLLL62 | Associated | 4.0 (Moderate) | 22899991 |
acc0650 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | A1847 | AZD1480 | Associated | 4.0 (Moderate) | 25646015 |
acc0651 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | OVCAR5 | AZD1480 | Associated | 4.0 (Moderate) | 25646015 |
acc0652 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | OVCAR-8 | AZD1480 | Associated | 4.0 (Moderate) | 25646015 |
acc0653 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Ovarian Cancer | MOVCAR-5009 | AZD1480 | Associated | 4.0 (Moderate) | 25646015 |
acc0654 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Ovarian Cancer | MOVCAR-5447 | AZD1480 | Associated | 4.0 (Moderate) | 25646015 |
acc0655 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | CAOV3 | LY294002 | Associated | 4.0 (Moderate) | 36625999 |
acc0656 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | SK-OV-3 | LY294002 | Associated | 4.0 (Moderate) | 36625999 |
acc0659 | PI3K | P42336 | PIK3CA | phosphorylation | Tyr458 | human | Ovarian Cancer | CAOV3 | LY294002 | Associated | 4.0 (Moderate) | 36625999 |
acc0660 | PI3K | P42336 | PIK3CA | phosphorylation | Tyr199 | human | Ovarian Cancer | CAOV3 | LY294002 | Associated | 4.0 (Moderate) | 36625999 |
acc0661 | PI3K | P42336 | PIK3CA | phosphorylation | Tyr458 | human | Ovarian Cancer | SK-OV-3 | LY294002 | Associated | 4.0 (Moderate) | 36625999 |
acc0662 | PI3K | P42336 | PIK3CA | phosphorylation | Tyr199 | human | Ovarian Cancer | SK-OV-3 | LY294002 | Associated | 4.0 (Moderate) | 36625999 |
acc0667 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Colorectal Cancer | HT29 | AZD6738 + FTD | Associated | 4.0 (Moderate) | 36734271 |
acc0668 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Colorectal Cancer | HT116 | AZD6738 + FTD | Associated | 4.0 (Moderate) | 36734271 |
acc0671 | DRP1 | O00429 | DNM1L | phosphorylation | Ser616 | human | Oral Cancer | CAL27 | alantolactone | Associated | 4.0 (Moderate) | 37198593 |
acc0672 | DRP1 | O00429 | DNM1L | phosphorylation | Ser616 | human | Oral Cancer | SCC9 | alantolactone | Associated | 4.0 (Moderate) | 37198593 |
acc0673 | FAK | Q05397 | PTK2 | phosphorylation | Tyr397 | human | Ovarian Cancer | SK-OV-3 | C1632 | Associated | 4.0 (Moderate) | 37541366 |
acc0678 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | HGC-27 | Lactate | Associated | 4.0 (Moderate) | 37968076 |
acc0679 | HMGB1 | P09429 | HMGB1 | phosphorylation | unclear | human | Gastric Cancer | HGC-27 | Lactate | Associated | 4.0 (Moderate) | 37968076 |
acc0681 | EGFR | P00533 | EGFR | phosphorylation | Tyr | human | Bladder Cancer | 253J B-V | CGP 54211 | Associated | 4.0 (Moderate) | 9815668 |
acc0682 | EGFR | P00533 | EGFR | phosphorylation | Tyr | human | Bladder Cancer | 5637 | CGP 54211 | Associated | 4.0 (Moderate) | 9815668 |
acc0683 | EGFR | P00533 | EGFR | phosphorylation | Tyr | human | Bladder Cancer | TCC | CGP 54211 | Associated | 4.0 (Moderate) | 9815668 |
acc0684 | EGFR | P00533 | EGFR | phosphorylation | Tyr | human | Bladder Cancer | T24 | CGP 54211 | Associated | 4.0 (Moderate) | 9815668 |
acc0685 | EGFR | P00533 | EGFR | phosphorylation | Tyr | human | Bladder Cancer | RT4 | CGP 54211 | Associated | 4.0 (Moderate) | 9815668 |
acc0686 | EGFR | P00533 | EGFR | phosphorylation | Tyr | human | Bladder Cancer | 253J B-V | CGP 53353 | Associated | 4.0 (Moderate) | 9815668 |
acc0687 | EGFR | P00533 | EGFR | phosphorylation | Tyr | human | Bladder Cancer | 5637 | CGP 53353 | Associated | 4.0 (Moderate) | 9815668 |
acc0688 | EGFR | P00533 | EGFR | phosphorylation | Tyr | human | Bladder Cancer | TCC | CGP 53353 | Associated | 4.0 (Moderate) | 9815668 |
acc0689 | EGFR | P00533 | EGFR | phosphorylation | Tyr | human | Bladder Cancer | T24 | CGP 53353 | Associated | 4.0 (Moderate) | 9815668 |
acc0690 | EGFR | P00533 | EGFR | phosphorylation | Tyr | human | Bladder Cancer | RT4 | CGP 53353 | Associated | 4.0 (Moderate) | 9815668 |
acc0699 | IGF2BP3 | O00425 | IGF2BP3 | ubiquitination | unclear | human | Colorectal Cancer | HCT116 | Berberine | Associated | 4.0 (Moderate) | 36822301 |
acc0700 | IGF2BP3 | O00425 | IGF2BP3 | ubiquitination | unclear | human | Colorectal Cancer | SW620 | Berberine | Associated | 4.0 (Moderate) | 36822301 |
acc0703 | AKT | P31749 | AKT1 | ubiquitination | unclear | human | Gastric Cancer | MGC803 | Estradiol cypionate | Associated | 4.0 (Moderate) | 37392652 |
acc0704 | AKT | P31749 | AKT1 | ubiquitination | unclear | human | Gastric Cancer | SGC7901 | Estradiol cypionate | Associated | 4.0 (Moderate) | 37392652 |
acc0705 | beta-catenin | P35222 | CTNNB1 | ubiquitination | unclear | human | Pancreas Cancer | MIA PaCa-2 | Niclosamide + Gemcitabine | Associated | 4.0 (Moderate) | 37917550 |
acc0714 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Ser65 | human | Breast Cancer | SK-BR-3 | MLN0128 + TSA | Associated | 4.0 (Moderate) | 24562770 |
acc0715 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | SK-BR-3 | MLN0128 + TSA | Associated | 4.0 (Moderate) | 24562770 |
acc0716 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Ser65 | human | Breast Cancer | MCF7 | MLN0128 + TSA | Associated | 4.0 (Moderate) | 24562770 |
acc0717 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MCF7 | MLN0128 + TSA | Associated | 4.0 (Moderate) | 24562770 |
acc0718 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Ser65 | human | Breast Cancer | HER2-18 | MLN0128 + TSA | Associated | 4.0 (Moderate) | 24562770 |
acc0719 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | HER2-18 | MLN0128 + TSA | Associated | 4.0 (Moderate) | 24562770 |
acc0720 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Ser65 | human | Breast Cancer | BT474 | MLN0128 + TSA | Associated | 4.0 (Moderate) | 24562770 |
acc0721 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | BT474 | MLN0128 + TSA | Associated | 4.0 (Moderate) | 24562770 |
acc0722 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Ser65 | human | Breast Cancer | MDA-MB-231 | MLN0128 + TSA | Associated | 4.0 (Moderate) | 24562770 |
acc0723 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MDA-MB-231 | MLN0128 + TSA | Associated | 4.0 (Moderate) | 24562770 |
acc0728 | CCAR2 | Q8N163 | CCAR2 | acetylation | Lys | human | Colorectal Cancer | HCT116 | Sulforaphane | Associated | 4.0 (Moderate) | 30643017 |
acc0729 | RelA | Q04206 | RELA | acetylation | Lys310 | human | Breast Cancer | MDA-MB-231 | BRD4 inhibitor 13a | Associated | 4.0 (Moderate) | 34378541 |
acc0730 | FOXO1 | Q12778 | FOXO1 | acetylation | Lys | human | Lung Cancer | PC9 | Depsipeptide + Erlotinib | Associated | 4.0 (Moderate) | 26036758 |
acc0731 | FOXO1 | Q12778 | FOXO1 | acetylation | Lys | human | Lung Cancer | H1650 | Depsipeptide + Erlotinib | Associated | 4.0 (Moderate) | 26036758 |
acc0732 | FOXO1 | Q12778 | FOXO1 | phosphorylation | Thr24 | human | Lung Cancer | PC9 | Ku0063794 + Erlotinib | Associated | 4.0 (Moderate) | 26036758 |
acc0733 | FOXO1 | Q12778 | FOXO1 | phosphorylation | Thr24 | human | Lung Cancer | H1650 | Ku0063794 + Erlotinib | Associated | 4.0 (Moderate) | 26036758 |
acc0734 | FOXO1 | Q12778 | FOXO1 | phosphorylation | Thr24 | human | Lung Cancer | PC9 | LY294002 + Erlotinib | Associated | 4.0 (Moderate) | 26036758 |
acc0735 | FOXO1 | Q12778 | FOXO1 | phosphorylation | Thr24 | human | Lung Cancer | H1650 | LY294002 + Erlotinib | Associated | 4.0 (Moderate) | 26036758 |
acc0737 | GLDC | P23378 | GLDC | acetylation | Lys514 | human | Glioblastoma | U251 | Rapamycin | Associated | 4.0 (Moderate) | 34244482 |
acc0738 | GLDC | P23378 | GLDC | acetylation | Lys514 | human | Glioblastoma | U87 | Rapamycin | Associated | 4.0 (Moderate) | 34244482 |
acc0739 | ERalpha | P03372 | ESR1 | methylation | unclear | human | Breast Cancer | MCF7 | Tamoxifen | Associated | 4.0 (Moderate) | 37458145 |
acc0743 | AR | P10275 | AR | acetylation | Lys609 | human | Prostate Cancer | C4-2B | (R)-9b | Associated | 4.0 (Moderate) | 35704598 |
acc0744 | AR | P10275 | AR | phosphorylation | Tyr267 | human | Prostate Cancer | C4-2B | (R)-9b | Associated | 4.0 (Moderate) | 35704598 |
acc0754 | PLC-gamma2 | P16885 | PLCG2 | phosphorylation | Tyr759 | human | Leukemia | acalabrutinib | Associated | 4.0 (Moderate) | 27903679 | |
acc0755 | PLC-gamma2 | Q8CIH5 | Plcg2 | phosphorylation | Tyr1217 | mouse | Leukemia | acalabrutinib | Associated | 4.0 (Moderate) | 27903679 | |
acc0756 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Leukemia | acalabrutinib | Associated | 4.0 (Moderate) | 27903679 | |
acc0757 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Leukemia | acalabrutinib | Associated | 4.0 (Moderate) | 27903679 | |
acc0758 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Leukemia | acalabrutinib | Associated | 4.0 (Moderate) | 27903679 | |
acc0759 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Leukemia | acalabrutinib | Associated | 4.0 (Moderate) | 27903679 | |
acc0760 | BTK | P35991 | Btk | phosphorylation | Tyr223 | mouse | Leukemia | acalabrutinib | Associated | 4.0 (Moderate) | 27903679 | |
acc0761 | S6 | P62754 | Rps6 | phosphorylation | Ser235 | mouse | Leukemia | acalabrutinib | Associated | 4.0 (Moderate) | 27903679 | |
acc0762 | S6 | P62754 | Rps6 | phosphorylation | Ser236 | mouse | Leukemia | acalabrutinib | Associated | 4.0 (Moderate) | 27903679 | |
acc0763 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Prostate Cancer | PC3 | Afatinib | Associated | 4.0 (Moderate) | 32978518 |
acc0764 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Prostate Cancer | PC3 | Afatinib | Associated | 4.0 (Moderate) | 32978518 |
acc0765 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Prostate Cancer | DU145 | Afatinib | Associated | 4.0 (Moderate) | 32978518 |
acc0766 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Prostate Cancer | DU145 | Afatinib | Associated | 4.0 (Moderate) | 32978518 |
acc0767 | FRS2alpha | Q8WU20 | FRS2 | phosphorylation | unclear | human | Breast Cancer | SUM 52PE | Alofanib | Associated | 4.0 (Moderate) | 27136102 |
acc0769 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MDA-MB-231 | Apigenin | Associated | 4.0 (Moderate) | 17961621 |
acc0770 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | SK-HEP-1 | Apigenin | Associated | 4.0 (Moderate) | 17961621 |
acc0771 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | A549 | Apigenin | Associated | 4.0 (Moderate) | 17961621 |
acc0772 | Smad2 | Q15796 | SMAD2 | phosphorylation | Ser465 | human | Prostate Cancer | PC3-M | Apigenin | Associated | 4.0 (Moderate) | 23359392 |
acc0773 | Smad2 | Q15796 | SMAD2 | phosphorylation | Ser465 | human | Prostate Cancer | LNCaP C4-2B | Apigenin | Associated | 4.0 (Moderate) | 23359392 |
acc0774 | FAK | Q05397 | PTK2 | phosphorylation | Tyr576 | human | Prostate Cancer | PC3-M | Apigenin | Associated | 4.0 (Moderate) | 23359392 |
acc0775 | FAK | Q05397 | PTK2 | phosphorylation | Tyr576 | human | Prostate Cancer | LNCaP C4-2B | Apigenin | Associated | 4.0 (Moderate) | 23359392 |
acc0776 | FAK | Q05397 | PTK2 | phosphorylation | Tyr577 | human | Prostate Cancer | PC3-M | Apigenin | Associated | 4.0 (Moderate) | 23359392 |
acc0777 | FAK | Q05397 | PTK2 | phosphorylation | Tyr577 | human | Prostate Cancer | LNCaP C4-2B | Apigenin | Associated | 4.0 (Moderate) | 23359392 |
acc0778 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Prostate Cancer | PC3-M | Apigenin | Associated | 4.0 (Moderate) | 23359392 |
acc0779 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Prostate Cancer | LNCaP C4-2B | Apigenin | Associated | 4.0 (Moderate) | 23359392 |
acc0780 | Smad3 | P84022 | SMAD3 | phosphorylation | Ser423 | human | Prostate Cancer | PC3-M | Apigenin | Associated | 4.0 (Moderate) | 23359392 |
acc0781 | Smad3 | P84022 | SMAD3 | phosphorylation | Ser423 | human | Prostate Cancer | LNCaP C4-2B | Apigenin | Associated | 4.0 (Moderate) | 23359392 |
acc0782 | Smad2 | Q15796 | SMAD2 | phosphorylation | Ser467 | human | Prostate Cancer | PC3-M | Apigenin | Associated | 4.0 (Moderate) | 23359392 |
acc0783 | Smad2 | Q15796 | SMAD2 | phosphorylation | Ser467 | human | Prostate Cancer | LNCaP C4-2B | Apigenin | Associated | 4.0 (Moderate) | 23359392 |
acc0784 | Smad3 | P84022 | SMAD3 | phosphorylation | Ser425 | human | Prostate Cancer | PC3-M | Apigenin | Associated | 4.0 (Moderate) | 23359392 |
acc0785 | Smad3 | P84022 | SMAD3 | phosphorylation | Ser425 | human | Prostate Cancer | LNCaP C4-2B | Apigenin | Associated | 4.0 (Moderate) | 23359392 |
acc0786 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Prostate Cancer | PC3-M | Apigenin | Associated | 4.0 (Moderate) | 23359392 |
acc0787 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Prostate Cancer | LNCaP C4-2B | Apigenin | Associated | 4.0 (Moderate) | 23359392 |
acc0788 | FOXO3a | O43524 | FOXO3 | phosphorylation | Thr32 | human | Hepatocellular Carcinoma | HepG2 | As(2)O(3) | Associated | 4.0 (Moderate) | 18937079 |
acc0789 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | H1993 | AZD6244 + BEZ235 | Associated | 4.0 (Moderate) | 24939055 |
acc0790 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | H1993 | AZD6244 + BEZ235 | Associated | 4.0 (Moderate) | 24939055 |
acc0791 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | H1975 | AZD6244 + BEZ235 | Associated | 4.0 (Moderate) | 24939055 |
acc0792 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | H1975 | AZD6244 + BEZ235 | Associated | 4.0 (Moderate) | 24939055 |
acc0793 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H1993 | AZD6244 + BEZ235 | Associated | 4.0 (Moderate) | 24939055 |
acc0794 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H1975 | AZD6244 + BEZ235 | Associated | 4.0 (Moderate) | 24939055 |
acc0795 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H460 | AZD6244 + BEZ235 | Associated | 4.0 (Moderate) | 24939055 |
acc0796 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | H1993 | AZD6244 + BEZ235 | Associated | 4.0 (Moderate) | 24939055 |
acc0797 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | H1993 | AZD6244 + BEZ235 | Associated | 4.0 (Moderate) | 24939055 |
acc0798 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | H460 | AZD6244 + BEZ235 | Associated | 4.0 (Moderate) | 24939055 |
acc0799 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | H460 | AZD6244 + BEZ235 | Associated | 4.0 (Moderate) | 24939055 |
acc0800 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | H460 | AZD6244 + BEZ235 | Associated | 4.0 (Moderate) | 24939055 |
acc0801 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | H460 | AZD6244 + BEZ235 | Associated | 4.0 (Moderate) | 24939055 |
acc0802 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | H1975 | AZD6244 + BEZ235 | Associated | 4.0 (Moderate) | 24939055 |
acc0803 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | H1975 | AZD6244 + BEZ235 | Associated | 4.0 (Moderate) | 24939055 |
acc0810 | RAF | P04049 | RAF1 | phosphorylation | Ser338 | human | Glioblastoma | U87 | Berberine | Associated | 4.0 (Moderate) | 25504754 |
acc0811 | RAF | P04049 | RAF1 | phosphorylation | Ser338 | human | Glioblastoma | U251 | Berberine | Associated | 4.0 (Moderate) | 25504754 |
acc0812 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Glioblastoma | U87 | Berberine | Associated | 4.0 (Moderate) | 25504754 |
acc0813 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Glioblastoma | U251 | Berberine | Associated | 4.0 (Moderate) | 25504754 |
acc0814 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Glioblastoma | U87 | Berberine | Associated | 4.0 (Moderate) | 25504754 |
acc0815 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Glioblastoma | U251 | Berberine | Associated | 4.0 (Moderate) | 25504754 |
acc0816 | MEK | Q02750 | MAP2K1 | phosphorylation | Ser217 | human | Glioblastoma | U87 | Berberine | Associated | 4.0 (Moderate) | 25504754 |
acc0817 | MEK | Q02750 | MAP2K1 | phosphorylation | Ser217 | human | Glioblastoma | U251 | Berberine | Associated | 4.0 (Moderate) | 25504754 |
acc0818 | MEK | Q02750 | MAP2K1 | phosphorylation | Ser221 | human | Glioblastoma | U87 | Berberine | Associated | 4.0 (Moderate) | 25504754 |
acc0819 | MEK | Q02750 | MAP2K1 | phosphorylation | Ser221 | human | Glioblastoma | U251 | Berberine | Associated | 4.0 (Moderate) | 25504754 |
acc0820 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Glioblastoma | U87 | Berberine | Associated | 4.0 (Moderate) | 25504754 |
acc0821 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Glioblastoma | U251 | Berberine | Associated | 4.0 (Moderate) | 25504754 |
acc0822 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Glioblastoma | U87 | Berberine | Associated | 4.0 (Moderate) | 25504754 |
acc0823 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Glioblastoma | U251 | Berberine | Associated | 4.0 (Moderate) | 25504754 |
acc0824 | Ezrin | P15311 | EZR | phosphorylation | Thr567 | human | Nasopharyngeal Carcinoma | 5-8F | Berberine | Associated | 4.0 (Moderate) | 19651779 |
acc1582 | ERalpha | P03372 | ESR1 | phosphorylation | Ser118 | human | Breast Cancer | MCF7 | PGE2 | Associated | 4.0 (Moderate) | 20093341 |
acc1583 | ERalpha | P03372 | ESR1 | phosphorylation | Ser167 | human | Breast Cancer | MCF7 | PGE2 | Associated | 4.0 (Moderate) | 20093341 |
acc1584 | ERalpha | P03372 | ESR1 | phosphorylation | Ser305 | human | Breast Cancer | MCF7 | PGE2 | Associated | 4.0 (Moderate) | 20093341 |
acc1585 | CREB | P16220 | CREB1 | phosphorylation | Ser133 | human | Breast Cancer | MCF7 | Radiotherapy | Associated | 4.0 (Moderate) | 26655813 |
acc1589 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | TAMR-MCF-7 | 5-Aza | Associated | 4.0 (Moderate) | 21170675 |
acc1590 | CIC | Q924A2 | Cic | phosphorylation | Tyr1455 | mouse | Glioma | GL261 | Dasatinib | Associated | 4.0 (Moderate) | 32029440 |
acc1591 | CIC | Q96RK0 | CIC | phosphorylation | Tyr1455 | human | Glioma | U87 | Dasatinib | Associated | 4.0 (Moderate) | 32029440 |
acc1592 | CIC | Q96RK0 | CIC | phosphorylation | Tyr1455 | human | Glioma | GSC-7-2 | Dasatinib | Associated | 4.0 (Moderate) | 32029440 |
acc1593 | cSrc | P05480 | Src | phosphorylation | Tyr416 | mouse | Glioma | GL261 | Dasatinib | Associated | 4.0 (Moderate) | 32029440 |
acc1594 | cSrc | P12931 | SRC | phosphorylation | Tyr416 | human | Glioma | U87 | Dasatinib | Associated | 4.0 (Moderate) | 32029440 |
acc1595 | cSrc | P12931 | SRC | phosphorylation | Tyr416 | human | Glioma | GSC-7-2 | Dasatinib | Associated | 4.0 (Moderate) | 32029440 |
acc1596 | CDK2 | P24941 | CDK2 | phosphorylation | unclear | human | Breast Cancer | MDA-MB-435 | Mevalonate | Associated | 4.0 (Moderate) | 15155733 |
acc1597 | p90RSK2 | Q15349 | RPS6KA2 | phosphorylation | Thr359 | human | Lung Cancer | H226B | Kazinol-E | Associated | 4.0 (Moderate) | 26774343 |
acc1598 | p90RSK2 | Q15349 | RPS6KA2 | phosphorylation | Ser363 | human | Lung Cancer | H226B | Kazinol-E | Associated | 4.0 (Moderate) | 26774343 |
acc1599 | CYLD | Q9NQC7 | CYLD | phosphorylation | Ser418 | human | Lymphoma | HBL-1 | Ibrutinib | Associated | 4.0 (Moderate) | 33827598 |
acc1600 | CYLD | Q9NQC7 | CYLD | phosphorylation | Ser418 | human | Lymphoma | OCI-Ly10 | Ibrutinib | Associated | 4.0 (Moderate) | 33827598 |
acc1601 | CYLD | Q9NQC7 | CYLD | phosphorylation | Ser418 | human | Lymphoma | HBL-1 | acalabrutinib (ACP-196) | Associated | 4.0 (Moderate) | 33827598 |
acc1602 | CYLD | Q9NQC7 | CYLD | phosphorylation | Ser418 | human | Lymphoma | OCI-Ly10 | acalabrutinib (ACP-196) | Associated | 4.0 (Moderate) | 33827598 |
acc1605 | DDR1 | Q08345 | DDR1 | phosphorylation | Tyr792 | human | Colorectal Cancer | HCT116 | Dapagliflozin | Associated | 4.0 (Moderate) | 31979355 |
acc1606 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Bladder Cancer | UM-UC-6 | Dacomitinib | Associated | 4.0 (Moderate) | 24166682 |
acc1607 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Bladder Cancer | UM-UC-6 | Dacomitinib | Associated | 4.0 (Moderate) | 24166682 |
acc1608 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Bladder Cancer | UM-UC-6 | Dacomitinib | Associated | 4.0 (Moderate) | 24166682 |
acc1609 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Bladder Cancer | UM-UC-9 | Dacomitinib | Associated | 4.0 (Moderate) | 24166682 |
acc1610 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Bladder Cancer | UM-UC-9 | Dacomitinib | Associated | 4.0 (Moderate) | 24166682 |
acc1611 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Mucoepidermoid Carcinoma | UM-HMC-1 | Tocilizumab | Associated | 4.0 (Moderate) | 26287605 |
acc1612 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Mucoepidermoid Carcinoma | UM-HMC-3A | Tocilizumab | Associated | 4.0 (Moderate) | 26287605 |
acc1613 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Mucoepidermoid Carcinoma | UM-HMC-3B | Tocilizumab | Associated | 4.0 (Moderate) | 26287605 |
acc1614 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Colorectal Cancer | HCT116 | Auranofin + ICG-001 | Associated | 4.0 (Moderate) | 34900688 |
acc1615 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Colorectal Cancer | SW480 | Auranofin + ICG-001 | Associated | 4.0 (Moderate) | 34900688 |
acc1616 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Colorectal Cancer | DLD-1 | Auranofin + ICG-001 | Associated | 4.0 (Moderate) | 34900688 |
acc1617 | EGFR | P00533 | EGFR | phosphorylation | Tyr1173 | human | Lung Cancer | HCC827 | Erlotinib | Associated | 4.0 (Moderate) | 27612423 |
acc1618 | EGFR | P00533 | EGFR | phosphorylation | Tyr1173 | human | Lung Cancer | NCI-H3255 | Erlotinib | Associated | 4.0 (Moderate) | 27612423 |
acc1619 | EGFR | P00533 | EGFR | phosphorylation | Tyr1173 | human | Lung Cancer | NCI-H1975 | Erlotinib | Associated | 4.0 (Moderate) | 27612423 |
acc1621 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | CL1-5 | Curcumin | Associated | 4.0 (Moderate) | 21858220 |
acc1622 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | A549 | Curcumin | Associated | 4.0 (Moderate) | 21858220 |
acc1625 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | H1975 | Curcumin | Associated | 4.0 (Moderate) | 21858220 |
acc1626 | EGFR | P00533 | EGFR | ubiquitination | unclear | human | Lung Cancer | CL1-5 | Curcumin | Associated | 4.0 (Moderate) | 21858220 |
acc1627 | EGFR | P00533 | EGFR | ubiquitination | unclear | human | Lung Cancer | A549 | Curcumin | Associated | 4.0 (Moderate) | 21858220 |
acc1628 | EGFR | P00533 | EGFR | ubiquitination | unclear | human | Lung Cancer | H1975 | Curcumin | Associated | 4.0 (Moderate) | 21858220 |
acc1633 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | PC9 | Docetaxel + Gefitinib | Associated | 4.0 (Moderate) | 24682085 |
acc1634 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Head and Neck Cancer | Lysophosphatidic acid (LPA) | Associated | 4.0 (Moderate) | 12414665 | |
acc1635 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Ovarian Cancer | SK-OV-3 | DpdtC | Associated | 4.0 (Moderate) | 29467385 |
acc1636 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Ovarian Cancer | SK-BR-3 | DpdtC | Associated | 4.0 (Moderate) | 29467385 |
acc1637 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Ovarian Cancer | SK-OV-3 | DpdtC | Associated | 4.0 (Moderate) | 29467385 |
acc1638 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Ovarian Cancer | SK-BR-3 | DpdtC | Associated | 4.0 (Moderate) | 29467385 |
acc1639 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Ovarian Cancer | SK-OV-3 | DpdtC | Associated | 4.0 (Moderate) | 29467385 |
acc1640 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Ovarian Cancer | SK-BR-3 | DpdtC | Associated | 4.0 (Moderate) | 29467385 |
acc1641 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Ovarian Cancer | SK-OV-3 | DpdtC | Associated | 4.0 (Moderate) | 29467385 |
acc1642 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Ovarian Cancer | SK-BR-3 | DpdtC | Associated | 4.0 (Moderate) | 29467385 |
acc1649 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Pancreas Cancer | L3.6pl | Gefitinib | Associated | 4.0 (Moderate) | 16585207 |
acc1650 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | L3.6pl | Gefitinib | Associated | 4.0 (Moderate) | 16585207 |
acc1652 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Prostate Cancer | DU145 | Boric acid | Associated | 4.0 (Moderate) | 30196486 |
acc1654 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Thyroid Cancer | FTC-133 | Rifabutin | Associated | 4.0 (Moderate) | 28864377 |
acc1655 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Thyroid Cancer | 8505C | Rifabutin | Associated | 4.0 (Moderate) | 28864377 |
acc1658 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Lung Cancer | H3255 | Rifabutin | Associated | 4.0 (Moderate) | 26944016 |
acc1659 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Ser552 | human | Lung Cancer | H3255 | Rifabutin | Associated | 4.0 (Moderate) | 26944016 |
acc1664 | endoglin | P17813 | ENG | phosphorylation | Thr | human | Prostate Cancer | PC3-M | TGF-beta1 | Associated | 4.0 (Moderate) | 19736306 |
acc1673 | EGFR | P00533 | EGFR | phosphorylation | unclear | human | Thyroid Cancer | Apigenin | Associated | 4.0 (Moderate) | 11299771 | |
acc1674 | ERK | P27361 | MAPK3 | phosphorylation | unclear | human | Thyroid Cancer | Apigenin | Associated | 4.0 (Moderate) | 11299771 | |
acc1675 | Rb | P06400 | RB1 | phosphorylation | unclear | human | Breast Cancer | MCF7 | Apigenin | Associated | 4.0 (Moderate) | 11299771 |
acc1676 | ERK | P27361 | MAPK3 | phosphorylation | unclear | human | Breast Cancer | MDA-MB-468 | Apigenin | Associated | 4.0 (Moderate) | 11299771 |
acc1683 | ERG | P11308 | ERG | phosphorylation | Ser96 | human | Prostate Cancer | HEK293T | TAK-242 | Associated | 4.0 (Moderate) | 33554122 |
acc1684 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Glioma | C6 | Temozolomide | Associated | 4.0 (Moderate) | 27878252 |
acc1685 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Glioma | C6 | Temozolomide | Associated | 4.0 (Moderate) | 27878252 |
acc1686 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Glioma | C6 | Temozolomide | Associated | 4.0 (Moderate) | 27878252 |
acc1687 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Glioma | C6 | Temozolomide | Associated | 4.0 (Moderate) | 27878252 |
acc1692 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Stomach Cancer | Vitamin K3 | Associated | 4.0 (Moderate) | 12678906 | |
acc1693 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Stomach Cancer | Vitamin K3 | Associated | 4.0 (Moderate) | 12678906 | |
acc1694 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Stomach Cancer | Vitamin K3 | Associated | 4.0 (Moderate) | 12678906 | |
acc1695 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Stomach Cancer | Vitamin K3 | Associated | 4.0 (Moderate) | 12678906 | |
acc1696 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Colorectal Cancer | HCT116 | DHA + ISL | Associated | 4.0 (Moderate) | 33502699 |
acc1697 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Colorectal Cancer | HCT116 | DHA + ISL | Associated | 4.0 (Moderate) | 33502699 |
acc1698 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Colorectal Cancer | HCT116 | DHA + ISL | Associated | 4.0 (Moderate) | 33502699 |
acc1699 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Colorectal Cancer | HCT116 | DHA + ISL | Associated | 4.0 (Moderate) | 33502699 |
acc1708 | ERK2 | P27361 | MAPK3 | phosphorylation | Thr185 | human | Prostate Cancer | PC3 | Bortezomib | Associated | 4.0 (Moderate) | 34363546 |
acc1709 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Prostate Cancer | PC3 | Bortezomib | Associated | 4.0 (Moderate) | 34363546 |
acc1710 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Colorectal Cancer | HT29 | Paris Saponin II | Associated | 4.0 (Moderate) | 30471409 |
acc1711 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Colorectal Cancer | HT29 | Paris Saponin II | Associated | 4.0 (Moderate) | 30471409 |
acc1712 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Colorectal Cancer | HT29 | Paris Saponin II | Associated | 4.0 (Moderate) | 30471409 |
acc1713 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Colorectal Cancer | HT29 | Paris Saponin II | Associated | 4.0 (Moderate) | 30471409 |
acc1714 | DRP1 | O00429 | DNM1L | phosphorylation | Ser616 | human | Colorectal Cancer | HT29 | Paris Saponin II | Associated | 4.0 (Moderate) | 30471409 |
acc1715 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Colorectal Cancer | HCT116 | Paris Saponin II | Associated | 4.0 (Moderate) | 30471409 |
acc1716 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr204 | human | Colorectal Cancer | HCT116 | Paris Saponin II | Associated | 4.0 (Moderate) | 30471409 |
acc1717 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr185 | human | Colorectal Cancer | HCT116 | Paris Saponin II | Associated | 4.0 (Moderate) | 30471409 |
acc1718 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Colorectal Cancer | HCT116 | Paris Saponin II | Associated | 4.0 (Moderate) | 30471409 |
acc1719 | DRP1 | O00429 | DNM1L | phosphorylation | Ser616 | human | Colorectal Cancer | HCT116 | Paris Saponin II | Associated | 4.0 (Moderate) | 30471409 |
acc1720 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | A549 | Thymoquinone | Associated | 4.0 (Moderate) | 25238880 |
acc1721 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | A549 | Thymoquinone | Associated | 4.0 (Moderate) | 25238880 |
acc1722 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | A549 | Thymoquinone | Associated | 4.0 (Moderate) | 25238880 |
acc1723 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | A549 | Thymoquinone | Associated | 4.0 (Moderate) | 25238880 |
acc1732 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Osteosarcoma | Quercetin | Associated | 4.0 (Moderate) | 35447220 | |
acc1733 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Osteosarcoma | Quercetin | Associated | 4.0 (Moderate) | 35447220 | |
acc1734 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Osteosarcoma | Quercetin | Associated | 4.0 (Moderate) | 35447220 | |
acc1735 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Osteosarcoma | Quercetin | Associated | 4.0 (Moderate) | 35447220 | |
acc1736 | AKT | P31749 | AKT1 | phosphorylation | Tyr347 | human | Osteosarcoma | Quercetin | Associated | 4.0 (Moderate) | 35447220 | |
acc1737 | BAD | P50408 | BAD | phosphorylation | Ser136 | human | Osteosarcoma | Quercetin | Associated | 4.0 (Moderate) | 35447220 | |
acc1747 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Hepatocellular Carcinoma | HuH-7 | Isofraxidin | Associated | 4.0 (Moderate) | 20930381 |
acc1748 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Hepatocellular Carcinoma | HuH-7 | Isofraxidin | Associated | 4.0 (Moderate) | 20930381 |
acc1749 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Hepatocellular Carcinoma | HuH-7 | Isofraxidin | Associated | 4.0 (Moderate) | 20930381 |
acc1750 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Hepatocellular Carcinoma | HuH-7 | Isofraxidin | Associated | 4.0 (Moderate) | 20930381 |
acc1751 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Hepatocellular Carcinoma | HepG2 | Isofraxidin | Associated | 4.0 (Moderate) | 20930381 |
acc1752 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Hepatocellular Carcinoma | HepG2 | Isofraxidin | Associated | 4.0 (Moderate) | 20930381 |
acc1753 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Hepatocellular Carcinoma | HepG2 | Isofraxidin | Associated | 4.0 (Moderate) | 20930381 |
acc1754 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Hepatocellular Carcinoma | HepG2 | Isofraxidin | Associated | 4.0 (Moderate) | 20930381 |
acc1755 | BAD | P50408 | BAD | phosphorylation | Ser75 | human | Melanoma | A2058 | Sorafenib | Associated | 4.0 (Moderate) | 16452220 |
acc1756 | BAD | P50408 | BAD | phosphorylation | Ser99 | human | Melanoma | A2058 | Sorafenib | Associated | 4.0 (Moderate) | 16452220 |
acc1757 | BAD | P50408 | BAD | phosphorylation | Ser75 | human | Melanoma | SK-MEL-5 | Sorafenib | Associated | 4.0 (Moderate) | 16452220 |
acc1758 | BAD | P50408 | BAD | phosphorylation | Ser99 | human | Melanoma | SK-MEL-5 | Sorafenib | Associated | 4.0 (Moderate) | 16452220 |
acc1760 | FAK | Q05397 | PTK2 | phosphorylation | Tyr925 | human | Meningioma | IOMM-Lee | pUC | Associated | 4.0 (Moderate) | 21347260 |
acc1761 | FAK | Q05397 | PTK2 | phosphorylation | Tyr925 | human | Meningioma | CH-157MN | pUC | Associated | 4.0 (Moderate) | 21347260 |
acc1762 | FAK | Q05397 | PTK2 | phosphorylation | Tyr397 | human | Glioma | LN229 | TAE226 | Associated | 4.0 (Moderate) | 17431114 |
acc1763 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1135 | human | Glioma | LN229 | TAE226 | Associated | 4.0 (Moderate) | 17431114 |
acc1764 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1136 | human | Glioma | LN229 | TAE226 | Associated | 4.0 (Moderate) | 17431114 |
acc1765 | FAK | Q05397 | PTK2 | phosphorylation | Tyr397 | human | Glioma | U87 | TAE226 | Associated | 4.0 (Moderate) | 17431114 |
acc1766 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1135 | human | Glioma | U87 | TAE226 | Associated | 4.0 (Moderate) | 17431114 |
acc1767 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1136 | human | Glioma | U87 | TAE226 | Associated | 4.0 (Moderate) | 17431114 |
acc1768 | FAK | Q05397 | PTK2 | phosphorylation | Tyr397 | human | Glioma | U251 | TAE226 | Associated | 4.0 (Moderate) | 17431114 |
acc1769 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1135 | human | Glioma | U251 | TAE226 | Associated | 4.0 (Moderate) | 17431114 |
acc1770 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1136 | human | Glioma | U251 | TAE226 | Associated | 4.0 (Moderate) | 17431114 |
acc1771 | c-Myc | P01106 | MYC | phosphorylation | Ser62 | human | Cholangiocarcinoma | QBC939 | PD98059 | Associated | 4.0 (Moderate) | 20101459 |
acc1772 | FAK | Q05397 | PTK2 | phosphorylation | Tyr397 | human | Myeloma | MM1 | Palmitoyl-cyclic phosphatidic acid (Pal-cPA) | Associated | 4.0 (Moderate) | 12738990 |
acc1773 | FAK | P34152 | Ptk2 | phosphorylation | Tyr397 | mouse | Melanoma | B16 | Palmitoyl-cyclic phosphatidic acid (Pal-cPA) | Associated | 4.0 (Moderate) | 12738990 |
acc1774 | FOXO1 | Q12778 | FOXO1 | phosphorylation | Ser256 | human | Breast Cancer | SUM159PT | Cold atmospheric plasma (CAP) | Associated | 4.0 (Moderate) | 35637961 |
acc1781 | 53BP1 | Q12888 | TP53BP1 | phosphorylation | Ser166 | human | Glioblastoma | U87 | Ionizing radiation + SB216763 | Associated | 4.0 (Moderate) | 29328365 |
acc1783 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Head and Neck Cancer | Tu212 | Erlotinib | Associated | 4.0 (Moderate) | 24019973 |
acc1784 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Head and Neck Cancer | Tu686 | Erlotinib | Associated | 4.0 (Moderate) | 24019973 |
acc1791 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Breast Cancer | MCF7(TamR) | Tamoxifen | Associated | 4.0 (Moderate) | 21044952 |
acc1792 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Colorectal Cancer | HCT116 | Enzastaurin | Associated | 4.0 (Moderate) | 16103100 |
acc1793 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Glioblastoma | U87-MG | Enzastaurin | Associated | 4.0 (Moderate) | 16103100 |
acc1794 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Prostate Cancer | PC3 | Enzastaurin | Associated | 4.0 (Moderate) | 16103100 |
acc1795 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Colorectal Cancer | HCT116 | Enzastaurin | Associated | 4.0 (Moderate) | 16103100 |
acc1796 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Glioblastoma | U87-MG | Enzastaurin | Associated | 4.0 (Moderate) | 16103100 |
acc1797 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Prostate Cancer | PC3 | Enzastaurin | Associated | 4.0 (Moderate) | 16103100 |
acc1818 | HER2 | P04626 | ERBB2 | phosphorylation | Tyr1221 | human | Breast Cancer | MDA-MB-453m1 | SUCI02 | Associated | 4.0 (Moderate) | 12917021 |
acc1819 | HER2 | P04626 | ERBB2 | phosphorylation | Tyr1222 | human | Breast Cancer | MDA-MB-453m1 | SUCI02 | Associated | 4.0 (Moderate) | 12917021 |
acc1820 | HER2 | P04626 | ERBB2 | phosphorylation | Tyr | human | Breast Cancer | MDA-MB-231 | Emodin | Associated | 4.0 (Moderate) | 10037184 |
acc1086 | beta-catenin | Q02248 | Ctnnb1 | phosphorylation | Ser33 | mouse | Melanoma | B16 | Imidazole | Associated | 4.0 (Moderate) | 20604839 |
acc1087 | beta-catenin | Q02248 | Ctnnb1 | phosphorylation | Ser37 | mouse | Melanoma | B16 | Imidazole | Associated | 4.0 (Moderate) | 20604839 |
acc1088 | beta-catenin | Q02248 | Ctnnb1 | phosphorylation | Thr41 | mouse | Melanoma | B16 | Imidazole | Associated | 4.0 (Moderate) | 20604839 |
acc1089 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Hepatocellular Carcinoma | BEL-7402 | 3-Bromopropionylamino benzoylurea (JIMB01) | Associated | 4.0 (Moderate) | 12754105 |
acc1094 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Glioblastoma | U87 | KU-60019 | Associated | 4.0 (Moderate) | 19808981 |
acc1101 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | PC-9/GR | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1102 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Lung Cancer | H1975 | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1103 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | PC-9/GR | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1104 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | PC-9/GR | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1105 | MEK1 | Q02750 | MAP2K1 | phosphorylation | Ser217 | human | Lung Cancer | PC-9/GR | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1106 | MEK1 | Q02750 | MAP2K1 | phosphorylation | Ser221 | human | Lung Cancer | H1975 | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1107 | MEK2 | P36507 | MAP2K2 | phosphorylation | Ser222 | human | Lung Cancer | H1975 | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1108 | MEK2 | P36507 | MAP2K2 | phosphorylation | Ser226 | human | Lung Cancer | H1975 | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1109 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | H1975 | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1110 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | H1975 | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1111 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | H1975 | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1112 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | H1975 | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1113 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | PC-9/GR | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1114 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H1975 | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1115 | MEK1 | Q02750 | MAP2K1 | phosphorylation | Ser217 | human | Lung Cancer | PC-9/GR | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1116 | MEK1 | Q02750 | MAP2K1 | phosphorylation | Ser221 | human | Lung Cancer | PC-9/GR | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1117 | MEK2 | P36507 | MAP2K2 | phosphorylation | Ser222 | human | Lung Cancer | PC-9/GR | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1118 | MEK2 | P36507 | MAP2K2 | phosphorylation | Ser226 | human | Lung Cancer | PC-9/GR | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1119 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | PC-9/GR | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1120 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | PC-9/GR | Gefitinib + Lovastatin | Associated | 4.0 (Moderate) | 29215723 |
acc1121 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | SK-OV-3 | PJ-34 | Associated | 4.0 (Moderate) | 21821012 |
acc1122 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | SK-OV-3 | 3-AB | Associated | 4.0 (Moderate) | 21821012 |
acc1123 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Osteosarcoma | U2OS | PJ-34 | Associated | 4.0 (Moderate) | 21821012 |
acc1124 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Osteosarcoma | U2OS | 3-AB | Associated | 4.0 (Moderate) | 21821012 |
acc1125 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H358 | PJ-34 | Associated | 4.0 (Moderate) | 21821012 |
acc1126 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H358 | 3-AB | Associated | 4.0 (Moderate) | 21821012 |
acc1127 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Pancreas Cancer | AsPC-1 | Bazedoxifene | Associated | 4.0 (Moderate) | 27535971 |
acc1128 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Pancreas Cancer | HPAF-2 | Bazedoxifene | Associated | 4.0 (Moderate) | 27535971 |
acc1129 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Pancreas Cancer | PANC-1 | Bazedoxifene | Associated | 4.0 (Moderate) | 27535971 |
acc1138 | c-Raf | P01106 | MYC | phosphorylation | Ser43 | human | Hepatocellular Carcinoma | Hep3B | Vitamin K1 + Sorafenib | Associated | 4.0 (Moderate) | 21734462 |
acc1139 | c-Raf | P01106 | MYC | phosphorylation | Ser259 | human | Hepatocellular Carcinoma | Hep3B | Vitamin K1 + Sorafenib | Associated | 4.0 (Moderate) | 21734462 |
acc1140 | c-Met | P08581 | MET | phosphorylation | Tyr1349 | human | Hepatocellular Carcinoma | Hep3B | Vitamin K1 + Sorafenib | Associated | 4.0 (Moderate) | 21734462 |
acc1141 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Ovarian Cancer | HEY | Lysophosphatidic acid (LPA) | Associated | 4.0 (Moderate) | 12181443 |
acc1142 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Ovarian Cancer | HEY | Sphingosine-1-phosphate | Associated | 4.0 (Moderate) | 12181443 |
acc1143 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | HEY | Lysophosphatidic acid (LPA) | Associated | 4.0 (Moderate) | 12181443 |
acc1144 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | HEY | Sphingosine-1-phosphate | Associated | 4.0 (Moderate) | 12181443 |
acc1148 | EGFR | P00533 | EGFR | phosphorylation | unclear | human | Hepatocellular Carcinoma | HepG2 | MCI-186 | Associated | 4.0 (Moderate) | 15868956 |
acc1149 | EGFR | P00533 | EGFR | phosphorylation | unclear | human | Mesothelioma | MSTO-211H | MCI-186 | Associated | 4.0 (Moderate) | 15868956 |
acc1150 | EGFR | P00533 | EGFR | phosphorylation | unclear | human | Gastric Cancer | TMK-1 | MCI-186 | Associated | 4.0 (Moderate) | 15868956 |
acc1151 | EGFR | P00533 | EGFR | phosphorylation | unclear | human | Breast Cancer | MCF7 | MCI-186 | Associated | 4.0 (Moderate) | 15868956 |
acc1154 | FOXO3a | Q9WVH4 | Foxo3 | phosphorylation | Ser253 | mouse | Ovarian Cancer | Melatonin + Cisplatin | Associated | 4.0 (Moderate) | 26882203 | |
acc1155 | PTEN | O08586 | Pten | phosphorylation | Ser380 | mouse | Ovarian Cancer | Melatonin + Cisplatin | Associated | 4.0 (Moderate) | 26882203 | |
acc1156 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Ovarian Cancer | Melatonin + Cisplatin | Associated | 4.0 (Moderate) | 26882203 | |
acc1157 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Colorectal Cancer | C57BL/6 mice | Metformin | Associated | 4.0 (Moderate) | 20228137 |
acc1158 | AMPK | Q5EG47 | Prkaa1 | phosphorylation | Thr183 | mouse | Colorectal Cancer | C57BL/6 mice | Metformin | Associated | 4.0 (Moderate) | 20228137 |
acc1159 | AMPK | Q8BRK8 | Prkaa2 | phosphorylation | Thr172 | mouse | Colorectal Cancer | C57BL/6 mice | Metformin | Associated | 4.0 (Moderate) | 20228137 |
acc1160 | acetyl-CoA carboxylase | Q5SWU9 | Acaca | phosphorylation | Ser79 | mouse | Colorectal Cancer | C57BL/6 mice | Metformin | Associated | 4.0 (Moderate) | 20228137 |
acc1164 | AMPK | P54645 | Prkaa1 | phosphorylation | Thr183 | rat | Uterine Leiomyomas | ELT-3 | Metformin | Associated | 4.0 (Moderate) | 22835064 |
acc1165 | AMPK | Q09137 | Prkaa2 | phosphorylation | Thr172 | rat | Uterine Leiomyomas | ELT-3 | Metformin | Associated | 4.0 (Moderate) | 22835064 |
acc1166 | S6 | P62755 | Rps6 | phosphorylation | Ser235 | rat | Uterine Leiomyomas | ELT-3 | Metformin | Associated | 4.0 (Moderate) | 22835064 |
acc1167 | S6 | P62755 | Rps6 | phosphorylation | Ser236 | rat | Uterine Leiomyomas | ELT-3 | Metformin | Associated | 4.0 (Moderate) | 22835064 |
acc1180 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | SMMC-7721 | NR027113 | Associated | 4.0 (Moderate) | 30468465 |
acc1181 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | SK-HEP-1 | NR027113 | Associated | 4.0 (Moderate) | 30468465 |
acc1188 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Gastric Cancer | MKN-28 | Nintedanib | Associated | 4.0 (Moderate) | 36002676 |
acc1189 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Gastric Cancer | AGS | Nintedanib | Associated | 4.0 (Moderate) | 36002676 |
acc1190 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Gastric Cancer | MKN-28 | Nintedanib | Associated | 4.0 (Moderate) | 36002676 |
acc1191 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Gastric Cancer | AGS | Nintedanib | Associated | 4.0 (Moderate) | 36002676 |
acc1200 | Bax | Q07812 | BAX | phosphorylation | Ser184 | human | Lung Cancer | A549 | Ceramide | Associated | 4.0 (Moderate) | 16679323 |
acc1201 | Bax | Q07812 | BAX | phosphorylation | Ser184 | human | Lung Cancer | A549 | Okadaic acid | Associated | 4.0 (Moderate) | 16679323 |
acc1202 | CDK2 | P24941 | CDK2 | phosphorylation | Thr160 | human | Colorectal Cancer | LoVo | adapalene | Associated | 4.0 (Moderate) | 26398439 |
acc1203 | CDK2 | P24941 | CDK2 | phosphorylation | Thr160 | human | Colorectal Cancer | DLD-1 | adapalene | Associated | 4.0 (Moderate) | 26398439 |
acc1204 | Rb | P06400 | RB1 | phosphorylation | Ser795 | human | Colorectal Cancer | LoVo | adapalene | Associated | 4.0 (Moderate) | 26398439 |
acc1205 | Rb | P06400 | RB1 | phosphorylation | Ser795 | human | Colorectal Cancer | DLD-1 | adapalene | Associated | 4.0 (Moderate) | 26398439 |
acc1206 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Lung Cancer | A549 | Oleic acid | Associated | 4.0 (Moderate) | 33957086 |
acc1207 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Lung Cancer | A549 | OEA | Associated | 4.0 (Moderate) | 33957086 |
acc1213 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Ovarian Cancer | A2780 | Paclitaxel + ABT-199 | Associated | 4.0 (Moderate) | 29953843 |
acc1214 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Cervical Cancer | HeLa | Paclitaxel + ABT-199 | Associated | 4.0 (Moderate) | 29953843 |
acc1215 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Lung Cancer | H460 | Paclitaxel + ABT-199 | Associated | 4.0 (Moderate) | 29953843 |
acc1216 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Ovarian Cancer | A2780/DDP | Paclitaxel + ABT-199 | Associated | 4.0 (Moderate) | 29953843 |
acc1217 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MDA-MB-468 | Eribulin + Everolimus | Associated | 4.0 (Moderate) | 31480338 |
acc1218 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | 4T1 | Eribulin + Everolimus | Associated | 4.0 (Moderate) | 31480338 |
acc1219 | S6K1 | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Breast Cancer | MDA-MB-468 | Eribulin + Everolimus | Associated | 4.0 (Moderate) | 31480338 |
acc1220 | S6K1 | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Breast Cancer | 4T1 | Eribulin + Everolimus | Associated | 4.0 (Moderate) | 31480338 |
acc1221 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Breast Cancer | MDA-MB-468 | Eribulin + Everolimus | Associated | 4.0 (Moderate) | 31480338 |
acc1222 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Breast Cancer | 4T1 | Eribulin + Everolimus | Associated | 4.0 (Moderate) | 31480338 |
acc1223 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Breast Cancer | MDA-MB-468 | Eribulin + Everolimus | Associated | 4.0 (Moderate) | 31480338 |
acc1224 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Breast Cancer | 4T1 | Eribulin + Everolimus | Associated | 4.0 (Moderate) | 31480338 |
acc1225 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Leukemia | HL-60 | Paclitaxel | Associated | 4.0 (Moderate) | 11160861 |
acc1226 | c-Jun | P05412 | JUN | phosphorylation | Ser63 | human | Gastric Cancer | NUGC-3 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1227 | c-Jun | P05412 | JUN | phosphorylation | Ser63 | human | Gastric Cancer | 44As3 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1228 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Gastric Cancer | 58As9 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1229 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Gastric Cancer | MKN-1 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1230 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Gastric Cancer | TMK-1 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1231 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Gastric Cancer | SH101-P | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1232 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Gastric Cancer | NUGC-3 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1233 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Gastric Cancer | 44As3 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1234 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Gastric Cancer | SNU-601 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1235 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Gastric Cancer | 58As9 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1236 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Gastric Cancer | MKN-1 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1237 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Gastric Cancer | TMK-1 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1238 | c-Jun | P05412 | JUN | phosphorylation | Ser63 | human | Gastric Cancer | SNU-601 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1239 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Gastric Cancer | SH101-P | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1240 | c-Jun | P05412 | JUN | phosphorylation | Ser63 | human | Gastric Cancer | 58As9 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1241 | c-Jun | P05412 | JUN | phosphorylation | Ser63 | human | Gastric Cancer | MKN-1 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1242 | c-Jun | P05412 | JUN | phosphorylation | Ser63 | human | Gastric Cancer | TMK-1 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1243 | c-Jun | P05412 | JUN | phosphorylation | Ser63 | human | Gastric Cancer | SH101-P | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1244 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Gastric Cancer | NUGC-3 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1245 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Gastric Cancer | 44As3 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1246 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Gastric Cancer | SNU-601 | Cisplatin | Associated | 4.0 (Moderate) | 35922477 |
acc1255 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Ser552 | human | Colorectal Cancer | HCT116 | Rp-8-Br-cAMPS | Associated | 4.0 (Moderate) | 22168384 |
acc1256 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Ser675 | human | Colorectal Cancer | HCT116 | Rp-8-Br-cAMPS | Associated | 4.0 (Moderate) | 22168384 |
acc1293 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | SW480 | Phytomedicine | Associated | 4.0 (Moderate) | 25647359 |
acc1294 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | DLD-1 | Phytomedicine | Associated | 4.0 (Moderate) | 25647359 |
acc1319 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser280 | human | Melanoma | A375(PLX4032-res) | PLX4032 + PF477736 | Associated | 4.0 (Moderate) | 30100999 |
acc1320 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser280 | human | Melanoma | WM9(PLX4032-res) | PLX4032 + PF477736 | Associated | 4.0 (Moderate) | 30100999 |
acc1321 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser296 | human | Melanoma | A375(PLX4032-res) | PLX4032 + PF477736 | Associated | 4.0 (Moderate) | 30100999 |
acc1322 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser296 | human | Melanoma | WM9(PLX4032-res) | PLX4032 + PF477736 | Associated | 4.0 (Moderate) | 30100999 |
acc1323 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser317 | human | Melanoma | A375(PLX4032-res) | PLX4032 + PF477736 | Associated | 4.0 (Moderate) | 30100999 |
acc1324 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser317 | human | Melanoma | WM9(PLX4032-res) | PLX4032 + PF477736 | Associated | 4.0 (Moderate) | 30100999 |
acc1325 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Melanoma | A375(PLX4032-res) | PLX4032 + PF477736 | Associated | 4.0 (Moderate) | 30100999 |
acc1326 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Melanoma | WM9(PLX4032-res) | PLX4032 + PF477736 | Associated | 4.0 (Moderate) | 30100999 |
acc1327 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Melanoma | SB01 | Bafetinib + Trametinib | Associated | 4.0 (Moderate) | 29717260 |
acc1328 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Melanoma | SB01 | Bafetinib + Trametinib | Associated | 4.0 (Moderate) | 29717260 |
acc1329 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Melanoma | SB01 | Bafetinib + Trametinib | Associated | 4.0 (Moderate) | 29717260 |
acc1330 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Melanoma | SB01 | Bafetinib + Trametinib | Associated | 4.0 (Moderate) | 29717260 |
acc1331 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MDA-MB-231 | Rapamycin | Associated | 4.0 (Moderate) | 22422409 |
acc1332 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MDA-MB-435 | Rapamycin | Associated | 4.0 (Moderate) | 22422409 |
acc1333 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Breast Cancer | MDA-MB-231 | Rapamycin | Associated | 4.0 (Moderate) | 22422409 |
acc1334 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Breast Cancer | MDA-MB-435 | Rapamycin | Associated | 4.0 (Moderate) | 22422409 |
acc1338 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Prostate Cancer | DU145 | MNK-inh | Associated | 4.0 (Moderate) | 18809972 |
acc0005 | PTEN | P60484 | PTEN | acetylation | unclear | human | Hepatocellular Carcinoma | SMMC-7721 | Pterostilbene | Associated | 4.0 (Moderate) | 29635894 |
acc0006 | c-Jun | P05412 | JUN | acetylation | unclear | human | Skin Cancer | A431 | Ginsenoside Rg3 | Associated | 4.0 (Moderate) | 31192452 |
acc0007 | c-Jun | P05412 | JUN | acetylation | unclear | human | Skin Cancer | SCC12 | Ginsenoside Rg3 | Associated | 4.0 (Moderate) | 31192452 |
acc0013 | METTL3 | Q86U44 | METTL3 | acetylation | unclear | human | Hepatocellular Carcinoma | HepG2 | Sulfatide | Associated | 4.0 (Moderate) | 36149370 |
acc0014 | METTL3 | Q86U44 | METTL3 | acetylation | unclear | human | Hepatocellular Carcinoma | Hep3B | Sulfatide | Associated | 4.0 (Moderate) | 36149370 |
acc0015 | METTL3 | Q86U44 | METTL3 | acetylation | unclear | human | Hepatocellular Carcinoma | SMMC-7721 | Sulfatide | Associated | 4.0 (Moderate) | 36149370 |
acc0041 | FLT3 | P36888 | FLT3 | methylation | Arg972 | human | Leukemia | MV4-11 | MS023 | Associated | 4.0 (Moderate) | 31217189 |
acc0042 | FLT3 | P36888 | FLT3 | methylation | Arg973 | human | Leukemia | MV4-11 | MS023 | Associated | 4.0 (Moderate) | 31217189 |
acc0043 | FLT3 | P36888 | FLT3 | methylation | Arg972 | human | Leukemia | MV4-11 | TC-E-5003 | Associated | 4.0 (Moderate) | 31217189 |
acc0044 | FLT3 | P36888 | FLT3 | methylation | Arg973 | human | Leukemia | MV4-11 | TC-E-5003 | Associated | 4.0 (Moderate) | 31217189 |
acc0049 | cullin | Q13616 | CUL1 | neddylation | unclear | human | Pancreas Cancer | MIA PaCa-2 | MLN4924 | Associated | 4.0 (Moderate) | 22072567 |
acc0050 | cullin | Q13616 | CUL1 | neddylation | unclear | human | Pancreas Cancer | BxPC-3 | MLN4924 | Associated | 4.0 (Moderate) | 22072567 |
acc0051 | cullin | Q13616 | CUL1 | neddylation | unclear | human | Glioblastoma | U251 | MLN4924 | Associated | 4.0 (Moderate) | 25904638 |
acc0052 | cullin | Q13616 | CUL1 | neddylation | unclear | human | Glioblastoma | A172 | MLN4924 | Associated | 4.0 (Moderate) | 25904638 |
acc0055 | VEGFR2 | P35918 | Kdr | phosphorylation | Tyr1059 | mouse | Osteosarcoma | MC3T3-E1 | Osimertinib | Associated | 4.0 (Moderate) | 23444047 |
acc0056 | VEGFR2 | P35918 | Kdr | phosphorylation | Tyr1059 | mouse | Osteosarcoma | UMR-106 | Osimertinib | Associated | 4.0 (Moderate) | 23444047 |
acc0057 | JNK | P49185 | Mapk8 | phosphorylation | Thr183 | rat | Insulinoma | RINm5F | Hypericin | Associated | 4.0 (Moderate) | 26182357 |
acc0058 | JNK | P49185 | Mapk8 | phosphorylation | Tyr185 | rat | Insulinoma | RINm5F | Hypericin | Associated | 4.0 (Moderate) | 26182357 |
acc0059 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Insulinoma | RINm5F | Hypericin | Associated | 4.0 (Moderate) | 26182357 |
acc0060 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Insulinoma | RINm5F | Hypericin | Associated | 4.0 (Moderate) | 26182357 |
acc0061 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Insulinoma | RINm5F | Hypericin | Associated | 4.0 (Moderate) | 26182357 |
acc0062 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Insulinoma | RINm5F | Hypericin | Associated | 4.0 (Moderate) | 26182357 |
acc0063 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | unclear | human | Glioblastoma | GBM | Luteolin | Associated | 4.0 (Moderate) | 30798142 |
acc0064 | PERK | Q9NZJ5 | EIF2AK3 | phosphorylation | unclear | human | Glioblastoma | GBM | Luteolin | Associated | 4.0 (Moderate) | 30798142 |
acc0065 | CHOP | P53778 | DDIT3 | phosphorylation | unclear | human | Glioblastoma | GBM | Luteolin | Associated | 4.0 (Moderate) | 30798142 |
acc0066 | ATF4 | P18848 | ATF4 | phosphorylation | unclear | human | Glioblastoma | GBM | Luteolin | Associated | 4.0 (Moderate) | 30798142 |
acc0067 | SMAD2 | Q15796 | SMAD2 | phosphorylation | unclear | human | Glioma | LN-308 | ISTH1047 | Associated | 4.0 (Moderate) | 31530630 |
acc0068 | Smad2 | Q62432 | Smad2 | phosphorylation | unclear | mouse | Glioma | SMA-560 | ISTH1047 | Associated | 4.0 (Moderate) | 31530630 |
acc0069 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Myeloma | MM | Z-VAD-FMK/PS-341 | Associated | 4.0 (Moderate) | 14627979 |
acc0070 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Myeloma | MM | Z-VAD-FMK/PS-341 | Associated | 4.0 (Moderate) | 14627979 |
acc0071 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Myeloma | MM | Z-VAD-FMK/PS-341 | Associated | 4.0 (Moderate) | 14627979 |
acc0072 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Myeloma | MM | Z-VAD-FMK/PS-341 | Associated | 4.0 (Moderate) | 14627979 |
acc0073 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Myeloma | MM | Z-VAD-FMK/PS-341 | Associated | 4.0 (Moderate) | 14627979 |
acc0074 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Myeloma | MM | Z-VAD-FMK/PS-341 | Associated | 4.0 (Moderate) | 14627979 |
acc0075 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Hepatocellular Carcinoma | HuH-7-EGFRvIII | CH12 + Sorafenib | Associated | 4.0 (Moderate) | 22787432 |
acc0076 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Hepatocellular Carcinoma | SMMC-7721 | CH12 + Sorafenib | Associated | 4.0 (Moderate) | 22787432 |
acc0077 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Hepatocellular Carcinoma | HuH-7-EGFRvIII | CH12 + Sorafenib | Associated | 4.0 (Moderate) | 22787432 |
acc0078 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Hepatocellular Carcinoma | SMMC-7721 | CH12 + Sorafenib | Associated | 4.0 (Moderate) | 22787432 |
acc0079 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | HuH-7-EGFRvIII | CH12 + Sorafenib | Associated | 4.0 (Moderate) | 22787432 |
acc0080 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | SMMC-7721 | CH12 + Sorafenib | Associated | 4.0 (Moderate) | 22787432 |
acc0099 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Skin Cancer | Colo16 | AEE788 | Associated | 4.0 (Moderate) | 15756022 |
acc0100 | VEGFR2 | P35968 | KDR | phosphorylation | Tyr1054 | human | Skin Cancer | Colo16 | AEE788 | Associated | 4.0 (Moderate) | 15756022 |
acc0101 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Skin Cancer | Colo16 | AEE788 | Associated | 4.0 (Moderate) | 15756022 |
acc0102 | MAPK | P28482 | MAPK1 | phosphorylation | Thr202 | human | Skin Cancer | Colo16 | AEE788 | Associated | 4.0 (Moderate) | 15756022 |
acc0103 | MAPK | P28482 | MAPK1 | phosphorylation | Tyr204 | human | Skin Cancer | Colo16 | AEE788 | Associated | 4.0 (Moderate) | 15756022 |
acc0105 | EGFR | P00533 | EGFR | phosphorylation | Tyr1173 | human | Pancreas Cancer | L3.6pl | AEE788 | Associated | 4.0 (Moderate) | 16026649 |
acc0106 | EGFR | P00533 | EGFR | phosphorylation | Tyr1173 | human | Pancreas Cancer | L3.6pl | AEE788 + gemcitabine | Associated | 4.0 (Moderate) | 16026649 |
acc0107 | VEGFR | P17948 | FLT1 | phosphorylation | unclear | human | Pancreas Cancer | L3.6pl | AEE788 | Associated | 4.0 (Moderate) | 16026649 |
acc0108 | VEGFR | P17948 | FLT1 | phosphorylation | unclear | human | Pancreas Cancer | L3.6pl | AEE788 + gemcitabine | Associated | 4.0 (Moderate) | 16026649 |
acc0109 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | L3.6pl | AEE788 | Associated | 4.0 (Moderate) | 16026649 |
acc0110 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | L3.6pl | AEE788 + gemcitabine | Associated | 4.0 (Moderate) | 16026649 |
acc0111 | EGFR | P00533 | EGFR | phosphorylation | Tyr1173 | human | Pancreas Cancer | L3.6pl | AEE788 + STI57 | Associated | 4.0 (Moderate) | 16288027 |
acc0112 | EGFR | P00533 | EGFR | phosphorylation | Tyr1173 | human | Pancreas Cancer | L3.6pl | AEE788 + STI57 + gemcitabine | Associated | 4.0 (Moderate) | 16288027 |
acc0113 | VEGFR | P17948 | FLT1 | phosphorylation | unclear | human | Pancreas Cancer | L3.6pl | AEE788 + STI57 | Associated | 4.0 (Moderate) | 16288027 |
acc0114 | VEGFR | P17948 | FLT1 | phosphorylation | unclear | human | Pancreas Cancer | L3.6pl | AEE788 + STI57 + gemcitabine | Associated | 4.0 (Moderate) | 16288027 |
acc0115 | PDGFR | P16234 | PDGFRA | phosphorylation | Tyr716 | human | Pancreas Cancer | L3.6pl | AEE788 + STI57 | Associated | 4.0 (Moderate) | 16288027 |
acc0116 | PDGFR | P16234 | PDGFRA | phosphorylation | Tyr716 | human | Pancreas Cancer | L3.6pl | AEE788 + STI57 + gemcitabine | Associated | 4.0 (Moderate) | 16288027 |
acc0117 | PDGFR | P16234 | PDGFRA | phosphorylation | Tyr716 | human | Pancreas Cancer | L3.6pl | STI571 | Associated | 4.0 (Moderate) | 16288027 |
acc0118 | PDGFR | P16234 | PDGFRA | phosphorylation | Tyr716 | human | Pancreas Cancer | GN963 | Associated | 4.0 (Moderate) | 16773192 | |
acc0119 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Ser41 | human | Colorectal Cancer | SW480 | Aspirin | Associated | 4.0 (Moderate) | 16878161 |
acc0120 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Thr45 | human | Colorectal Cancer | SW480 | Aspirin | Associated | 4.0 (Moderate) | 16878161 |
acc0121 | PP2A | Q15257 | PTPA | phosphorylation | Tyr307 | human | Colorectal Cancer | SW480 | Aspirin | Associated | 4.0 (Moderate) | 16878161 |
acc0122 | beta-catenin | P35222 | CTNNB1 | ubiquitination | unclear | human | Colorectal Cancer | SW480 | Aspirin | Associated | 4.0 (Moderate) | 16878161 |
acc0127 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MCF7 | INCB3619 | Associated | 4.0 (Moderate) | 17363546 |
acc0130 | FOXO3a | O43524 | FOXO3 | phosphorylation | Tyr | human | Breast Cancer | BT474 | Lapatinib | Associated | 4.0 (Moderate) | 17513611 |
acc0131 | FOXO3a | O43524 | FOXO3 | phosphorylation | Tyr | human | Breast Cancer | SK-BR-3 | Lapatinib | Associated | 4.0 (Moderate) | 17513611 |
acc0132 | FOXO3a | O43524 | FOXO3 | phosphorylation | Tyr | human | Breast Cancer | MDA-MB-468 | Lapatinib | Associated | 4.0 (Moderate) | 17513611 |
acc0133 | FOXO3a | O43524 | FOXO3 | phosphorylation | Tyr | human | Breast Cancer | T47D | Lapatinib | Associated | 4.0 (Moderate) | 17513611 |
acc0134 | EGFR | P00533 | EGFR | phosphorylation | Tyr | human | Colorectal Cancer | HT29 | NS-398 | Associated | 4.0 (Moderate) | 17877615 |
acc0135 | EGFR | P00533 | EGFR | phosphorylation | Tyr | human | Colorectal Cancer | HCA7 | NS-398 | Associated | 4.0 (Moderate) | 17877615 |
acc0142 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Leukemia | HL-60 | AD 198 | Associated | 4.0 (Moderate) | 17187856 |
acc0143 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Leukemia | HL-60 | AD 198 | Associated | 4.0 (Moderate) | 17187856 |
acc0144 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Leukemia | HL-60 | AD 198 | Associated | 4.0 (Moderate) | 17187856 |
acc0145 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Leukemia | HL-60 | AD 198 | Associated | 4.0 (Moderate) | 17187856 |
acc0146 | STAT5 | P42229 | STAT5A | phosphorylation | Tyr694 | human | Leukemia | HL-60 | AD 198 | Associated | 4.0 (Moderate) | 17187856 |
acc0149 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Endometrial Cancer | Ishikawa | Perifosine | Associated | 4.0 (Moderate) | 18687514 |
acc0150 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Endometrial Cancer | HEC-1A | Perifosine | Associated | 4.0 (Moderate) | 18687514 |
acc0152 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Endometrial Cancer | Ishikawa | Perifosine | Associated | 4.0 (Moderate) | 18687514 |
acc0153 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Endometrial Cancer | HEC-1A | Perifosine | Associated | 4.0 (Moderate) | 18687514 |
acc0155 | Smad3 | P84022 | SMAD3 | phosphorylation | Ser425 | human | Renal Cancer | FU-UR-1 | Halofuginone | Associated | 4.0 (Moderate) | 18714394 |
acc0156 | EphA2 | P29317 | EPHA2 | phosphorylation | Tyr100 | human | Pancreas Cancer | BxPC-3 | Dasatinib | Associated | 4.0 (Moderate) | 18797457 |
acc0157 | EphA2 | P29317 | EPHA2 | phosphorylation | Tyr100 | human | Pancreas Cancer | PANC-1 | Dasatinib | Associated | 4.0 (Moderate) | 18797457 |
acc0158 | EphA2 | P29317 | EPHA2 | phosphorylation | Tyr100 | human | Pancreas Cancer | MIA PaCa-2 | Dasatinib | Associated | 4.0 (Moderate) | 18797457 |
acc0163 | ATM | Q13315 | ATM | phosphorylation | Ser1981 | human | Leukemia | Doxorubicin | Associated | 4.0 (Moderate) | 19411853 | |
acc0165 | ATM | Q13315 | ATM | phosphorylation | Ser1981 | human | Leukemia | Daunomycin | Associated | 4.0 (Moderate) | 19411853 | |
acc0167 | ATM | Q13315 | ATM | phosphorylation | Ser1981 | human | Leukemia | Mitoxantrone | Associated | 4.0 (Moderate) | 19411853 | |
acc0169 | ATM | Q13315 | ATM | phosphorylation | Ser1981 | human | Leukemia | Idarubicin | Associated | 4.0 (Moderate) | 19411853 | |
acc0171 | Src | P12931 | SRC | phosphorylation | Tyr419 | human | Sarcoma | SaOS-2 | Dasatinib | Associated | 4.0 (Moderate) | 19447875 |
acc0172 | Src | P12931 | SRC | phosphorylation | Tyr419 | human | Sarcoma | 143B | Dasatinib | Associated | 4.0 (Moderate) | 19447875 |
acc0174 | PDGFR | P16234 | PDGFRA | phosphorylation | Tyr751 | human | Sarcoma | MPNST | Imatinib | Associated | 4.0 (Moderate) | 19627534 |
acc0175 | STAT5 | P42229 | STAT5A | phosphorylation | Tyr694 | human | Leukemia | MV4-11 | Cabozantinib | Associated | 4.0 (Moderate) | 27060207 |
acc0176 | FLT3 | P36888 | FLT3 | phosphorylation | Tyr589 | human | Leukemia | MV4-11 | Cabozantinib | Associated | 4.0 (Moderate) | 27060207 |
acc0177 | FLT3 | P36888 | FLT3 | phosphorylation | Tyr591 | human | Leukemia | MV4-11 | Cabozantinib | Associated | 4.0 (Moderate) | 27060207 |
acc0178 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Leukemia | MV4-11 | Cabozantinib | Associated | 4.0 (Moderate) | 27060207 |
acc0179 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Leukemia | MV4-11 | Cabozantinib | Associated | 4.0 (Moderate) | 27060207 |
acc0180 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Leukemia | MV4-11 | Cabozantinib | Associated | 4.0 (Moderate) | 27060207 |
acc0181 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Leukemia | MV4-11 | Cabozantinib | Associated | 4.0 (Moderate) | 27060207 |
acc0182 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Leukemia | MV4-11 | Cabozantinib | Associated | 4.0 (Moderate) | 27060207 |
acc0183 | MAPK | P28482 | MAPK1 | phosphorylation | unclear | human | Ovarian Cancer | A2780 | Tamoxifen | Associated | 4.0 (Moderate) | 20056081 |
acc0184 | MAPK | P28482 | MAPK1 | phosphorylation | unclear | human | Ovarian Cancer | CAOV-3 | Tamoxifen | Associated | 4.0 (Moderate) | 20056081 |
acc0185 | AKT | P31749 | AKT1 | phosphorylation | unclear | human | Ovarian Cancer | SK-OV-3 | Tamoxifen | Associated | 4.0 (Moderate) | 20056081 |
acc0186 | AKT | P31749 | AKT1 | phosphorylation | unclear | human | Ovarian Cancer | ES-2 | Tamoxifen | Associated | 4.0 (Moderate) | 20056081 |
acc0187 | ER | P03372 | ESR1 | phosphorylation | Ser118 | human | Ovarian Cancer | A2780 | Tamoxifen | Associated | 4.0 (Moderate) | 20056081 |
acc0188 | ER | P03372 | ESR1 | phosphorylation | Ser167 | human | Ovarian Cancer | A2780 | Tamoxifen | Associated | 4.0 (Moderate) | 20056081 |
acc0189 | ER | P03372 | ESR1 | phosphorylation | Ser118 | human | Ovarian Cancer | CAOV-3 | Tamoxifen | Associated | 4.0 (Moderate) | 20056081 |
acc0190 | ER | P03372 | ESR1 | phosphorylation | Ser167 | human | Ovarian Cancer | CAOV-3 | Tamoxifen | Associated | 4.0 (Moderate) | 20056081 |
acc0191 | ER | P03372 | ESR1 | phosphorylation | Ser118 | human | Ovarian Cancer | SK-OV-3 | Tamoxifen | Associated | 4.0 (Moderate) | 20056081 |
acc0192 | ER | P03372 | ESR1 | phosphorylation | Ser167 | human | Ovarian Cancer | SK-OV-3 | Tamoxifen | Associated | 4.0 (Moderate) | 20056081 |
acc0193 | ER | P03372 | ESR1 | phosphorylation | Ser118 | human | Ovarian Cancer | ES-2 | Tamoxifen | Associated | 4.0 (Moderate) | 20056081 |
acc0194 | ER | P03372 | ESR1 | phosphorylation | Ser167 | human | Ovarian Cancer | ES-2 | Tamoxifen | Associated | 4.0 (Moderate) | 20056081 |
acc0195 | MAPK | P28482 | MAPK1 | phosphorylation | unclear | human | Ovarian Cancer | SK-OV-3 | Tamoxifen | Associated | 4.0 (Moderate) | 20056081 |
acc0196 | MAPK | P28482 | MAPK1 | phosphorylation | unclear | human | Ovarian Cancer | ES-2 | Tamoxifen | Associated | 4.0 (Moderate) | 20056081 |
acc0197 | AKT | P31749 | AKT1 | phosphorylation | unclear | human | Ovarian Cancer | A2780 | Tamoxifen | Associated | 4.0 (Moderate) | 20056081 |
acc0198 | AKT | P31749 | AKT1 | phosphorylation | unclear | human | Ovarian Cancer | CAOV-3 | Tamoxifen | Associated | 4.0 (Moderate) | 20056081 |
acc0199 | IkB | P25963 | NFKBIA | phosphorylation | unclear | human | Prostate Cancer | DU145 | EC-70124 | Associated | 4.0 (Moderate) | 26826115 |
acc0200 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Prostate Cancer | DU145 | EC-70124 | Associated | 4.0 (Moderate) | 26826115 |
acc0201 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Prostate Cancer | DU145 | EC-70124 | Associated | 4.0 (Moderate) | 26826115 |
acc0202 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Prostate Cancer | DU145 | EC-70124 | Associated | 4.0 (Moderate) | 26826115 |
acc0203 | FAK | P34152 | Ptk2 | phosphorylation | Tyr397 | mouse | Breast Cancer | 4T1 | PND-1186 | Associated | 4.0 (Moderate) | 20234191 |
acc0204 | FAK | P34152 | Ptk2 | phosphorylation | Tyr397 | mouse | Ovarian Cancer | ID8 | PND-1186 | Associated | 4.0 (Moderate) | 20234191 |
acc0205 | AKT | P31749 | AKT1 | phosphorylation | unclear | human | Ovarian Cancer | SK-OV-3 | JMR-132 | Associated | 4.0 (Moderate) | 20509930 |
acc0206 | AKT | P31749 | AKT1 | phosphorylation | unclear | human | Ovarian Cancer | CaOV3 | JMR-132 | Associated | 4.0 (Moderate) | 20509930 |
acc0207 | IkappaBalpha | P25963 | NFKBIA | phosphorylation | unclear | human | Pancreas Cancer | PANC-1 | Nafamostat mesilate | Associated | 4.0 (Moderate) | 20811662 |
acc0217 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Ovarian Cancer | OVCAR-3 | GnRH-II | Associated | 4.0 (Moderate) | 21239435 |
acc0218 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Ovarian Cancer | CaOV-3 | GnRH-II | Associated | 4.0 (Moderate) | 21239435 |
acc0219 | MYC | P01106 | MYC | phosphorylation | Ser62 | human | Hepatocellular Carcinoma | HuH-7 | Atorvastatin | Associated | 4.0 (Moderate) | 21262914 |
acc0220 | MYC | P01106 | MYC | phosphorylation | Ser62 | human | Hepatocellular Carcinoma | HepG2 | Atorvastatin | Associated | 4.0 (Moderate) | 21262914 |
acc0221 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Hepatocellular Carcinoma | SNU-449 | Celecoxib | Associated | 4.0 (Moderate) | 21490132 |
acc0222 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Hepatocellular Carcinoma | HuH-7 | Celecoxib | Associated | 4.0 (Moderate) | 21490132 |
acc0223 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | SNU-367 | Celecoxib | Associated | 4.0 (Moderate) | 21490132 |
acc0224 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | HepG2 | Celecoxib | Associated | 4.0 (Moderate) | 21490132 |
acc0225 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Hepatocellular Carcinoma | SNU-367 | Celecoxib | Associated | 4.0 (Moderate) | 21490132 |
acc0226 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Hepatocellular Carcinoma | HepG2 | Celecoxib | Associated | 4.0 (Moderate) | 21490132 |
acc0227 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Hepatocellular Carcinoma | SNU-449 | Celecoxib | Associated | 4.0 (Moderate) | 21490132 |
acc0228 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Hepatocellular Carcinoma | HuH-7 | Celecoxib | Associated | 4.0 (Moderate) | 21490132 |
acc0229 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Hepatocellular Carcinoma | SNU-367 | Celecoxib | Associated | 4.0 (Moderate) | 21490132 |
acc0230 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Hepatocellular Carcinoma | HepG2 | Celecoxib | Associated | 4.0 (Moderate) | 21490132 |
acc0231 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | SNU-449 | Celecoxib | Associated | 4.0 (Moderate) | 21490132 |
acc0232 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | HuH-7 | Celecoxib | Associated | 4.0 (Moderate) | 21490132 |
acc0233 | JNK | P45983 | MAPK8 | phosphorylation | Thr181 | human | Breast Cancer | MCF7 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0234 | JNK | P45983 | MAPK8 | phosphorylation | Thr181 | human | Renal Cancer | A489 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0235 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Renal Cancer | A489 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0236 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Renal Cancer | A489 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0237 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Renal Cancer | A489 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0238 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Renal Cancer | A489 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0239 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Breast Cancer | MCF7 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0240 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Renal Cancer | A489 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0241 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Breast Cancer | MCF7 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0242 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Renal Cancer | A489 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0243 | JNK | P45983 | MAPK8 | phosphorylation | Thr185 | human | Breast Cancer | MCF7 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0244 | JNK | P45983 | MAPK8 | phosphorylation | Thr185 | human | Renal Cancer | A489 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0245 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | MCF7 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0246 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Renal Cancer | A489 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0247 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Breast Cancer | MCF7 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0248 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Breast Cancer | MCF7 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0249 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Breast Cancer | MCF7 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0250 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Breast Cancer | MCF7 | NSC-743380 | Associated | 4.0 (Moderate) | 22174819 |
acc0251 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | A2780 | arsenic trioxide (ATO) | Associated | 4.0 (Moderate) | 21655183 |
acc0252 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | COC1 | arsenic trioxide (ATO) | Associated | 4.0 (Moderate) | 21655183 |
acc0253 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | COC1/CP | arsenic trioxide (ATO) | Associated | 4.0 (Moderate) | 21655183 |
acc0254 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | A2780/CP | arsenic trioxide (ATO) | Associated | 4.0 (Moderate) | 21655183 |
acc0255 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | OVCAR-3 | arsenic trioxide (ATO) | Associated | 4.0 (Moderate) | 21655183 |
acc0256 | p65 | Q9QZJ5 | Esr1 | phosphorylation | Ser536 | hamster | Oral Cancer | Andrographolide | Associated | 4.0 (Moderate) | 21841043 | |
acc0257 | IkappaBalpha | A0A1U7QI43 | Ikbkb | phosphorylation | Ser32 | hamster | Oral Cancer | Andrographolide | Associated | 4.0 (Moderate) | 21841043 | |
acc0258 | IkappaBalpha | A0A1U7QI43 | Ikbkb | phosphorylation | Ser36 | hamster | Oral Cancer | Andrographolide | Associated | 4.0 (Moderate) | 21841043 | |
acc0259 | VEGFR2 | P35968 | KDR | phosphorylation | Tyr1175 | human | Hepatocellular Carcinoma | KYN-2 | Vandetanib | Associated | 4.0 (Moderate) | 22611027 |
acc0260 | VEGFR2 | P35968 | KDR | phosphorylation | Tyr1175 | human | Hepatocellular Carcinoma | HAK1-B | Vandetanib | Associated | 4.0 (Moderate) | 22611027 |
acc0261 | VEGFR2 | P35968 | KDR | phosphorylation | Tyr1175 | human | Hepatocellular Carcinoma | HuH-7 | Vandetanib | Associated | 4.0 (Moderate) | 22611027 |
acc0262 | EGFR | P00533 | EGFR | phosphorylation | Tyr1173 | human | Hepatocellular Carcinoma | KYN-2 | Vandetanib | Associated | 4.0 (Moderate) | 22611027 |
acc0263 | EGFR | P00533 | EGFR | phosphorylation | Tyr1173 | human | Hepatocellular Carcinoma | HAK1-B | Vandetanib | Associated | 4.0 (Moderate) | 22611027 |
acc0264 | EGFR | P00533 | EGFR | phosphorylation | Tyr1173 | human | Hepatocellular Carcinoma | HuH-7 | Vandetanib | Associated | 4.0 (Moderate) | 22611027 |
acc0265 | MET | P08581 | MET | phosphorylation | Tyr1234 | human | Ovarian Cancer | 58As9 | Crizotinib | Associated | 4.0 (Moderate) | 22729845 |
acc0266 | MET | P08581 | MET | phosphorylation | Tyr1234 | human | Gastric Cancer | SNU5 | Crizotinib | Associated | 4.0 (Moderate) | 22729845 |
acc0267 | MET | P08581 | MET | phosphorylation | Tyr1234 | human | Hepatocellular Carcinoma | HSC58 | Crizotinib | Associated | 4.0 (Moderate) | 22729845 |
acc0268 | MET | P08581 | MET | phosphorylation | Tyr1234 | human | Ovarian Cancer | 58As1 | Crizotinib | Associated | 4.0 (Moderate) | 22729845 |
acc0269 | MET | P08581 | MET | phosphorylation | Tyr1235 | human | Ovarian Cancer | 58As9 | Crizotinib | Associated | 4.0 (Moderate) | 22729845 |
acc0270 | MET | P08581 | MET | phosphorylation | Tyr1235 | human | Gastric Cancer | SNU5 | Crizotinib | Associated | 4.0 (Moderate) | 22729845 |
acc0271 | MET | P08581 | MET | phosphorylation | Tyr1235 | human | Hepatocellular Carcinoma | HSC58 | Crizotinib | Associated | 4.0 (Moderate) | 22729845 |
acc0272 | MET | P08581 | MET | phosphorylation | Tyr1235 | human | Ovarian Cancer | 58As1 | Crizotinib | Associated | 4.0 (Moderate) | 22729845 |
acc0273 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Colorectal Cancer | HT29 | PMA | Associated | 4.0 (Moderate) | 22812190 |
acc0274 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Colorectal Cancer | HT29 | PMA | Associated | 4.0 (Moderate) | 22812190 |
acc0275 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Colorectal Cancer | HT29 | PMA | Associated | 4.0 (Moderate) | 22812190 |
acc0276 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Colorectal Cancer | HT29 | PMA | Associated | 4.0 (Moderate) | 22812190 |
acc0277 | ITGB4 | P23229 | ITGB4 | phosphorylation | Ser1356 | human | Skin Cancer | A431 | Cyclosporine A | Associated | 4.0 (Moderate) | 22865863 |
acc0278 | ITGB4 | P23229 | ITGB4 | phosphorylation | Ser1356 | human | Tongue Cancer | SCC25 | Cyclosporine A | Associated | 4.0 (Moderate) | 22865863 |
acc0279 | ITGB4 | P23229 | ITGB4 | phosphorylation | Ser1356 | human | Skin Cancer | Colo16 | Cyclosporine A | Associated | 4.0 (Moderate) | 22865863 |
acc0280 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Sarcoma | CME-1 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0281 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Sarcoma | 1273/99 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0282 | FAK | Q05397 | PTK2 | phosphorylation | Tyr576 | human | Sarcoma | FUJI | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0283 | FAK | Q05397 | PTK2 | phosphorylation | Tyr576 | human | Sarcoma | SYO-1 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0284 | FAK | Q05397 | PTK2 | phosphorylation | Tyr577 | human | Sarcoma | CME-1 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0285 | FAK | Q05397 | PTK2 | phosphorylation | Tyr577 | human | Sarcoma | 1273/99 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0286 | FAK | Q05397 | PTK2 | phosphorylation | Tyr577 | human | Sarcoma | FUJI | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0287 | FAK | Q05397 | PTK2 | phosphorylation | Tyr577 | human | Sarcoma | SYO-1 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0288 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Sarcoma | CME-1 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0289 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Sarcoma | 1273/99 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0290 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Sarcoma | FUJI | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0291 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Sarcoma | SYO-1 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0292 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Sarcoma | FUJI | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0293 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1131 | human | Sarcoma | CME-1 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0294 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1131 | human | Sarcoma | 1273/99 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0295 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1131 | human | Sarcoma | FUJI | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0296 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1131 | human | Sarcoma | SYO-1 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0297 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Sarcoma | SYO-1 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0298 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Sarcoma | CME-1 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0299 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Sarcoma | 1273/99 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0300 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Sarcoma | FUJI | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0301 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Sarcoma | SYO-1 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0302 | FAK | Q05397 | PTK2 | phosphorylation | Tyr576 | human | Sarcoma | CME-1 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0303 | FAK | Q05397 | PTK2 | phosphorylation | Tyr576 | human | Sarcoma | 1273/99 | Dasatinib | Associated | 4.0 (Moderate) | 23580575 |
acc0304 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Ovarian Cancer | A2780/CP | beta-Elemene + Cisplatin | Associated | 4.0 (Moderate) | 23277286 |
acc0305 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Ovarian Cancer | MCAS | beta-Elemene + Cisplatin | Associated | 4.0 (Moderate) | 23277286 |
acc0310 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | PC9 | BEZ235 | Associated | 4.0 (Moderate) | 23319394 |
acc0311 | p70S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Lung Cancer | PC9 | BEZ235 | Associated | 4.0 (Moderate) | 23319394 |
acc0312 | S6RP | P62753 | RPS6 | phosphorylation | Ser235 | human | Lung Cancer | PC9 | BEZ235 | Associated | 4.0 (Moderate) | 23319394 |
acc0313 | S6RP | P62753 | RPS6 | phosphorylation | Ser236 | human | Lung Cancer | PC9 | BEZ235 | Associated | 4.0 (Moderate) | 23319394 |
acc0314 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Prostate Cancer | BxPC3 | Rapamycin | Associated | 4.0 (Moderate) | 23443316 |
acc0315 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | PANC-1 | Rapamycin | Associated | 4.0 (Moderate) | 23443316 |
acc0316 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | HT29 | 3-deazaneplanocin A (DZNep) | Associated | 4.0 (Moderate) | 23588203 |
acc0317 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | 3-deazaneplanocin A (DZNep) | Associated | 4.0 (Moderate) | 23588203 | |
acc0318 | IkappaBalpha | P25963 | NFKBIA | phosphorylation | Ser32 | human | Ovarian Cancer | OVCAR-3 | Minocycline | Associated | 4.0 (Moderate) | 23858099 |
acc0319 | IkappaBalpha | P25963 | NFKBIA | phosphorylation | Ser32 | human | Ovarian Cancer | SK-OV-3 | Minocycline | Associated | 4.0 (Moderate) | 23858099 |
acc0320 | IkappaBalpha | P25963 | NFKBIA | phosphorylation | Ser36 | human | Ovarian Cancer | OVCAR-3 | Minocycline | Associated | 4.0 (Moderate) | 23858099 |
acc0321 | IkappaBalpha | P25963 | NFKBIA | phosphorylation | Ser36 | human | Ovarian Cancer | SK-OV-3 | Minocycline | Associated | 4.0 (Moderate) | 23858099 |
acc0322 | p65 | Q04206 | RELA | phosphorylation | Ser536 | human | Ovarian Cancer | OVCAR-3 | Minocycline | Associated | 4.0 (Moderate) | 23858099 |
acc0323 | p65 | Q04206 | RELA | phosphorylation | Ser536 | human | Ovarian Cancer | SK-OV-3 | Minocycline | Associated | 4.0 (Moderate) | 23858099 |
acc0324 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Hepatocellular Carcinoma | CSQT-2 | all-trans retinoic acid (ATRA) + cisplatin | Associated | 4.0 (Moderate) | 23867314 |
acc0325 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Hepatocellular Carcinoma | HuH-7 | all-trans retinoic acid (ATRA) + cisplatin | Associated | 4.0 (Moderate) | 23867314 |
acc0326 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hemangioma | Rapamycin | Associated | 4.0 (Moderate) | 23938603 | |
acc0327 | PKCalpha | P17252 | PRKCA | phosphorylation | Ser657 | human | Hemangioma | Rapamycin | Associated | 4.0 (Moderate) | 23938603 | |
acc0328 | EGFR | P00533 | EGFR | phosphorylation | Tyr1173 | human | Thyroid Cancer | 8305C | Sunitinib | Associated | 4.0 (Moderate) | 23969186 |
acc0329 | EGFR | P00533 | EGFR | phosphorylation | Tyr1173 | human | Thyroid Cancer | FB3 | Sunitinib | Associated | 4.0 (Moderate) | 23969186 |
acc0330 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Thyroid Cancer | FB3 | Sunitinib | Associated | 4.0 (Moderate) | 23969186 |
acc0331 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Thyroid Cancer | FB3 | Sunitinib | Associated | 4.0 (Moderate) | 23969186 |
acc0332 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Thyroid Cancer | 8305C | Sunitinib | Associated | 4.0 (Moderate) | 23969186 |
acc0333 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Thyroid Cancer | FB3 | Sunitinib | Associated | 4.0 (Moderate) | 23969186 |
acc0334 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Thyroid Cancer | 8305C | Sunitinib | Associated | 4.0 (Moderate) | 23969186 |
acc0335 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Thyroid Cancer | 8305C | Sunitinib | Associated | 4.0 (Moderate) | 23969186 |
acc0336 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Thyroid Cancer | 8305C | Sunitinib | Associated | 4.0 (Moderate) | 23969186 |
acc0337 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Thyroid Cancer | 8305C | Sunitinib | Associated | 4.0 (Moderate) | 23969186 |
acc0338 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Thyroid Cancer | FB3 | Sunitinib | Associated | 4.0 (Moderate) | 23969186 |
acc0339 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Thyroid Cancer | FB3 | Sunitinib | Associated | 4.0 (Moderate) | 23969186 |
acc0342 | S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Colorectal Cancer | HT29 | AZD2014 | Associated | 4.0 (Moderate) | 24309100 |
acc0343 | S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Colorectal Cancer | DLD-1 | AZD2014 | Associated | 4.0 (Moderate) | 24309100 |
acc0344 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Colorectal Cancer | HT29 | AZD2014 | Associated | 4.0 (Moderate) | 24309100 |
acc0345 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Colorectal Cancer | DLD-1 | AZD2014 | Associated | 4.0 (Moderate) | 24309100 |
acc0346 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Colorectal Cancer | HT29 | AZD2014 | Associated | 4.0 (Moderate) | 24309100 |
acc0347 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Colorectal Cancer | DLD-1 | AZD2014 | Associated | 4.0 (Moderate) | 24309100 |
acc0348 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | HT29 | AZD2014 | Associated | 4.0 (Moderate) | 24309100 |
acc0349 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | DLD-1 | AZD2014 | Associated | 4.0 (Moderate) | 24309100 |
acc0354 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Prostate Cancer | PC3 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0355 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Breast Cancer | MCF7 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0356 | p70S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Prostate Cancer | PC3 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0357 | p70S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Breast Cancer | MCF7 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0358 | p70S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Lung Cancer | A549 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0359 | p70S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Ovarian Cancer | OVCAR-3 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0360 | p70S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Glioblastoma | U87-MG | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0361 | S6 | P62753 | RPS6 | phosphorylation | Ser240 | human | Prostate Cancer | PC3 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0362 | S6 | P62753 | RPS6 | phosphorylation | Ser240 | human | Breast Cancer | MCF7 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0363 | S6 | P62753 | RPS6 | phosphorylation | Ser240 | human | Lung Cancer | A549 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0364 | S6 | P62753 | RPS6 | phosphorylation | Ser240 | human | Ovarian Cancer | OVCAR-3 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0365 | S6 | P62753 | RPS6 | phosphorylation | Ser240 | human | Glioblastoma | U87-MG | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0366 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | A549 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0367 | S6 | P62753 | RPS6 | phosphorylation | Ser244 | human | Prostate Cancer | PC3 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0368 | S6 | P62753 | RPS6 | phosphorylation | Ser244 | human | Breast Cancer | MCF7 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0369 | S6 | P62753 | RPS6 | phosphorylation | Ser244 | human | Lung Cancer | A549 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0370 | S6 | P62753 | RPS6 | phosphorylation | Ser244 | human | Ovarian Cancer | OVCAR-3 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0371 | S6 | P62753 | RPS6 | phosphorylation | Ser244 | human | Glioblastoma | U87-MG | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0372 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Ovarian Cancer | OVCAR-3 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0373 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Glioblastoma | U87-MG | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0374 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Prostate Cancer | PC3 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0375 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MCF7 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0376 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | A549 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0377 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | OVCAR-3 | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0378 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Glioblastoma | U87-MG | XL765 (SAR245409) | Associated | 4.0 (Moderate) | 24634413 |
acc0379 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | BxPc-3 | alpha -Mangostin | Associated | 4.0 (Moderate) | 24812621 |
acc0380 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | PANC-1 | alpha -Mangostin | Associated | 4.0 (Moderate) | 24812621 |
acc0381 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Meningioma | IOMM-Lee | LB-100 | Associated | 4.0 (Moderate) | 36203966 |
acc0386 | VASP | P70460 | Vasp | phosphorylation | Ser239 | mouse | Colorectal Cancer | CT26 | Baicalein | Associated | 4.0 (Moderate) | 25268843 |
acc0387 | VASP | P70460 | Vasp | phosphorylation | Ser157 | mouse | Colorectal Cancer | CT26 | Baicalein | Associated | 4.0 (Moderate) | 25268843 |
acc0395 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Ovarian Cancer | TOV112D | Bortezomib | Associated | 4.0 (Moderate) | 25375375 |
acc0396 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Ovarian Cancer | TOV21G | Bortezomib | Associated | 4.0 (Moderate) | 25375375 |
acc0403 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Endometrial Cancer | Ishikawa | Bortezomib | Associated | 4.0 (Moderate) | 25375375 |
acc0404 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Hepatocellular Carcinoma | HepG2 | Bortezomib | Associated | 4.0 (Moderate) | 25375375 |
acc0405 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Ovarian Cancer | TOV112D | Bortezomib | Associated | 4.0 (Moderate) | 25375375 |
acc0406 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Ovarian Cancer | TOV21G | Bortezomib | Associated | 4.0 (Moderate) | 25375375 |
acc0407 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Endometrial Cancer | Ishikawa | Bortezomib | Associated | 4.0 (Moderate) | 25375375 |
acc0408 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Hepatocellular Carcinoma | HepG2 | Bortezomib | Associated | 4.0 (Moderate) | 25375375 |
acc0435 | CSE1L | P55060 | CSE1L | phosphorylation | unclear | human | Colorectal Cancer | HT29 | Vemurafenib + Sorafenib | Associated | 4.0 (Moderate) | 26070816 |
acc0436 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Colorectal Cancer | HT29 | Vemurafenib + Sorafenib | Associated | 4.0 (Moderate) | 26070816 |
acc0437 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Colorectal Cancer | HT29 | Vemurafenib + Sorafenib | Associated | 4.0 (Moderate) | 26070816 |
acc0438 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Colorectal Cancer | HT29 | Vemurafenib + Sorafenib | Associated | 4.0 (Moderate) | 26070816 |
acc0439 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Colorectal Cancer | HT29 | Vemurafenib + Sorafenib | Associated | 4.0 (Moderate) | 26070816 |
acc0440 | CSE1L | P55060 | CSE1L | phosphorylation | unclear | human | Melanoma | A375 | Vemurafenib + Sorafenib | Associated | 4.0 (Moderate) | 26070816 |
acc0441 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Melanoma | A375 | Vemurafenib + Sorafenib | Associated | 4.0 (Moderate) | 26070816 |
acc0442 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Melanoma | A375 | Vemurafenib + Sorafenib | Associated | 4.0 (Moderate) | 26070816 |
acc0443 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Melanoma | A375 | Vemurafenib + Sorafenib | Associated | 4.0 (Moderate) | 26070816 |
acc0444 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Melanoma | A375 | Vemurafenib + Sorafenib | Associated | 4.0 (Moderate) | 26070816 |
acc0445 | AMPK | Q9Y478 | PRKAB1 | phosphorylation | Thr180 | human | Colorectal Cancer | HT29 | TPA | Associated | 4.0 (Moderate) | 26116564 |
acc0446 | AMPK | Q9Y478 | PRKAB1 | phosphorylation | Thr180 | human | Colorectal Cancer | SW620 | TPA | Associated | 4.0 (Moderate) | 26116564 |
acc0447 | AMPK | Q9Y478 | PRKAB1 | phosphorylation | Tyr182 | human | Colorectal Cancer | HT29 | TPA | Associated | 4.0 (Moderate) | 26116564 |
acc0448 | AMPK | Q9Y478 | PRKAB1 | phosphorylation | Tyr182 | human | Colorectal Cancer | SW620 | TPA | Associated | 4.0 (Moderate) | 26116564 |
acc0452 | PI3K | P42336 | PIK3CA | phosphorylation | Tyr199 | human | Gastric Cancer | YCC1 | Mefloquine | Associated | 4.0 (Moderate) | 26780727 |
acc0453 | PI3K | P42336 | PIK3CA | phosphorylation | Tyr199 | human | Gastric Cancer | SNU1 | Mefloquine | Associated | 4.0 (Moderate) | 26780727 |
acc0454 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | SNU1 | Mefloquine | Associated | 4.0 (Moderate) | 26780727 |
acc0455 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | Hs746T | Mefloquine | Associated | 4.0 (Moderate) | 26780727 |
acc0456 | mTOR | P42345 | MTOR | phosphorylation | Ser2481 | human | Gastric Cancer | YCC1 | Mefloquine | Associated | 4.0 (Moderate) | 26780727 |
acc0457 | mTOR | P42345 | MTOR | phosphorylation | Ser2481 | human | Gastric Cancer | SNU1 | Mefloquine | Associated | 4.0 (Moderate) | 26780727 |
acc0458 | mTOR | P42345 | MTOR | phosphorylation | Ser2481 | human | Gastric Cancer | Hs746T | Mefloquine | Associated | 4.0 (Moderate) | 26780727 |
acc0459 | PI3K | P42336 | PIK3CA | phosphorylation | Tyr199 | human | Gastric Cancer | Hs746T | Mefloquine | Associated | 4.0 (Moderate) | 26780727 |
acc0460 | rS6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Gastric Cancer | YCC1 | Mefloquine | Associated | 4.0 (Moderate) | 26780727 |
acc0461 | rS6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Gastric Cancer | SNU1 | Mefloquine | Associated | 4.0 (Moderate) | 26780727 |
acc0462 | rS6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Gastric Cancer | Hs746T | Mefloquine | Associated | 4.0 (Moderate) | 26780727 |
acc0463 | rS6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Gastric Cancer | YCC1 | Mefloquine | Associated | 4.0 (Moderate) | 26780727 |
acc0464 | rS6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Gastric Cancer | SNU1 | Mefloquine | Associated | 4.0 (Moderate) | 26780727 |
acc0465 | rS6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Gastric Cancer | Hs746T | Mefloquine | Associated | 4.0 (Moderate) | 26780727 |
acc0466 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | YCC1 | Mefloquine | Associated | 4.0 (Moderate) | 26780727 |
acc0476 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Lung Cancer | H157 | CGP57380 + RAD001 | Associated | 4.0 (Moderate) | 27050281 |
acc0477 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H157 | CGP57380 + RAD001 | Associated | 4.0 (Moderate) | 27050281 |
acc0478 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Lung Cancer | A549 | CGP57380 + RAD001 | Associated | 4.0 (Moderate) | 27050281 |
acc0479 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | A549 | CGP57380 + RAD001 | Associated | 4.0 (Moderate) | 27050281 |
acc0480 | CCND1 | P24385 | CCND1 | phosphorylation | Thr286 | human | Colorectal Cancer | HCT116 | Kahweol | Associated | 4.0 (Moderate) | 27424123 |
acc0481 | CCND1 | P24385 | CCND1 | phosphorylation | Thr286 | human | Colorectal Cancer | SW480 | Kahweol | Associated | 4.0 (Moderate) | 27424123 |
acc0482 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | SGC7901 | MK-2206 + 5-fluorouracil | Associated | 4.0 (Moderate) | 27499633 |
acc0483 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | SGC7901 | MK-2206 + doxorubicin | Associated | 4.0 (Moderate) | 27499633 |
acc0484 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | MKN45 | MK-2206 + 5-fluorouracil | Associated | 4.0 (Moderate) | 27499633 |
acc0485 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | MKN45 | MK-2206 + doxorubicin | Associated | 4.0 (Moderate) | 27499633 |
acc0486 | STAT1 | P42224 | STAT1 | phosphorylation | Ser727 | human | Leukemia | SET-2 | Cortistatin A | Associated | 4.0 (Moderate) | 29239838 |
acc0487 | STAT1 | P42224 | STAT1 | phosphorylation | Ser727 | human | Leukemia | UKE-1 | Cortistatin A | Associated | 4.0 (Moderate) | 29239838 |
acc0490 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Hepatocellular Carcinoma | HepG2 | Cabozantinib + CT-707 | Associated | 4.0 (Moderate) | 27638856 |
acc0491 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Hepatocellular Carcinoma | Bel-7402 | Cabozantinib + CT-707 | Associated | 4.0 (Moderate) | 27638856 |
acc0492 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Hepatocellular Carcinoma | HepG2 | Cercosporamide | Associated | 4.0 (Moderate) | 27662474 |
acc0493 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Hepatocellular Carcinoma | HCC-EC | Cercosporamide | Associated | 4.0 (Moderate) | 27662474 |
acc0496 | PPARgamma | P37231 | PPARG | phosphorylation | Ser84 | human | Hepatocellular Carcinoma | HepG2 | PD0325901 | Associated | 4.0 (Moderate) | 27769068 |
acc0497 | PPARgamma | P37238 | Pparg | phosphorylation | Ser82 | mouse | Hepatocellular Carcinoma | Hepa1-6 | PD0325901 | Associated | 4.0 (Moderate) | 27769068 |
acc0498 | ATR | Q13535 | ATR | phosphorylation | Ser428 | human | Head and Neck Cancer | SCC61 | Cisplatin | Associated | 4.0 (Moderate) | 27863405 |
acc0499 | ATR | Q13535 | ATR | phosphorylation | Ser428 | human | Head and Neck Cancer | SCC25 | Cisplatin | Associated | 4.0 (Moderate) | 27863405 |
acc0500 | ATR | Q13535 | ATR | phosphorylation | Ser428 | human | Ovarian Cancer | OVCAR-8 | Cisplatin | Associated | 4.0 (Moderate) | 27863405 |
acc0501 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | KLM1-R | LY294002 | Associated | 4.0 (Moderate) | 28000865 |
acc0502 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | PK59 | LY294002 | Associated | 4.0 (Moderate) | 28000865 |
acc0509 | VEGFR2 | P35968 | KDR | phosphorylation | Tyr1175 | human | Bladder Cancer | T24 | AE-AS | Associated | 4.0 (Moderate) | 28710377 |
acc0511 | Smad2 | Q15796 | SMAD2 | phosphorylation | Ser465 | human | Breast Cancer | MDA-MB-231 | Nafamostat mesilate | Associated | 4.0 (Moderate) | 29196918 |
acc0512 | Smad2 | Q15796 | SMAD2 | phosphorylation | Ser467 | human | Breast Cancer | MDA-MB-231 | Nafamostat mesilate | Associated | 4.0 (Moderate) | 29196918 |
acc0513 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Breast Cancer | MDA-MB-231 | NM | Associated | 4.0 (Moderate) | 29196918 |
acc0514 | DNMT1 | P26358 | DNMT1 | ubiquitination | unclear | human | Colorectal Cancer | HCT-8-7T | Alisertib | Associated | 4.0 (Moderate) | 34522170 |
acc0515 | DNMT1 | P26358 | DNMT1 | ubiquitination | unclear | human | Colorectal Cancer | HCT-8-9T | Alisertib | Associated | 4.0 (Moderate) | 34522170 |
acc0521 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Leukemia | Trametinib | Associated | 4.0 (Moderate) | 29419436 | |
acc0522 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Leukemia | Trametinib | Associated | 4.0 (Moderate) | 29419436 | |
acc0523 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Leukemia | Trametinib | Associated | 4.0 (Moderate) | 29419436 | |
acc0524 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Leukemia | Trametinib | Associated | 4.0 (Moderate) | 29419436 | |
acc0525 | GFAT1 | Q06210 | GFPT1 | phosphorylation | Ser243 | human | Pancreas Cancer | MIA PaCa-2 | 2-Deoxy-d-glucose | Associated | 4.0 (Moderate) | 29753740 |
acc0526 | AMPK | P54646 | PRKAA2 | phosphorylation | Thr172 | human | Pancreas Cancer | MIA PaCa-2 | 2-Deoxy-d-glucose | Associated | 4.0 (Moderate) | 29753740 |
acc0527 | AMPK | Q13131 | PRKAA1 | phosphorylation | Thr183 | human | Pancreas Cancer | MIA PaCa-2 | 2-Deoxy-d-glucose | Associated | 4.0 (Moderate) | 29753740 |
acc0528 | GFAT1 | Q06210 | GFPT1 | phosphorylation | Ser243 | human | Pancreas Cancer | MIA PaCa-2 | Met + 2-Deoxy-d-glucose | Associated | 4.0 (Moderate) | 29753740 |
acc0529 | AMPK | P54646 | PRKAA2 | phosphorylation | Thr172 | human | Pancreas Cancer | MIA PaCa-2 | Met + 2-Deoxy-d-glucose | Associated | 4.0 (Moderate) | 29753740 |
acc0530 | AMPK | Q13131 | PRKAA1 | phosphorylation | Thr183 | human | Pancreas Cancer | MIA PaCa-2 | Met + 2-Deoxy-d-glucose | Associated | 4.0 (Moderate) | 29753740 |
acc0531 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Pituitary Tumor | GH3 | Trastuzumab + TGFB1 | Associated | 4.0 (Moderate) | 29875136 |
acc0532 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Pituitary Tumor | GH3 | Trastuzumab + TGFB1 | Associated | 4.0 (Moderate) | 29875136 |
acc0533 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Pituitary Tumor | GH3 | Trastuzumab + TGFB1 | Associated | 4.0 (Moderate) | 29875136 |
acc0534 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Pituitary Tumor | GH3 | Trastuzumab + TGFB1 | Associated | 4.0 (Moderate) | 29875136 |
acc0535 | Smad2 | O70436 | Smad2 | phosphorylation | Ser465 | rat | Pituitary Tumor | GH3 | Trastuzumab + TGFB1 | Associated | 4.0 (Moderate) | 29875136 |
acc0536 | Smad2 | O70436 | Smad2 | phosphorylation | Ser467 | rat | Pituitary Tumor | GH3 | Trastuzumab + TGFB1 | Associated | 4.0 (Moderate) | 29875136 |
acc0537 | Smad3 | P84025 | Smad3 | phosphorylation | Ser423 | rat | Pituitary Tumor | GH3 | Trastuzumab + TGFB1 | Associated | 4.0 (Moderate) | 29875136 |
acc0538 | Smad3 | P84025 | Smad3 | phosphorylation | Ser425 | rat | Pituitary Tumor | GH3 | Trastuzumab + TGFB1 | Associated | 4.0 (Moderate) | 29875136 |
acc0539 | Smad2 | Q15796 | SMAD2 | phosphorylation | Thr8 | human | Pancreas Cancer | BxPC-3 | Metformin | Associated | 4.0 (Moderate) | 29956804 |
acc0540 | Smad2 | Q15796 | SMAD2 | phosphorylation | Thr8 | human | Pancreas Cancer | PANC-1 | Metformin | Associated | 4.0 (Moderate) | 29956804 |
acc0541 | Smad3 | P84022 | SMAD3 | phosphorylation | Thr8 | human | Pancreas Cancer | BxPC-3 | Metformin | Associated | 4.0 (Moderate) | 29956804 |
acc0542 | Smad3 | P84022 | SMAD3 | phosphorylation | Thr8 | human | Pancreas Cancer | PANC-1 | Metformin | Associated | 4.0 (Moderate) | 29956804 |
acc0543 | HK-2 | P52789 | HK2 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | HepG2 | Limonin | Associated | 4.0 (Moderate) | 30013360 |
acc0544 | STAT1 | P42224 | STAT1 | phosphorylation | Ser727 | human | Pancreas Cancer | L3.6pl | EGFRBi armed ATC | Associated | 4.0 (Moderate) | 23185240 |
acc0545 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Pancreas Cancer | L3.6pl | EGFRBi armed ATC | Associated | 4.0 (Moderate) | 23185240 |
acc0551 | UVRAG | Q9P2Y5 | UVRAG | ubiquitination | Lys517 | human | Hepatocellular Carcinoma | HuH-7 | D4476 | Associated | 4.0 (Moderate) | 30686098 |
acc0552 | UVRAG | Q9P2Y5 | UVRAG | ubiquitination | Lys599 | human | Hepatocellular Carcinoma | HuH-7 | D4476 | Associated | 4.0 (Moderate) | 30686098 |
acc0553 | UVRAG | Q9P2Y5 | UVRAG | phosphorylation | Ser522 | human | Hepatocellular Carcinoma | HuH-7 | D4476 | Associated | 4.0 (Moderate) | 30686098 |
acc0554 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | OVCAR8-TR | CDDO-Me | Associated | 4.0 (Moderate) | 18587580 |
acc0555 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Ovarian Cancer | OVCAR8-TR | CDDO-Me | Associated | 4.0 (Moderate) | 18587580 |
acc0558 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Ovarian Cancer | OVCAR8-TR | CDDO-Me | Associated | 4.0 (Moderate) | 18587580 |
acc0566 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Ser33 | human | Lung Cancer | A549 | CGK062 | Associated | 4.0 (Moderate) | 30968157 |
acc0567 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Ser37 | human | Lung Cancer | A549 | CGK062 | Associated | 4.0 (Moderate) | 30968157 |
acc0568 | DRP1 | O00429 | DNM1L | phosphorylation | Ser637 | human | Breast Cancer | MCF7 | Silibinin | Associated | 4.0 (Moderate) | 31085166 |
acc0569 | DRP1 | O00429 | DNM1L | phosphorylation | Ser637 | human | Breast Cancer | MDA-MB-231 | Silibinin | Associated | 4.0 (Moderate) | 31085166 |
acc0572 | Beclin-1 | Q9Y243 | BECN1 | phosphorylation | Ser15 | human | Leukemia | K562 | Promethazine | Associated | 4.0 (Moderate) | 31682805 |
acc0573 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Leukemia | K562 | Promethazine | Associated | 4.0 (Moderate) | 31682805 |
acc0577 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Colorectal Cancer | HCT116 | Convallatoxin | Associated | 4.0 (Moderate) | 32004989 |
acc0578 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Colorectal Cancer | HCT116 | Convallatoxin | Associated | 4.0 (Moderate) | 32004989 |
acc0579 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | OVCAR-3 | Curcumin | Associated | 4.0 (Moderate) | 19647363 |
acc0849 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Pituitary Tumor | GH3 | BKM120 | Associated | 4.0 (Moderate) | 26983879 |
acc0850 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Pituitary Tumor | GH3 | BEZ235 | Associated | 4.0 (Moderate) | 26983879 |
acc0851 | S6 | P62755 | Rps6 | phosphorylation | Ser235 | rat | Pituitary Tumor | GH3 | BEZ235 | Associated | 4.0 (Moderate) | 26983879 |
acc0852 | S6 | P62755 | Rps6 | phosphorylation | Ser236 | rat | Pituitary Tumor | GH3 | BEZ235 | Associated | 4.0 (Moderate) | 26983879 |
acc0853 | mTOR | P42346 | Mtor | phosphorylation | Ser2448 | rat | Pituitary Tumor | GH3 | BEZ235 | Associated | 4.0 (Moderate) | 26983879 |
acc0854 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Neuroblastoma | TBJ | Bortezomib | Associated | 4.0 (Moderate) | 16670342 |
acc0855 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Neuroblastoma | Neuro-2a | Bortezomib | Associated | 4.0 (Moderate) | 16670342 |
acc0856 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Leukemia | MV4-11 | Cabozantinib | Associated | 4.0 (Moderate) | 30862120 |
acc0857 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Leukemia | MV4-11 | MK2206 | Associated | 4.0 (Moderate) | 30862120 |
acc0858 | Chk1 | O35280 | Chek1 | phosphorylation | Ser345 | mouse | Skin Cancer | SKH-1 mice | Caffeine | Associated | 4.0 (Moderate) | 18381462 |
acc0859 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H82 | Darifenacin | Associated | 4.0 (Moderate) | 17440109 |
acc0860 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | H82 | Darifenacin | Associated | 4.0 (Moderate) | 17440109 |
acc0861 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | H82 | Darifenacin | Associated | 4.0 (Moderate) | 17440109 |
acc0862 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | H82 | Darifenacin | Associated | 4.0 (Moderate) | 17440109 |
acc0863 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | H82 | Darifenacin | Associated | 4.0 (Moderate) | 17440109 |
acc0864 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Ser33 | human | Hepatocellular Carcinoma | HuH-7 | Canagliflozin | Associated | 4.0 (Moderate) | 31142735 |
acc0865 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Ser37 | human | Hepatocellular Carcinoma | HuH-7 | Canagliflozin | Associated | 4.0 (Moderate) | 31142735 |
acc0866 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Thr41 | human | Hepatocellular Carcinoma | HuH-7 | Canagliflozin | Associated | 4.0 (Moderate) | 31142735 |
acc0867 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Ser45 | human | Hepatocellular Carcinoma | HuH-7 | Canagliflozin | Associated | 4.0 (Moderate) | 31142735 |
acc0869 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Melanoma | A375 | Chondroitin-4-sulfate (CHSA) | Associated | 4.0 (Moderate) | 29547721 |
acc0870 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Melanoma | SK-MEL-5 | Chondroitin-4-sulfate (CHSA) | Associated | 4.0 (Moderate) | 29547721 |
acc0871 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Melanoma | A375 | Chondroitin-4-sulfate (CHSA) | Associated | 4.0 (Moderate) | 29547721 |
acc0872 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Melanoma | SK-MEL-5 | Chondroitin-4-sulfate (CHSA) | Associated | 4.0 (Moderate) | 29547721 |
acc0873 | PTEN | P60484 | PTEN | phosphorylation | Ser380 | human | Melanoma | A375 | Chondroitin-4-sulfate (CHSA) | Associated | 4.0 (Moderate) | 29547721 |
acc0874 | PTEN | P60484 | PTEN | phosphorylation | Ser380 | human | Melanoma | SK-MEL-5 | Chondroitin-4-sulfate (CHSA) | Associated | 4.0 (Moderate) | 29547721 |
acc0875 | PTEN | P60484 | PTEN | phosphorylation | Thr382 | human | Melanoma | A375 | Chondroitin-4-sulfate (CHSA) | Associated | 4.0 (Moderate) | 29547721 |
acc0876 | PTEN | P60484 | PTEN | phosphorylation | Thr382 | human | Melanoma | SK-MEL-5 | Chondroitin-4-sulfate (CHSA) | Associated | 4.0 (Moderate) | 29547721 |
acc0877 | PTEN | P60484 | PTEN | phosphorylation | Thr383 | human | Melanoma | A375 | Chondroitin-4-sulfate (CHSA) | Associated | 4.0 (Moderate) | 29547721 |
acc0878 | PTEN | P60484 | PTEN | phosphorylation | Thr383 | human | Melanoma | SK-MEL-5 | Chondroitin-4-sulfate (CHSA) | Associated | 4.0 (Moderate) | 29547721 |
acc0882 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | ES-2 | Goserelin | Associated | 4.0 (Moderate) | 23684357 |
acc0883 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | SK-OV-3-ip | Goserelin | Associated | 4.0 (Moderate) | 23684357 |
acc0886 | FOXO3a | O43524 | FOXO3 | phosphorylation | Thr32 | human | Lung Cancer | A549 | Cisplatin | Associated | 4.0 (Moderate) | 24814195 |
acc0887 | PI3K | P42336 | PIK3CA | phosphorylation | Tyr458 | human | Lung Cancer | A549 | Cisplatin | Associated | 4.0 (Moderate) | 24814195 |
acc0888 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | A549 | Cisplatin | Associated | 4.0 (Moderate) | 24814195 |
acc0889 | Chk2 | O96017 | CHEK2 | phosphorylation | Thr68 | human | Testicular Cancer | 833K | Cisplatin | Associated | 4.0 (Moderate) | 20846399 |
acc0890 | Chk2 | O96017 | CHEK2 | phosphorylation | Thr68 | human | Testicular Cancer | SuSa | Cisplatin | Associated | 4.0 (Moderate) | 20846399 |
acc0892 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Osteosarcoma | U2OS | CQ-HES | Associated | 4.0 (Moderate) | 28708385 |
acc0893 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Osteosarcoma | U2OS | CQ-HES | Associated | 4.0 (Moderate) | 28708385 |
acc0894 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Osteosarcoma | U2OS | CQ-HES | Associated | 4.0 (Moderate) | 28708385 |
acc0895 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Osteosarcoma | U2OS | CQ-HES | Associated | 4.0 (Moderate) | 28708385 |
acc0896 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Osteosarcoma | U2OS | CQ-HES | Associated | 4.0 (Moderate) | 28708385 |
acc0897 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Breast Cancer | SK-BR-3 | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0898 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Breast Cancer | SK-BR-3 | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0899 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Breast Cancer | SK-BR-3 | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0900 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Breast Cancer | 435eB | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0901 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Breast Cancer | SK-BR-3 | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0902 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Breast Cancer | 435eB | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0903 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Breast Cancer | SK-BR-3 | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0904 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Breast Cancer | 435eB | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0905 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Breast Cancer | SK-BR-3 | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0906 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Breast Cancer | 435eB | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0907 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Breast Cancer | SK-BR-3 | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0908 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Breast Cancer | SK-BR-3 | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0909 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Breast Cancer | 435eB | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0910 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Breast Cancer | 435eB | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0911 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Breast Cancer | 435eB | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0912 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Breast Cancer | 435eB | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0913 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | SK-BR-3 | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0914 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | 435eB | Curcumin + Tricostatin A | Associated | 4.0 (Moderate) | 22290509 |
acc0926 | CAMKII | P11274 | CAMK2A | phosphorylation | Thr286 | human | Colorectal Cancer | HT29 | DCA | Associated | 4.0 (Moderate) | 27086143 |
acc0927 | EGFR | P00533 | EGFR | phosphorylation | Tyr845 | human | Colorectal Cancer | HT29 | DCA | Associated | 4.0 (Moderate) | 27086143 |
acc0928 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Colorectal Cancer | HT29 | DCA | Associated | 4.0 (Moderate) | 27086143 |
acc0929 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Colorectal Cancer | HT29 | DCA | Associated | 4.0 (Moderate) | 27086143 |
acc0930 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Colorectal Cancer | HT29 | DCA | Associated | 4.0 (Moderate) | 27086143 |
acc0931 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Colorectal Cancer | HT29 | DCA | Associated | 4.0 (Moderate) | 27086143 |
acc0932 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Prostate Cancer | PC3 | delta-T | Associated | 4.0 (Moderate) | 26465359 |
acc0933 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | NCI-H69 | Naltrindole | Associated | 4.0 (Moderate) | 15574783 |
acc0934 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | NCI-H69 | Naltrindole | Associated | 4.0 (Moderate) | 15574783 |
acc0935 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | BEL-7402 | Forskolin | Associated | 4.0 (Moderate) | 16177565 |
acc0936 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | SMMC-7721 | Forskolin | Associated | 4.0 (Moderate) | 16177565 |
acc0937 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Hepatocellular Carcinoma | BEL-7402 | Forskolin | Associated | 4.0 (Moderate) | 16177565 |
acc0938 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Hepatocellular Carcinoma | SMMC-7721 | Forskolin | Associated | 4.0 (Moderate) | 16177565 |
acc0947 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Pancreas Cancer | PANC-1 | Rapamycin | Associated | 4.0 (Moderate) | 23437362 |
acc0948 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Pancreas Cancer | PANC-1 | Rapamycin | Associated | 4.0 (Moderate) | 23437362 |
acc0949 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Pancreas Cancer | MIA PaCa-2 | Metformin | Associated | 4.0 (Moderate) | 23437362 |
acc0950 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Pancreas Cancer | MIA PaCa-2 | Metformin | Associated | 4.0 (Moderate) | 23437362 |
acc0951 | S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Pancreas Cancer | PANC-1 | Metformin | Associated | 4.0 (Moderate) | 23437362 |
acc0952 | S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Pancreas Cancer | MIA PaCa-2 | Metformin | Associated | 4.0 (Moderate) | 23437362 |
acc0953 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | PANC-1 | Metformin | Associated | 4.0 (Moderate) | 23437362 |
acc0954 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | MIA PaCa-2 | Metformin | Associated | 4.0 (Moderate) | 23437362 |
acc0955 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Pancreas Cancer | MIA PaCa-2 | Metformin | Associated | 4.0 (Moderate) | 23437362 |
acc0956 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Pancreas Cancer | MIA PaCa-2 | Metformin | Associated | 4.0 (Moderate) | 23437362 |
acc0957 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | MIA PaCa-2 | Metformin | Associated | 4.0 (Moderate) | 23437362 |
acc0958 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | MIA PaCa-2 | Metformin | Associated | 4.0 (Moderate) | 23437362 |
acc0959 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Pancreas Cancer | MIA PaCa-2 | Rapamycin | Associated | 4.0 (Moderate) | 23437362 |
acc0960 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Pancreas Cancer | PANC-1 | Metformin | Associated | 4.0 (Moderate) | 23437362 |
acc0961 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Pancreas Cancer | PANC-1 | Metformin | Associated | 4.0 (Moderate) | 23437362 |
acc0962 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | PANC-1 | Metformin | Associated | 4.0 (Moderate) | 23437362 |
acc0963 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | PANC-1 | Metformin | Associated | 4.0 (Moderate) | 23437362 |
acc0964 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Pancreas Cancer | PANC-1 | PP242 | Associated | 4.0 (Moderate) | 23437362 |
acc0965 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Pancreas Cancer | PANC-1 | PP242 | Associated | 4.0 (Moderate) | 23437362 |
acc0966 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Pancreas Cancer | MIA PaCa-2 | PP242 | Associated | 4.0 (Moderate) | 23437362 |
acc0967 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Pancreas Cancer | MIA PaCa-2 | PP242 | Associated | 4.0 (Moderate) | 23437362 |
acc0968 | S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Pancreas Cancer | PANC-1 | PP242 | Associated | 4.0 (Moderate) | 23437362 |
acc0969 | S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Pancreas Cancer | MIA PaCa-2 | PP242 | Associated | 4.0 (Moderate) | 23437362 |
acc0970 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Pancreas Cancer | MIA PaCa-2 | Rapamycin | Associated | 4.0 (Moderate) | 23437362 |
acc0971 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | PANC-1 | PP242 | Associated | 4.0 (Moderate) | 23437362 |
acc0972 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | MIA PaCa-2 | PP242 | Associated | 4.0 (Moderate) | 23437362 |
acc0973 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Pancreas Cancer | MIA PaCa-2 | PP242 | Associated | 4.0 (Moderate) | 23437362 |
acc0974 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Pancreas Cancer | MIA PaCa-2 | PP242 | Associated | 4.0 (Moderate) | 23437362 |
acc0975 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | MIA PaCa-2 | PP242 | Associated | 4.0 (Moderate) | 23437362 |
acc0976 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | MIA PaCa-2 | PP242 | Associated | 4.0 (Moderate) | 23437362 |
acc0977 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Pancreas Cancer | PANC-1 | PP242 | Associated | 4.0 (Moderate) | 23437362 |
acc0978 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Pancreas Cancer | PANC-1 | PP242 | Associated | 4.0 (Moderate) | 23437362 |
acc0979 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | PANC-1 | PP242 | Associated | 4.0 (Moderate) | 23437362 |
acc0980 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | PANC-1 | PP242 | Associated | 4.0 (Moderate) | 23437362 |
acc0981 | S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Pancreas Cancer | PANC-1 | Rapamycin | Associated | 4.0 (Moderate) | 23437362 |
acc0982 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Pancreas Cancer | PANC-1 | KU63794 | Associated | 4.0 (Moderate) | 23437362 |
acc0983 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Pancreas Cancer | PANC-1 | KU63794 | Associated | 4.0 (Moderate) | 23437362 |
acc0984 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Pancreas Cancer | MIA PaCa-2 | KU63794 | Associated | 4.0 (Moderate) | 23437362 |
acc0985 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Pancreas Cancer | MIA PaCa-2 | KU63794 | Associated | 4.0 (Moderate) | 23437362 |
acc0986 | S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Pancreas Cancer | PANC-1 | KU63794 | Associated | 4.0 (Moderate) | 23437362 |
acc0987 | S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Pancreas Cancer | MIA PaCa-2 | KU63794 | Associated | 4.0 (Moderate) | 23437362 |
acc0988 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | PANC-1 | KU63794 | Associated | 4.0 (Moderate) | 23437362 |
acc0989 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | MIA PaCa-2 | KU63794 | Associated | 4.0 (Moderate) | 23437362 |
acc0990 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Pancreas Cancer | MIA PaCa-2 | KU63794 | Associated | 4.0 (Moderate) | 23437362 |
acc0991 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Pancreas Cancer | MIA PaCa-2 | KU63794 | Associated | 4.0 (Moderate) | 23437362 |
acc0992 | S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Pancreas Cancer | MIA PaCa-2 | Rapamycin | Associated | 4.0 (Moderate) | 23437362 |
acc0993 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | MIA PaCa-2 | KU63794 | Associated | 4.0 (Moderate) | 23437362 |
acc0994 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | MIA PaCa-2 | KU63794 | Associated | 4.0 (Moderate) | 23437362 |
acc0995 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Pancreas Cancer | PANC-1 | KU63794 | Associated | 4.0 (Moderate) | 23437362 |
acc0996 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Pancreas Cancer | PANC-1 | KU63794 | Associated | 4.0 (Moderate) | 23437362 |
acc0997 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | PANC-1 | KU63794 | Associated | 4.0 (Moderate) | 23437362 |
acc0998 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | PANC-1 | KU63794 | Associated | 4.0 (Moderate) | 23437362 |
acc0999 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | PANC-1 | Rapamycin | Associated | 4.0 (Moderate) | 23437362 |
acc1000 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | MIA PaCa-2 | Rapamycin | Associated | 4.0 (Moderate) | 23437362 |
acc1001 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Pancreas Cancer | PANC-1 | Metformin | Associated | 4.0 (Moderate) | 23437362 |
acc1002 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Pancreas Cancer | PANC-1 | Metformin | Associated | 4.0 (Moderate) | 23437362 |
acc1003 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Prostate Cancer | LNCaP-Bic | Sorafenib | Associated | 4.0 (Moderate) | 22383427 |
acc1004 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Prostate Cancer | PC3-DR | Sorafenib | Associated | 4.0 (Moderate) | 22383427 |
acc1028 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Ser33 | human | Hepatocellular Carcinoma | SMMC-7721 | Esculetin | Associated | 4.0 (Moderate) | 28789402 |
acc1029 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Ser37 | human | Hepatocellular Carcinoma | SMMC-7721 | Esculetin | Associated | 4.0 (Moderate) | 28789402 |
acc1030 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Thr41 | human | Hepatocellular Carcinoma | SMMC-7721 | Esculetin | Associated | 4.0 (Moderate) | 28789402 |
acc1033 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MCF7 | Estradiol | Associated | 4.0 (Moderate) | 17138652 |
acc1034 | ErbB2 | P04626 | ERBB2 | phosphorylation | Tyr1248 | human | Breast Cancer | MCF7 | AG826 | Associated | 4.0 (Moderate) | 17138652 |
acc1035 | ErbB2 | P04626 | ERBB2 | phosphorylation | Tyr1248 | human | Breast Cancer | MCF7 | AG826 | Associated | 4.0 (Moderate) | 17138652 |
acc1036 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Esophageal Cancer | TE1 | Eupatilin | Associated | 4.0 (Moderate) | 29693162 |
acc1037 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Esophageal Cancer | TE1 | Eupatilin | Associated | 4.0 (Moderate) | 29693162 |
acc1038 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Esophageal Cancer | TE1 | Eupatilin | Associated | 4.0 (Moderate) | 29693162 |
acc1039 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Esophageal Cancer | TE1 | Eupatilin | Associated | 4.0 (Moderate) | 29693162 |
acc1040 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Esophageal Cancer | TE1 | Eupatilin | Associated | 4.0 (Moderate) | 29693162 |
acc1041 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Pituitary Tumor | MMQ | Everolimus + Cabergoline | Associated | 4.0 (Moderate) | 35721701 |
acc1042 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pituitary Tumor | NF-PitNET | Everolimus + Cabergoline | Associated | 4.0 (Moderate) | 35721701 |
acc1044 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Melanoma | B16F10 | Fenofibrate | Associated | 4.0 (Moderate) | 16707598 |
acc1051 | cdc2 | P06493 | CDK1 | phosphorylation | Tyr15 | human | Prostate Cancer | DU145 | Gallic acid | Associated | 4.0 (Moderate) | 17172433 |
acc1052 | Cdc25A | P30304 | CDC25A | phosphorylation | Ser17 | human | Prostate Cancer | DU145 | Gallic acid | Associated | 4.0 (Moderate) | 17172433 |
acc1053 | Cdc25C | P30305 | CDC25C | phosphorylation | Ser216 | human | Prostate Cancer | DU145 | Gallic acid | Associated | 4.0 (Moderate) | 17172433 |
acc1054 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | SK-HEP-1 | Imatinib + GNF5 | Associated | 4.0 (Moderate) | 30671399 |
acc1055 | EGFR | P00533 | EGFR | phosphorylation | Tyr845 | human | Colorectal Cancer | SW620 | Ganglioside + CD82 OV | Associated | 4.0 (Moderate) | 33000220 |
acc1056 | EGFR | P00533 | EGFR | phosphorylation | Tyr1045 | human | Colorectal Cancer | SW620 | Ganglioside + CD82 OV | Associated | 4.0 (Moderate) | 33000220 |
acc1057 | EGFR | P00533 | EGFR | phosphorylation | Tyr1173 | human | Colorectal Cancer | SW620 | Ganglioside + CD82 OV | Associated | 4.0 (Moderate) | 33000220 |
acc1058 | ER | P03372 | ESR1 | phosphorylation | Ser118 | human | Breast Cancer | Gefitinib + Anastrozole | Associated | 4.0 (Moderate) | 15925816 | |
acc1059 | EGFR | P00533 | EGFR | phosphorylation | Tyr845 | human | Breast Cancer | Gefitinib + Anastrozole | Associated | 4.0 (Moderate) | 15925816 | |
acc1063 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Myeloma | XG-1 | Genistein | Associated | 4.0 (Moderate) | 19107739 |
acc1064 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Myeloma | RPMI8226 | Genistein | Associated | 4.0 (Moderate) | 19107739 |
acc1067 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | SK-HEP-1 | Glycyrrhizic acid | Associated | 4.0 (Moderate) | 32054305 |
acc1068 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Hepatocellular Carcinoma | SK-HEP-1 | Glycyrrhizic acid | Associated | 4.0 (Moderate) | 32054305 |
acc1069 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Hepatocellular Carcinoma | Hep3B | Glycyrrhizic acid | Associated | 4.0 (Moderate) | 32054305 |
acc1070 | EGFR | P00533 | EGFR | phosphorylation | Tyr1069 | human | Hepatocellular Carcinoma | Hep3B | Glycyrrhizic acid | Associated | 4.0 (Moderate) | 32054305 |
acc1071 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Hepatocellular Carcinoma | SK-HEP-1 | Glycyrrhizic acid | Associated | 4.0 (Moderate) | 32054305 |
acc1072 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Hepatocellular Carcinoma | SK-HEP-1 | Glycyrrhizic acid | Associated | 4.0 (Moderate) | 32054305 |
acc1073 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Hepatocellular Carcinoma | SK-HEP-1 | Glycyrrhizic acid | Associated | 4.0 (Moderate) | 32054305 |
acc1074 | EGFR | P00533 | EGFR | phosphorylation | Tyr1069 | human | Hepatocellular Carcinoma | SK-HEP-1 | Glycyrrhizic acid | Associated | 4.0 (Moderate) | 32054305 |
acc1075 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | Hep3B | Glycyrrhizic acid | Associated | 4.0 (Moderate) | 32054305 |
acc1076 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Hepatocellular Carcinoma | Hep3B | Glycyrrhizic acid | Associated | 4.0 (Moderate) | 32054305 |
acc1077 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Hepatocellular Carcinoma | Hep3B | Glycyrrhizic acid | Associated | 4.0 (Moderate) | 32054305 |
acc1078 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Hepatocellular Carcinoma | Hep3B | Glycyrrhizic acid | Associated | 4.0 (Moderate) | 32054305 |
acc1339 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Prostate Cancer | PC3 | Rapamycin | Associated | 4.0 (Moderate) | 18809972 |
acc1340 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Prostate Cancer | LNCaP | Rapamycin | Associated | 4.0 (Moderate) | 18809972 |
acc1349 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | A549 | Resveratrol | Associated | 4.0 (Moderate) | 31665911 |
acc1350 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | A549 | Resveratrol | Associated | 4.0 (Moderate) | 31665911 |
acc1351 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Lung Cancer | A549 | Resveratrol | Associated | 4.0 (Moderate) | 31665911 |
acc1353 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | A2780/T | Rg5 + docetaxel | Associated | 4.0 (Moderate) | 32148406 |
acc1354 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H1792 | Rosiglitazone | Associated | 4.0 (Moderate) | 16505118 |
acc1355 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H1838 | Rosiglitazone | Associated | 4.0 (Moderate) | 16505118 |
acc1356 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | PANC-1 | Sinapic acid | Associated | 4.0 (Moderate) | 34859906 |
acc1357 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Pancreas Cancer | SW1990 | Sinapic acid | Associated | 4.0 (Moderate) | 34859906 |
acc1359 | AR | P10275 | AR | phosphorylation | Ser81 | human | Prostate Cancer | C4-2 | Salinomycin | Associated | 4.0 (Moderate) | 27557496 |
acc1360 | AMPK | P54646 | PRKAA2 | phosphorylation | Thr172 | human | Prostate Cancer | C4-2 | Salinomycin | Associated | 4.0 (Moderate) | 27557496 |
acc1361 | AMPK | Q13131 | PRKAA1 | phosphorylation | Thr183 | human | Prostate Cancer | C4-2 | Salinomycin | Associated | 4.0 (Moderate) | 27557496 |
acc1362 | Raptor | Q8N122 | RPTOR | phosphorylation | Ser792 | human | Prostate Cancer | C4-2 | Salinomycin | Associated | 4.0 (Moderate) | 27557496 |
acc1363 | TSC-2 | P49815 | TSC2 | phosphorylation | Ser1387 | human | Prostate Cancer | C4-2 | Salinomycin | Associated | 4.0 (Moderate) | 27557496 |
acc1364 | TSC-2 | P49815 | TSC2 | phosphorylation | Ser939 | human | Prostate Cancer | C4-2 | Salinomycin | Associated | 4.0 (Moderate) | 27557496 |
acc1365 | TSC-2 | P49815 | TSC2 | phosphorylation | Thr1462 | human | Prostate Cancer | C4-2 | Salinomycin | Associated | 4.0 (Moderate) | 27557496 |
acc1368 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Prostate Cancer | DU145 | SB225003 | Associated | 4.0 (Moderate) | 29917166 |
acc1369 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Prostate Cancer | PC3 | SB225003 | Associated | 4.0 (Moderate) | 29917166 |
acc1370 | AKT2 | P31751 | AKT2 | phosphorylation | Thr309 | human | Prostate Cancer | LNCaP | SB225003 | Associated | 4.0 (Moderate) | 29917166 |
acc1371 | AKT3 | Q9Y243 | AKT3 | phosphorylation | Thr305 | human | Prostate Cancer | LNCaP | SB225003 | Associated | 4.0 (Moderate) | 29917166 |
acc1372 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Prostate Cancer | LNCaP | SB225003 | Associated | 4.0 (Moderate) | 29917166 |
acc1373 | AKT1 | P31749 | AKT1 | phosphorylation | Thr308 | human | Prostate Cancer | DU145 | SB225003 | Associated | 4.0 (Moderate) | 29917166 |
acc1374 | AKT2 | P31751 | AKT2 | phosphorylation | Thr309 | human | Prostate Cancer | DU145 | SB225003 | Associated | 4.0 (Moderate) | 29917166 |
acc1375 | AKT3 | Q9Y243 | AKT3 | phosphorylation | Thr305 | human | Prostate Cancer | DU145 | SB225003 | Associated | 4.0 (Moderate) | 29917166 |
acc1376 | AKT1 | P31749 | AKT1 | phosphorylation | Thr308 | human | Prostate Cancer | PC3 | SB225003 | Associated | 4.0 (Moderate) | 29917166 |
acc1377 | AKT2 | P31751 | AKT2 | phosphorylation | Thr309 | human | Prostate Cancer | PC3 | SB225003 | Associated | 4.0 (Moderate) | 29917166 |
acc1378 | AKT3 | Q9Y243 | AKT3 | phosphorylation | Thr305 | human | Prostate Cancer | PC3 | SB225003 | Associated | 4.0 (Moderate) | 29917166 |
acc1379 | AKT1 | P31749 | AKT1 | phosphorylation | Thr308 | human | Prostate Cancer | LNCaP | SB225003 | Associated | 4.0 (Moderate) | 29917166 |
acc1380 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Sarcoma | EW8 | SCH717454 | Associated | 4.0 (Moderate) | 22188815 |
acc1381 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Sarcoma | JR1 | SCH717454 | Associated | 4.0 (Moderate) | 22188815 |
acc1382 | IN-R | P06213 | INSR | phosphorylation | Tyr1146 | human | Sarcoma | Rh18 | SCH717454 | Associated | 4.0 (Moderate) | 22188815 |
acc1383 | IN-R | P06213 | INSR | phosphorylation | Tyr1146 | human | Sarcoma | Rh30 | SCH717454 | Associated | 4.0 (Moderate) | 22188815 |
acc1384 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Sarcoma | Rh18 | SCH717454 | Associated | 4.0 (Moderate) | 22188815 |
acc1385 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Sarcoma | Rh30 | SCH717454 | Associated | 4.0 (Moderate) | 22188815 |
acc1386 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1131 | human | Sarcoma | EW8 | SCH717454 | Associated | 4.0 (Moderate) | 22188815 |
acc1387 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1131 | human | Sarcoma | JR1 | SCH717454 | Associated | 4.0 (Moderate) | 22188815 |
acc1388 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1131 | human | Sarcoma | Rh18 | SCH717454 | Associated | 4.0 (Moderate) | 22188815 |
acc1389 | IGF-IR | P08069 | IGF1R | phosphorylation | Tyr1131 | human | Sarcoma | Rh30 | SCH717454 | Associated | 4.0 (Moderate) | 22188815 |
acc1390 | IN-R | P06213 | INSR | phosphorylation | Tyr1146 | human | Sarcoma | EW8 | SCH717454 | Associated | 4.0 (Moderate) | 22188815 |
acc1391 | IN-R | P06213 | INSR | phosphorylation | Tyr1146 | human | Sarcoma | JR1 | SCH717454 | Associated | 4.0 (Moderate) | 22188815 |
acc1395 | FOXO1 | Q12778 | FOXO1 | phosphorylation | Ser218 | human | Sarcoma | ISO-HAS-B | ATG(aPKC inhibitor) | Associated | 4.0 (Moderate) | 30559384 |
acc1396 | FOXO1 | Q12778 | FOXO1 | phosphorylation | Ser218 | human | Sarcoma | AS-M | ATM(aPKC inhibitor) | Associated | 4.0 (Moderate) | 30559384 |
acc1397 | FOXO1 | Q12778 | FOXO1 | phosphorylation | Ser218 | human | Sarcoma | ISO-HAS-B | ATM(aPKC inhibitor) | Associated | 4.0 (Moderate) | 30559384 |
acc1398 | FOXO1 | Q12778 | FOXO1 | phosphorylation | Ser218 | human | Sarcoma | AS-M | ATG(aPKC inhibitor) | Associated | 4.0 (Moderate) | 30559384 |
acc1399 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Leukemia | KG-1 | KP372-1 | Associated | 4.0 (Moderate) | 16585200 |
acc1400 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Leukemia | U937 | KP372-1 | Associated | 4.0 (Moderate) | 16585200 |
acc1401 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Leukemia | TF-1 | KP372-1 | Associated | 4.0 (Moderate) | 16585200 |
acc1402 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Lung Cancer | NCI-H69 | NNK | Associated | 4.0 (Moderate) | 15210690 |
acc1403 | c-Myc | P01106 | MYC | phosphorylation | Thr58 | human | Lung Cancer | NCI-H69 | NNK | Associated | 4.0 (Moderate) | 15210690 |
acc1404 | c-Myc | P01106 | MYC | phosphorylation | Thr58 | human | Lung Cancer | NCI-H82 | Staurosporine | Associated | 4.0 (Moderate) | 15210690 |
acc1405 | c-Myc | P01106 | MYC | phosphorylation | Ser62 | human | Lung Cancer | NCI-H82 | Staurosporine | Associated | 4.0 (Moderate) | 15210690 |
acc1406 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Lung Cancer | NCI-H82 | Staurosporine | Associated | 4.0 (Moderate) | 15210690 |
acc1407 | c-Myc | P01106 | MYC | phosphorylation | Ser62 | human | Lung Cancer | NCI-H69 | NNK | Associated | 4.0 (Moderate) | 15210690 |
acc1408 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Lung Cancer | NCI-H82 | NNK | Associated | 4.0 (Moderate) | 15210690 |
acc1409 | c-Myc | P01106 | MYC | phosphorylation | Thr58 | human | Lung Cancer | NCI-H82 | NNK | Associated | 4.0 (Moderate) | 15210690 |
acc1410 | c-Myc | P01106 | MYC | phosphorylation | Ser62 | human | Lung Cancer | NCI-H82 | NNK | Associated | 4.0 (Moderate) | 15210690 |
acc1412 | c-Myc | P01106 | MYC | phosphorylation | Thr58 | human | Lung Cancer | NCI-H82 | PD98059 | Associated | 4.0 (Moderate) | 15210690 |
acc1413 | c-Myc | P01106 | MYC | phosphorylation | Ser62 | human | Lung Cancer | NCI-H82 | PD98059 | Associated | 4.0 (Moderate) | 15210690 |
acc1414 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Lung Cancer | NCI-H82 | PD98059 | Associated | 4.0 (Moderate) | 15210690 |
acc1415 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | H2286 | Dasatinib + Crizotinib | Associated | 4.0 (Moderate) | 25348954 |
acc1416 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | H2286 | Dasatinib + BMS-754807 | Associated | 4.0 (Moderate) | 25348954 |
acc1417 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H2286 | Dasatinib + Crizotinib | Associated | 4.0 (Moderate) | 25348954 |
acc1418 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | HCC366 | Dasatinib + BMS-754807 | Associated | 4.0 (Moderate) | 25348954 |
acc1419 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | H2286 | Dasatinib + Crizotinib | Associated | 4.0 (Moderate) | 25348954 |
acc1420 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | H2286 | Dasatinib + BMS-754807 | Associated | 4.0 (Moderate) | 25348954 |
acc1421 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | HCC366 | Dasatinib + Crizotinib | Associated | 4.0 (Moderate) | 25348954 |
acc1422 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | HCC366 | Dasatinib + BMS-754807 | Associated | 4.0 (Moderate) | 25348954 |
acc1423 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | HCC366 | Dasatinib + Crizotinib | Associated | 4.0 (Moderate) | 25348954 |
acc1424 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | HCC366 | Dasatinib + BMS-754807 | Associated | 4.0 (Moderate) | 25348954 |
acc1425 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | H2286 | Dasatinib + Crizotinib | Associated | 4.0 (Moderate) | 25348954 |
acc1426 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Lung Cancer | HCC366 | Dasatinib + BMS-754807 | Associated | 4.0 (Moderate) | 25348954 |
acc1438 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | Rapamycin | Associated | 4.0 (Moderate) | 23874880 | |
acc1440 | mTOR | P42346 | Mtor | phosphorylation | Ser2448 | rat | Glioma | C6 | Xanthatin | Associated | 4.0 (Moderate) | 36572650 |
acc1441 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Glioma | C6 | Xanthatin | Associated | 4.0 (Moderate) | 36572650 |
acc1442 | ULK1 | D3ZMG0 | Ulk1 | phosphorylation | Ser467 | rat | Glioma | C6 | Xanthatin | Associated | 4.0 (Moderate) | 36572650 |
acc1443 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Glioma | U251 | Xanthatin | Associated | 4.0 (Moderate) | 36572650 |
acc1444 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Glioma | U251 | Xanthatin | Associated | 4.0 (Moderate) | 36572650 |
acc1445 | ULK1 | O75385 | ULK1 | phosphorylation | Ser467 | human | Glioma | U251 | Xanthatin | Associated | 4.0 (Moderate) | 36572650 |
acc1446 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Hepatocellular Carcinoma | SMMC-7721 | mAb AA98 | Associated | 4.0 (Moderate) | 17121934 |
acc1447 | p53 | P04637 | TP53 | phosphorylation | Ser15 | human | Melanoma | A375 | "3,3'-diselenodipropionic acid (DSeA)" | Associated | 4.0 (Moderate) | 25277183 |
acc1449 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Melanoma | A375 | "3,3'-diselenodipropionic acid (DSeA)" | Associated | 4.0 (Moderate) | 25277183 |
acc1451 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MCF7 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1452 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Breast Cancer | MCF7 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1453 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Colorectal Cancer | COLO205 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1454 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Colorectal Cancer | COLO205 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1455 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | A549 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1456 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Lung Cancer | A549 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1457 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Lung Cancer | A549 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1458 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | SW620 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1459 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Colorectal Cancer | SW620 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1460 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Colorectal Cancer | SW620 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1461 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Glioma | U87-MG | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1462 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Glioma | U87-MG | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1463 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Breast Cancer | MCF7 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1464 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Glioma | U87-MG | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1465 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MDA-MB-468 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1466 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Breast Cancer | MDA-MB-468 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1467 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Breast Cancer | MDA-MB-468 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1468 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | BT474 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1469 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Breast Cancer | BT474 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1470 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Breast Cancer | BT474 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1471 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | COLO205 | SHR8443 | Associated | 4.0 (Moderate) | 29296217 |
acc1472 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Pancreas Cancer | Capan-1 | SN-38 | Associated | 4.0 (Moderate) | 21390185 |
acc1473 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Pancreas Cancer | MIA PaCa-2 | SN-38 | Associated | 4.0 (Moderate) | 21390185 |
acc1474 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Pancreas Cancer | Capan-1 | SN-38 + Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1475 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Pancreas Cancer | MIA PaCa-2 | SN-38 + Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1476 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | Capan-1 | SN-38 | Associated | 4.0 (Moderate) | 21390185 |
acc1477 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | MIA PaCa-2 | SN-38 | Associated | 4.0 (Moderate) | 21390185 |
acc1478 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | Capan-1 | Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1479 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | MIA PaCa-2 | Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1480 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | Capan-1 | SN-38 + Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1481 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | MIA PaCa-2 | SN-38 + Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1482 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | Capan-1 | SN-38 | Associated | 4.0 (Moderate) | 21390185 |
acc1483 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | MIA PaCa-2 | SN-38 | Associated | 4.0 (Moderate) | 21390185 |
acc1484 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Pancreas Cancer | Capan-1 | Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1485 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | Capan-1 | Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1486 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | MIA PaCa-2 | Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1487 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | Capan-1 | SN-38 + Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1488 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreas Cancer | MIA PaCa-2 | SN-38 + Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1489 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | Capan-1 | SN-38 | Associated | 4.0 (Moderate) | 21390185 |
acc1490 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | MIA PaCa-2 | SN-38 | Associated | 4.0 (Moderate) | 21390185 |
acc1491 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | Capan-1 | Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1492 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | MIA PaCa-2 | Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1493 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | Capan-1 | SN-38 + Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1494 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | MIA PaCa-2 | SN-38 + Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1495 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Pancreas Cancer | MIA PaCa-2 | Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1496 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | Capan-1 | SN-38 | Associated | 4.0 (Moderate) | 21390185 |
acc1497 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | MIA PaCa-2 | SN-38 | Associated | 4.0 (Moderate) | 21390185 |
acc1498 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | Capan-1 | Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1499 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | MIA PaCa-2 | Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1500 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | Capan-1 | SN-38 + Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1501 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreas Cancer | MIA PaCa-2 | SN-38 + Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1502 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Pancreas Cancer | Capan-1 | SN-38 + Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1503 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Pancreas Cancer | MIA PaCa-2 | SN-38 + Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1504 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Pancreas Cancer | Capan-1 | SN-38 | Associated | 4.0 (Moderate) | 21390185 |
acc1505 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Pancreas Cancer | MIA PaCa-2 | SN-38 | Associated | 4.0 (Moderate) | 21390185 |
acc1506 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Pancreas Cancer | Capan-1 | Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1507 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Pancreas Cancer | MIA PaCa-2 | Axitinib | Associated | 4.0 (Moderate) | 21390185 |
acc1508 | ErbB3 | P21860 | ERBB3 | phosphorylation | unclear | human | Breast Cancer | MDA-MB-453 | SNDX-275 + Trastuzumab | Associated | 4.0 (Moderate) | 21497990 |
acc1509 | ErbB3 | P21860 | ERBB3 | phosphorylation | unclear | human | Breast Cancer | BT474 | SNDX-275 + Trastuzumab | Associated | 4.0 (Moderate) | 21497990 |
acc1510 | Akt | P31750 | Akt1 | phosphorylation | unclear | mouse | Hepatocellular Carcinoma | NK92-MI | Sorafenib | Associated | 4.0 (Moderate) | 23409093 |
acc1511 | ERK | P27361 | MAPK3 | phosphorylation | unclear | human | Bladder Cancer | T24 | Sorafenib | Associated | 4.0 (Moderate) | 20649572 |
acc1512 | ERK | P27361 | MAPK3 | phosphorylation | unclear | human | Bladder Cancer | J82 | Sorafenib | Associated | 4.0 (Moderate) | 20649572 |
acc1513 | ERK | P27361 | MAPK3 | phosphorylation | unclear | human | Bladder Cancer | RT4 | Sorafenib | Associated | 4.0 (Moderate) | 20649572 |
acc1514 | FKHR | Q12778 | FOXO1 | phosphorylation | Ser256 | human | Lung Cancer | GLC-82 | SYUNZ-16 | Associated | 4.0 (Moderate) | 19904742 |
acc1515 | FKHRL1 | O43524 | FOXO3 | phosphorylation | Ser318 | human | Lung Cancer | GLC-82 | SYUNZ-16 | Associated | 4.0 (Moderate) | 19904742 |
acc1516 | FKHRL1 | O43524 | FOXO3 | phosphorylation | Ser321 | human | Lung Cancer | GLC-82 | SYUNZ-16 | Associated | 4.0 (Moderate) | 19904742 |
acc1517 | FKHR | Q12778 | FOXO1 | phosphorylation | Ser256 | human | Hepatocellular Carcinoma | Hep3B | SYUNZ-16 | Associated | 4.0 (Moderate) | 19904742 |
acc1518 | FKHRL1 | O43524 | FOXO3 | phosphorylation | Ser318 | human | Hepatocellular Carcinoma | Hep3B | SYUNZ-16 | Associated | 4.0 (Moderate) | 19904742 |
acc1519 | FKHRL1 | O43524 | FOXO3 | phosphorylation | Ser321 | human | Hepatocellular Carcinoma | Hep3B | SYUNZ-16 | Associated | 4.0 (Moderate) | 19904742 |
acc1520 | bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Breast Cancer | MCF-18 | Docetaxel | Associated | 4.0 (Moderate) | 12576925 |
acc1521 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Prostate Cancer | Taxol | Associated | 4.0 (Moderate) | 8640809 | |
acc1522 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Gastric Cancer | MKN45 | HP590 | Associated | 4.0 (Moderate) | 36103247 |
acc1523 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Gastric Cancer | MKN45 | HP590 | Associated | 4.0 (Moderate) | 36103247 |
acc1524 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Gastric Cancer | AGS | HP590 | Associated | 4.0 (Moderate) | 36103247 |
acc1525 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Gastric Cancer | AGS | HP590 | Associated | 4.0 (Moderate) | 36103247 |
acc1526 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Gastric Cancer | MGC803 | HP590 | Associated | 4.0 (Moderate) | 36103247 |
acc1527 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Gastric Cancer | MGC803 | HP590 | Associated | 4.0 (Moderate) | 36103247 |
acc1538 | PDGFRB | P09619 | PDGFRB | phosphorylation | Tyr751 | human | Glioblastoma | A172 | EGCG | Associated | 4.0 (Moderate) | 10198059 |
acc1539 | PDGFRB | P05622 | Pdgfrb | phosphorylation | Tyr751 | mouse | Glioblastoma | NIH 3T3 | EGCG | Associated | 4.0 (Moderate) | 10198059 |
acc1540 | Cdc25C | P30305 | CDC25C | phosphorylation | Ser216 | human | Lung Cancer | A549 | LBH589 | Associated | 4.0 (Moderate) | 21179472 |
acc1541 | cdc2 | P06493 | CDK1 | phosphorylation | Tyr15 | human | Lung Cancer | A549 | LBH589 | Associated | 4.0 (Moderate) | 21179472 |
acc1542 | Cdc25C | P30305 | CDC25C | phosphorylation | Ser216 | human | Lung Cancer | A549 | Scriptaid | Associated | 4.0 (Moderate) | 21179472 |
acc1543 | cdc2 | P06493 | CDK1 | phosphorylation | Tyr15 | human | Lung Cancer | A549 | Scriptaid | Associated | 4.0 (Moderate) | 21179472 |
acc1544 | Cdc25C | P30305 | CDC25C | phosphorylation | Ser216 | human | Lung Cancer | PC9 | LBH589 | Associated | 4.0 (Moderate) | 21179472 |
acc1545 | cdc2 | P06493 | CDK1 | phosphorylation | Tyr15 | human | Lung Cancer | PC9 | LBH589 | Associated | 4.0 (Moderate) | 21179472 |
acc1546 | Cdc25C | P30305 | CDC25C | phosphorylation | Ser216 | human | Lung Cancer | PC9 | Scriptaid | Associated | 4.0 (Moderate) | 21179472 |
acc1547 | cdc2 | P06493 | CDK1 | phosphorylation | Tyr15 | human | Lung Cancer | PC9 | Scriptaid | Associated | 4.0 (Moderate) | 21179472 |
acc1548 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Sarcoma | SA-4 | Vemurafenib | Associated | 4.0 (Moderate) | 29570692 |
acc1549 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Sarcoma | SA-4 | Vemurafenib | Associated | 4.0 (Moderate) | 29570692 |
acc1550 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Sarcoma | SA-4 | Vemurafenib | Associated | 4.0 (Moderate) | 29570692 |
acc1551 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Sarcoma | SA-4 | Vemurafenib | Associated | 4.0 (Moderate) | 29570692 |
acc1552 | EGFR | P00533 | EGFR | phosphorylation | unclear | human | Ovarian Cancer | SK-OV-3 | Y-142 | Associated | 4.0 (Moderate) | 23251664 |
acc1553 | ERBB4 | Q15303 | ERBB4 | phosphorylation | unclear | human | Ovarian Cancer | SK-OV-3 | Y-142 | Associated | 4.0 (Moderate) | 23251664 |
acc1554 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Myeloma | MOPC-31C | YM529 + ONO-5920 | Associated | 4.0 (Moderate) | 17979996 |
acc1555 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Myeloma | MOPC-31C | YM529 + ONO-5920 | Associated | 4.0 (Moderate) | 17979996 |
acc1556 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Myeloma | MOPC-31C | YM529 + ONO-5920 | Associated | 4.0 (Moderate) | 17979996 |
acc1557 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Myeloma | MOPC-31C | YM529 + ONO-5920 | Associated | 4.0 (Moderate) | 17979996 |
acc1558 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Myeloma | MOPC-31C | YM529 + ONO-5920 | Associated | 4.0 (Moderate) | 17979996 |
acc1563 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Merkel Cell Carcinoma | MGH-mcc1 | ZST474 | Associated | 4.0 (Moderate) | 22261808 |
acc1564 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Merkel Cell Carcinoma | MGH-mcc1 | ZST474 | Associated | 4.0 (Moderate) | 22261808 |
acc1565 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Merkel Cell Carcinoma | MGH-mcc1 | NVP-BEZ235 | Associated | 4.0 (Moderate) | 22261808 |
acc1566 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Merkel Cell Carcinoma | MGH-mcc1 | NVP-BEZ235 | Associated | 4.0 (Moderate) | 22261808 |
acc1567 | cullin | Q13616 | CUL1 | neddylation | unclear | human | Breast Cancer | MCF7 | MLN4924 | Associated | 4.0 (Moderate) | 23151137 |
acc1568 | cullin | Q13616 | CUL1 | neddylation | unclear | human | Cervical Cancer | EGFP-LC3+ HeLa | MLN4924 | Associated | 4.0 (Moderate) | 23151137 |
acc1575 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Prostate Cancer | DU145 | CN-CPT | Associated | 4.0 (Moderate) | 27301177 |
acc1576 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Prostate Cancer | PC3 | CN-CPT | Associated | 4.0 (Moderate) | 27301177 |
acc1577 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Myeloma | U266 | LLL12 | Associated | 4.0 (Moderate) | 21520044 |
acc1579 | YB1 | P46937 | YAP1 | phosphorylation | Ser102 | human | Hepatocellular Carcinoma | HuH-7R(sorafenib-resistant) | Sorafenib | Associated | 4.0 (Moderate) | 33379356 |
acc1580 | AMPK | P54646 | PRKAA2 | phosphorylation | Thr172 | human | Leukemia | acadesine | Associated | 4.0 (Moderate) | 12522004 | |
acc1581 | AMPK | Q13131 | PRKAA1 | phosphorylation | Thr183 | human | Leukemia | acadesine | Associated | 4.0 (Moderate) | 12522004 | |
acc2308 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Melanoma | Hs294T | FLLL32 | Associated | 4.0 (Moderate) | 20576164 |
acc2309 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Prostate Cancer | DU145 | Pimozide | Associated | 4.0 (Moderate) | 26549437 |
acc2310 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Prostate Cancer | LNCaP | Pimozide | Associated | 4.0 (Moderate) | 26549437 |
acc2314 | Neu | P04626 | ERBB2 | phosphorylation | Tyr1201 | human | Breast Cancer | MCF7 | Heregulin | Associated | 4.0 (Moderate) | 19525980 |
acc2315 | Neu | P04626 | ERBB2 | phosphorylation | Tyr1226 | human | Breast Cancer | MCF7 | Heregulin | Associated | 4.0 (Moderate) | 19525980 |
acc2316 | Neu | P04626 | ERBB2 | phosphorylation | Tyr1227 | human | Breast Cancer | MCF7 | Heregulin | Associated | 4.0 (Moderate) | 19525980 |
acc2317 | Neu | P04626 | ERBB2 | phosphorylation | Tyr1201 | human | Breast Cancer | T47D | Heregulin | Associated | 4.0 (Moderate) | 19525980 |
acc2318 | Neu | P04626 | ERBB2 | phosphorylation | Tyr1226 | human | Breast Cancer | T47D | Heregulin | Associated | 4.0 (Moderate) | 19525980 |
acc2319 | Neu | P04626 | ERBB2 | phosphorylation | Tyr1227 | human | Breast Cancer | T47D | Heregulin | Associated | 4.0 (Moderate) | 19525980 |
acc2320 | Neu | P70424 | Erbb2 | phosphorylation | Tyr1201 | mouse | Breast Cancer | 4T1 | Heregulin | Associated | 4.0 (Moderate) | 19525980 |
acc2321 | Neu | P70424 | Erbb2 | phosphorylation | Tyr1226 | mouse | Breast Cancer | 4T1 | Heregulin | Associated | 4.0 (Moderate) | 19525980 |
acc2322 | Neu | P70424 | Erbb2 | phosphorylation | Tyr1227 | mouse | Breast Cancer | 4T1 | Heregulin | Associated | 4.0 (Moderate) | 19525980 |
acc2338 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Melanoma | A375 | Gentian violet | Associated | 4.0 (Moderate) | 27373978 |
acc2339 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Melanoma | SSM2c | Gentian violet | Associated | 4.0 (Moderate) | 27373978 |
acc2340 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Melanoma | M33x | Gentian violet | Associated | 4.0 (Moderate) | 27373978 |
acc2341 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | MCF7 | Niclosamide | Associated | 4.0 (Moderate) | 33002501 |
acc2342 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Breast Cancer | MCF7 | Niclosamide | Associated | 4.0 (Moderate) | 33002501 |
acc2343 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | MCF7 | Stattic | Associated | 4.0 (Moderate) | 33002501 |
acc2344 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Myeloma | ARH-77 | LLL12 | Associated | 4.0 (Moderate) | 21520044 |
acc2347 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | HepG2 | XZH-5 | Associated | 4.0 (Moderate) | 21311975 |
acc2348 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | HuH-7 | XZH-5 | Associated | 4.0 (Moderate) | 21311975 |
acc2349 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | SNU-387 | XZH-5 | Associated | 4.0 (Moderate) | 21311975 |
acc2350 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | SNU-398 | XZH-5 | Associated | 4.0 (Moderate) | 21311975 |
acc2351 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | MDA-MB-468 | Vinorelbine | Associated | 4.0 (Moderate) | 20693278 |
acc2352 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | MDA-MB-468 | Paclitaxel | Associated | 4.0 (Moderate) | 20693278 |
acc2353 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Prostate Cancer | DU145 | Vinorelbine | Associated | 4.0 (Moderate) | 20693278 |
acc2354 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Prostate Cancer | DU145 | Paclitaxel | Associated | 4.0 (Moderate) | 20693278 |
acc2355 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Breast Cancer | MDA-MB-468 | Vinorelbine | Associated | 4.0 (Moderate) | 20693278 |
acc2356 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Breast Cancer | MDA-MB-468 | Paclitaxel | Associated | 4.0 (Moderate) | 20693278 |
acc2357 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Breast Cancer | BT549 | Vinorelbine | Associated | 4.0 (Moderate) | 20693278 |
acc2358 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Breast Cancer | BT549 | Paclitaxel | Associated | 4.0 (Moderate) | 20693278 |
acc2359 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Breast Cancer | MCF7 | Vinorelbine | Associated | 4.0 (Moderate) | 20693278 |
acc2360 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Breast Cancer | MCF7 | Paclitaxel | Associated | 4.0 (Moderate) | 20693278 |
acc2361 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Ovarian Cancer | OVCAR8 | Vinorelbine | Associated | 4.0 (Moderate) | 20693278 |
acc2362 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Ovarian Cancer | OVCAR8 | Paclitaxel | Associated | 4.0 (Moderate) | 20693278 |
acc2363 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | BT549 | Vinorelbine | Associated | 4.0 (Moderate) | 20693278 |
acc2364 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Ovarian Cancer | SK-OV-3 | Vinorelbine | Associated | 4.0 (Moderate) | 20693278 |
acc2365 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Ovarian Cancer | SK-OV-3 | Paclitaxel | Associated | 4.0 (Moderate) | 20693278 |
acc2366 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Prostate Cancer | DU145 | Vinorelbine | Associated | 4.0 (Moderate) | 20693278 |
acc2367 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Prostate Cancer | DU145 | Paclitaxel | Associated | 4.0 (Moderate) | 20693278 |
acc2368 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | BT549 | Paclitaxel | Associated | 4.0 (Moderate) | 20693278 |
acc2369 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | MCF7 | Vinorelbine | Associated | 4.0 (Moderate) | 20693278 |
acc2370 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | MCF7 | Paclitaxel | Associated | 4.0 (Moderate) | 20693278 |
acc2371 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | OVCAR8 | Vinorelbine | Associated | 4.0 (Moderate) | 20693278 |
acc2372 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | OVCAR8 | Paclitaxel | Associated | 4.0 (Moderate) | 20693278 |
acc2373 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | SK-OV-3 | Vinorelbine | Associated | 4.0 (Moderate) | 20693278 |
acc2374 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | SK-OV-3 | Paclitaxel | Associated | 4.0 (Moderate) | 20693278 |
acc2375 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Liver Cancer | HepG2 | Bazedoxifene | Associated | 4.0 (Moderate) | 30648776 |
acc2376 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Liver Cancer | SSMC-7721 | Bazedoxifene | Associated | 4.0 (Moderate) | 30648776 |
acc2377 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Liver Cancer | HuH-7 | Bazedoxifene | Associated | 4.0 (Moderate) | 30648776 |
acc2378 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Prostate Cancer | DU145 | Scoparone | Associated | 4.0 (Moderate) | 24260381 |
acc2379 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Prostate Cancer | DU145 | Scoparone | Associated | 4.0 (Moderate) | 24260381 |
acc2380 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | SK-OV-3 | Bazedoxifene + SCH527123 | Associated | 4.0 (Moderate) | 35315502 |
acc2381 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | SK-OV-3 | Bazedoxifene + SCH527123 | Associated | 4.0 (Moderate) | 35315502 |
acc2382 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | CAOV3 | Bazedoxifene + SCH527123 | Associated | 4.0 (Moderate) | 35315502 |
acc2383 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | CAOV3 | Bazedoxifene + SCH527123 | Associated | 4.0 (Moderate) | 35315502 |
acc2384 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | OVCAR-3 | Bazedoxifene + SCH527123 | Associated | 4.0 (Moderate) | 35315502 |
acc2385 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | OVCAR-3 | Bazedoxifene + SCH527123 | Associated | 4.0 (Moderate) | 35315502 |
acc2386 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | OV75 | Bazedoxifene + SCH527123 | Associated | 4.0 (Moderate) | 35315502 |
acc2387 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | OV75 | Bazedoxifene + SCH527123 | Associated | 4.0 (Moderate) | 35315502 |
acc2388 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Ovarian Cancer | SK-OV-3TR(paclitaxel-res) | CDDO-Me | Associated | 4.0 (Moderate) | 18587580 |
acc2389 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Ovarian Cancer | SK-OV-3TR(paclitaxel-res) | CDDO-Me | Associated | 4.0 (Moderate) | 18587580 |
acc2390 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Ovarian Cancer | SK-OV-3TR(paclitaxel-res) | CDDO-Me | Associated | 4.0 (Moderate) | 18587580 |
acc2391 | Src | P12931 | SRC | phosphorylation | Tyr530 | human | Ovarian Cancer | SK-OV-3TR(paclitaxel-res) | CDDO-Me | Associated | 4.0 (Moderate) | 18587580 |
acc2392 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Leukemia | K562 | Cryptotanshinone | Associated | 4.0 (Moderate) | 30054832 |
acc2393 | STAT5 | P42229 | STAT5A | phosphorylation | Tyr694 | human | Leukemia | Cryptotanshinone | Associated | 4.0 (Moderate) | 30054832 | |
acc2394 | STAT5 | P42229 | STAT5A | phosphorylation | Tyr694 | human | Leukemia | Imatinib mesylate | Associated | 4.0 (Moderate) | 28387753 | |
acc2395 | STAT5 | P42229 | STAT5A | phosphorylation | Tyr694 | human | Breast Cancer | HC11-Cuzd1 | Pimozide | Associated | 4.0 (Moderate) | 29321207 |
acc2396 | STAT5 | P42229 | STAT5A | phosphorylation | Tyr694 | human | Breast Cancer | MCF7-Cuzd1 | Pimozide | Associated | 4.0 (Moderate) | 29321207 |
acc2400 | STAT6 | P52633 | Stat6 | phosphorylation | Tyr641 | mouse | Breast Cancer | 4T1 | Emodin | Associated | 4.0 (Moderate) | 25311112 |
acc2401 | STAT6 | P42226 | STAT6 | phosphorylation | Tyr641 | human | Breast Cancer | EO771 | Emodin | Associated | 4.0 (Moderate) | 25311112 |
acc2425 | RIPK1 | Q13546 | RIPK1 | ubiquitination | unclear | human | Leukemia | MT4 | Birinapant | Associated | 4.0 (Moderate) | 32024820 |
acc2426 | CYLD | Q9NQC7 | CYLD | phosphorylation | Ser418 | human | Leukemia | MT4 | Birinapant | Associated | 4.0 (Moderate) | 32024820 |
acc2427 | RIPK1 | Q13546 | RIPK1 | ubiquitination | unclear | human | Leukemia | MT4 | MRT67307 | Associated | 4.0 (Moderate) | 32024820 |
acc2428 | CYLD | Q9NQC7 | CYLD | phosphorylation | Ser418 | human | Leukemia | MT4 | MRT67307 | Associated | 4.0 (Moderate) | 32024820 |
acc2429 | RIPK1 | Q13546 | RIPK1 | ubiquitination | unclear | human | Leukemia | MT4 | TPCA | Associated | 4.0 (Moderate) | 32024820 |
acc2430 | CYLD | Q9NQC7 | CYLD | phosphorylation | Ser418 | human | Leukemia | MT4 | TPCA | Associated | 4.0 (Moderate) | 32024820 |
acc2431 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Hepatocellular Carcinoma | Hep3B | EGCG | Associated | 4.0 (Moderate) | 19360302 |
acc2432 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Hepatocellular Carcinoma | Hep3B | EGCG | Associated | 4.0 (Moderate) | 19360302 |
acc2433 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Hepatocellular Carcinoma | Hep3B | EGCG | Associated | 4.0 (Moderate) | 19360302 |
acc2434 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Hepatocellular Carcinoma | Hep3B | EGCG | Associated | 4.0 (Moderate) | 19360302 |
acc2435 | NFKBIA | P25963 | NFKBIA | phosphorylation | Ser32 | human | Myeloma | MM.1S | PS-1145 | Associated | 4.0 (Moderate) | 11872748 |
acc2436 | NFKBIA | P25963 | NFKBIA | phosphorylation | Ser32 | human | Myeloma | RPMI8226 | PS-1145 | Associated | 4.0 (Moderate) | 11872748 |
acc2437 | NFKBIA | P25963 | NFKBIA | phosphorylation | Ser32 | human | Myeloma | U266 | PS-1145 | Associated | 4.0 (Moderate) | 11872748 |
acc2438 | NFKBIA | P25963 | NFKBIA | phosphorylation | Ser32 | human | Myeloma | MM.1S | PS-1145 + Dex | Associated | 4.0 (Moderate) | 11872748 |
acc2439 | TOPK | Q96KB5 | PBK | phosphorylation | Thr9 | human | Melanoma | RPMI7951 | arsenite | Associated | 4.0 (Moderate) | 17145805 |
acc2457 | TrkB | Q16620 | NTRK2 | phosphorylation | Tyr | human | Neuroblastoma | SH-SY5Y | Retinoic acid | Associated | 4.0 (Moderate) | 8394722 |
acc2458 | TrkB | Q16620 | NTRK2 | phosphorylation | Tyr | human | Neuroblastoma | SMS-KCNR | Retinoic acid | Associated | 4.0 (Moderate) | 8394722 |
acc2459 | TrkB | Q16620 | NTRK2 | phosphorylation | Tyr | human | Neuroblastoma | NGP-2 | Retinoic acid | Associated | 4.0 (Moderate) | 8394722 |
acc2460 | TrkB | Q16620 | NTRK2 | phosphorylation | Tyr | human | Neuroblastoma | LAN-I-15N | Retinoic acid | Associated | 4.0 (Moderate) | 8394722 |
acc2461 | MERTK | Q12866 | MERTK | phosphorylation | Tyr749 | human | Leukemia | K562 | Metformin | Associated | 4.0 (Moderate) | 32460059 |
acc2462 | TYRO3 | Q06418 | TYRO3 | phosphorylation | Tyr681 | human | Leukemia | K562 | Metformin | Associated | 4.0 (Moderate) | 32460059 |
acc2465 | TYRO3 | Q06418 | TYRO3 | phosphorylation | Tyr681 | human | Leukemia | OCI/AML3 | Metformin | Associated | 4.0 (Moderate) | 32460059 |
acc2466 | TYRO3 | Q06418 | TYRO3 | phosphorylation | Tyr681 | human | Leukemia | THP-1 | Metformin | Associated | 4.0 (Moderate) | 32460059 |
acc2473 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Leukemia | OCI/AML2 | Metformin | Associated | 4.0 (Moderate) | 32460059 |
acc2474 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Leukemia | OCI/AML3 | Metformin | Associated | 4.0 (Moderate) | 32460059 |
acc2475 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Leukemia | THP-1 | Metformin | Associated | 4.0 (Moderate) | 32460059 |
acc2476 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Leukemia | K562 | Metformin | Associated | 4.0 (Moderate) | 32460059 |
acc2490 | VEGFR2 | P35968 | KDR | phosphorylation | Tyr1059 | human | Hepatocellular Carcinoma | SMMC-7721 | I131-metuximab | Associated | 4.0 (Moderate) | 29210217 |
acc2491 | VEGFR2 | P35968 | KDR | phosphorylation | Tyr996 | human | Leukemia | HL-60 | SU4312 | Associated | 4.0 (Moderate) | 34872003 |
acc2492 | VEGFR2 | P35968 | KDR | phosphorylation | Tyr996 | human | Leukemia | K562 | SU4312 | Associated | 4.0 (Moderate) | 34872003 |
acc2493 | VEGFR2 | P35968 | KDR | phosphorylation | Tyr996 | human | Leukemia | KG-1 | SU4312 | Associated | 4.0 (Moderate) | 34872003 |
acc2494 | VEGFR2 | P35968 | KDR | phosphorylation | Tyr996 | human | Leukemia | HL-60 | Cytarabine | Associated | 4.0 (Moderate) | 34872003 |
acc2495 | VEGFR2 | P35968 | KDR | phosphorylation | Tyr996 | human | Leukemia | K562 | Cytarabine | Associated | 4.0 (Moderate) | 34872003 |
acc2496 | VEGFR2 | P35968 | KDR | phosphorylation | Tyr996 | human | Leukemia | KG-1 | Cytarabine | Associated | 4.0 (Moderate) | 34872003 |
acc2499 | Cdc2 | P06493 | CDK1 | phosphorylation | Tyr15 | human | Ovarian Cancer | HT29 | PD0166285 | Associated | 4.0 (Moderate) | 11719452 |
acc2500 | Cdc2 | P06493 | CDK1 | phosphorylation | Thr14 | human | Colorectal Cancer | HT29 | PD0166285 | Associated | 4.0 (Moderate) | 11719452 |
acc2505 | PKCepsilon | Q02156 | PRKCE | phosphorylation | Ser87 | human | Breast Cancer | MCF7 | 4-OHE2 | Associated | 4.0 (Moderate) | 31493422 |
acc2506 | PKCepsilon | Q02156 | PRKCE | phosphorylation | Ser87 | human | Breast Cancer | MDA-MB-231 | 4-OHE2 | Associated | 4.0 (Moderate) | 31493422 |
acc2507 | PKCepsilon | Q02156 | PRKCE | phosphorylation | Ser87 | human | Cervical Cancer | HeLa | 4-OHE2 | Associated | 4.0 (Moderate) | 31493422 |
acc2508 | PKCepsilon | Q02156 | PRKCE | phosphorylation | Ser87 | human | Prostate Cancer | PC3 | 4-OHE2 | Associated | 4.0 (Moderate) | 31493422 |
acc2509 | UVRAG | Q9P2Y5 | UVRAG | phosphorylation | Ser522 | human | Hepatocellular Carcinoma | MHCC97H | D4476 | Associated | 4.0 (Moderate) | 30686098 |
acc2510 | UVRAG | Q9P2Y5 | UVRAG | phosphorylation | Ser522 | human | Hepatocellular Carcinoma | HuH-7 | D4476 | Associated | 4.0 (Moderate) | 30686098 |
acc2511 | UVRAG | Q9P2Y5 | UVRAG | ubiquitination | Lys517 | human | Hepatocellular Carcinoma | MHCC97H | D4476 | Associated | 4.0 (Moderate) | 30686098 |
acc2512 | UVRAG | Q9P2Y5 | UVRAG | ubiquitination | Lys517 | human | Hepatocellular Carcinoma | HuH-7 | D4476 | Associated | 4.0 (Moderate) | 30686098 |
acc2513 | UVRAG | Q9P2Y5 | UVRAG | ubiquitination | Lys559 | human | Hepatocellular Carcinoma | MHCC97H | D4476 | Associated | 4.0 (Moderate) | 30686098 |
acc2514 | UVRAG | Q9P2Y5 | UVRAG | ubiquitination | Lys559 | human | Hepatocellular Carcinoma | HuH-7 | D4476 | Associated | 4.0 (Moderate) | 30686098 |
acc2515 | ITGalpha6 | P23229 | ITGA6 | S-nitrosylation | Cys86 | human | Prostate Cancer | PC3 | 1400W(iNOS inhibitors) | Associated | 4.0 (Moderate) | 23106339 |
acc2516 | ITGalpha6 | P23229 | ITGA6 | S-nitrosylation | Cys86 | human | Prostate Cancer | DU145 | 1400W(iNOS inhibitors) | Associated | 4.0 (Moderate) | 23106339 |
acc2520 | PD-L1 | Q9NZQ7 | CD274 | ubiquitination | unclear | human | Lung Cancer | A549 | DHA | Associated | 4.0 (Moderate) | 36309154 |
acc2521 | PD-L1 | Q9EP73 | Cd274 | ubiquitination | unclear | mouse | Lung Cancer | LLC | DHA | Associated | 4.0 (Moderate) | 36309154 |
acc2522 | PD-L1 | Q9NZQ7 | CD274 | ubiquitination | unclear | human | Hepatocellular Carcinoma | HepG2 | DHA | Associated | 4.0 (Moderate) | 36309154 |
acc2523 | PD-L1 | Q9NZQ7 | CD274 | ubiquitination | unclear | human | Hepatocellular Carcinoma | SMMC-7721 | DHA | Associated | 4.0 (Moderate) | 36309154 |
acc2525 | HER2 | P04626 | ERBB2 | ubiquitination | unclear | human | Breast Cancer | SK-BR-3 | Peptide p37 | Associated | 4.0 (Moderate) | 25898135 |
acc2526 | HER2 | P04626 | ERBB2 | ubiquitination | unclear | human | Breast Cancer | BT474 | Peptide p37 | Associated | 4.0 (Moderate) | 25898135 |
acc2527 | HER2 | P04626 | ERBB2 | ubiquitination | unclear | human | Breast Cancer | ZR-75-30 | Peptide p37 | Associated | 4.0 (Moderate) | 25898135 |
acc2528 | HER2 | P04626 | ERBB2 | ubiquitination | unclear | human | Breast Cancer | MDA-MB-361 | Peptide p37 | Associated | 4.0 (Moderate) | 25898135 |
acc2529 | HER2 | P04626 | ERBB2 | ubiquitination | unclear | human | Breast Cancer | SK-BR-3 | Peptide p37 + Trastuzumab | Associated | 4.0 (Moderate) | 25898135 |
acc2534 | Nrf2 | Q16236 | NFE2L2 | phosphorylation | unclear | human | Neuroblastoma | IMR-32 | DMAT(CK2 inhibitor) | Associated | 4.0 (Moderate) | 18273910 |
acc2537 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Colorectal Cancer | HT29 | SBA | Associated | 4.0 (Moderate) | 20503249 |
acc2538 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | HT29 | SBA | Associated | 4.0 (Moderate) | 20503249 |
acc2539 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | Hep3B | XZH-5 | Impairing | 4.0 (Moderate) | 21311975 |
acc2540 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | HepG2 | XZH-5 | Impairing | 4.0 (Moderate) | 21311975 |
acc2541 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | HuH-7 | XZH-5 | Impairing | 4.0 (Moderate) | 21311975 |
acc2542 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | SNU-387 | XZH-5 | Impairing | 4.0 (Moderate) | 21311975 |
acc2543 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | SNU-398 | XZH-5 | Impairing | 4.0 (Moderate) | 21311975 |
acc2550 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Neuroblastoma | SK-N-SH neuroblastoma cells | Okadaic acid | Enhancing | 4.0 (Moderate) | 23127854 |
acc2551 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Neuroblastoma | SK-N-SH neuroblastoma cells | Rapamycin | Enhancing | 4.0 (Moderate) | 23127854 |
acc2552 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Neuroblastoma | SK-N-SH neuroblastoma cells | Okadaic acid | Enhancing | 4.0 (Moderate) | 23127854 |
acc2553 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Neuroblastoma | SK-N-SH neuroblastoma cells | Rapamycin | Enhancing | 4.0 (Moderate) | 23127854 |
acc2555 | VASP | P50552 | VASP | phosphorylation | Ser239 | human | Lung Cancer | Baicalein | Enhancing | 4.0 (Moderate) | 25268843 | |
acc2556 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Myeloma | Ritonavir | Associated | 4.0 (Moderate) | 25542900 | |
acc2558 | mTORC1 | P42345 | MTOR | phosphorylation | Thr172 | human | Myeloma | Ritonavir | Associated | 4.0 (Moderate) | 25542900 | |
acc2566 | Trx1 | P10599 | TXN | oxidation | Cys62 | human | Neuroblastoma | SH-SH5Y | As(2-mercaptopyridine)3 | Enhancing | 4.0 (Moderate) | 26169724 |
acc2567 | Trx1 | P10599 | TXN | oxidation | Cys69 | human | Neuroblastoma | SH-SH5Y | As(2-mercaptopyridine)3 | Enhancing | 4.0 (Moderate) | 26169724 |
acc2568 | Trx1 | P10599 | TXN | oxidation | Cys62 | human | Neuroblastoma | SH-SH5Y | As(2-mercaptopyridine N-oxide)3 | Enhancing | 4.0 (Moderate) | 26169724 |
acc2569 | Trx1 | P10599 | TXN | oxidation | Cys69 | human | Neuroblastoma | SH-SH5Y | As(2-mercaptopyridine N-oxide)3 | Enhancing | 4.0 (Moderate) | 26169724 |
acc2571 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Leukemia | Sanguinarine | Associated | 4.0 (Moderate) | 27154977 | |
acc2572 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | SKOV3 | Delphinidin | Impairing | 4.0 (Moderate) | 29122484 |
acc2578 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Cervical Cancer | C33A | Emodin | Associated | 4.0 (Moderate) | 30057674 |
acc2579 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Oral Cancer | HSC-3 | Emodin | Associated | 4.0 (Moderate) | 30057674 |
acc2580 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Prostate Cancer | DU145 | Boric acid | Associated | 4.0 (Moderate) | 30196486 |
acc2582 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | HGC-27 | Aloin | Associated | 4.0 (Moderate) | 32021099 |
acc2583 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | BGC-823 | Aloin | Associated | 4.0 (Moderate) | 32021099 |
acc1822 | HER2 | P04626 | ERBB2 | phosphorylation | Tyr | human | Breast Cancer | MDA-MB-361 | Emodin | Associated | 4.0 (Moderate) | 10037184 |
acc1829 | IDO | P14902 | IDO1 | acetylation | unclear | human | Nasopharyngeal Carcinoma | CNE2 | NaB | Associated | 4.0 (Moderate) | 25854569 |
acc1830 | IDO | P14902 | IDO1 | acetylation | unclear | human | Nasopharyngeal Carcinoma | CNE2 | NaB | Associated | 4.0 (Moderate) | 25854569 |
acc1835 | NF-kappaB's RelA | Q04206 | RELA | acetylation | Lys310 | human | Breast Cancer | MDA-MB-231 | 13a | Associated | 4.0 (Moderate) | 34378541 |
acc1836 | p53 | P04637 | TP53 | acetylation | Lys382 | human | Glioblastoma | U251 | DWP0016 | Associated | 4.0 (Moderate) | 23297003 |
acc1837 | p53 | P04637 | TP53 | acetylation | Lys370 | human | Colorectal Cancer | HCT116 | MS-275 | Associated | 4.0 (Moderate) | 36257192 |
acc1838 | p53 | P04637 | TP53 | acetylation | Lys372 | human | Colorectal Cancer | HCT116 | MS-275 | Associated | 4.0 (Moderate) | 36257192 |
acc1839 | p53 | P04637 | TP53 | acetylation | Lys370 | human | Breast Cancer | MCF7 | MS-275 | Associated | 4.0 (Moderate) | 36257192 |
acc1840 | p53 | P04637 | TP53 | acetylation | Lys372 | human | Breast Cancer | MCF7 | MS-275 | Associated | 4.0 (Moderate) | 36257192 |
acc1841 | p53 | P04637 | TP53 | acetylation | Lys373 | human | Breast Cancer | MCF7 | MS-275 | Associated | 4.0 (Moderate) | 36257192 |
acc1842 | p53 | P04637 | TP53 | acetylation | Lys381 | human | Breast Cancer | MCF7 | MS-275 | Associated | 4.0 (Moderate) | 36257192 |
acc1843 | p53 | P04637 | TP53 | acetylation | Lys382 | human | Breast Cancer | MCF7 | MS-275 | Associated | 4.0 (Moderate) | 36257192 |
acc1844 | p53 | P04637 | TP53 | acetylation | Lys373 | human | Colorectal Cancer | HCT116 | MS-275 | Associated | 4.0 (Moderate) | 36257192 |
acc1845 | p53 | P04637 | TP53 | acetylation | Lys381 | human | Colorectal Cancer | HCT116 | MS-275 | Associated | 4.0 (Moderate) | 36257192 |
acc1846 | p53 | P04637 | TP53 | acetylation | Lys382 | human | Colorectal Cancer | HCT116 | MS-275 | Associated | 4.0 (Moderate) | 36257192 |
acc1847 | p53 | P04637 | TP53 | acetylation | Lys370 | human | Lung Cancer | A549 | MS-275 | Associated | 4.0 (Moderate) | 36257192 |
acc1848 | p53 | P04637 | TP53 | acetylation | Lys372 | human | Lung Cancer | A549 | MS-275 | Associated | 4.0 (Moderate) | 36257192 |
acc1849 | p53 | P04637 | TP53 | acetylation | Lys373 | human | Lung Cancer | A549 | MS-275 | Associated | 4.0 (Moderate) | 36257192 |
acc1850 | p53 | P04637 | TP53 | acetylation | Lys381 | human | Lung Cancer | A549 | MS-275 | Associated | 4.0 (Moderate) | 36257192 |
acc1851 | p53 | P04637 | TP53 | acetylation | Lys382 | human | Lung Cancer | A549 | MS-275 | Associated | 4.0 (Moderate) | 36257192 |
acc1852 | SKP2 | Q13309 | SKP2 | acetylation | Lys68 | human | Prostate Cancer | LNCaP | Dihydrotestosterone | Associated | 4.0 (Moderate) | 36871351 |
acc1853 | SKP2 | Q13309 | SKP2 | acetylation | Lys71 | human | Prostate Cancer | LNCaP | Dihydrotestosterone | Associated | 4.0 (Moderate) | 36871351 |
acc1854 | SKP2 | Q13309 | SKP2 | acetylation | Lys68 | human | Prostate Cancer | C4-2 | Dihydrotestosterone | Associated | 4.0 (Moderate) | 36871351 |
acc1855 | SKP2 | Q13309 | SKP2 | acetylation | Lys71 | human | Prostate Cancer | C4-2 | Dihydrotestosterone | Associated | 4.0 (Moderate) | 36871351 |
acc1862 | MST1 | Q13043 | STK4 | methylation | Lys59 | human | Breast Cancer | MDA-MB-231 | Neuregulin | Associated | 4.0 (Moderate) | 28114269 |
acc1863 | HER3 | P21860 | ERBB3 | phosphorylation | Tyr1307 | human | Breast Cancer | MDA-MB-231 | Neuregulin | Associated | 4.0 (Moderate) | 28114269 |
acc1869 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Colorectal Cancer | SW480 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1870 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Colorectal Cancer | HT29 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1871 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr46 | human | Colorectal Cancer | HT29 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1872 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr46 | human | Colorectal Cancer | HCT116 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1873 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Colorectal Cancer | SW480 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1874 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Colorectal Cancer | HT29 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1875 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Colorectal Cancer | HCT116 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1876 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Colorectal Cancer | SW480 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1877 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Colorectal Cancer | HT29 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1878 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Colorectal Cancer | HCT116 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1879 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Colorectal Cancer | SW480 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1880 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Colorectal Cancer | HT29 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1881 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Colorectal Cancer | HCT116 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1882 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Colorectal Cancer | HCT116 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1883 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Colorectal Cancer | SW480 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1884 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Colorectal Cancer | HT29 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1885 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Colorectal Cancer | HCT116 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1886 | p70s6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Colorectal Cancer | SW480 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1887 | p70s6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Colorectal Cancer | HT29 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1888 | p70s6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Colorectal Cancer | HCT116 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1889 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr37 | human | Colorectal Cancer | SW480 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1890 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr37 | human | Colorectal Cancer | HT29 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1891 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr37 | human | Colorectal Cancer | HCT116 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1892 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr46 | human | Colorectal Cancer | SW480 | PD98059 + Rapamycin | Associated | 4.0 (Moderate) | 19194827 |
acc1893 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Pancreas Cancer | CFPAC-1 | Pralatrexate | Associated | 4.0 (Moderate) | 36544829 |
acc1894 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr37 | human | Pancreas Cancer | CFPAC-1 | Pralatrexate | Associated | 4.0 (Moderate) | 36544829 |
acc1895 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr46 | human | Pancreas Cancer | CFPAC-1 | Pralatrexate | Associated | 4.0 (Moderate) | 36544829 |
acc1896 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Pancreas Cancer | BxPC-3(gemcitabine R) | Pralatrexate | Associated | 4.0 (Moderate) | 36544829 |
acc1897 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr37 | human | Pancreas Cancer | BxPC-3(gemcitabine R) | Pralatrexate | Associated | 4.0 (Moderate) | 36544829 |
acc1898 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr46 | human | Pancreas Cancer | BxPC-3(gemcitabine R) | Pralatrexate | Associated | 4.0 (Moderate) | 36544829 |
acc1911 | HSP27 | P04792 | HSPB1 | phosphorylation | Ser15 | human | Lung Cancer | SK-MES-1 | Dioscin | Associated | 4.0 (Moderate) | 33061803 |
acc1912 | HSP27 | P04792 | HSPB1 | phosphorylation | Ser15 | human | Lung Cancer | NCI-H520 | Dioscin | Associated | 4.0 (Moderate) | 33061803 |
acc1928 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Colorectal Cancer | HCT116 | Evista (Raloxifene·HCl) | Associated | 4.0 (Moderate) | 28711499 |
acc1929 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | MDA-MB-231 | Evista (Raloxifene·HCl) | Associated | 4.0 (Moderate) | 28711499 |
acc1930 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | SUM159 | Evista (Raloxifene·HCl) | Associated | 4.0 (Moderate) | 28711499 |
acc1931 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Cervical Cancer | HeLa | angelicin | Associated | 4.0 (Moderate) | 31602210 |
acc1932 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Cervical Cancer | SiHa | angelicin | Associated | 4.0 (Moderate) | 31602210 |
acc1935 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Oral Cancer | SAS | Magnolol | Associated | 4.0 (Moderate) | 33551310 |
acc1936 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Oral Cancer | GNM | Magnolol | Associated | 4.0 (Moderate) | 33551310 |
acc1937 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Sarcoma | Rh30 | Celecoxib | Associated | 4.0 (Moderate) | 21397587 |
acc1938 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Sarcoma | RH28 | Celecoxib | Associated | 4.0 (Moderate) | 21397587 |
acc1939 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Sarcoma | RD2 | Celecoxib | Associated | 4.0 (Moderate) | 21397587 |
acc1940 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Prostate Cancer | DU145 | PEITC | Associated | 4.0 (Moderate) | 19437484 |
acc1941 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Prostate Cancer | LNCaP | PEITC | Associated | 4.0 (Moderate) | 19437484 |
acc1942 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Prostate Cancer | DU145 | PEITC | Associated | 4.0 (Moderate) | 19437484 |
acc1943 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Prostate Cancer | LNCaP | PEITC | Associated | 4.0 (Moderate) | 19437484 |
acc1944 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Prostate Cancer | DU145 | PEITC | Associated | 4.0 (Moderate) | 19437484 |
acc1945 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Prostate Cancer | LNCaP | PEITC | Associated | 4.0 (Moderate) | 19437484 |
acc1946 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | MDA-MB-231 | B12 | Associated | 4.0 (Moderate) | 33774344 |
acc1947 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Colorectal Cancer | HCT116 | B12 | Associated | 4.0 (Moderate) | 33774344 |
acc1948 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Colorectal Cancer | SW480 | B12 | Associated | 4.0 (Moderate) | 33774344 |
acc1949 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Pancreas Cancer | L3.6pl | B12 | Associated | 4.0 (Moderate) | 33774344 |
acc1950 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Thyroid Cancer | NPA-87 | Phenylmethimazole(C10) | Associated | 4.0 (Moderate) | 17525119 |
acc1951 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Thyroid Cancer | NPA-87 | Phenylmethimazole(C10) | Associated | 4.0 (Moderate) | 17525119 |
acc1954 | ErbB2 | P04626 | ERBB2 | phosphorylation | Tyr | human | Ovarian Cancer | SK-OV-3 | IFN-gamma | Associated | 4.0 (Moderate) | 7914514 |
acc1955 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Glioblastoma | GBM4 | SAR317461 | Associated | 4.0 (Moderate) | 26283544 |
acc1956 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Glioblastoma | GBM8 | SAR317461 | Associated | 4.0 (Moderate) | 26283544 |
acc1957 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Colorectal Cancer | HCT116 | SC-43 | Associated | 4.0 (Moderate) | 30109144 |
acc1958 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Colorectal Cancer | HT29 | SC-43 | Associated | 4.0 (Moderate) | 30109144 |
acc1959 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Colorectal Cancer | HCT116 | SC-78 | Associated | 4.0 (Moderate) | 30109144 |
acc1960 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Colorectal Cancer | HT29 | SC-78 | Associated | 4.0 (Moderate) | 30109144 |
acc1961 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | MCF7 | Tanshinone I | Associated | 4.0 (Moderate) | 26202747 |
acc1962 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Hepatocellular Carcinoma | Hep3B | Ursolic acid | Associated | 4.0 (Moderate) | 28714512 |
acc1963 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Liver Cancer | HepG2 | Ursolic acid | Associated | 4.0 (Moderate) | 28714512 |
acc1964 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Liver Cancer | SSMC-7721 | Ursolic acid | Associated | 4.0 (Moderate) | 28714512 |
acc1965 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Liver Cancer | HuH-7 | Ursolic acid | Associated | 4.0 (Moderate) | 28714512 |
acc1975 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | MDA-MB-231 | LLL12 | Associated | 4.0 (Moderate) | 20072652 |
acc1976 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | SK-BR-3 | LLL12 | Associated | 4.0 (Moderate) | 20072652 |
acc1977 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Pancreas Cancer | PANC-1 | LLL12 | Associated | 4.0 (Moderate) | 20072652 |
acc1978 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Pancreas Cancer | HPAC | LLL12 | Associated | 4.0 (Moderate) | 20072652 |
acc1979 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Glioblastoma | U87 | LLL12 | Associated | 4.0 (Moderate) | 20072652 |
acc1980 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Glioblastoma | U373 | LLL12 | Associated | 4.0 (Moderate) | 20072652 |
acc1981 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | MDA-MB-231 | LLL12 + Doxorubicin | Associated | 4.0 (Moderate) | 20072652 |
acc1982 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Pancreas Cancer | HPAC | LLL12 + Doxorubicin | Associated | 4.0 (Moderate) | 20072652 |
acc1983 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Breast Cancer | MDA-MB-231 | LLL12 + Gemcitabine | Associated | 4.0 (Moderate) | 20072652 |
acc1984 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Pancreas Cancer | HPAC | LLL12 + Gemcitabine | Associated | 4.0 (Moderate) | 20072652 |
acc1985 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Lung Cancer | A549 | Pyrvinium pamoate | Associated | 4.0 (Moderate) | 32298693 |
acc1986 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Lung Cancer | A549 | Pyrvinium pamoate | Associated | 4.0 (Moderate) | 32298693 |
acc1987 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Lung Cancer | H441 | Pyrvinium pamoate | Associated | 4.0 (Moderate) | 32298693 |
acc1988 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Lung Cancer | H441 | Pyrvinium pamoate | Associated | 4.0 (Moderate) | 32298693 |
acc1989 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Lung Cancer | H292 | Pyrvinium pamoate | Associated | 4.0 (Moderate) | 32298693 |
acc1990 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Lung Cancer | H292 | Pyrvinium pamoate | Associated | 4.0 (Moderate) | 32298693 |
acc1993 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Leukemia | HL-60 | Rapamycin | Associated | 4.0 (Moderate) | 35116779 |
acc1994 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Leukemia | THP-1 | Rapamycin | Associated | 4.0 (Moderate) | 35116779 |
acc1995 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr727 | human | Leukemia | HL-60 | Rapamycin | Associated | 4.0 (Moderate) | 35116779 |
acc1996 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr727 | human | Leukemia | THP-1 | Rapamycin | Associated | 4.0 (Moderate) | 35116779 |
acc2013 | PIN1 | Q13526 | PIN1 | phosphorylation | Ser115 | human | Cholangiocarcinoma | Retinoic acid | Associated | 4.0 (Moderate) | 34048060 | |
acc2014 | JNK1 | P45983 | MAPK8 | phosphorylation | Thr183 | human | Hepatocellular Carcinoma | HuH-7 | Resveratrol | Associated | 4.0 (Moderate) | 23437203 |
acc2015 | JNK1 | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Hepatocellular Carcinoma | HuH-7 | Resveratrol | Associated | 4.0 (Moderate) | 23437203 |
acc2016 | JNK2 | P45984 | MAPK9 | phosphorylation | Thr183 | human | Hepatocellular Carcinoma | HuH-7 | Resveratrol | Associated | 4.0 (Moderate) | 23437203 |
acc2017 | JNK2 | P45984 | MAPK9 | phosphorylation | Tyr185 | human | Hepatocellular Carcinoma | HuH-7 | Resveratrol | Associated | 4.0 (Moderate) | 23437203 |
acc2018 | KIT | P10721 | KIT | phosphorylation | Tyr703 | human | Lung Cancer | HCC78 | Crizotinib + Ponatinib | Associated | 4.0 (Moderate) | 27068398 |
acc2019 | KIT | P10721 | KIT | phosphorylation | Tyr703 | human | Lung Cancer | CUTO2 | Crizotinib + Ponatinib | Associated | 4.0 (Moderate) | 27068398 |
acc2022 | AMPK | P54646 | PRKAA2 | phosphorylation | Thr172 | human | Breast Cancer | MCF7 | Docosahexaenoic acid (DHA) | Associated | 4.0 (Moderate) | 24025358 |
acc2023 | AMPK | Q13131 | PRKAA1 | phosphorylation | Thr183 | human | Breast Cancer | MCF7 | Docosahexaenoic acid (DHA) | Associated | 4.0 (Moderate) | 24025358 |
acc2025 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Melanoma | SB01-VR | Bafetinib | Associated | 4.0 (Moderate) | 29717260 |
acc2026 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Melanoma | SB01-VR | Bafetinib | Associated | 4.0 (Moderate) | 29717260 |
acc2027 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Melanoma | SB01-VR | Bafetinib + Trametinib | Associated | 4.0 (Moderate) | 29717260 |
acc2028 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Melanoma | SB01-VR | Bafetinib + Trametinib | Associated | 4.0 (Moderate) | 29717260 |
acc2029 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Melanoma | SB01-VR | Bafetinib | Associated | 4.0 (Moderate) | 29717260 |
acc2030 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Melanoma | SB01-VR | Bafetinib | Associated | 4.0 (Moderate) | 29717260 |
acc2031 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Melanoma | SB01-VR | Trametinib | Associated | 4.0 (Moderate) | 29717260 |
acc2032 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Melanoma | SB01-VR | Trametinib | Associated | 4.0 (Moderate) | 29717260 |
acc2033 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Melanoma | SB01-VR | Trametinib | Associated | 4.0 (Moderate) | 29717260 |
acc2034 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Melanoma | SB01-VR | Trametinib | Associated | 4.0 (Moderate) | 29717260 |
acc2035 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Melanoma | SB01-VR | Bafetinib + Trametinib | Associated | 4.0 (Moderate) | 29717260 |
acc2036 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Melanoma | SB01-VR | Bafetinib + Trametinib | Associated | 4.0 (Moderate) | 29717260 |
acc2037 | MEK1 | Q02750 | MAP2K1 | phosphorylation | Ser217 | human | Breast Cancer | MCF7 | DHA | Associated | 4.0 (Moderate) | 21771724 |
acc2038 | MEK1 | Q02750 | MAP2K1 | phosphorylation | Ser221 | human | Breast Cancer | MCF7 | DHA | Associated | 4.0 (Moderate) | 21771724 |
acc2039 | MEK2 | P36507 | MAP2K2 | phosphorylation | Ser217 | human | Breast Cancer | SK-BR-3 | DHA | Associated | 4.0 (Moderate) | 21771724 |
acc2040 | MEK2 | P36507 | MAP2K2 | phosphorylation | Ser221 | human | Breast Cancer | SK-BR-3 | DHA | Associated | 4.0 (Moderate) | 21771724 |
acc2041 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Breast Cancer | SK-BR-3 | DHA | Associated | 4.0 (Moderate) | 21771724 |
acc2042 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Breast Cancer | SK-BR-3 | DHA | Associated | 4.0 (Moderate) | 21771724 |
acc2043 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Breast Cancer | SK-BR-3 | DHA | Associated | 4.0 (Moderate) | 21771724 |
acc2044 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Breast Cancer | SK-BR-3 | DHA | Associated | 4.0 (Moderate) | 21771724 |
acc2045 | MEK2 | P36507 | MAP2K2 | phosphorylation | Ser217 | human | Breast Cancer | MCF7 | DHA | Associated | 4.0 (Moderate) | 21771724 |
acc2046 | MEK2 | P36507 | MAP2K2 | phosphorylation | Ser221 | human | Breast Cancer | MCF7 | DHA | Associated | 4.0 (Moderate) | 21771724 |
acc2047 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Breast Cancer | MCF7 | DHA | Associated | 4.0 (Moderate) | 21771724 |
acc2048 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Breast Cancer | MCF7 | DHA | Associated | 4.0 (Moderate) | 21771724 |
acc2049 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Breast Cancer | MCF7 | DHA | Associated | 4.0 (Moderate) | 21771724 |
acc2050 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Breast Cancer | MCF7 | DHA | Associated | 4.0 (Moderate) | 21771724 |
acc2051 | MEK1 | Q02750 | MAP2K1 | phosphorylation | Ser217 | human | Breast Cancer | SK-BR-3 | DHA | Associated | 4.0 (Moderate) | 21771724 |
acc2052 | MEK1 | Q02750 | MAP2K1 | phosphorylation | Ser221 | human | Breast Cancer | SK-BR-3 | DHA | Associated | 4.0 (Moderate) | 21771724 |
acc2053 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | Calu-6 | AZD6244 | Associated | 4.0 (Moderate) | 19783898 |
acc2054 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | Calu-6 | AZD6244 | Associated | 4.0 (Moderate) | 19783898 |
acc2057 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | Calu-6 | AZD6244 | Associated | 4.0 (Moderate) | 19783898 |
acc2058 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | Calu-6 | AZD6244 | Associated | 4.0 (Moderate) | 19783898 |
acc2059 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | HCC2450 | AZD6244 | Associated | 4.0 (Moderate) | 19783898 |
acc2060 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | HCC2450 | AZD6244 | Associated | 4.0 (Moderate) | 19783898 |
acc2061 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | HCC2450 | AZD6244 | Associated | 4.0 (Moderate) | 19783898 |
acc2062 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | HCC2450 | AZD6244 | Associated | 4.0 (Moderate) | 19783898 |
acc2065 | MEK | Q02750 | MAP2K1 | phosphorylation | unclear | human | Breast Cancer | MCF7 | Silibinin | Associated | 4.0 (Moderate) | 23353996 |
acc2066 | ERK | P27361 | MAPK3 | phosphorylation | unclear | human | Breast Cancer | MCF7 | Silibinin | Associated | 4.0 (Moderate) | 23353996 |
acc2067 | MEK | Q02750 | MAP2K1 | phosphorylation | unclear | human | Thyroid Cancer | TPC-1 | Silibinin | Associated | 4.0 (Moderate) | 23353996 |
acc2068 | ERK | P27361 | MAPK3 | phosphorylation | unclear | human | Thyroid Cancer | TPC-1 | Silibinin | Associated | 4.0 (Moderate) | 23353996 |
acc2069 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Leukemia | HL-60 | Paclitaxel | Associated | 4.0 (Moderate) | 10400418 |
acc2070 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Leukemia | U937 | Paclitaxel | Associated | 4.0 (Moderate) | 10400418 |
acc2071 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Leukemia | Jurkat | Paclitaxel | Associated | 4.0 (Moderate) | 10400418 |
acc2072 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | PC9 | Erlotinib | Associated | 4.0 (Moderate) | 23979919 |
acc2073 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | PC9 | Erlotinib | Associated | 4.0 (Moderate) | 23979919 |
acc2074 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | PC9 | Erlotinib | Associated | 4.0 (Moderate) | 23979919 |
acc3359 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Cognitive Abnormalities | Huperzine A | Associated | 4.0 (Moderate) | 16687166 | |
acc3360 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Cognitive Abnormalities | Huperzine A | Associated | 4.0 (Moderate) | 16687166 | |
acc3361 | Tau | P10636 | MAPT | phosphorylation | Ser202 | human | Alzheimer's Disease | Troglitazone | Associated | 4.0 (Moderate) | 16787414 | |
acc3362 | Tau | P10636 | MAPT | phosphorylation | Ser396 | human | Alzheimer's Disease | Troglitazone | Associated | 4.0 (Moderate) | 16787414 | |
acc3363 | Tau | P10636 | MAPT | phosphorylation | Ser404 | human | Alzheimer's Disease | Troglitazone | Associated | 4.0 (Moderate) | 16787414 | |
acc3364 | ACC1 | Q5SWU9 | Acaca | phosphorylation | Ser79 | mouse | Atherosclerosis | S17834 | Associated | 4.0 (Moderate) | 16873680 | |
acc3365 | ACC2 | E9Q4Z2 | Acacb | phosphorylation | Ser221 | mouse | Atherosclerosis | S17834 | Associated | 4.0 (Moderate) | 16873680 | |
acc3366 | AMPK | Q5EG47 | Prkaa1 | phosphorylation | Thr183 | mouse | Atherosclerosis | S17834 | Associated | 4.0 (Moderate) | 16873680 | |
acc3367 | AMPK | Q8BRK8 | Prkaa2 | phosphorylation | Thr172 | mouse | Atherosclerosis | S17834 | Associated | 4.0 (Moderate) | 16873680 | |
acc3370 | Akt | Q09YN5 | MET | phosphorylation | Ser473 | rabbit | Myocardial Infarction | DADLE/Bradykinin | Associated | 4.0 (Moderate) | 17292392 | |
acc3371 | ERK1 | G1T5Z7 | MAPK3 | phosphorylation | Thr202 | rabbit | Myocardial Infarction | DADLE/Bradykinin | Associated | 4.0 (Moderate) | 17292392 | |
acc3372 | ERK1 | G1T5Z7 | MAPK3 | phosphorylation | Thr204 | rabbit | Myocardial Infarction | DADLE/Bradykinin | Associated | 4.0 (Moderate) | 17292392 | |
acc3373 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Sarcoma | Rapamycin | Associated | 4.0 (Moderate) | 17336708 | |
acc3374 | P70S6K | P23443 | RPS6KB1 | phosphorylation | Ser411 | human | Sarcoma | Rapamycin | Associated | 4.0 (Moderate) | 17336708 | |
acc3376 | NR2A | Q00959 | Grin2a | phosphorylation | Tyr | rat | Ischemia | PP2 | Associated | 4.0 (Moderate) | 17556100 | |
acc3377 | NOS3 | Q62600 | Nos3 | phosphorylation | Ser1177 | rat | Diabetes Mellitus | Carvedilol | Associated | 4.0 (Moderate) | 17559835 | |
acc3378 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | "HEY, OVCA 433, SKOV-3, A-2780" | ZD4054 | Associated | 4.0 (Moderate) | 17620430 |
acc3379 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Ovarian Cancer | "HEY, OVCA 433, SKOV-3, A-2780" | ZD4054 | Associated | 4.0 (Moderate) | 17620430 |
acc3380 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Ovarian Cancer | "HEY, OVCA 433, SKOV-3, A-2780" | ZD4054 | Associated | 4.0 (Moderate) | 17620430 |
acc3381 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Ovarian Cancer | "HEY, OVCA 433, SKOV-3, A-2780" | ZD4054 | Associated | 4.0 (Moderate) | 17620430 |
acc3382 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Ovarian Cancer | "HEY, OVCA 433, SKOV-3, A-2780" | ZD4054 | Associated | 4.0 (Moderate) | 17620430 |
acc3383 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Ovarian Cancer | "HEY, OVCA 433, SKOV-3, A-2780" | ZD4054 | Associated | 4.0 (Moderate) | 17620430 |
acc3384 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Cerebral Damage | Ketamine | Associated | 4.0 (Moderate) | 17870450 | |
acc3385 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Cerebral Damage | Ketamine | Associated | 4.0 (Moderate) | 17870450 | |
acc3386 | FOXO1 | G3V7R4 | Foxo1 | phosphorylation | Thr24 | rat | Aging | CR reduces insulin | Associated | 4.0 (Moderate) | 17972158 | |
acc3387 | FOXO1 | G3V7R4 | Foxo1 | phosphorylation | Ser256 | rat | Aging | CR reduces insulin | Associated | 4.0 (Moderate) | 17972158 | |
acc3388 | p38 MAP kinase | P70618 | Mapk14 | phosphorylation | Thr180 | rat | Hyperosmotic Stress | Sorbitol | Associated | 4.0 (Moderate) | 17996851 | |
acc3389 | p38 MAP kinase | P70618 | Mapk14 | phosphorylation | Thr182 | rat | Hyperosmotic Stress | Sorbitol | Associated | 4.0 (Moderate) | 17996851 | |
acc3390 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Osteoporotic Osteoblasts | Human osteoblasts | PD098059 | Associated | 4.0 (Moderate) | 18079194 |
acc3391 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Osteoporotic Osteoblasts | Human osteoblasts | PD098059 | Associated | 4.0 (Moderate) | 18079194 |
acc3398 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Glioblastoma | T98G | IFN-gamma + retinoid | Associated | 4.0 (Moderate) | 18368485 |
acc3399 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Glioblastoma | U87MG | IFN-gamma + retinoid | Associated | 4.0 (Moderate) | 18368485 |
acc3400 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Diabetes Mellitus | Simvastatin | Associated | 4.0 (Moderate) | 18391484 | |
acc3401 | eNOS | Q62600 | Nos3 | phosphorylation | unclear | rat | Hypertension | Telmisartan | Associated | 4.0 (Moderate) | 18437150 | |
acc3402 | MLC | P02600 | Myl1 | phosphorylation | Thr18 | rat | Hypertension | Telmisartan | Associated | 4.0 (Moderate) | 18437150 | |
acc3403 | MLC | P02600 | Myl1 | phosphorylation | Ser19 | rat | Hypertension | Telmisartan | Associated | 4.0 (Moderate) | 18437150 | |
acc3404 | p70S6K | P67999 | Rps6kb1 | phosphorylation | Thr389 | rat | Hypertension | Telmisartan | Associated | 4.0 (Moderate) | 18437150 | |
acc3405 | ACC | P11497 | Acaca | phosphorylation | Ser79 | rat | Obesity | Juniperus chinensis hot water extract (JCE) | Associated | 4.0 (Moderate) | 18591785 | |
acc3406 | AMPK | Q09137 | Prkaa2 | phosphorylation | Thr172 | rat | Obesity | Juniperus chinensis hot water extract (JCE) | Associated | 4.0 (Moderate) | 18591785 | |
acc3407 | AMPK | P54645 | Prkaa1 | phosphorylation | Thr183 | rat | Obesity | Juniperus chinensis hot water extract (JCE) | Associated | 4.0 (Moderate) | 18591785 | |
acc3408 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Oxidative Stress | Glucose | Associated | 4.0 (Moderate) | 18599524 | |
acc3409 | tuberin | P49816 | Tsc2 | phosphorylation | Thr1462 | rat | Oxidative Stress | Glucose | Associated | 4.0 (Moderate) | 18599524 | |
acc3410 | STAT4 | P42228 | Stat4 | ubiquitination | unclear | mouse | Experimental Autoimmune Encephalomyelitis (Eae) | Berbamine | Associated | 4.0 (Moderate) | 18606704 | |
acc3411 | eNOS | P29473 | NOS3 | phosphorylation | Ser1179 | bovine | Cardiovascular Disease | BAECs | H2O2 | Associated | 4.0 (Moderate) | 18617528 |
acc3412 | GluR6 | P42260 | Grik2 | S-nitrosylation | unclear | rat | Cerebral Ischemia | Nitric oxide | Associated | 4.0 (Moderate) | 18676085 | |
acc3413 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Subarachnoid Hemorrhage | Simvastatin | Associated | 4.0 (Moderate) | 18683242 | |
acc3414 | eNOS | Q62600 | Nos3 | phosphorylation | Ser1177 | rat | Subarachnoid Hemorrhage | Simvastatin | Associated | 4.0 (Moderate) | 18683242 | |
acc3418 | ERK | P21708 | Mapk1 | phosphorylation | unclear | rat | Pancreatitis | PAR2-AP | Impairing | 4.0 (Moderate) | 18755806 | |
acc3419 | JNK | P49185 | Mapk8 | phosphorylation | unclear | rat | Pancreatitis | PAR2-AP | Impairing | 4.0 (Moderate) | 18755806 | |
acc3420 | ERK | P21708 | Mapk1 | nitration | Tyr | rat | Gastric Mucosal Healing | Rebamipid | Associated | 4.0 (Moderate) | 18787063 | |
acc3421 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Gastric Mucosal Healing | Rebamipid | Associated | 4.0 (Moderate) | 18787063 | |
acc3422 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Gastric Mucosal Healing | Rebamipid | Associated | 4.0 (Moderate) | 18787063 | |
acc3423 | IkappaBalpha | Q63746 | Nfkbia | phosphorylation | unclear | rat | Inflammatory | Troglitazone | Associated | 4.0 (Moderate) | 18827362 | |
acc3424 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Arterial Calcinosis | Erythrocyte-derived depressing factor (EDDF) | Associated | 4.0 (Moderate) | 18992368 | |
acc3425 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Arterial Calcinosis | Erythrocyte-derived depressing factor (EDDF) | Associated | 4.0 (Moderate) | 18992368 | |
acc3426 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Arterial Calcinosis | Erythrocyte-derived depressing factor (EDDF) | Associated | 4.0 (Moderate) | 18992368 | |
acc3427 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Arterial Calcinosis | Erythrocyte-derived depressing factor (EDDF) | Associated | 4.0 (Moderate) | 18992368 | |
acc3428 | STAT1 | P42225 | Stat1 | phosphorylation | Tyr701 | mouse | Atherosclerosis | Pravastatin | Associated | 4.0 (Moderate) | 19018808 | |
acc3429 | Akt | P31750 | Akt1 | phosphorylation | Thr308 | mouse | Insulin Resistance | C2C12 | Prkcq OE | Associated | 4.0 (Moderate) | 19047061 |
acc3430 | Akt | P31750 | Akt1 | phosphorylation | Thr308 | mouse | Insulin Resistance | C2C12 | Palmitate | Associated | 4.0 (Moderate) | 19047061 |
acc3431 | PDK1 | Q8BFP9 | Pdk1 | phosphorylation | Ser504 | mouse | Insulin Resistance | C2C12 | Prkcq OE | Associated | 4.0 (Moderate) | 19047061 |
acc3432 | PDK1 | Q8BFP9 | Pdk1 | phosphorylation | Ser532 | mouse | Insulin Resistance | C2C12 | Prkcq OE | Associated | 4.0 (Moderate) | 19047061 |
acc3433 | PDK1 | Q8BFP9 | Pdk1 | phosphorylation | Ser504 | mouse | Insulin Resistance | C2C12 | Palmitate | Associated | 4.0 (Moderate) | 19047061 |
acc3434 | PDK1 | Q8BFP9 | Pdk1 | phosphorylation | Ser532 | mouse | Insulin Resistance | C2C12 | Palmitate | Associated | 4.0 (Moderate) | 19047061 |
acc3435 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Diabetes Mellitus | Sphingosine-1-phosphate | Associated | 4.0 (Moderate) | 19091959 | |
acc3436 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Diabetes Mellitus | Sphingosine-1-phosphate | Associated | 4.0 (Moderate) | 19091959 | |
acc3437 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Diabetes Mellitus | Sphingosine-1-phosphate + SEW2871 | Associated | 4.0 (Moderate) | 19091959 | |
acc3438 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Diabetes Mellitus | Sphingosine-1-phosphate + SEW2871 | Associated | 4.0 (Moderate) | 19091959 | |
acc3439 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Diabetes Mellitus | Sphingosine-1-phosphate | Associated | 4.0 (Moderate) | 19091959 | |
acc3440 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Diabetes Mellitus | Sphingosine-1-phosphate | Associated | 4.0 (Moderate) | 19091959 | |
acc3441 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Diabetes Mellitus | Sphingosine-1-phosphate + SEW2871 | Associated | 4.0 (Moderate) | 19091959 | |
acc3442 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Diabetes Mellitus | Sphingosine-1-phosphate + SEW2871 | Associated | 4.0 (Moderate) | 19091959 | |
acc3443 | p38 | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | Neurotoxic | BV-2 | tBHQ | Associated | 4.0 (Moderate) | 19174151 |
acc3444 | p38 | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | Neurotoxic | BV-2 | tBHQ | Associated | 4.0 (Moderate) | 19174151 |
acc3445 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Heart Insulin Signaling | Estradiol | Associated | 4.0 (Moderate) | 19226537 | |
acc3446 | IR | P15127 | Insr | phosphorylation | Tyr | rat | Heart Insulin Signaling | Estradiol | Associated | 4.0 (Moderate) | 19226537 | |
acc3447 | AMPK | P54645 | Prkaa1 | phosphorylation | Thr183 | rat | Left Ventricular Hypertrophy | Resveratrol | Associated | 4.0 (Moderate) | 19289642 | |
acc3448 | AMPK | Q09137 | Prkaa2 | phosphorylation | Thr172 | rat | Left Ventricular Hypertrophy | Resveratrol | Associated | 4.0 (Moderate) | 19289642 | |
acc3449 | LKB1 | D4AE59 | Stk11 | phosphorylation | Ser428 | rat | Left Ventricular Hypertrophy | Resveratrol | Associated | 4.0 (Moderate) | 19289642 | |
acc3450 | mTOR | P42346 | Mtor | phosphorylation | Ser2448 | rat | Left Ventricular Hypertrophy | Resveratrol | Associated | 4.0 (Moderate) | 19289642 | |
acc3451 | p70S6K | P67999 | Rps6kb1 | phosphorylation | Thr421 | rat | Left Ventricular Hypertrophy | Resveratrol | Associated | 4.0 (Moderate) | 19289642 | |
acc3452 | p70S6K | P67999 | Rps6kb1 | phosphorylation | Ser424 | rat | Left Ventricular Hypertrophy | Resveratrol | Associated | 4.0 (Moderate) | 19289642 | |
acc3457 | JNK | P49185 | Mapk8 | phosphorylation | Thr183 | rat | Acute Kidney Injury | Glutamine | Associated | 4.0 (Moderate) | 19384198 | |
acc3458 | JNK | P49185 | Mapk8 | phosphorylation | Tyr185 | rat | Acute Kidney Injury | Glutamine | Associated | 4.0 (Moderate) | 19384198 | |
acc3459 | protein 14-3-3 | P63102 | Ywhaz | phosphorylation | Ser185 | rat | Acute Kidney Injury | Glutamine | Associated | 4.0 (Moderate) | 19384198 | |
acc3461 | STAT1 | P42225 | Stat1 | phosphorylation | unclear | mouse | Visceral Leishmaniasis | macrophage | Miltefosine | Associated | 4.0 (Moderate) | 19454711 |
acc3462 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Endotoxic Shock | U0126 | Associated | 4.0 (Moderate) | 19494320 | |
acc3463 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Endotoxic Shock | U0126 | Associated | 4.0 (Moderate) | 19494320 | |
acc3464 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Endotoxic Shock | U0126 | Associated | 4.0 (Moderate) | 19494320 | |
acc3465 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Endotoxic Shock | U0126 | Associated | 4.0 (Moderate) | 19494320 | |
acc3466 | MKP-1 | P28563 | Dusp1 | phosphorylation | Ser539 | mouse | Endotoxic Shock | U0126 | Associated | 4.0 (Moderate) | 19494320 | |
acc3467 | HbA1c | P01946 | HbA1c | glycosylation | unclear | rat | Diabetes Mellitus | Dihydroxy gymnemic triacetate | Associated | 4.0 (Moderate) | 19703537 | |
acc3468 | eNOS | P29474 | NOS3 | phosphorylation | Ser1177 | human | Pre-Eclampsia | SMCs | VEGF | Associated | 4.0 (Moderate) | 19909254 |
acc3469 | eNOS | P29474 | NOS3 | phosphorylation | Ser1177 | human | Pre-Eclampsia | SMCs | Statins | Associated | 4.0 (Moderate) | 19909254 |
acc3470 | NR1 | P35439 | Grin1 | phosphorylation | unclear | rat | Nociceptive Behaviors | Clonidine | Associated | 4.0 (Moderate) | 20007733 | |
acc3471 | FOXO1 | Q9R1E0 | Foxo1 | acetylation | Lys | mouse | Alcoholic Fatty Liver | Rosiglitazone | Associated | 4.0 (Moderate) | 20007851 | |
acc3472 | PGC1alpha | O70343 | Ppargc1a | acetylation | Lys | mouse | Alcoholic Fatty Liver | Rosiglitazone | Associated | 4.0 (Moderate) | 20007851 | |
acc3473 | ACC | Q5SWU9 | Acaca | phosphorylation | Ser79 | mouse | Alcoholic Fatty Liver | Rosiglitazone | Associated | 4.0 (Moderate) | 20007851 | |
acc3474 | AMPKalpha | Q5EG47 | Prkaa1 | phosphorylation | Thr172 | mouse | Alcoholic Fatty Liver | Rosiglitazone | Associated | 4.0 (Moderate) | 20007851 | |
acc3475 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Diabetes Mellitus | arjunolic acid | Associated | 4.0 (Moderate) | 20053369 | |
acc3476 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Diabetes Mellitus | arjunolic acid | Associated | 4.0 (Moderate) | 20053369 | |
acc3477 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Diabetes Mellitus | arjunolic acid | Associated | 4.0 (Moderate) | 20053369 | |
acc3478 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Diabetes Mellitus | arjunolic acid | Associated | 4.0 (Moderate) | 20053369 | |
acc3479 | IkappaBalpha | Q63746 | Nfkbia | phosphorylation | Ser32 | rat | Diabetes Mellitus | arjunolic acid | Associated | 4.0 (Moderate) | 20053369 | |
acc3480 | JNK | P49185 | Mapk8 | phosphorylation | Thr183 | rat | Diabetes Mellitus | arjunolic acid | Associated | 4.0 (Moderate) | 20053369 | |
acc3481 | JNK | P49185 | Mapk8 | phosphorylation | Tyr185 | rat | Diabetes Mellitus | arjunolic acid | Associated | 4.0 (Moderate) | 20053369 | |
acc3482 | p38 MAPK | P70618 | Mapk14 | phosphorylation | Thr180 | rat | Diabetes Mellitus | arjunolic acid | Associated | 4.0 (Moderate) | 20053369 | |
acc3483 | p38 MAPK | P70618 | Mapk14 | phosphorylation | Tyr182 | rat | Diabetes Mellitus | arjunolic acid | Associated | 4.0 (Moderate) | 20053369 | |
acc3484 | p65 | Q7TQN4 | Rela | phosphorylation | Ser536 | rat | Diabetes Mellitus | arjunolic acid | Associated | 4.0 (Moderate) | 20053369 | |
acc3485 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Myocardial I/R Injury | Tanshinone IIA | Associated | 4.0 (Moderate) | 20380652 | |
acc3486 | p65 | Q7TQN4 | Rela | phosphorylation | Ser536 | rat | Myocardial I/R Injury | Tanshinone IIA | Associated | 4.0 (Moderate) | 20380652 | |
acc3487 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Diabetes Mellitus | Chitosan | Associated | 4.0 (Moderate) | 20397731 | |
acc3488 | AMPK | P54645 | Prkaa1 | phosphorylation | unclear | rat | Diabetes Mellitus | Chitosan | Associated | 4.0 (Moderate) | 20397731 | |
acc3489 | Smad3 | P84025 | Smad3 | phosphorylation | Ser423 | rat | Diabetes Mellitus | Fenofibrate | Associated | 4.0 (Moderate) | 20404057 | |
acc3490 | Smad3 | P84025 | Smad3 | phosphorylation | Ser425 | rat | Diabetes Mellitus | Fenofibrate | Associated | 4.0 (Moderate) | 20404057 | |
acc3491 | cPLA2 | P47712 | PLA2G4A | phosphorylation | unclear | human | Periodontal Disease | Orento | Associated | 4.0 (Moderate) | 20410594 | |
acc3492 | ERK | P27361 | MAPK3 | phosphorylation | Thr202 | human | Periodontal Disease | Orento | Associated | 4.0 (Moderate) | 20410594 | |
acc3493 | ERK | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Periodontal Disease | Orento | Associated | 4.0 (Moderate) | 20410594 | |
acc3494 | NR2A | Q00959 | Grin2a | phosphorylation | Tyr | rat | Neuronal Loss | PP2 | Associated | 4.0 (Moderate) | 20441772 | |
acc3495 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Dilated Cardiomyopathy | Propylthiouracil (PTU) | Associated | 4.0 (Moderate) | 20453157 | |
acc3496 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | Dilated Cardiomyopathy | Propylthiouracil (PTU) | Associated | 4.0 (Moderate) | 20453157 | |
acc3497 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | Dilated Cardiomyopathy | Propylthiouracil (PTU) | Associated | 4.0 (Moderate) | 20453157 | |
acc3498 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Multiple Sclerosis | Dimethyl fumarate | Associated | 4.0 (Moderate) | 20482831 | |
acc3499 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Multiple Sclerosis | Dimethyl fumarate | Associated | 4.0 (Moderate) | 20482831 | |
acc3500 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Multiple Sclerosis | Dimethyl fumarate | Associated | 4.0 (Moderate) | 20482831 | |
acc3501 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Multiple Sclerosis | Dimethyl fumarate | Associated | 4.0 (Moderate) | 20482831 | |
acc3502 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Postoperative Allodynia | Morphine | Associated | 4.0 (Moderate) | 20493931 | |
acc3503 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Postoperative Allodynia | Morphine | Associated | 4.0 (Moderate) | 20493931 | |
acc3504 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Postoperative Allodynia | Morphine | Associated | 4.0 (Moderate) | 20493931 | |
acc3505 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Postoperative Allodynia | Morphine | Associated | 4.0 (Moderate) | 20493931 | |
acc3506 | p38 | P70618 | Mapk14 | phosphorylation | Tyr180 | rat | Postoperative Allodynia | Morphine | Associated | 4.0 (Moderate) | 20493931 | |
acc3507 | p38 | P70618 | Mapk14 | phosphorylation | Tyr182 | rat | Postoperative Allodynia | Morphine | Associated | 4.0 (Moderate) | 20493931 | |
acc3508 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Ischemia | Monosialotetrahexosy-1 ganglioside (GM1) | Associated | 4.0 (Moderate) | 20546707 | |
acc3509 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Ischemia | Monosialotetrahexosy-1 ganglioside (GM1) | Associated | 4.0 (Moderate) | 20546707 | |
acc3510 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Ischemia | Monosialotetrahexosy-1 ganglioside (GM1) | Associated | 4.0 (Moderate) | 20546707 | |
acc3511 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Ischemia | Monosialotetrahexosy-1 ganglioside (GM1) | Associated | 4.0 (Moderate) | 20546707 | |
acc3512 | p38 MAPK | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Colorectal Cancer | HT-29 | Fisetin + Radiation | Impairing | 4.0 (Moderate) | 20637980 |
acc3513 | p38 MAPK | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Colorectal Cancer | HT-29 | Fisetin + Radiation | Impairing | 4.0 (Moderate) | 20637980 |
acc3514 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | HT-29 | Fisetin + Radiation | Impairing | 4.0 (Moderate) | 20637980 |
acc3515 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Colorectal Cancer | HT-29 | Fisetin + Radiation | Impairing | 4.0 (Moderate) | 20637980 |
acc3516 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Colorectal Cancer | HT-29 | Fisetin + Radiation | Impairing | 4.0 (Moderate) | 20637980 |
acc3517 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Colorectal Cancer | HT-29 | Fisetin + Radiation | Impairing | 4.0 (Moderate) | 20637980 |
acc3518 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Colorectal Cancer | HT-29 | Fisetin + Radiation | Impairing | 4.0 (Moderate) | 20637980 |
acc3521 | PPARgamma | P37238 | Pparg | phosphorylation | Ser273 | mouse | Obese | Rosiglitazone | Associated | 4.0 (Moderate) | 20651683 | |
acc3522 | NR2B | Q01097 | Grin2b | phosphorylation | Tyr1472 | mouse | Fear Memory and Social Recognition | Tat–Src (40–58) | Associated | 4.0 (Moderate) | 20660101 | |
acc3523 | SERCA2 | P11507 | Atp2a2 | nitration | unclear | rat | Endotoxemic | Thaliporphine | Associated | 4.0 (Moderate) | 20848273 | |
acc3524 | TAK1 | P49117 | Nr2c2 | phosphorylation | Ser412 | mouse | Endotoxemic | Raw264.7 | Thaliporphine | Associated | 4.0 (Moderate) | 20848273 |
acc3525 | TAK1 | P0C8E4 | Map3k7 | phosphorylation | Ser412 | rat | Endotoxemic | H9c2 | Thaliporphine | Associated | 4.0 (Moderate) | 20848273 |
acc3526 | HSP27 | P04792 | SAFB | phosphorylation | unclear | human | Intimal Hyperplasia | A7R5 | MK2i | Associated | 4.0 (Moderate) | 20864298 |
acc3527 | GluR6 | P42260 | Grik2 | phosphorylation | Ser | rat | Cerebral Ischemia | KN93 | Associated | 4.0 (Moderate) | 20888327 | |
acc3528 | GluR6 | P42260 | Grik2 | phosphorylation | Ser | rat | Cerebral Ischemia | MK801 | Associated | 4.0 (Moderate) | 20888327 | |
acc3529 | GluR6 | P42260 | Grik2 | phosphorylation | Ser | rat | Cerebral Ischemia | L-VGCC | Associated | 4.0 (Moderate) | 20888327 | |
acc3538 | NR2B | Q62923 | Grin2b | phosphorylation | unclear | rat | Changes In Sensory Pathway Properties | CYP | Associated | 4.0 (Moderate) | 21106858 | |
acc3539 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Asthma | Florfenicol | Associated | 4.0 (Moderate) | 21163707 | |
acc3540 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Asthma | Florfenicol | Associated | 4.0 (Moderate) | 21163707 | |
acc3541 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Asthma | Florfenicol | Associated | 4.0 (Moderate) | 21163707 | |
acc3542 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Asthma | Florfenicol | Associated | 4.0 (Moderate) | 21163707 | |
acc3543 | GATA3 | P23772 | Gata3 | phosphorylation | unclear | mouse | Asthma | Florfenicol | Associated | 4.0 (Moderate) | 21163707 | |
acc3552 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Diabetes Mellitus | HL-1 | H2O2 | Associated | 4.0 (Moderate) | 21270272 |
acc3553 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Diabetes Mellitus | HL-1 | H2O2 | Associated | 4.0 (Moderate) | 21270272 |
acc3554 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Diabetes Mellitus | H2O2 | Associated | 4.0 (Moderate) | 21270272 | |
acc3555 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Diabetes Mellitus | H2O2 | Associated | 4.0 (Moderate) | 21270272 | |
acc3556 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Diabetes Mellitus | HL-1 | H2O2 | Associated | 4.0 (Moderate) | 21270272 |
acc3557 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Diabetes Mellitus | HL-1 | H2O2 | Associated | 4.0 (Moderate) | 21270272 |
acc3558 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Diabetes Mellitus | H2O2 | Associated | 4.0 (Moderate) | 21270272 | |
acc3559 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Diabetes Mellitus | H2O2 | Associated | 4.0 (Moderate) | 21270272 | |
acc3560 | NHE-1 | P26431 | Slc9a1 | phosphorylation | Ser703 | rat | Myocardial Infarction | Sildenafil | Associated | 4.0 (Moderate) | 21325817 | |
acc3561 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Pulmonary Hypertension | Ang-(1-7) | Associated | 4.0 (Moderate) | 21381494 | |
acc3562 | eNOS | Q62600 | Nos3 | phosphorylation | Ser1177 | rat | Pulmonary Hypertension | Ang-(1-7) | Associated | 4.0 (Moderate) | 21381494 | |
acc3581 | ERK1 | Q63844 | Mapk3 | phosphorylation | unclear | mouse | Muscular Dystrophy | AT-1 receptor blockers (ARB) | Associated | 4.0 (Moderate) | 21645240 | |
acc3582 | ERK2 | P63085 | Mapk1 | phosphorylation | unclear | mouse | Muscular Dystrophy | AT-1 receptor blockers (ARB) | Associated | 4.0 (Moderate) | 21645240 | |
acc3584 | GATA4 | Q08369 | Gata4 | phosphorylation | Ser105 | rat | Systolic Dysfunction | Tiron | Associated | 4.0 (Moderate) | 21702924 | |
acc3585 | GATA4 | Q08369 | Gata4 | phosphorylation | Ser105 | rat | Systolic Dysfunction | PD98059 | Associated | 4.0 (Moderate) | 21702924 | |
acc3586 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Diabetes Mellitus | alpha-linolenic acid (ALA) | Associated | 4.0 (Moderate) | 21722811 | |
acc3587 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Hepatic Injury | IL-22 | Associated | 4.0 (Moderate) | 21843953 | |
acc3588 | CaMKIIalpha | P11275 | Camk2a | phosphorylation | Thr286 | rat | Mania-Like Behavior | Ouabain | Associated | 4.0 (Moderate) | 21871514 | |
acc3589 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Mania-Like Behavior | Ouabain | Associated | 4.0 (Moderate) | 21871514 | |
acc3590 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Mania-Like Behavior | Ouabain | Associated | 4.0 (Moderate) | 21871514 | |
acc3591 | p38 MAP kinase | P70618 | Mapk14 | phosphorylation | Thr180 | rat | Mania-Like Behavior | Ouabain | Associated | 4.0 (Moderate) | 21871514 | |
acc3592 | p38 MAP kinase | P70618 | Mapk14 | phosphorylation | Tyr182 | rat | Mania-Like Behavior | Ouabain | Associated | 4.0 (Moderate) | 21871514 | |
acc3593 | p90RSK | Q63531 | Rps6ka1 | phosphorylation | Thr359 | rat | Mania-Like Behavior | Ouabain | Associated | 4.0 (Moderate) | 21871514 | |
acc3594 | p90RSK | Q63531 | Rps6ka1 | phosphorylation | Ser363 | rat | Mania-Like Behavior | Ouabain | Associated | 4.0 (Moderate) | 21871514 | |
acc3595 | TH | P04177 | Th | phosphorylation | Ser19 | rat | Mania-Like Behavior | Ouabain | Associated | 4.0 (Moderate) | 21871514 | |
acc3596 | TH | P04177 | Th | phosphorylation | Ser31 | rat | Mania-Like Behavior | Ouabain | Associated | 4.0 (Moderate) | 21871514 | |
acc3597 | TH | P04177 | Th | phosphorylation | Ser40 | rat | Mania-Like Behavior | Ouabain | Associated | 4.0 (Moderate) | 21871514 | |
acc3598 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Myocardial Infarction | NAC + ALP | Associated | 4.0 (Moderate) | 21912612 | |
acc3599 | AMPKalpha | P54645 | Prkaa1 | phosphorylation | Thr172 | rat | Myocardial Infarction | NAC + ALP | Associated | 4.0 (Moderate) | 21912612 | |
acc3600 | eNOS | Q62600 | Nos3 | phosphorylation | Ser1177 | rat | Myocardial Infarction | NAC + ALP | Associated | 4.0 (Moderate) | 21912612 | |
acc3601 | STAT3 | P52631 | Stat3 | phosphorylation | Ser727 | rat | Myocardial Infarction | NAC + ALP | Associated | 4.0 (Moderate) | 21912612 | |
acc3602 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Porphyrias | Vanadate | Associated | 4.0 (Moderate) | 22070747 | |
acc3603 | tubulin | P49815 | TSC2 | acetylation | unclear | human | Barrier Dysfunction | HPAEC | Tubacin | Associated | 4.0 (Moderate) | 22074808 |
acc3604 | tubulin | Q61037 | Tsc2 | acetylation | unclear | mouse | Barrier Dysfunction | HPAEC | Tubacin | Associated | 4.0 (Moderate) | 22074808 |
acc3613 | MLC | Q15049 | MLC1 | phosphorylation | Thr18 | human | Barrier Dysfunction | HPAEC | 2-methoxyestradiol(2-ME) | Associated | 4.0 (Moderate) | 22074808 |
acc3614 | MLC | Q15049 | MLC1 | phosphorylation | Ser19 | human | Barrier Dysfunction | HPAEC | 2-methoxyestradiol(2-ME) | Associated | 4.0 (Moderate) | 22074808 |
acc3615 | MLC | Q8VHK5 | Mlc1 | phosphorylation | Thr18 | mouse | Barrier Dysfunction | HPAEC | 2-methoxyestradiol(2-ME) | Associated | 4.0 (Moderate) | 22074808 |
acc3616 | MLC | Q8VHK5 | Mlc1 | phosphorylation | Ser19 | mouse | Barrier Dysfunction | HPAEC | 2-methoxyestradiol(2-ME) | Associated | 4.0 (Moderate) | 22074808 |
acc3617 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Barrier Dysfunction | HPAEC | 2-methoxyestradiol(2-ME) | Associated | 4.0 (Moderate) | 22074808 |
acc3618 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Barrier Dysfunction | HPAEC | 2-methoxyestradiol(2-ME) | Associated | 4.0 (Moderate) | 22074808 |
acc3619 | p38 | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | Barrier Dysfunction | HPAEC | 2-methoxyestradiol(2-ME) | Associated | 4.0 (Moderate) | 22074808 |
acc3620 | p38 | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | Barrier Dysfunction | HPAEC | 2-methoxyestradiol(2-ME) | Associated | 4.0 (Moderate) | 22074808 |
acc3621 | ERK | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Allergic | HMC-1 | Angelica acutiloba | Associated | 4.0 (Moderate) | 22129085 |
acc3622 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Allergic | HMC-1 | Angelica acutiloba | Associated | 4.0 (Moderate) | 22129085 |
acc3623 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Allergic | HMC-1 | Angelica acutiloba | Associated | 4.0 (Moderate) | 22129085 |
acc3624 | p38 MAPK | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Allergic | HMC-1 | Angelica acutiloba | Associated | 4.0 (Moderate) | 22129085 |
acc3625 | ERK | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Memory Retrieval | Muscimol | Associated | 4.0 (Moderate) | 22169949 | |
acc3626 | ERK | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Memory Retrieval | Diazepam | Associated | 4.0 (Moderate) | 22169949 | |
acc3627 | ERK | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Memory Retrieval | BMI | Associated | 4.0 (Moderate) | 22169949 | |
acc3628 | Tau | P10637 | Mapt | phosphorylation | Ser199 | mouse | Alzheimer's Disease | L-3-n-butylphthalide | Associated | 4.0 (Moderate) | 22233765 | |
acc3629 | Tau | P10637 | Mapt | phosphorylation | Thr205 | mouse | Alzheimer's Disease | L-3-n-butylphthalide | Associated | 4.0 (Moderate) | 22233765 | |
acc3630 | Tau | P10637 | Mapt | phosphorylation | Ser396 | mouse | Alzheimer's Disease | L-3-n-butylphthalide | Associated | 4.0 (Moderate) | 22233765 | |
acc3631 | Tau | P10637 | Mapt | phosphorylation | Ser404 | mouse | Alzheimer's Disease | L-3-n-butylphthalide | Associated | 4.0 (Moderate) | 22233765 | |
acc3632 | AKT | P31749 | AKT1 | phosphorylation | unclear | human | Pancreatic Cancer | MIAPaCa-2 | ISIR-042 | Associated | 4.0 (Moderate) | 22263802 |
acc3633 | STAT1 | A0A1D5R9X3 | STAT1 | phosphorylation | Tyr701 | monkey | Chronic Hepatitis C | cynomolgus monkey hepatocytes | pegIFNlambda | Associated | 4.0 (Moderate) | 22280056 |
acc3634 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Hypertension | Ginsenoside protopanaxatriol | Associated | 4.0 (Moderate) | 22380784 | |
acc3635 | eNOS | Q62600 | Nos3 | phosphorylation | Ser1177 | rat | Hypertension | Ginsenoside protopanaxatriol | Associated | 4.0 (Moderate) | 22380784 | |
acc3636 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Polycystic Ovarian Syndrome | granulosa cells | Dihydrotestosterone | Enhancing | 4.0 (Moderate) | 22454147 |
acc3637 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Polycystic Ovarian Syndrome | granulosa cells | Dihydrotestosterone | Enhancing | 4.0 (Moderate) | 22454147 |
acc3638 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Polycystic Ovarian Syndrome | granulosa cells | Dihydrotestosterone | Enhancing | 4.0 (Moderate) | 22454147 |
acc3639 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Polycystic Ovarian Syndrome | granulosa cells | Dihydrotestosterone | Enhancing | 4.0 (Moderate) | 22454147 |
acc3640 | AMPK | P54645 | Prkaa1 | phosphorylation | Thr183 | rat | Polycystic Ovarian Syndrome | granulosa cells | Dihydrotestosterone | Associated | 4.0 (Moderate) | 22454147 |
acc3641 | AMPK | Q09137 | Prkaa2 | phosphorylation | Thr172 | rat | Polycystic Ovarian Syndrome | granulosa cells | Dihydrotestosterone | Associated | 4.0 (Moderate) | 22454147 |
acc3643 | FOXO1 | Q9R1E0 | Foxo1 | phosphorylation | Ser256 | mouse | Cognitive Abnormalities | Domoic acid | Associated | 4.0 (Moderate) | 22474074 | |
acc3644 | JNK1 | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Cognitive Abnormalities | Domoic acid | Associated | 4.0 (Moderate) | 22474074 | |
acc3645 | JNK1 | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Cognitive Abnormalities | Domoic acid | Associated | 4.0 (Moderate) | 22474074 | |
acc3646 | p47phox | Q09014 | Ncf1 | phosphorylation | Ser | mouse | Cognitive Abnormalities | Domoic acid | Associated | 4.0 (Moderate) | 22474074 | |
acc3647 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Cardiac Hypertrophy | KS370 | Associated | 4.0 (Moderate) | 22484506 | |
acc3648 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Cardiac Hypertrophy | KS370 | Associated | 4.0 (Moderate) | 22484506 | |
acc2843 | Tau | P19332 | MAPT | phosphorylation | Ser396 | rat | Acute Hyperhomocysteinemia | Homocysteine | Associated | 4.0 (Moderate) | 22525229 | |
acc2844 | Cdc2 | P06493 | CDK1 | phosphorylation | Tyr15 | human | Cancer | HCT116 | Doxorubicin | Associated | 4.0 (Moderate) | 22589537 |
acc2845 | Chk2 | O96017 | CHEK2 | phosphorylation | Thr68 | human | Cancer | HCT116 | Doxorubicin | Associated | 4.0 (Moderate) | 22589537 |
acc2846 | VEGFR2 | P35968 | KDR | phosphorylation | Tyr1175 | human | Angiogenesis | HUVEC | Triphala churna | Associated | 4.0 (Moderate) | 22937129 |
acc2847 | RelA | Q04206 | RELA | phosphorylation | Ser536 | human | Hepatic Fibrosis | LX-2 | P6 | Associated | 4.0 (Moderate) | 22996371 |
acc2853 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Breast Cancer | MCF-7 | Selenocystine + Auranofin | Associated | 4.0 (Moderate) | 23342042 |
acc2856 | beta-catenin | Q02248 | Ctnnb1 | phosphorylation | Ser675 | mouse | Diabetes Mellitus | GLP–1(28–36)amide | Associated | 4.0 (Moderate) | 23571712 | |
acc2857 | CREB | P16220 | CREB1 | phosphorylation | unclear | human | Inflammatory | KRJ-I | MRS1754 | Associated | 4.0 (Moderate) | 23638125 |
acc2858 | CREB | P16220 | CREB1 | phosphorylation | unclear | human | Inflammatory | KRJ-I | MRS1754 | Associated | 4.0 (Moderate) | 23638125 |
acc2859 | TPH-1 | P17752 | TPH1 | phosphorylation | unclear | human | Inflammatory | KRJ-I | NECA | Associated | 4.0 (Moderate) | 23638125 |
acc2860 | TPH-1 | P17752 | TPH1 | phosphorylation | unclear | human | Inflammatory | KRJ-I | NECA | Associated | 4.0 (Moderate) | 23638125 |
acc2861 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Multiple Sclerosis | CB52 | Associated | 4.0 (Moderate) | 24036373 | |
acc2862 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Multiple Sclerosis | CB52 | Associated | 4.0 (Moderate) | 24036373 | |
acc2863 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Multiple Sclerosis | CB52 | Associated | 4.0 (Moderate) | 24036373 | |
acc2864 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Multiple Sclerosis | CB52 | Associated | 4.0 (Moderate) | 24036373 | |
acc2865 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Hyperammonic Brain Disorder | ammonia | Associated | 4.0 (Moderate) | 24044899 | |
acc2866 | EGFR | Q01279 | Egfr | phosphorylation | Tyr846 | mouse | Hyperammonic Brain Disorder | ammonia | Associated | 4.0 (Moderate) | 24044899 | |
acc2867 | EGFR | Q01279 | Egfr | phosphorylation | Tyr1068 | mouse | Hyperammonic Brain Disorder | ammonia | Associated | 4.0 (Moderate) | 24044899 | |
acc2868 | ERK | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Hyperammonic Brain Disorder | ammonia | Associated | 4.0 (Moderate) | 24044899 | |
acc2869 | Bcl-2 | P10415 | BCL2 | phosphorylation | Thr56 | human | Leukemia | Jurkat T | Nocodazole | Associated | 4.0 (Moderate) | 24166139 |
acc2870 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Leukemia | Jurkat T | Nocodazole | Associated | 4.0 (Moderate) | 24166139 |
acc2871 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser87 | human | Leukemia | Jurkat T | Nocodazole | Associated | 4.0 (Moderate) | 24166139 |
acc2872 | Bim | O43521 | BCL2L11 | phosphorylation | unclear | human | Leukemia | Jurkat T | Nocodazole | Associated | 4.0 (Moderate) | 24166139 |
acc2874 | HSP27 | P04792 | SAFB | phosphorylation | Ser82 | human | Cervical Cancer | HeLa | LY303511 + TRAIL | Associated | 4.0 (Moderate) | 24176848 |
acc2875 | p65 | Q7TQN4 | Rela | phosphorylation | unclear | rat | Pancreatitis | Pioglitazone | Associated | 4.0 (Moderate) | 24185678 | |
acc2879 | MGMT | P16455 | MGMT?? | ubiquitination | Cys145 | human | Glioblastoma | T98 | Disulfiram | Associated | 4.0 (Moderate) | 24193513 |
acc2880 | Tau | P10636 | MAPT | acetylation | Lys163 | human | Alzheimer's Disease | N2aSwe | Cilostazol + Resveratrol | Associated | 4.0 (Moderate) | 24254769 |
acc2881 | Tau | P10636 | MAPT | acetylation | Lys174 | human | Alzheimer's Disease | N2aSwe | Cilostazol + Resveratrol | Associated | 4.0 (Moderate) | 24254769 |
acc2882 | Tau | P10636 | MAPT | acetylation | Lys180 | human | Alzheimer's Disease | N2aSwe | Cilostazol + Resveratrol | Associated | 4.0 (Moderate) | 24254769 |
acc2883 | CK2alpha | P68400 | CSNK2A1 | phosphorylation | Thr360 | human | Alzheimer's Disease | N2aSwe | Cilostazol + Resveratrol | Associated | 4.0 (Moderate) | 24254769 |
acc2884 | CK2alpha | P68400 | CSNK2A1 | phosphorylation | Ser362 | human | Alzheimer's Disease | N2aSwe | Cilostazol + Resveratrol | Associated | 4.0 (Moderate) | 24254769 |
acc2885 | GSK3beta | P49841 | GSK3B | phosphorylation | Tyr216 | human | Alzheimer's Disease | N2aSwe | Cilostazol + Resveratrol | Associated | 4.0 (Moderate) | 24254769 |
acc2886 | SIRT1 | Q96EB6 | SIRT1 | phosphorylation | Ser649 | human | Alzheimer's Disease | N2aSwe | Cilostazol + Resveratrol | Associated | 4.0 (Moderate) | 24254769 |
acc2887 | Tau | P10636 | MAPT | phosphorylation | Ser202 | human | Alzheimer's Disease | N2aSwe | Cilostazol + Resveratrol | Associated | 4.0 (Moderate) | 24254769 |
acc2888 | Tau | P10636 | MAPT | phosphorylation | Thr205 | human | Alzheimer's Disease | N2aSwe | Cilostazol + Resveratrol | Associated | 4.0 (Moderate) | 24254769 |
acc2889 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | SMMC-7721 | Ethyl pyruvate | Associated | 4.0 (Moderate) | 24361892 |
acc2890 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | HepG2 | Ethyl pyruvate | Associated | 4.0 (Moderate) | 24361892 |
acc2891 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | HCC-LM3 | Ethyl pyruvate | Associated | 4.0 (Moderate) | 24361892 |
acc2892 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Hepatocellular Carcinoma | Ethyl pyruvate | Associated | 4.0 (Moderate) | 24361892 | |
acc2899 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Diabetes Mellitus | rhabdomyosarcoma | C2-ceramide | Associated | 4.0 (Moderate) | 24650522 |
acc2900 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Diabetes Mellitus | C2C12 | C2-ceramide | Associated | 4.0 (Moderate) | 24650522 |
acc2901 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Diabetes Mellitus | rhabdomyosarcoma | C2-ceramide + rapamycin | Associated | 4.0 (Moderate) | 24650522 |
acc2902 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Diabetes Mellitus | C2C12 | C2-ceramide + rapamycin | Associated | 4.0 (Moderate) | 24650522 |
acc2906 | 4EBP1 | Q62622 | Eif4ebp1 | phosphorylation | Thr70 | rat | Parkinson's Disease | PC12 | "6-hydroxydopamine,N-methyl-4-phenylpyridine,rotenone" | Associated | 4.0 (Moderate) | 24726895 |
acc2907 | mTOR | P42346 | Mtor | phosphorylation | Ser2448 | rat | Parkinson's Disease | PC12 | "6-hydroxydopamine,N-methyl-4-phenylpyridine,rotenone" | Associated | 4.0 (Moderate) | 24726895 |
acc2908 | S6K1 | P67999 | Rps6kb1 | phosphorylation | Thr389 | rat | Parkinson's Disease | PC12 | "6-hydroxydopamine,N-methyl-4-phenylpyridine,rotenone" | Associated | 4.0 (Moderate) | 24726895 |
acc2913 | IRS1 | P35570 | Irs1 | glycosylation | unclear | rat | Myocardial I/R Injury | "Neonatal rat Cardiomyocytes, NRCMs" | Glucose | Associated | 4.0 (Moderate) | 24845581 |
acc2914 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Myocardial I/R Injury | "Neonatal rat Cardiomyocytes, NRCMs" | Glucose | Associated | 4.0 (Moderate) | 24845581 |
acc2915 | IRS1 | P35570 | Irs1 | phosphorylation | Tyr | rat | Myocardial I/R Injury | "Neonatal rat Cardiomyocytes, NRCMs" | Glucose | Associated | 4.0 (Moderate) | 24845581 |
acc2916 | AKT | P31749 | AKT1 | phosphorylation | unclear | human | HIV | CHME5 | Ginsenoside Rb1 | Associated | 4.0 (Moderate) | 24983400 |
acc2917 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | HIV | CHME5 | Ginsenoside Rb1 | Associated | 4.0 (Moderate) | 24983400 |
acc2919 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | HT-29 | Efipladib | Associated | 4.0 (Moderate) | 25365190 |
acc2920 | Akt | P31750 | Akt1 | phosphorylation | unclear | mouse | Gastritis | Pc-ME | Associated | 4.0 (Moderate) | 25446596 | |
acc2921 | IkappaBalpha | Q9Z1E3 | Nfkbia | phosphorylation | unclear | mouse | Gastritis | Pc-ME | Associated | 4.0 (Moderate) | 25446596 | |
acc2922 | Src | P05480 | Src | phosphorylation | unclear | mouse | Gastritis | Pc-ME | Associated | 4.0 (Moderate) | 25446596 | |
acc2923 | Syk | P48025 | Syk | phosphorylation | unclear | mouse | Gastritis | Pc-ME | Associated | 4.0 (Moderate) | 25446596 | |
acc2924 | TRPV1 | O35433 | Trpv1 | phosphorylation | Ser800 | rat | Muscle Mechanical Hyperalgesia | AMG9810 | Associated | 4.0 (Moderate) | 25451626 | |
acc2925 | Akt | Q09YN5 | MET | phosphorylation | Ser473 | rabbit | Atherosclerosis | des-fluoro-anacetrapib | Associated | 4.0 (Moderate) | 25633313 | |
acc2926 | IkappaBalpha | P25963 | NFKBIA | phosphorylation | unclear | human | Colorectal Cancer | SW620 | As4O6 | Associated | 4.0 (Moderate) | 25845556 |
acc2927 | p65 | Q7TQN4 | Rela | phosphorylation | unclear | rat | Acute Lung Injury | Magnolol | Associated | 4.0 (Moderate) | 26072062 | |
acc2928 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Cardiac Injury | Apocynin | Associated | 4.0 (Moderate) | 26109504 | |
acc2929 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Cardiac Injury | Apocynin | Associated | 4.0 (Moderate) | 26109504 | |
acc2930 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Cardiac Injury | Apocynin | Associated | 4.0 (Moderate) | 26109504 | |
acc2931 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Cardiac Injury | Apocynin | Associated | 4.0 (Moderate) | 26109504 | |
acc2932 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Pain | Morphine | Associated | 4.0 (Moderate) | 26162710 | |
acc2933 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Pain | Aspirin | Associated | 4.0 (Moderate) | 26162710 | |
acc2935 | Caveolin-1 | P49817 | Cav1 | phosphorylation | Tyr14 | mouse | Microphage Apoptosis | macrophage | EPS | Associated | 4.0 (Moderate) | 26424181 |
acc2943 | c-Met | P08581 | MET | phosphorylation | Tyr1234 | human | Prostate Cancer | DU145 | Isothiocyanatostilbenes | Associated | 4.0 (Moderate) | 26543230 |
acc2944 | c-Met | P08581 | MET | phosphorylation | Tyr1235 | human | Prostate Cancer | DU145 | Isothiocyanatostilbenes | Associated | 4.0 (Moderate) | 26543230 |
acc2945 | GluA1 | P23818 | Gria1 | phosphorylation | Ser845 | mouse | Pain | IEM1460 | Associated | 4.0 (Moderate) | 26585043 | |
acc2950 | TNFR1 | P25118 | Tnfrsf1a | ubiquitination | Lys256 | mouse | Inflammatory | TNF | Associated | 4.0 (Moderate) | 26649818 | |
acc2951 | DARPP-32 | Q6J4I0 | Ppp1r1b | phosphorylation | Thr34 | rat | Parkinson's Disease | Levodopa | Associated | 4.0 (Moderate) | 26893543 | |
acc2954 | p38 MAPK | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Cardiovascular Disease | Uric acid | Associated | 4.0 (Moderate) | 27400779 | |
acc2955 | p38 MAPK | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Cardiovascular Disease | Uric acid | Associated | 4.0 (Moderate) | 27400779 | |
acc2956 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Cardiovascular Disease | Uric acid | Associated | 4.0 (Moderate) | 27400779 | |
acc2957 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Cardiovascular Disease | Uric acid | Associated | 4.0 (Moderate) | 27400779 | |
acc2958 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Cardiovascular Disease | Uric acid | Associated | 4.0 (Moderate) | 27400779 | |
acc2959 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Cardiovascular Disease | Uric acid | Associated | 4.0 (Moderate) | 27400779 | |
acc2960 | PDGFRB | P09619 | PDGFRB | phosphorylation | Tyr751 | human | Cardiovascular Disease | Uric acid | Associated | 4.0 (Moderate) | 27400779 | |
acc2961 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Endothelial Dysfunction | human umbilical vein endothelial cells (HUVECs) | Berberine | Associated | 4.0 (Moderate) | 27478481 |
acc2962 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Endothelial Dysfunction | human umbilical vein endothelial cells (HUVECs) | Berberine | Associated | 4.0 (Moderate) | 27478481 |
acc2963 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Myocardial I/R Injury | H9c2 | Asiatic acid | Impairing | 4.0 (Moderate) | 27657024 |
acc2964 | GSK3beta | P18266 | Gsk3b | phosphorylation | Ser9 | rat | Myocardial I/R Injury | H9c2 | Asiatic acid | Impairing | 4.0 (Moderate) | 27657024 |
acc2965 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Asthma | Caffeic acid phenethyl ester (CAPE) | Associated | 4.0 (Moderate) | 27746262 | |
acc2966 | ERK | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Asthma | Caffeic acid phenethyl ester (CAPE) | Associated | 4.0 (Moderate) | 27746262 | |
acc2967 | ERK | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Asthma | Caffeic acid phenethyl ester (CAPE) | Associated | 4.0 (Moderate) | 27746262 | |
acc2968 | JNK | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Asthma | Caffeic acid phenethyl ester (CAPE) | Associated | 4.0 (Moderate) | 27746262 | |
acc2969 | JNK | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Asthma | Caffeic acid phenethyl ester (CAPE) | Associated | 4.0 (Moderate) | 27746262 | |
acc2970 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | Asthma | Caffeic acid phenethyl ester (CAPE) | Associated | 4.0 (Moderate) | 27746262 | |
acc2971 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | Asthma | Caffeic acid phenethyl ester (CAPE) | Associated | 4.0 (Moderate) | 27746262 | |
acc2972 | STAT6 | P52633 | Stat6 | phosphorylation | Tyr641 | mouse | Graves' Disease | AS1517499 | Associated | 4.0 (Moderate) | 27906181 | |
acc2973 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Inflammation | xylene-induced ear edema model | Ig | Associated | 4.0 (Moderate) | 27914361 |
acc2974 | beta-catenin | P35222 | CTNNB1 | phosphorylation | Tyr489 | human | Bronchopulmonary Dysplasia | Dasatinib | Associated | 4.0 (Moderate) | 27941077 | |
acc2975 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Alzheimer's Disease | Cannabidiol | Associated | 4.0 (Moderate) | 28025562 | |
acc2976 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Alzheimer's Disease | Cannabidiol + Mesenchymal stem cells | Associated | 4.0 (Moderate) | 28025562 | |
acc2977 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Alzheimer's Disease | Cannabidiol + Mesenchymal stem cells | Associated | 4.0 (Moderate) | 28025562 | |
acc2978 | PI3K | P42336 | PIK3CA | phosphorylation | Tyr458 | human | Alzheimer's Disease | Cannabidiol + Mesenchymal stem cells | Associated | 4.0 (Moderate) | 28025562 | |
acc2979 | PI3K | P42336 | PIK3CA | phosphorylation | Tyr199 | human | Alzheimer's Disease | Cannabidiol + Mesenchymal stem cells | Associated | 4.0 (Moderate) | 28025562 | |
acc2980 | Tau | P10636 | MAPT | phosphorylation | unclear | human | Alzheimer's Disease | Cannabidiol + Mesenchymal stem cells | Associated | 4.0 (Moderate) | 28025562 | |
acc2981 | PP2A-C | P67775 | PPP2CA | phosphorylation | Tyr307 | human | Bladder Cancer | T24T | XIAP KO | Associated | 4.0 (Moderate) | 28057023 |
acc2982 | PP2A-C | P67775 | PPP2CA | phosphorylation | Tyr307 | human | Bladder Cancer | UMUC3 | XIAP KO | Associated | 4.0 (Moderate) | 28057023 |
acc2983 | ATM | Q13315 | ATM | phosphorylation | Ser1981 | human | Prostate Cancer | DU145 | Etoposide | Associated | 4.0 (Moderate) | 28387728 |
acc2985 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Cholangiocarcinoma | KKU-M213 | Cimetidine | Associated | 4.0 (Moderate) | 28454273 |
acc2986 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Infarction | tBHQ | Associated | 4.0 (Moderate) | 28534651 | |
acc2987 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Infarction | tBHQ | Associated | 4.0 (Moderate) | 28534651 | |
acc2988 | AKT | P31749 | AKT1 | phosphorylation | unclear | human | Hepatocellular Carcinoma | Bel-7402 | ONTD | Associated | 4.0 (Moderate) | 28834734 |
acc2989 | Drp1 | Q8K1M6 | Dnm1l | phosphorylation | Ser616 | mouse | Heart Failure | extract of Sheng-Mai-San (ESMS) | Associated | 4.0 (Moderate) | 28841143 | |
acc2990 | Drp1 | Q8K1M6 | Dnm1l | phosphorylation | Ser637 | mouse | Heart Failure | extract of Sheng-Mai-San (ESMS) | Associated | 4.0 (Moderate) | 28841143 | |
acc3013 | GluA1 | P23818 | Gria1 | phosphorylation | Ser831 | mouse | Pain | Nitroglycerin | Associated | 4.0 (Moderate) | 29486167 | |
acc3017 | IkappaBalpha | P25963 | NFKBIA | phosphorylation | Ser32 | human | Rheumatoid Arthritis | Licochalcone A | Associated | 4.0 (Moderate) | 29864947 | |
acc3018 | p65 | Q04206 | RELA | phosphorylation | Ser536 | human | Rheumatoid Arthritis | Licochalcone A | Associated | 4.0 (Moderate) | 29864947 | |
acc3019 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Inflammation | RAW264.7 | Solanine A | Associated | 4.0 (Moderate) | 29890469 |
acc3020 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Inflammation | RAW264.7 | Solanine A | Associated | 4.0 (Moderate) | 29890469 |
acc3021 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Inflammation | RAW264.7 | Solanine A | Associated | 4.0 (Moderate) | 29890469 |
acc3022 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Inflammation | RAW264.7 | Solanine A | Associated | 4.0 (Moderate) | 29890469 |
acc3023 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Inflammation | RAW264.7 | Solanine A | Associated | 4.0 (Moderate) | 29890469 |
acc3024 | IkappaBalpha | Q9Z1E3 | Nfkbia | phosphorylation | Ser32 | mouse | Inflammation | RAW264.7 | Solanine A | Associated | 4.0 (Moderate) | 29890469 |
acc3025 | IkappaBalpha | Q9Z1E3 | Nfkbia | phosphorylation | Ser36 | mouse | Inflammation | RAW264.7 | Solanine A | Associated | 4.0 (Moderate) | 29890469 |
acc3026 | NF-kappaB p65 | Q04207 | Rela | phosphorylation | Ser536 | mouse | Inflammation | RAW264.7 | Solanine A | Associated | 4.0 (Moderate) | 29890469 |
acc3027 | STAT1 | P42225 | Stat1 | phosphorylation | Tyr701 | mouse | Inflammation | RAW264.7 | Solanine A | Associated | 4.0 (Moderate) | 29890469 |
acc3028 | FAK | O35346 | Ptk2 | phosphorylation | Tyr397 | rat | Intracranial Aneurysms (Ias) | Berberine | Associated | 4.0 (Moderate) | 29899701 | |
acc3029 | p65 | Q04206 | RELA | phosphorylation | Ser536 | human | Breast Cancer | MCF-7 | TRAIL + BIX-01294 | Associated | 4.0 (Moderate) | 29964331 |
acc3030 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Breast Cancer | MCF-7 | BIX-01294 | Enhancing | 4.0 (Moderate) | 29964331 |
acc3031 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Breast Cancer | MCF-7 | BIX-01294 | Enhancing | 4.0 (Moderate) | 29964331 |
acc3032 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Breast Cancer | MCF-7 | BIX-01294 | Enhancing | 4.0 (Moderate) | 29964331 |
acc3033 | PERK | Q9NZJ5 | EIF2AK3 | phosphorylation | Thr981 | human | Breast Cancer | MCF-7 | BIX-01294 | Enhancing | 4.0 (Moderate) | 29964331 |
acc3034 | c-Jun | P05412 | JUN | phosphorylation | Ser73 | human | Breast Cancer | MCF-7 | TRAIL + BIX-01294 | Associated | 4.0 (Moderate) | 29964331 |
acc3035 | c-Jun | P05412 | JUN | phosphorylation | Ser73 | human | Breast Cancer | MCF-7 | BIX-01294 | Associated | 4.0 (Moderate) | 29964331 |
acc3036 | p65 | Q04206 | RELA | phosphorylation | Ser536 | human | Breast Cancer | MCF-7 | BIX-01294 | Associated | 4.0 (Moderate) | 29964331 |
acc3037 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Breast Cancer | MCF-7 | TRAIL + BIX-01294 | Associated | 4.0 (Moderate) | 29964331 |
acc3038 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Breast Cancer | MCF-7 | TRAIL + BIX-01294 | Associated | 4.0 (Moderate) | 29964331 |
acc3041 | Smad3 | P84025 | Smad3 | phosphorylation | Ser425 | rat | Hepatic Fibrosis | hepatic stellate cells | TF-SC | Associated | 4.0 (Moderate) | 29990830 |
acc3045 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | A549 | DTX | Associated | 4.0 (Moderate) | 30061946 |
acc3046 | BAD | Q92934 | BAD | phosphorylation | Ser112 | human | Lung Cancer | A549 | DTX | Associated | 4.0 (Moderate) | 30061946 |
acc3047 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Lung Cancer | A549 | DTX | Associated | 4.0 (Moderate) | 30061946 |
acc3048 | STAT1 | Q6P6Q7 | Stat1 | phosphorylation | Ser727 | rat | Diabetes Mellitus | active vitamin D | Associated | 4.0 (Moderate) | 30478987 | |
acc3051 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Memory Deficit | Nimodipine + Vitamin E | Associated | 4.0 (Moderate) | 30776390 | |
acc3052 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Memory Deficit | Nimodipine + Vitamin E | Associated | 4.0 (Moderate) | 30776390 | |
acc3053 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Memory Deficit | Nimodipine + Vitamin E | Associated | 4.0 (Moderate) | 30776390 | |
acc3054 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Memory Deficit | Nimodipine + Vitamin E | Associated | 4.0 (Moderate) | 30776390 | |
acc3055 | STAT3 | P52631 | Stat3 | phosphorylation | Tyr705 | rat | Diabetes Mellitus | AG490 | Associated | 4.0 (Moderate) | 30913399 | |
acc3060 | JNK | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Osteoclastogenesis | RAW264.7 | ZOL | Associated | 4.0 (Moderate) | 31173157 |
acc3061 | JNK | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Osteoclastogenesis | RAW264.7 | ZOL | Associated | 4.0 (Moderate) | 31173157 |
acc3062 | cSrc | P12931 | SRC | phosphorylation | Tyr527 | human | Breast Cancer | T47D | Folic acid + Progesterone | Associated | 4.0 (Moderate) | 31502059 |
acc3063 | cSrc | P12931 | SRC | phosphorylation | Tyr527 | human | Breast Cancer | MCF-7 | Folic acid + Progesterone | Associated | 4.0 (Moderate) | 31502059 |
acc3064 | cSrc | P12931 | SRC | phosphorylation | Tyr527 | human | Breast Cancer | BT473 | Folic acid + Progesterone | Associated | 4.0 (Moderate) | 31502059 |
acc3065 | cSrc | P12931 | SRC | phosphorylation | Tyr527 | human | Breast Cancer | BT483 | Folic acid + Progesterone | Associated | 4.0 (Moderate) | 31502059 |
acc3067 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Leukemia | U937 | SEL201 | Associated | 4.0 (Moderate) | 31903169 |
acc3069 | XPF | Q92889 | ERCC4 | acetylation | Lys911 | human | Genome Instability | HeLa | Mitomycin C | Associated | 4.0 (Moderate) | 32034146 |
acc3070 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Melanoma | A375 | TM | Associated | 4.0 (Moderate) | 32085796 |
acc3071 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Melanoma | RPMI | TM | Associated | 4.0 (Moderate) | 32085796 |
acc3072 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Melanoma | SH4 | TM | Associated | 4.0 (Moderate) | 32085796 |
acc3073 | S6 | P62753 | RPS6 | phosphorylation | Ser240 | human | Melanoma | RPMI | TM | Associated | 4.0 (Moderate) | 32085796 |
acc3074 | S6 | P62753 | RPS6 | phosphorylation | Ser240 | human | Melanoma | SH4 | TM | Associated | 4.0 (Moderate) | 32085796 |
acc3075 | S6 | P62753 | RPS6 | phosphorylation | Ser244 | human | Melanoma | RPMI | TM | Associated | 4.0 (Moderate) | 32085796 |
acc3076 | S6 | P62753 | RPS6 | phosphorylation | Ser244 | human | Melanoma | SH4 | TM | Associated | 4.0 (Moderate) | 32085796 |
acc3077 | STAT3 | P52631 | Stat3 | phosphorylation | Tyr705 | rat | Acute Lung Injury | KNK437 | Associated | 4.0 (Moderate) | 32091104 | |
acc3078 | TBK1 | Q9UHD2 | TBK1 | phosphorylation | Ser172 | human | Renal Cancer | UMRC2 | CMPD1 | Associated | 4.0 (Moderate) | 32127406 |
acc3079 | Akt | P31750 | Akt1 | phosphorylation | Tyr308 | mouse | Alzheimer's Disease | Maslinic acid | Associated | 4.0 (Moderate) | 32133639 | |
acc3080 | CREB | Q01147 | Creb1 | phosphorylation | Ser133 | mouse | Alzheimer's Disease | Maslinic acid | Associated | 4.0 (Moderate) | 32133639 | |
acc3081 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Alzheimer's Disease | Maslinic acid | Associated | 4.0 (Moderate) | 32133639 | |
acc3082 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Alzheimer's Disease | Maslinic acid | Associated | 4.0 (Moderate) | 32133639 | |
acc3083 | PI3K | P42337 | Pik3ca | phosphorylation | Tyr199 | mouse | Alzheimer's Disease | Maslinic acid | Associated | 4.0 (Moderate) | 32133639 | |
acc3086 | STAT6 | P42226 | STAT6 | phosphorylation | Tyr641 | human | Atopic Dermatitis | HaCaT | Piperine | Associated | 4.0 (Moderate) | 32392825 |
acc3087 | STAT6 | P52633 | Stat6 | phosphorylation | Tyr641 | mouse | Atopic Dermatitis | Piperine | Associated | 4.0 (Moderate) | 32392825 | |
acc2075 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | PC9 | Erlotinib | Associated | 4.0 (Moderate) | 23979919 |
acc2076 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | HCC827 | Erlotinib | Associated | 4.0 (Moderate) | 23979919 |
acc2077 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | HCC827 | Erlotinib | Associated | 4.0 (Moderate) | 23979919 |
acc2078 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | HCC827 | Erlotinib | Associated | 4.0 (Moderate) | 23979919 |
acc2079 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | HCC827 | Erlotinib | Associated | 4.0 (Moderate) | 23979919 |
acc2080 | FAK | Q05397 | PTK2 | phosphorylation | Tyr | human | Breast Cancer | MDA-MB-231 | Met-F-AEA | Associated | 4.0 (Moderate) | 16343481 |
acc2081 | Src | P12931 | SRC | phosphorylation | Tyr | human | Breast Cancer | MDA-MB-231 | Met-F-AEA | Associated | 4.0 (Moderate) | 16343481 |
acc2082 | FAK | P34152 | Ptk2 | phosphorylation | Tyr | mouse | Breast Cancer | TSA-E1 | Met-F-AEA | Associated | 4.0 (Moderate) | 16343481 |
acc2083 | Src | P05480 | Src | phosphorylation | Tyr | mouse | Breast Cancer | TSA-E1 | Met-F-AEA | Associated | 4.0 (Moderate) | 16343481 |
acc2084 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Melanoma | Sbcl2 | Azacitidine | Associated | 4.0 (Moderate) | 34866327 |
acc2085 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Melanoma | Sbcl2 | Azacitidine | Associated | 4.0 (Moderate) | 34866327 |
acc2086 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Melanoma | Sbcl2 | Azacitidine + Trametinib | Associated | 4.0 (Moderate) | 34866327 |
acc2087 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Melanoma | Sbcl2 | Azacitidine + Trametinib | Associated | 4.0 (Moderate) | 34866327 |
acc2088 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Melanoma | Sbcl2 | Azacitidine | Associated | 4.0 (Moderate) | 34866327 |
acc2089 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Melanoma | Sbcl2 | Azacitidine | Associated | 4.0 (Moderate) | 34866327 |
acc2090 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Melanoma | Sbcl2 | Trametinib | Associated | 4.0 (Moderate) | 34866327 |
acc2091 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Melanoma | Sbcl2 | Trametinib | Associated | 4.0 (Moderate) | 34866327 |
acc2092 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Melanoma | Sbcl2 | Trametinib | Associated | 4.0 (Moderate) | 34866327 |
acc2093 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Melanoma | Sbcl2 | Trametinib | Associated | 4.0 (Moderate) | 34866327 |
acc2094 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Melanoma | Sbcl2 | Azacitidine + Trametinib | Associated | 4.0 (Moderate) | 34866327 |
acc2095 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Melanoma | Sbcl2 | Azacitidine + Trametinib | Associated | 4.0 (Moderate) | 34866327 |
acc2096 | MMP-9 | P14780 | MMP9 | phosphorylation | unclear | human | Breast Cancer | MCF7 | SFN | Associated | 4.0 (Moderate) | 35988280 |
acc2097 | MMP-9 | P14780 | MMP9 | phosphorylation | unclear | human | Breast Cancer | MDA-MB-231 | SFN | Associated | 4.0 (Moderate) | 35988280 |
acc2098 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Leukemia | MV4-11 | Merestinib | Associated | 4.0 (Moderate) | 27307295 |
acc2099 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Leukemia | MM6 | Merestinib | Associated | 4.0 (Moderate) | 27307295 |
acc2102 | KNL1 | Q8NG31 | KNL1 | phosphorylation | Thr875 | human | Breast Cancer | MDA-MB-231 | BOS172722 | Associated | 4.0 (Moderate) | 31575759 |
acc2103 | KNL1 | Q8NG31 | KNL1 | phosphorylation | Thr875 | human | Breast Cancer | MDA-MB-468 | BOS172722 | Associated | 4.0 (Moderate) | 31575759 |
acc2106 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Ser65 | human | Breast Cancer | BT474 | Trastuzumab | Associated | 4.0 (Moderate) | 21498638 |
acc2107 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Ser65 | human | Breast Cancer | SK-BR-3 | Trastuzumab | Associated | 4.0 (Moderate) | 21498638 |
acc2108 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Ser65 | human | Colorectal Cancer | HCT-8 | Cetuximab | Associated | 4.0 (Moderate) | 21498638 |
acc2109 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Ser65 | human | Colorectal Cancer | HCT116 | Cetuximab | Associated | 4.0 (Moderate) | 21498638 |
acc2110 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Ser65 | human | Head and Neck Cancer | CAL33 | Erlotinib | Associated | 4.0 (Moderate) | 21498638 |
acc2111 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Ser65 | human | Head and Neck Cancer | CAL33-LTE | Erlotinib | Associated | 4.0 (Moderate) | 21498638 |
acc2116 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Lung Cancer | A549 | ACHP | Associated | 4.0 (Moderate) | 31847229 |
acc2117 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Lung Cancer | H1299 | ACHP | Associated | 4.0 (Moderate) | 31847229 |
acc2118 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Cervical Cancer | HeLa | Resveratrol | Associated | 4.0 (Moderate) | 33040485 |
acc2119 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Cervical Cancer | SiHa | Resveratrol | Associated | 4.0 (Moderate) | 33040485 |
acc2120 | p21WAF1/CIP2 | P38936 | CDKN1A | phosphorylation | Ser146 | human | Hepatocellular Carcinoma | HepG2 | Asiatic acid | Associated | 4.0 (Moderate) | 24568526 |
acc2136 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Colorectal Cancer | RKO | Melatonin | Associated | 4.0 (Moderate) | 29152648 |
acc2137 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Colorectal Cancer | RKO | Melatonin | Associated | 4.0 (Moderate) | 29152648 |
acc2138 | p53 | P04637 | TP53 | phosphorylation | Ser392 | human | Lung Cancer | HCC-827 | MX-C4 | Associated | 4.0 (Moderate) | 35902040 |
acc2139 | p53 | P04637 | TP53 | phosphorylation | Ser392 | human | Lung Cancer | HCI-H460 | MX-C4 | Associated | 4.0 (Moderate) | 35902040 |
acc2163 | PAX3-FOXO1 | P23760 | PAX3 | phosphorylation | Ser201 | human | Sarcoma | Rh30 | LiCl | Associated | 4.0 (Moderate) | 25821947 |
acc2164 | PAX3-FOXO1 | P23760 | PAX3 | phosphorylation | Ser205 | human | Sarcoma | Rh30 | LiCl | Associated | 4.0 (Moderate) | 25821947 |
acc2165 | PAX3-FOXO1 | P23760 | PAX3 | phosphorylation | Ser201 | human | Sarcoma | RH4 | LiCl | Associated | 4.0 (Moderate) | 25821947 |
acc2166 | PAX3-FOXO1 | P23760 | PAX3 | phosphorylation | Ser205 | human | Sarcoma | RH4 | LiCl | Associated | 4.0 (Moderate) | 25821947 |
acc2167 | PAX3-FOXO1 | P23760 | PAX3 | phosphorylation | Ser201 | human | Sarcoma | Rh30 | AR-A014418 | Associated | 4.0 (Moderate) | 25821947 |
acc2168 | PAX3-FOXO1 | P23760 | PAX3 | phosphorylation | Ser205 | human | Sarcoma | Rh30 | AR-A014418 | Associated | 4.0 (Moderate) | 25821947 |
acc2169 | PAX3-FOXO1 | P23760 | PAX3 | phosphorylation | Ser201 | human | Sarcoma | RH4 | AR-A014418 | Associated | 4.0 (Moderate) | 25821947 |
acc2170 | PAX3-FOXO1 | P23760 | PAX3 | phosphorylation | Ser205 | human | Sarcoma | RH4 | AR-A014418 | Associated | 4.0 (Moderate) | 25821947 |
acc2171 | PCK1 | P35558 | PCK1 | phosphorylation | Ser90 | human | Hepatocellular Carcinoma | HuH-7 | MK-220 | Associated | 4.0 (Moderate) | 32322062 |
acc2172 | PCK1 | P35558 | PCK1 | phosphorylation | Ser90 | human | Hepatocellular Carcinoma | Hep3B | MK-220 | Associated | 4.0 (Moderate) | 32322062 |
acc2182 | AMPKalpha1 | Q13131 | PRKAA1 | phosphorylation | Thr467 | human | Cervical Cancer | Ishikawa | SMI-4a + AICAR | Associated | 4.0 (Moderate) | 31358902 |
acc2189 | STAT1 | P42224 | STAT1 | phosphorylation | Ser727 | human | Oral Cancer | HSC-3 | EGCG | Associated | 4.0 (Moderate) | 19928918 |
acc2190 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Oral Cancer | HSC-3 | EGCG | Associated | 4.0 (Moderate) | 19928918 |
acc2191 | JAK1 | P23458 | JAK1 | phosphorylation | Tyr1022 | human | Oral Cancer | HSC-3 | EGCG | Associated | 4.0 (Moderate) | 19928918 |
acc2192 | JAK1 | P23458 | JAK1 | phosphorylation | Tyr1023 | human | Oral Cancer | HSC-3 | EGCG | Associated | 4.0 (Moderate) | 19928918 |
acc2193 | JAK-2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Oral Cancer | HSC-3 | EGCG | Associated | 4.0 (Moderate) | 19928918 |
acc2194 | JAK-2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Oral Cancer | HSC-3 | EGCG | Associated | 4.0 (Moderate) | 19928918 |
acc2195 | PKCdelta | Q05655 | PRKCD | phosphorylation | Thr507 | human | Colorectal Cancer | HT29 | Magnolol | Associated | 4.0 (Moderate) | 32429376 |
acc2196 | PKCdelta | Q05655 | PRKCD | phosphorylation | Thr507 | human | Colorectal Cancer | CT26 | Magnolol | Associated | 4.0 (Moderate) | 32429376 |
acc2197 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | HT29 | Rottlerin | Associated | 4.0 (Moderate) | 32429376 |
acc2198 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | CT26 | Rottlerin | Associated | 4.0 (Moderate) | 32429376 |
acc2199 | NF-kappaB | P25963 | NFKBIA | phosphorylation | Ser276 | human | Colorectal Cancer | HT29 | Magnolol | Associated | 4.0 (Moderate) | 32429376 |
acc2200 | NF-kappaB | P25963 | NFKBIA | phosphorylation | Ser276 | human | Colorectal Cancer | CT26 | Magnolol | Associated | 4.0 (Moderate) | 32429376 |
acc2201 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | HT29 | Magnolol | Associated | 4.0 (Moderate) | 32429376 |
acc2202 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | CT26 | Magnolol | Associated | 4.0 (Moderate) | 32429376 |
acc2203 | PKCdelta | Q05655 | PRKCD | phosphorylation | Thr507 | human | Colorectal Cancer | HT29 | Rottlerin | Associated | 4.0 (Moderate) | 32429376 |
acc2204 | PKCdelta | Q05655 | PRKCD | phosphorylation | Thr507 | human | Colorectal Cancer | CT26 | Rottlerin | Associated | 4.0 (Moderate) | 32429376 |
acc2205 | NF-kappaB | P25963 | NFKBIA | phosphorylation | Ser276 | human | Colorectal Cancer | HT29 | Rottlerin | Associated | 4.0 (Moderate) | 32429376 |
acc2206 | NF-kappaB | P25963 | NFKBIA | phosphorylation | Ser276 | human | Colorectal Cancer | CT26 | Rottlerin | Associated | 4.0 (Moderate) | 32429376 |
acc2207 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Breast Cancer | MCF7 | VPA | Associated | 4.0 (Moderate) | 34263655 |
acc2208 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Breast Cancer | MDA-MB-231 | VPA | Associated | 4.0 (Moderate) | 34263655 |
acc2209 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Breast Cancer | MCF7 | VPA | Associated | 4.0 (Moderate) | 34263655 |
acc2210 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Breast Cancer | MDA-MB-231 | VPA | Associated | 4.0 (Moderate) | 34263655 |
acc2213 | pp125FAK | Q05397 | PTK2 | phosphorylation | Tyr | human | Prostate Cancer | PC3 | Bombesin | Associated | 4.0 (Moderate) | 9247295 |
acc2214 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MDA-MB-468 | Tamoxifen | Associated | 4.0 (Moderate) | 29261144 |
acc2215 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | HCC-1937 | Tamoxifen | Associated | 4.0 (Moderate) | 29261144 |
acc2216 | PRAS40 | Q96B36 | AKT1S1 | phosphorylation | Thr246 | human | Prostate Cancer | LNCaP | AZD5363 | Associated | 4.0 (Moderate) | 22294718 |
acc2217 | PRAS40 | Q96B36 | AKT1S1 | phosphorylation | Thr246 | human | Breast Cancer | BT474c | AZD5363 | Associated | 4.0 (Moderate) | 22294718 |
acc2218 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Prostate Cancer | LNCaP | AZD5363 | Associated | 4.0 (Moderate) | 22294718 |
acc2219 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Breast Cancer | BT474c | AZD5363 | Associated | 4.0 (Moderate) | 22294718 |
acc2220 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Ser65 | human | Prostate Cancer | LNCaP | AZD5363 | Associated | 4.0 (Moderate) | 22294718 |
acc2221 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Ser65 | human | Breast Cancer | BT474c | AZD5363 | Associated | 4.0 (Moderate) | 22294718 |
acc2222 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Prostate Cancer | LNCaP | AZD5363 | Associated | 4.0 (Moderate) | 22294718 |
acc2223 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Breast Cancer | BT474c | AZD5363 | Associated | 4.0 (Moderate) | 22294718 |
acc2224 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Prostate Cancer | LNCaP | AZD5363 | Associated | 4.0 (Moderate) | 22294718 |
acc2225 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Breast Cancer | BT474c | AZD5363 | Associated | 4.0 (Moderate) | 22294718 |
acc2226 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Prostate Cancer | LNCaP | AZD5363 | Associated | 4.0 (Moderate) | 22294718 |
acc2227 | S6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Breast Cancer | BT474c | AZD5363 | Associated | 4.0 (Moderate) | 22294718 |
acc2228 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Prostate Cancer | LNCaP | AZD5363 | Associated | 4.0 (Moderate) | 22294718 |
acc2229 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | BT474c | AZD5363 | Associated | 4.0 (Moderate) | 22294718 |
acc2251 | RB1 | P06400 | RB1 | phosphorylation | Thr356 | human | Head and Neck Cancer | FaDu | Palbociclib | Associated | 4.0 (Moderate) | 26265441 |
acc2252 | RB1 | P06400 | RB1 | phosphorylation | Thr356 | human | Head and Neck Cancer | SCC61 | Palbociclib | Associated | 4.0 (Moderate) | 26265441 |
acc2279 | RPS6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Breast Cancer | SK-BR-3 | Erlotinib | Associated | 4.0 (Moderate) | 23552733 |
acc2280 | RPS6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Breast Cancer | SK-BR-3 | Erlotinib | Associated | 4.0 (Moderate) | 23552733 |
acc2281 | RPS6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Breast Cancer | HCC1954 | Erlotinib + Pertuzumab | Associated | 4.0 (Moderate) | 23552733 |
acc2282 | RPS6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Breast Cancer | HCC1954 | Erlotinib + Pertuzumab | Associated | 4.0 (Moderate) | 23552733 |
acc2283 | RB | P06400 | RB1 | phosphorylation | Ser807 | human | Breast Cancer | SK-BR-3 | Erlotinib + Pertuzumab | Associated | 4.0 (Moderate) | 23552733 |
acc2284 | RB | P06400 | RB1 | phosphorylation | Ser811 | human | Breast Cancer | SK-BR-3 | Erlotinib + Pertuzumab | Associated | 4.0 (Moderate) | 23552733 |
acc2285 | RB | P06400 | RB1 | phosphorylation | Ser807 | human | Breast Cancer | HCC1954 | Erlotinib + Pertuzumab | Associated | 4.0 (Moderate) | 23552733 |
acc2286 | RB | P06400 | RB1 | phosphorylation | Ser811 | human | Breast Cancer | HCC1954 | Erlotinib + Pertuzumab | Associated | 4.0 (Moderate) | 23552733 |
acc2287 | RPS6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Breast Cancer | SK-BR-3 | Erlotinib + Trastuzumab | Associated | 4.0 (Moderate) | 23552733 |
acc2288 | RPS6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Breast Cancer | SK-BR-3 | Erlotinib + Trastuzumab | Associated | 4.0 (Moderate) | 23552733 |
acc2289 | RPS6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Breast Cancer | HCC1954 | Erlotinib + Trastuzumab | Associated | 4.0 (Moderate) | 23552733 |
acc2290 | RPS6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Breast Cancer | HCC1954 | Erlotinib + Trastuzumab | Associated | 4.0 (Moderate) | 23552733 |
acc2291 | RPS6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Breast Cancer | HCC1954 | Erlotinib | Associated | 4.0 (Moderate) | 23552733 |
acc2292 | RB | P06400 | RB1 | phosphorylation | Ser807 | human | Breast Cancer | SK-BR-3 | Erlotinib + Trastuzumab | Associated | 4.0 (Moderate) | 23552733 |
acc2293 | RB | P06400 | RB1 | phosphorylation | Ser811 | human | Breast Cancer | SK-BR-3 | Erlotinib + Trastuzumab | Associated | 4.0 (Moderate) | 23552733 |
acc2294 | RB | P06400 | RB1 | phosphorylation | Ser807 | human | Breast Cancer | HCC1954 | Erlotinib + Trastuzumab | Associated | 4.0 (Moderate) | 23552733 |
acc2295 | RB | P06400 | RB1 | phosphorylation | Ser811 | human | Breast Cancer | HCC1954 | Erlotinib + Trastuzumab | Associated | 4.0 (Moderate) | 23552733 |
acc2296 | RPS6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Breast Cancer | HCC1954 | Erlotinib | Associated | 4.0 (Moderate) | 23552733 |
acc2297 | RB | P06400 | RB1 | phosphorylation | Ser807 | human | Breast Cancer | SK-BR-3 | Erlotinib | Associated | 4.0 (Moderate) | 23552733 |
acc2298 | RB | P06400 | RB1 | phosphorylation | Ser811 | human | Breast Cancer | SK-BR-3 | Erlotinib | Associated | 4.0 (Moderate) | 23552733 |
acc2299 | RB | P06400 | RB1 | phosphorylation | Ser807 | human | Breast Cancer | HCC1954 | Erlotinib | Associated | 4.0 (Moderate) | 23552733 |
acc2300 | RB | P06400 | RB1 | phosphorylation | Ser811 | human | Breast Cancer | HCC1954 | Erlotinib | Associated | 4.0 (Moderate) | 23552733 |
acc2301 | RPS6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Breast Cancer | SK-BR-3 | Erlotinib + Pertuzumab | Associated | 4.0 (Moderate) | 23552733 |
acc2302 | RPS6 | P62753 | RPS6 | phosphorylation | Ser236 | human | Breast Cancer | SK-BR-3 | Erlotinib + Pertuzumab | Associated | 4.0 (Moderate) | 23552733 |
acc2306 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Colorectal Cancer | HCT116 | Celastrol derivative 4m | Associated | 4.0 (Moderate) | 34894961 |
acc2307 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Melanoma | A375 | FLLL32 | Associated | 4.0 (Moderate) | 20576164 |
acc2584 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Gastric Cancer | HGC-27 | Aloin | Associated | 4.0 (Moderate) | 32021099 |
acc2585 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Gastric Cancer | BGC-823 | Aloin | Associated | 4.0 (Moderate) | 32021099 |
acc2586 | IkappaBalpha | P25963 | NFKBIA | phosphorylation | Ser32 | human | Gastric Cancer | HGC-27 | Aloin | Associated | 4.0 (Moderate) | 32021099 |
acc2587 | IkappaBalpha | P25963 | NFKBIA | phosphorylation | Ser32 | human | Gastric Cancer | BGC-823 | Aloin | Associated | 4.0 (Moderate) | 32021099 |
acc2588 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Gastric Cancer | HGC-27 | Aloin | Associated | 4.0 (Moderate) | 32021099 |
acc2589 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Gastric Cancer | BGC-823 | Aloin | Associated | 4.0 (Moderate) | 32021099 |
acc2595 | CDKN1B | P52957 | CDKN1B | phosphorylation | unclear | human | Breast Cancer | NP-ALT | Associated | 4.0 (Moderate) | 34446542 | |
acc2597 | ASK1 | Q99683 | MAP3K5 | phosphorylation | Ser967 | human | Ovarian Cancer | SKOV3 | PUMA OE + paclitaxel | Associated | 4.0 (Moderate) | 36122664 |
acc2598 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Ovarian Cancer | SKOV3 | PUMA OE + paclitaxel | Associated | 4.0 (Moderate) | 36122664 |
acc2599 | BCL-XL | Q07817 | BCL2L1 | phosphorylation | Ser62 | human | Ovarian Cancer | SKOV3 | PUMA OE + paclitaxel | Associated | 4.0 (Moderate) | 36122664 |
acc2608 | BAD | Q92934 | BAD | phosphorylation | unclear | human | Colorectal Cancer | COLO205 | Gossypol | Associated | 4.0 (Moderate) | 17597109 |
acc2609 | BAD | Q92934 | BAD | phosphorylation | unclear | human | Colorectal Cancer | HT29 | Gossypol | Associated | 4.0 (Moderate) | 17597109 |
acc2610 | BAD | Q92934 | BAD | phosphorylation | unclear | human | Colorectal Cancer | COLO205 | Gossypol acetic acid | Associated | 4.0 (Moderate) | 17597109 |
acc2611 | BAD | Q92934 | BAD | phosphorylation | unclear | human | Colorectal Cancer | HT29 | Gossypol acetic acid | Associated | 4.0 (Moderate) | 17597109 |
acc2613 | ATM | Q13315 | ATM | phosphorylation | Ser1981 | human | Ovarian Cancer | IGROV-1 | ST1926 | Associated | 4.0 (Moderate) | 19676051 |
acc2617 | H2AX | P16104 | H2AX | phosphorylation | unclear | human | Ovarian Cancer | IGROV-1 | ST1926 | Associated | 4.0 (Moderate) | 19676051 |
acc2621 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Myocardial Infarction | Rapamycin | Associated | 4.0 (Moderate) | 31738412 | |
acc2622 | S6 | P62754 | Rps6 | phosphorylation | Ser235 | mouse | Myocardial Infarction | Rapamycin | Associated | 4.0 (Moderate) | 31738412 | |
acc2623 | S6 | P62754 | Rps6 | phosphorylation | Ser236 | mouse | Myocardial Infarction | Rapamycin | Associated | 4.0 (Moderate) | 31738412 | |
acc2624 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Myocardial Infarction | Rapamycin | Associated | 4.0 (Moderate) | 31738412 | |
acc2628 | PLC-gamma2 | Q8CIH5 | Plcg2 | phosphorylation | Tyr | mouse | Phospholipid Hydrolysis | Plcg1(-/-) cells | Platelet-derived growth factor (PDGF) | Associated | 4.0 (Moderate) | 9685408 |
acc2629 | STAT3 | P52631 | Stat3 | phosphorylation | Tyr705 | human | Prostate Cancer | PGE2 | Associated | 4.0 (Moderate) | 11779161 | |
acc2630 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Hypertension | Wortmannin | Associated | 4.0 (Moderate) | 12003815 | |
acc2631 | eNOS | Q62600 | Nos3 | phosphorylation | Ser1176 | rat | Hypertension | Wortmannin | Associated | 4.0 (Moderate) | 12003815 | |
acc2632 | nNOS | P29476 | Nos1 | phosphorylation | Ser847 | rat | Ischemia | KN93 | Associated | 4.0 (Moderate) | 12218415 | |
acc2633 | ERK | Q63844 | Mapk3 | phosphorylation | unclear | mouse | Apoptosis of Cardiac Muscle Cell | HL-1 | Mercury | Associated | 4.0 (Moderate) | 12788478 |
acc2634 | GATA4 | Q08369 | Gata4 | phosphorylation | unclear | mouse | Apoptosis of Cardiac Muscle Cell | HL-1 | Mercury | Associated | 4.0 (Moderate) | 12788478 |
acc2635 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Melanoma | LU1205 | PD98059 + LY294002 | Associated | 4.0 (Moderate) | 12821943 |
acc2636 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Melanoma | LU1205 | PD98059 + LY294002 | Associated | 4.0 (Moderate) | 12821943 |
acc2637 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Melanoma | LU1205 | PD98059 + LY294002 | Associated | 4.0 (Moderate) | 12821943 |
acc2638 | STAT5 | P42229 | STAT5 | phosphorylation | Tyr694 | human | Melanoma | LU1205 | PD98059 + LY294002 | Associated | 4.0 (Moderate) | 12821943 |
acc2639 | NR2A | Q00959 | Grin2a | phosphorylation | Tyr1472 | rat | Cerebral Ischemia | Lithium | Associated | 4.0 (Moderate) | 12932824 | |
acc2640 | RhoA | P61586 | RHOA | geranylgeranylation | unclear | human | Colorectal Cancer | COLO 320DM | GGTI-298 | Associated | 4.0 (Moderate) | 14598891 |
acc2641 | Tau | P10636 | MAPT | phosphorylation | Ser199 | human | Alzheimer's Disease | SH-SY5Y | Lithium | Associated | 4.0 (Moderate) | 15184080 |
acc2642 | Tau | P10636 | MAPT | phosphorylation | Ser202 | human | Alzheimer's Disease | SH-SY5Y | Lithium | Associated | 4.0 (Moderate) | 15184080 |
acc2643 | Tau | P10636 | MAPT | phosphorylation | Thr205 | human | Alzheimer's Disease | SH-SY5Y | Lithium | Associated | 4.0 (Moderate) | 15184080 |
acc2644 | Tau | P10636 | MAPT | phosphorylation | Ser396 | human | Alzheimer's Disease | SH-SY5Y | Lithium | Associated | 4.0 (Moderate) | 15184080 |
acc2645 | Tau | P10636 | MAPT | phosphorylation | Ser404 | human | Alzheimer's Disease | SH-SY5Y | Lithium | Associated | 4.0 (Moderate) | 15184080 |
acc2650 | ATM | Q13315 | ATM | phosphorylation | Ser1981 | human | Cancer | A2780 | Irofulven | Associated | 4.0 (Moderate) | 15269203 |
acc2651 | ATM | Q13315 | ATM | phosphorylation | Ser1981 | human | Cancer | CAOV3 | Irofulven | Associated | 4.0 (Moderate) | 15269203 |
acc2652 | Chk2 | O96017 | CHEK2 | phosphorylation | Thr68 | human | Cancer | A2780 | Irofulven | Associated | 4.0 (Moderate) | 15269203 |
acc2653 | Chk2 | O96017 | CHEK2 | phosphorylation | Thr68 | human | Cancer | A2780/CP70 | Irofulven | Associated | 4.0 (Moderate) | 15269203 |
acc2654 | Chk2 | O96017 | CHEK2 | phosphorylation | Thr68 | human | Cancer | CAOV3 | Irofulven | Associated | 4.0 (Moderate) | 15269203 |
acc2655 | Chk2 | O96017 | CHEK2 | phosphorylation | Thr68 | human | Cancer | OVCAR3 | Irofulven | Associated | 4.0 (Moderate) | 15269203 |
acc2656 | Chk2 | O96017 | CHEK2 | phosphorylation | Thr68 | human | Cancer | SKOV3 | Irofulven | Associated | 4.0 (Moderate) | 15269203 |
acc2657 | NBS1 | O60934 | NBN | phosphorylation | Ser343 | human | Cancer | SKOV3 | Irofulven | Associated | 4.0 (Moderate) | 15269203 |
acc2658 | NBS1 | O60934 | NBN | phosphorylation | Ser343 | human | Cancer | OVCAR3 | Irofulven | Associated | 4.0 (Moderate) | 15269203 |
acc2659 | p53 | P04637 | TP53 | phosphorylation | Ser15 | human | Cancer | A2780 | Irofulven | Associated | 4.0 (Moderate) | 15269203 |
acc2660 | p53 | P04637 | TP53 | phosphorylation | Ser20 | human | Cancer | A2780 | Irofulven | Associated | 4.0 (Moderate) | 15269203 |
acc2661 | SMC1 | Q14683 | SMC1A | phosphorylation | Ser957 | human | Cancer | CAOV3 | Irofulven | Associated | 4.0 (Moderate) | 15269203 |
acc2662 | SMC1 | Q14683 | SMC1A | phosphorylation | Ser957 | human | Cancer | SKOV3 | Irofulven | Associated | 4.0 (Moderate) | 15269203 |
acc2663 | SMC1 | Q14683 | SMC1A | phosphorylation | Ser957 | human | Cancer | OVCAR3 | Irofulven | Associated | 4.0 (Moderate) | 15269203 |
acc2664 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MDA-MB-231 | Ganoderma lucidum | Associated | 4.0 (Moderate) | 15489214 |
acc2670 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MDA-MB-231 | EPA + DHA | Associated | 4.0 (Moderate) | 15986129 |
acc2679 | ACC | Q13085 | ACACA | phosphorylation | Ser79 | human | Cancer | "MCF-7,T98G,U87MG,PC-3,K-562,CEM T" | AICAR | Associated | 4.0 (Moderate) | 16176927 |
acc2680 | ACC | P11497 | Acaca | phosphorylation | Ser79 | rat | Glioma | C6 | AICAR | Associated | 4.0 (Moderate) | 16176927 |
acc2681 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Cancer | "MCF-7,T98G,U87MG,K-562,CEM T" | AICAR | Associated | 4.0 (Moderate) | 16176927 |
acc2682 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Glioma | C6 | AICAR | Associated | 4.0 (Moderate) | 16176927 |
acc2683 | AMPK | Q13131 | PRKAA1 | phosphorylation | Thr172 | human | Cancer | "MCF-7,T98G,U87MG,K-562,CEM T" | AICAR | Associated | 4.0 (Moderate) | 16176927 |
acc2684 | AMPK | Q09137 | Prkaa2 | phosphorylation | Thr172 | rat | Glioma | C6 | AICAR | Associated | 4.0 (Moderate) | 16176927 |
acc2685 | AMPK | P54645 | Prkaa1 | phosphorylation | Thr183 | rat | Glioma | C6 | AICAR | Associated | 4.0 (Moderate) | 16176927 |
acc2686 | mTOR | Q9JLN9 | Mtor | phosphorylation | Ser1448 | human | Cancer | "MCF-7,T98G,U87MG,K-562,CEM T" | AICAR | Associated | 4.0 (Moderate) | 16176927 |
acc2687 | mTOR | P42346 | Mtor | phosphorylation | Ser1448 | rat | Glioma | C6 | AICAR | Associated | 4.0 (Moderate) | 16176927 |
acc2688 | Wwox | Q9NZC7 | WWOX | phosphorylation | Tyr287 | human | Prostate Cancer | LNCaP | Geldanamycin | Associated | 4.0 (Moderate) | 16288044 |
acc2690 | eIF2alpha | Q8BJW6 | Eif2a | phosphorylation | Ser51 | mouse | Apoptosis | TNFalpha | Associated | 4.0 (Moderate) | 16717090 | |
acc2695 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Atherosclerosis | NQ304 | Associated | 4.0 (Moderate) | 16875883 | |
acc2696 | ERK1 | P21708 | Mapk3 | phosphorylation | unclear | rat | Atherosclerosis | NQ304 | Associated | 4.0 (Moderate) | 16875883 | |
acc2697 | ERK2 | P63086 | Mapk1 | phosphorylation | unclear | rat | Atherosclerosis | NQ304 | Associated | 4.0 (Moderate) | 16875883 | |
acc2698 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | HCV | HeLa | H2O2 | Associated | 4.0 (Moderate) | 17030858 |
acc2699 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Lung Cancer | H1299 | RASSF1A | Associated | 4.0 (Moderate) | 17088994 |
acc2700 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Lung Cancer | H1299 | RASSF1A | Associated | 4.0 (Moderate) | 17088994 |
acc2701 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Lung Cancer | A549 | RASSF1A | Associated | 4.0 (Moderate) | 17088994 |
acc2702 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Lung Cancer | A549 | RASSF1A | Associated | 4.0 (Moderate) | 17088994 |
acc2703 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Breast Cancer | MCF-7 | RASSF1A | Associated | 4.0 (Moderate) | 17088994 |
acc2704 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Breast Cancer | MCF-7 | RASSF1A | Associated | 4.0 (Moderate) | 17088994 |
acc2705 | CREB | Q01147 | Creb1 | phosphorylation | Ser133 | mouse | Memory Deficit | Oroxylin A | Associated | 4.0 (Moderate) | 17174385 | |
acc2706 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Choriocarcinoma | JEG-3 | Pervanadate | Associated | 4.0 (Moderate) | 17237409 |
acc2707 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Choriocarcinoma | JEG-3 | Pervanadate | Associated | 4.0 (Moderate) | 17237409 |
acc2708 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Choriocarcinoma | JEG-3 | Pervanadate | Associated | 4.0 (Moderate) | 17237409 |
acc2709 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Ischemia | L-NAME | Associated | 4.0 (Moderate) | 17268885 | |
acc2710 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Ischemia | L-NAME | Associated | 4.0 (Moderate) | 17268885 | |
acc2711 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Ischemia | PD98059 | Associated | 4.0 (Moderate) | 17268885 | |
acc2712 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Ischemia | PD98059 | Associated | 4.0 (Moderate) | 17268885 | |
acc2713 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Ischemia | FR167653 | Associated | 4.0 (Moderate) | 17268885 | |
acc2714 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Ischemia | FR167653 | Associated | 4.0 (Moderate) | 17268885 | |
acc2715 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Ischemia | L-NAME | Associated | 4.0 (Moderate) | 17268885 | |
acc2716 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Ischemia | L-NAME | Associated | 4.0 (Moderate) | 17268885 | |
acc2717 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Ischemia | PD98059 | Associated | 4.0 (Moderate) | 17268885 | |
acc2718 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Ischemia | PD98059 | Associated | 4.0 (Moderate) | 17268885 | |
acc2719 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Ischemia | FR167653 | Associated | 4.0 (Moderate) | 17268885 | |
acc2720 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Ischemia | FR167653 | Associated | 4.0 (Moderate) | 17268885 | |
acc2721 | p38 MAPK | P47811 | Mapk14 | phosphorylation | unclear | mouse | Ischemia | L-NAME | Associated | 4.0 (Moderate) | 17268885 | |
acc2722 | p38 MAPK | P47811 | Mapk14 | phosphorylation | unclear | mouse | Ischemia | PD98059 | Associated | 4.0 (Moderate) | 17268885 | |
acc2723 | p38 MAPK | P47811 | Mapk14 | phosphorylation | unclear | mouse | Ischemia | FR167653 | Associated | 4.0 (Moderate) | 17268885 | |
acc2729 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Mast Cell Activation | hCBMC | Omalizumab | Associated | 4.0 (Moderate) | 17368811 |
acc2730 | Cdc2 | P06493 | CDK1 | phosphorylation | Tyr15 | human | Cancer | SMMC-7721 | Lithium | Associated | 4.0 (Moderate) | 18247328 |
acc2731 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Growth Arrest | ML-1 | TPA | Associated | 4.0 (Moderate) | 18270969 |
acc2732 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Growth Arrest | ML-1 | TPA | Associated | 4.0 (Moderate) | 18270969 |
acc2733 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Growth Arrest | ML-1 | TPA | Associated | 4.0 (Moderate) | 18270969 |
acc2734 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Growth Arrest | ML-1 | TPA | Associated | 4.0 (Moderate) | 18270969 |
acc2737 | AKT | P31749 | AKT1 | phosphorylation | unclear | human | Ependymoma | IGRG88 | Gefitinib + Radiotherapy | Associated | 4.0 (Moderate) | 18386816 |
acc2738 | AKT | P31749 | AKT1 | phosphorylation | unclear | human | Ependymoma | IGREP83 | Gefitinib + Radiotherapy | Associated | 4.0 (Moderate) | 18386816 |
acc2739 | MAPK | P28482 | MAPK1 | phosphorylation | unclear | human | Ependymoma | IGRG88 | Gefitinib + Radiotherapy | Associated | 4.0 (Moderate) | 18386816 |
acc2740 | MAPK | P28482 | MAPK1 | phosphorylation | unclear | human | Ependymoma | IGREP83 | Gefitinib + Radiotherapy | Associated | 4.0 (Moderate) | 18386816 |
acc2741 | eIF2alpha | P68101 | Eif2s1 | phosphorylation | Ser51 | rat | Hypomyelination and Oligodendrocyte Loss | Salubrinal | Associated | 4.0 (Moderate) | 18818381 | |
acc2742 | Tau | P10636 | MAPT | phosphorylation | Tyr18 | human | Alzheimer's Disease | SHSY-5Y | Abeta | Associated | 4.0 (Moderate) | 19158430 |
acc2743 | Tau | P10636 | MAPT | phosphorylation | Ser396 | human | Alzheimer's Disease | SHSY-5Y | Abeta | Associated | 4.0 (Moderate) | 19158430 |
acc2744 | Tau | P10636 | MAPT | phosphorylation | Ser404 | human | Alzheimer's Disease | SHSY-5Y | Abeta | Associated | 4.0 (Moderate) | 19158430 |
acc2745 | Tau | P10636 | MAPT | phosphorylation | Ser396 | human | Alzheimer's Disease | SHSY-5Y | Roscovitine | Associated | 4.0 (Moderate) | 19158430 |
acc2746 | Tau | P10636 | MAPT | phosphorylation | Ser404 | human | Alzheimer's Disease | SHSY-5Y | Roscovitine | Associated | 4.0 (Moderate) | 19158430 |
acc2747 | Akt | Q09YN5 | MET | phosphorylation | Ser473 | rabbit | Infarction | Glimepiride | Associated | 4.0 (Moderate) | 19202319 | |
acc2748 | GSK3beta | Q9WV60 | Gsk3b | phosphorylation | Ser9 | mouse | Alzheimer's Disease | A-582941 | Associated | 4.0 (Moderate) | 19230830 | |
acc2749 | Tau | P10637 | Mapt | phosphorylation | Ser202 | mouse | Alzheimer's Disease | A-582941 | Associated | 4.0 (Moderate) | 19230830 | |
acc2750 | Tau | P10637 | Mapt | phosphorylation | Thr205 | mouse | Alzheimer's Disease | A-582941 | Associated | 4.0 (Moderate) | 19230830 | |
acc2751 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | HCV | OR6 | Cyclosporine A | Associated | 4.0 (Moderate) | 19492433 |
acc2752 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | HCV | OR6 | Cyclosporine A | Associated | 4.0 (Moderate) | 19492433 |
acc2753 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | HCV | OR6 | Cyclosporine A | Associated | 4.0 (Moderate) | 19492433 |
acc2754 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | HCV | OR6 | Cyclosporine A | Associated | 4.0 (Moderate) | 19492433 |
acc2755 | ATM | Q13315 | ATM | phosphorylation | Ser1981 | human | Hepatocellular Carcinoma | Hep3B | HKH40A | Associated | 4.0 (Moderate) | 19530246 |
acc2756 | Cdc25C | P30307 | CDC25C | phosphorylation | Ser216 | human | Hepatocellular Carcinoma | Hep3B | HKH40A | Associated | 4.0 (Moderate) | 19530246 |
acc2757 | Cdc25C | P30307 | CDC25C | phosphorylation | Ser198 | human | Hepatocellular Carcinoma | Hep3B | HKH40A | Associated | 4.0 (Moderate) | 19530246 |
acc2758 | Cdk1 | P06493 | CDK1 | phosphorylation | Tyr15 | human | Hepatocellular Carcinoma | Hep3B | HKH40A | Associated | 4.0 (Moderate) | 19530246 |
acc2759 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser317 | human | Hepatocellular Carcinoma | Hep3B | HKH40A | Associated | 4.0 (Moderate) | 19530246 |
acc2760 | Chk2 | O96017 | CHEK2 | phosphorylation | Thr68 | human | Hepatocellular Carcinoma | Hep3B | HKH40A | Associated | 4.0 (Moderate) | 19530246 |
acc2761 | c-Jun | P05412 | JUN | phosphorylation | Ser63 | human | Hepatocellular Carcinoma | Hep3B | HKH40A | Associated | 4.0 (Moderate) | 19530246 |
acc2762 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Hepatocellular Carcinoma | Hep3B | HKH40A | Associated | 4.0 (Moderate) | 19530246 |
acc2763 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Hepatocellular Carcinoma | Hep3B | HKH40A | Associated | 4.0 (Moderate) | 19530246 |
acc2764 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Nephritis | Candesartan | Associated | 4.0 (Moderate) | 19846573 | |
acc2765 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Nephritis | Candesartan | Associated | 4.0 (Moderate) | 19846573 | |
acc2766 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr218 | rat | Nephritis | Candesartan | Associated | 4.0 (Moderate) | 19846573 | |
acc2767 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr220 | rat | Nephritis | Candesartan | Associated | 4.0 (Moderate) | 19846573 | |
acc2768 | CREB | Q01147 | Creb1 | phosphorylation | Ser133 | mouse | Depression | Flavonol | Associated | 4.0 (Moderate) | 19917299 | |
acc2771 | GSK3alpha | Q2NL51 | Gsk3a | phosphorylation | Ser21 | mouse | Fragile X Syndrome | Lithium | Associated | 4.0 (Moderate) | 20600866 | |
acc2772 | GSK3beta | Q9WV60 | Gsk3b | phosphorylation | Ser9 | mouse | Fragile X Syndrome | Lithium | Associated | 4.0 (Moderate) | 20600866 | |
acc2773 | AMPK | P54646 | PRKAA2 | phosphorylation | Thr172 | human | Apoptosis | HUVEC | adiponectin | Associated | 4.0 (Moderate) | 20675307 |
acc2774 | AMPK | Q13131 | PRKAA1 | phosphorylation | Thr183 | human | Apoptosis | HUVEC | adiponectin | Associated | 4.0 (Moderate) | 20675307 |
acc2775 | IkappaBalpha | Q9Z1E3 | Nfkbia | phosphorylation | Ser32 | mouse | Inflammation | "icariin derivative (3,5-dihydroxy-4'-methoxy-6'',6''-dimethy1-4'',5''-dihydropyrano[2'',3'':7,8]-fl | Associated | 4.0 (Moderate) | 20686223 | |
acc2776 | p38 | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | Inflammation | "icariin derivative (3,5-dihydroxy-4'-methoxy-6'',6''-dimethy1-4'',5''-dihydropyrano[2'',3'':7,8]-fl | Associated | 4.0 (Moderate) | 20686223 | |
acc2782 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Cataract | SRA 01-04 | Honokiol | Associated | 4.0 (Moderate) | 20965163 |
acc2783 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Cataract | SRA 01-04 | Honokiol | Associated | 4.0 (Moderate) | 20965163 |
acc2784 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Cataract | SRA 01-04 | Honokiol | Associated | 4.0 (Moderate) | 20965163 |
acc2785 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Cataract | SRA 01-04 | Honokiol | Associated | 4.0 (Moderate) | 20965163 |
acc2786 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Cataract | SRA 01-04 | Honokiol | Associated | 4.0 (Moderate) | 20965163 |
acc2787 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Cataract | SRA 01-04 | Honokiol | Associated | 4.0 (Moderate) | 20965163 |
acc2788 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Cataract | SRA 01-04 | Honokiol | Associated | 4.0 (Moderate) | 20965163 |
acc2789 | NF-kappaB p65 | Q04206 | RELA | phosphorylation | Ser536 | human | Cataract | SRA 01-04 | Honokiol | Associated | 4.0 (Moderate) | 20965163 |
acc2790 | p38 MAPK | Q16539 | MAPK14 | phosphorylation | Tyr180 | human | Cataract | SRA 01-04 | Honokiol | Associated | 4.0 (Moderate) | 20965163 |
acc2791 | p38 MAPK | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Cataract | SRA 01-04 | Honokiol | Associated | 4.0 (Moderate) | 20965163 |
acc2792 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Memory Impairment | 4-O-methylhonokiol | Associated | 4.0 (Moderate) | 20974250 | |
acc2793 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Memory Impairment | 4-O-methylhonokiol | Associated | 4.0 (Moderate) | 20974250 | |
acc2794 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Memory Impairment | 4-O-methylhonokiol | Associated | 4.0 (Moderate) | 20974250 | |
acc2795 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Memory Impairment | 4-O-methylhonokiol | Associated | 4.0 (Moderate) | 20974250 | |
acc2796 | eNOS | Q62600 | Nos3 | phosphorylation | Ser1177 | rat | Insulin Resistance | Losartan | Associated | 4.0 (Moderate) | 21153603 | |
acc2797 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Insulin Resistance | Losartan | Associated | 4.0 (Moderate) | 21153603 | |
acc2798 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | HT-29 | LPS | Associated | 4.0 (Moderate) | 21363926 |
acc2799 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Colorectal Cancer | HT-29 | LPS | Associated | 4.0 (Moderate) | 21363926 |
acc2800 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Colorectal Cancer | HT-29 | LPS | Associated | 4.0 (Moderate) | 21363926 |
acc2801 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Colorectal Cancer | HT-29 | LPS | Associated | 4.0 (Moderate) | 21363926 |
acc2802 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Colorectal Cancer | HT-29 | LPS | Associated | 4.0 (Moderate) | 21363926 |
acc2803 | p38alpha | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Colorectal Cancer | HT-29 | LPS | Associated | 4.0 (Moderate) | 21363926 |
acc2804 | p38alpha | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Colorectal Cancer | HT-29 | LPS | Associated | 4.0 (Moderate) | 21363926 |
acc2805 | AMPKalpha | Q13131 | PRKAA1 | phosphorylation | Thr172 | human | Renal Cancer | H295R | Rosiglitazone | Associated | 4.0 (Moderate) | 21376716 |
acc2806 | RB | P06400 | RB1 | phosphorylation | Ser780 | human | Renal Cancer | SW13 | Rosiglitazone | Associated | 4.0 (Moderate) | 21376716 |
acc2807 | Lyn | P25911 | Lyn | phosphorylation | unclear | mouse | Allergic | "RBL-1,RBL-2H3" | Valencene | Associated | 4.0 (Moderate) | 21380805 |
acc2808 | Lyn | P25911 | Lyn | phosphorylation | unclear | mouse | Allergic | "RBL-1,RBL-2H3" | Cyperus rotundus (CRE) | Associated | 4.0 (Moderate) | 21380805 |
acc2809 | Tau | P10637 | Mapt | phosphorylation | Ser202 | mouse | Neurodegeneration | Roscovitine | Associated | 4.0 (Moderate) | 21435449 | |
acc2810 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | High Glucose | T-cell vaccination (TCV) | Associated | 4.0 (Moderate) | 21519350 | |
acc2811 | JNK | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Fatigue | HEK 293 | N-acetylcysteine | Associated | 4.0 (Moderate) | 21827635 |
acc2812 | JNK | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Fatigue | HEK 293 | N-acetylcysteine | Associated | 4.0 (Moderate) | 21827635 |
acc2813 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Alzheimer's Disease | Nicotine | Associated | 4.0 (Moderate) | 21884524 | |
acc2814 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | High Glucose | 3T3L1 | "H(2)S, L-cysteine (LC)" | Associated | 4.0 (Moderate) | 21953448 |
acc2815 | IRS1 | P35569 | Irs1 | phosphorylation | Tyr941 | mouse | High Glucose | 3T3L1 | "H(2)S, L-cysteine (LC)" | Associated | 4.0 (Moderate) | 21953448 |
acc2816 | NF-kappaB p65 | Q04207 | Rela | phosphorylation | Ser276 | mouse | High Glucose | 3T3L1 | "H(2)S, L-cysteine (LC)" | Associated | 4.0 (Moderate) | 21953448 |
acc2817 | PKC lambda | Q62074 | Prkci | phosphorylation | Thr403 | mouse | High Glucose | 3T3L1 | "H(2)S, L-cysteine (LC)" | Associated | 4.0 (Moderate) | 21953448 |
acc2818 | PKC zeta | Q02956 | Prkcz | phosphorylation | Thr410 | mouse | High Glucose | 3T3L1 | "H(2)S, L-cysteine (LC)" | Associated | 4.0 (Moderate) | 21953448 |
acc2819 | PKC gamma | P63318 | Prkcg | phosphorylation | Thr514 | mouse | High Glucose | 3T3L1 | "H(2)S, L-cysteine (LC)" | Associated | 4.0 (Moderate) | 21953448 |
acc2820 | Elk-1 | A4GTP4 | Elk1 | phosphorylation | Ser383 | rat | Diabetes Mellitus | A10 | EGCG | Associated | 4.0 (Moderate) | 21973165 |
acc2821 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Diabetes Mellitus | A10 | EGCG | Associated | 4.0 (Moderate) | 21973165 |
acc2822 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Diabetes Mellitus | A10 | EGCG | Associated | 4.0 (Moderate) | 21973165 |
acc2823 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Diabetes Mellitus | A10 | EGCG | Associated | 4.0 (Moderate) | 21973165 |
acc2824 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Diabetes Mellitus | A10 | EGCG | Associated | 4.0 (Moderate) | 21973165 |
acc2825 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Diabetes Mellitus | TPEN | Associated | 4.0 (Moderate) | 22000581 | |
acc2826 | GS | Q8VCB3 | Gys2 | phosphorylation | Ser641 | mouse | Diabetes Mellitus | TPEN | Associated | 4.0 (Moderate) | 22000581 | |
acc2827 | GSK3beta | Q9WV60 | Gsk3b | phosphorylation | Ser9 | mouse | Diabetes Mellitus | TPEN | Associated | 4.0 (Moderate) | 22000581 | |
acc2828 | PTEN | O08586 | Pten | phosphorylation | Ser380 | mouse | Diabetes Mellitus | TPEN | Associated | 4.0 (Moderate) | 22000581 | |
acc2829 | PTEN | O08586 | Pten | phosphorylation | Thr382 | mouse | Diabetes Mellitus | TPEN | Associated | 4.0 (Moderate) | 22000581 | |
acc2830 | PTEN | O08586 | Pten | phosphorylation | Thr383 | mouse | Diabetes Mellitus | TPEN | Associated | 4.0 (Moderate) | 22000581 | |
acc2831 | ERK1 | A0A8D1EXN6 | MAPK3 | phosphorylation | Thr202 | pig | Fibrotic Disorder | porcine valvular interstitial cells | Terguride | Associated | 4.0 (Moderate) | 22049464 |
acc2832 | ERK1 | A0A8D1EXN6 | MAPK3 | phosphorylation | Tyr204 | pig | Fibrotic Disorder | porcine valvular interstitial cells | Terguride | Associated | 4.0 (Moderate) | 22049464 |
acc2833 | ERK2 | A0A5K1UVT7 | MAPK1 | phosphorylation | Thr185 | pig | Fibrotic Disorder | porcine valvular interstitial cells | Terguride | Associated | 4.0 (Moderate) | 22049464 |
acc2834 | ERK2 | A0A5K1UVT7 | MAPK1 | phosphorylation | Tyr187 | pig | Fibrotic Disorder | porcine valvular interstitial cells | Terguride | Associated | 4.0 (Moderate) | 22049464 |
acc2835 | Akt | P31750 | Akt1 | phosphorylation | unclear | mouse | Abnormal Platelet Function | alpha-PGG | Associated | 4.0 (Moderate) | 22073153 | |
acc2836 | IRS1 | P35569 | Irs1 | phosphorylation | unclear | mouse | Abnormal Platelet Function | alpha-PGG | Associated | 4.0 (Moderate) | 22073153 | |
acc2837 | Titin | A0A8P0NVN9 | TTN | phosphorylation | unclear | dog | Hypertension | Sildenafil | Associated | 4.0 (Moderate) | 22144574 | |
acc2838 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Pain | Carrageenan | Associated | 4.0 (Moderate) | 22243518 | |
acc2841 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Acute Hyperhomocysteinemia | Homocysteine | Associated | 4.0 (Moderate) | 22525229 | |
acc2842 | GSK3beta | P18266 | Gsk3b | phosphorylation | Ser9 | rat | Acute Hyperhomocysteinemia | Homocysteine | Associated | 4.0 (Moderate) | 22525229 | |
acc3088 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Inflammatory | Decitabine | Associated | 4.0 (Moderate) | 32468024 | |
acc3089 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Inflammatory | Decitabine | Associated | 4.0 (Moderate) | 32468024 | |
acc3090 | JNK | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Inflammatory | Decitabine | Associated | 4.0 (Moderate) | 32468024 | |
acc3091 | JNK | Q9WTU6 | Mapk9 | phosphorylation | Thr183 | mouse | Inflammatory | Decitabine | Associated | 4.0 (Moderate) | 32468024 | |
acc3092 | JNK | Q61831 | Mapk10 | phosphorylation | Thr221 | mouse | Inflammatory | Decitabine | Associated | 4.0 (Moderate) | 32468024 | |
acc3093 | p38 | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | Inflammatory | Decitabine | Associated | 4.0 (Moderate) | 32468024 | |
acc3094 | MEK1 | Q02750 | MAP2K1 | phosphorylation | Ser218 | human | Sarcoma | SK-ES-1 | Magnolol | Associated | 4.0 (Moderate) | 32509168 |
acc3095 | MEK2 | P36507 | MAP2K2 | phosphorylation | Ser222 | human | Sarcoma | SK-ES-1 | Magnolol | Associated | 4.0 (Moderate) | 32509168 |
acc3096 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Sarcoma | SK-ES-1 | Magnolol | Associated | 4.0 (Moderate) | 32509168 |
acc3097 | NLRX1 | Q3TL44 | Nlrx1 | ubiquitination | Lys63 | mouse | Heart Injury | CYP2J2 | Associated | 4.0 (Moderate) | 32574674 | |
acc3098 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Abdominal Aortic Aneurysm | Simvastatin | Associated | 4.0 (Moderate) | 32617140 | |
acc3099 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Abdominal Aortic Aneurysm | Simvastatin | Associated | 4.0 (Moderate) | 32617140 | |
acc3100 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Abdominal Aortic Aneurysm | Simvastatin | Associated | 4.0 (Moderate) | 32617140 | |
acc3101 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Abdominal Aortic Aneurysm | Simvastatin | Associated | 4.0 (Moderate) | 32617140 | |
acc3102 | IkappaBalpha | Q9Z1E3 | Nfkbia | phosphorylation | Ser176 | mouse | VSV infection | mouse peritoneal macrophages | Cirsitakaoside | Associated | 4.0 (Moderate) | 32652505 |
acc3103 | IkappaBalpha | Q9Z1E3 | Nfkbia | phosphorylation | Ser180 | mouse | VSV infection | mouse peritoneal macrophages | Cirsitakaoside | Associated | 4.0 (Moderate) | 32652505 |
acc3104 | p65 | Q04207 | Rela | phosphorylation | Ser536 | mouse | VSV infection | mouse peritoneal macrophages | Cirsitakaoside | Associated | 4.0 (Moderate) | 32652505 |
acc3105 | IRF3 | P70671 | Irf3 | phosphorylation | Ser396 | mouse | VSV infection | mouse peritoneal macrophages | Cirsitakaoside | Associated | 4.0 (Moderate) | 32652505 |
acc3106 | TBK1 | Q9WUN2 | Tbk1 | phosphorylation | Ser172 | mouse | VSV infection | mouse peritoneal macrophages | Cirsitakaoside | Associated | 4.0 (Moderate) | 32652505 |
acc3107 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Breast Cancer | MCF-7 | D9 + MK-2206 | Associated | 4.0 (Moderate) | 32678295 |
acc3108 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Breast Cancer | T47D | D9 + MK-2206 | Associated | 4.0 (Moderate) | 32678295 |
acc3109 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MCF-7 | D9 + MK-2206 | Associated | 4.0 (Moderate) | 32678295 |
acc3110 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | T47D | D9 + MK-2206 | Associated | 4.0 (Moderate) | 32678295 |
acc3112 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Diabetes Mellitus | S-allylcysteine (SAC) | Associated | 4.0 (Moderate) | 32862702 | |
acc3113 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Diabetes Mellitus | S-allylcysteine (SAC) | Associated | 4.0 (Moderate) | 32862702 | |
acc3114 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Diabetes Mellitus | Metformin | Associated | 4.0 (Moderate) | 32862702 | |
acc3115 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Diabetes Mellitus | Metformin | Associated | 4.0 (Moderate) | 32862702 | |
acc3116 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Diabetes Mellitus | S-allylcysteine (SAC) | Associated | 4.0 (Moderate) | 32862702 | |
acc3117 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Diabetes Mellitus | S-allylcysteine (SAC) | Associated | 4.0 (Moderate) | 32862702 | |
acc3118 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Diabetes Mellitus | Metformin | Associated | 4.0 (Moderate) | 32862702 | |
acc3119 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Diabetes Mellitus | Metformin | Associated | 4.0 (Moderate) | 32862702 | |
acc3120 | MEK1 | Q01986 | Map2k1 | phosphorylation | Ser217 | rat | Diabetes Mellitus | S-allylcysteine (SAC) | Associated | 4.0 (Moderate) | 32862702 | |
acc3121 | MEK2 | P36506 | Map2k2 | phosphorylation | Ser217 | rat | Diabetes Mellitus | S-allylcysteine (SAC) | Associated | 4.0 (Moderate) | 32862702 | |
acc3122 | MEK1 | Q01986 | Map2k1 | phosphorylation | Ser217 | rat | Diabetes Mellitus | Metformin | Associated | 4.0 (Moderate) | 32862702 | |
acc3123 | MEK2 | P36506 | Map2k2 | phosphorylation | Ser217 | rat | Diabetes Mellitus | Metformin | Associated | 4.0 (Moderate) | 32862702 | |
acc3124 | RSK2 | A0A8I6AR08 | Rps6ka3 | phosphorylation | SER227 | rat | Diabetes Mellitus | S-allylcysteine (SAC) | Associated | 4.0 (Moderate) | 32862702 | |
acc3125 | RSK2 | A0A8I6AR08 | Rps6ka3 | phosphorylation | Ser227 | rat | Diabetes Mellitus | Metformin | Associated | 4.0 (Moderate) | 32862702 | |
acc3126 | AMPK | P54645 | Prkaa1 | phosphorylation | Thr183 | rat | Colitis | Xian-He-Cao-Chang-Yan formula | Associated | 4.0 (Moderate) | 33164773 | |
acc3127 | AMPK | Q09137 | Prkaa2 | phosphorylation | Thr172 | rat | Colitis | Xian-He-Cao-Chang-Yan formula | Associated | 4.0 (Moderate) | 33164773 | |
acc3138 | FOXO3a | Q9WVH4 | Foxo3 | acetylation | Lys271 | mouse | Myocardial Infarction | H9c2 | Mangiferin | Associated | 4.0 (Moderate) | 33523605 |
acc3139 | FOXO3a | Q9WVH4 | Foxo3 | acetylation | Lys290 | mouse | Myocardial Infarction | H9c2 | Mangiferin | Associated | 4.0 (Moderate) | 33523605 |
acc3140 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Glioblastoma | U251 | Paris saponin H | Associated | 4.0 (Moderate) | 33537802 |
acc3141 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Glioblastoma | U251 | Paris saponin H | Associated | 4.0 (Moderate) | 33537802 |
acc3142 | ERK | P27361 | MAPK3 | phosphorylation | Thr202 | human | Glioblastoma | U251 | Paris saponin H | Associated | 4.0 (Moderate) | 33537802 |
acc3143 | ERK | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Glioblastoma | U251 | Paris saponin H | Associated | 4.0 (Moderate) | 33537802 |
acc3144 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hemangioma | HUVECs | Propranolol | Associated | 4.0 (Moderate) | 33575332 |
acc3145 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Hemangioma | HUVECs | Propranolol | Associated | 4.0 (Moderate) | 33575332 |
acc3146 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Hemangioma | HUVECs | Propranolol | Associated | 4.0 (Moderate) | 33575332 |
acc3147 | FAK | Q05397 | PTK2 | phosphorylation | Tyr397 | human | Hemangioma | HUVECs | Propranolol | Associated | 4.0 (Moderate) | 33575332 |
acc3148 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Hemangioma | HUVECs | Propranolol | Associated | 4.0 (Moderate) | 33575332 |
acc3149 | PDK4 | Q16654 | PDK4 | ubiquitination | unclear | human | Colitis | Cyclosporine A | Associated | 4.0 (Moderate) | 33634990 | |
acc3150 | mTOR | Q9JLN9 | Mtor | phosphorylation | Ser2448 | mouse | Cocaine Memories | SB-277011 | Associated | 4.0 (Moderate) | 33803578 | |
acc3151 | ASK-1 | Q99683 | MAP3K5 | phosphorylation | Thr845 | human | Glioma | H4 | Gefitinib | Associated | 4.0 (Moderate) | 33920356 |
acc3152 | IRE1 | O75460 | ERN1 | phosphorylation | Ser724 | human | Glioma | H4 | Gefitinib | Associated | 4.0 (Moderate) | 33920356 |
acc3153 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Glioma | H4 | Gefitinib | Associated | 4.0 (Moderate) | 33920356 |
acc3154 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Glioma | H4 | Gefitinib | Associated | 4.0 (Moderate) | 33920356 |
acc3155 | STAT1 | P42225 | Stat1 | phosphorylation | Tyr701 | mouse | Arthritis | Kurarinone | Associated | 4.0 (Moderate) | 33924467 | |
acc3156 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Arthritis | Kurarinone | Associated | 4.0 (Moderate) | 33924467 | |
acc3163 | eIF4E | P06730 | EIF4E | phosphorylation | Ser209 | human | Leukemia | Tomivosertib | Associated | 4.0 (Moderate) | 34012509 | |
acc3164 | GSK3beta | Q9U2Q9 | gsk-3 | phosphorylation | Ser9 | C.elegans | Alzheimer's Disease | EBR + ROSC | Impairing | 4.0 (Moderate) | 34386848 | |
acc3165 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Thiamine Deficiency | Thiamine + Trolox | Associated | 4.0 (Moderate) | 34468817 | |
acc3166 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Thiamine Deficiency | Thiamine + Trolox | Associated | 4.0 (Moderate) | 34468817 | |
acc3167 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Thiamine Deficiency | Thiamine + Trolox | Associated | 4.0 (Moderate) | 34468817 | |
acc3168 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Thiamine Deficiency | Thiamine + Trolox | Associated | 4.0 (Moderate) | 34468817 | |
acc3169 | Src | P12931 | SRC | phosphorylation | unclear | human | Pancreas Cancer | Disulfiram | Associated | 4.0 (Moderate) | 34471060 | |
acc3170 | Src | P12931 | SRC | phosphorylation | unclear | human | Pancreas Cancer | Disulfiram | Associated | 4.0 (Moderate) | 34471060 | |
acc3172 | IkappaBalpha | Q9Z1E3 | Nfkbia | phosphorylation | Ser32 | mouse | Aseptic Loosening of Prosthesis | RAW 264.7 | Cimifugin | Associated | 4.0 (Moderate) | 34658863 |
acc3173 | IkappaBalpha | Q9Z1E3 | Nfkbia | phosphorylation | Ser36 | mouse | Aseptic Loosening of Prosthesis | RAW 264.7 | Cimifugin | Associated | 4.0 (Moderate) | 34658863 |
acc3174 | AMPK | Q5EG47 | Prkaa1 | phosphorylation | Thr183 | mouse | Hyperlipidemia | Rosmarinic Acid | Associated | 4.0 (Moderate) | 34680102 | |
acc3175 | AMPK | Q8BRK8 | Prkaa2 | phosphorylation | Thr172 | mouse | Hyperlipidemia | Rosmarinic Acid | Associated | 4.0 (Moderate) | 34680102 | |
acc3176 | cGMP | O77676 | PRKG1 | phosphorylation | Ser16 | rabbit | Atherosclerosis | BGP-15 | Associated | 4.0 (Moderate) | 34811751 | |
acc3177 | N2B-titin | O97791 | titin | phosphorylation | Ser4080 | rabbit | Atherosclerosis | BGP-15 | Associated | 4.0 (Moderate) | 34811751 | |
acc3178 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Insulin Resistance | L6 | ALY688 | Associated | 4.0 (Moderate) | 34910600 |
acc3179 | IRS1 | P35570 | Irs1 | phosphorylation | Tyr612 | rat | Insulin Resistance | L6 | ALY688 | Associated | 4.0 (Moderate) | 34910600 |
acc3180 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Cardiac Hypertrophy | C57BL/6J mouse | Sarpogrelate | Associated | 4.0 (Moderate) | 34959669 |
acc3181 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Cardiac Hypertrophy | C57BL/6J mouse | Sarpogrelate | Associated | 4.0 (Moderate) | 34959669 |
acc3182 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Cardiac Hypertrophy | C57BL/6J mouse | Sarpogrelate | Associated | 4.0 (Moderate) | 34959669 |
acc3183 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Cardiac Hypertrophy | C57BL/6J mouse | Sarpogrelate | Associated | 4.0 (Moderate) | 34959669 |
acc3184 | GATA4 | Q08369 | Gata4 | phosphorylation | Ser105 | mouse | Cardiac Hypertrophy | C57BL/6J mouse | Sarpogrelate | Associated | 4.0 (Moderate) | 34959669 |
acc3186 | Ets-1 | P41156 | Ets1 | phosphorylation | Thr38 | rat | Cardiac Fibrosis | Spironolactone | Associated | 4.0 (Moderate) | 35495592 | |
acc3187 | Smad2 | O70436 | Smad2 | phosphorylation | Ser465 | rat | Cardiac Fibrosis | Spironolactone | Associated | 4.0 (Moderate) | 35495592 | |
acc3188 | Smad2 | O70436 | Smad2 | phosphorylation | Ser467 | rat | Cardiac Fibrosis | Spironolactone | Associated | 4.0 (Moderate) | 35495592 | |
acc3189 | Smad3 | P84025 | Smad3 | phosphorylation | Ser423 | rat | Cardiac Fibrosis | Spironolactone | Associated | 4.0 (Moderate) | 35495592 | |
acc3190 | Smad3 | P84025 | Smad3 | phosphorylation | Ser425 | rat | Cardiac Fibrosis | Spironolactone | Associated | 4.0 (Moderate) | 35495592 | |
acc3191 | MIF | P34884 | Mif?? | acetylation | Lys78 | mouse | Ischemic Stroke | HDAC6 inhibitor + aspirin | Associated | 4.0 (Moderate) | 35585040 | |
acc3192 | IkappaBalpha | Q9Z1E3 | Nfkbia | phosphorylation | Ser32 | mouse | Colitis | IRAK1/4 inhibitor | Associated | 4.0 (Moderate) | 35699749 | |
acc3193 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Leukemia | Venetoclax + Gilteritinib | Associated | 4.0 (Moderate) | 35857899 | |
acc3194 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Leukemia | Venetoclax + Gilteritinib | Associated | 4.0 (Moderate) | 35857899 | |
acc3195 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Leukemia | Venetoclax + Gilteritinib | Associated | 4.0 (Moderate) | 35857899 | |
acc3196 | MCL-1 | Q07820 | MCL1 | phosphorylation | Ser159 | human | Leukemia | Venetoclax + Gilteritinib | Associated | 4.0 (Moderate) | 35857899 | |
acc3197 | MCL-1 | Q07820 | MCL1 | phosphorylation | Thr161 | human | Leukemia | Venetoclax + Gilteritinib | Associated | 4.0 (Moderate) | 35857899 | |
acc3198 | AMPKalpha | Q5EG47 | Prkaa1 | phosphorylation | Thr172 | mouse | Lung Cancer | Lewis | Yifei sanjie Pills (YFSJ) | Associated | 4.0 (Moderate) | 36045663 |
acc3199 | mTOR | Q9JLN9 | Mtor | phosphorylation | Ser2448 | mouse | Lung Cancer | Lewis | DDP | Associated | 4.0 (Moderate) | 36045663 |
acc3204 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Glioma | C6 | Beauvericin | Associated | 4.0 (Moderate) | 36610128 |
acc3205 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Glioma | C6 | Beauvericin | Associated | 4.0 (Moderate) | 36610128 |
acc3206 | HMGB1 | P09429 | HMGB1 | acetylation | Lys29 | human | Kidney Damage | SRT 1720 | Associated | 4.0 (Moderate) | 37216866 | |
acc3207 | HMGB1 | P09429 | HMGB1 | acetylation | Lys29 | human | Kidney Damage | FPS–ZM 1 | Associated | 4.0 (Moderate) | 37216866 | |
acc3208 | JNK1 | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Acute Liver Failure | Fluorofenidone (AKF-PD) | Associated | 4.0 (Moderate) | 37224750 | |
acc3209 | JNK1 | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Acute Liver Failure | Fluorofenidone (AKF-PD) | Associated | 4.0 (Moderate) | 37224750 | |
acc3210 | MKK4 | P47809 | Map2k4 | phosphorylation | Ser257 | mouse | Acute Liver Failure | Fluorofenidone (AKF-PD) | Associated | 4.0 (Moderate) | 37224750 | |
acc3211 | Akt | P31750 | Akt1 | phosphorylation | Thr450 | mouse | Colitis | GPS extract | Associated | 4.0 (Moderate) | 37249930 | |
acc3212 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Colitis | GPS extract | Associated | 4.0 (Moderate) | 37249930 | |
acc3213 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Colitis | GPS extract | Associated | 4.0 (Moderate) | 37249930 | |
acc3214 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Colitis | GPS extract | Associated | 4.0 (Moderate) | 37249930 | |
acc3215 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Colitis | GPS extract | Associated | 4.0 (Moderate) | 37249930 | |
acc3216 | JNK | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Colitis | GPS extract | Associated | 4.0 (Moderate) | 37249930 | |
acc3217 | JNK | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Colitis | GPS extract | Associated | 4.0 (Moderate) | 37249930 | |
acc3218 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | Colitis | GPS extract | Associated | 4.0 (Moderate) | 37249930 | |
acc3219 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | Colitis | GPS extract | Associated | 4.0 (Moderate) | 37249930 | |
acc3220 | Beta-catenin | Q02248 | Ctnnb1 | phosphorylation | Ser298 | mouse | Pigmentation | B16F10 | 6-methylcoumarin | Associated | 4.0 (Moderate) | 37299026 |
acc3221 | GSK3beta | Q9WV60 | Gsk3b | phosphorylation | Ser9 | mouse | Pigmentation | B16F10 | 6-methylcoumarin | Associated | 4.0 (Moderate) | 37299026 |
acc3226 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Diabetes Mellitus | Oleanolic acid | Associated | 4.0 (Moderate) | 21254272 | |
acc3227 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Diabetes Mellitus | Oleanolic acid | Associated | 4.0 (Moderate) | 21254272 | |
acc3228 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Diabetes Mellitus | Oleanolic acid | Associated | 4.0 (Moderate) | 21254272 | |
acc3229 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Diabetes Mellitus | Oleanolic acid | Associated | 4.0 (Moderate) | 21254272 | |
acc3230 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Diabetes Mellitus | Oleanolic acid | Associated | 4.0 (Moderate) | 21254272 | |
acc3231 | mTOR | P42346 | Mtor | phosphorylation | Ser2448 | rat | Diabetes Mellitus | Oleanolic acid | Associated | 4.0 (Moderate) | 21254272 | |
acc3232 | p38 | P70618 | Mapk14 | phosphorylation | Thr180 | rat | Diabetes Mellitus | Oleanolic acid | Associated | 4.0 (Moderate) | 21254272 | |
acc3233 | p38 | P70618 | Mapk14 | phosphorylation | Tyr182 | rat | Diabetes Mellitus | Oleanolic acid | Associated | 4.0 (Moderate) | 21254272 | |
acc3234 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Prostate Cancer | PC3 | compound 8.12 | Associated | 4.0 (Moderate) | 24971579 |
acc3235 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | HepG2 | compound 8.12 | Associated | 4.0 (Moderate) | 24971579 |
acc3236 | JNK | Q91Y86 | Mapk8 | phosphorylation | Ser2448 | mouse | Lung Cancer | Lewis | Yifei sanjie Pills (YFSJ) + DDP | Associated | 4.0 (Moderate) | 36045663 |
acc3237 | p53 | P02340 | Tp53 | phosphorylation | Ser15 | mouse | Lung Cancer | Lewis | Yifei sanjie Pills (YFSJ) + DDP | Associated | 4.0 (Moderate) | 36045663 |
acc3238 | PKC | P17252 | PRKCA | phosphorylation | unclear | human | Colorectal Cancer | HT29 | Bile acids | Associated | 4.0 (Moderate) | 1399121 |
acc3239 | EGFR | P00533 | EGFR | phosphorylation | unclear | human | Epidermal Hyperplasia | RG50864 + RG13022 | Associated | 4.0 (Moderate) | 8562483 | |
acc3240 | IRS1 | P35570 | Irs1 | phosphorylation | unclear | rat | Obese | Captopril | Associated | 4.0 (Moderate) | 9801794 | |
acc3241 | myosin light chain 20 | P10916 | MYL2 | phosphorylation | Thr18 | human | Subarachnoid Hemorrhage | aortic SMCs | Fasudil | Associated | 4.0 (Moderate) | 10448094 |
acc3242 | myosin light chain 20 | P10916 | MYL2 | phosphorylation | Ser19 | human | Subarachnoid Hemorrhage | aortic SMCs | Fasudil | Associated | 4.0 (Moderate) | 10448094 |
acc3243 | myosin light chain 20 | Q7M2V4 | MYL2 | phosphorylation | Thr18 | rabbit | Subarachnoid Hemorrhage | SM-3 | Fasudil | Associated | 4.0 (Moderate) | 10448094 |
acc3244 | myosin light chain 20 | Q7M2V4 | MYL2 | phosphorylation | Ser19 | rabbit | Subarachnoid Hemorrhage | SM-4 | Fasudil | Associated | 4.0 (Moderate) | 10448094 |
acc3245 | c-Jun | P05412 | JUN | phosphorylation | Ser63 | human | Asthma | Prednisolone | Associated | 4.0 (Moderate) | 10482829 | |
acc3246 | c-Jun | P05412 | JUN | phosphorylation | Ser63 | human | Asthma | Prednisolone | Associated | 4.0 (Moderate) | 10482829 | |
acc3247 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Asthma | Prednisolone | Associated | 4.0 (Moderate) | 10482829 | |
acc3248 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Asthma | Prednisolone | Associated | 4.0 (Moderate) | 10482829 | |
acc3249 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Asthma | Prednisolone | Associated | 4.0 (Moderate) | 10482829 | |
acc3250 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Asthma | Prednisolone | Associated | 4.0 (Moderate) | 10482829 | |
acc3251 | STAT3 | P52631 | Stat3 | phosphorylation | Tyr705 | rat | Alcoholic Liver Disease | Ethanol | Associated | 4.0 (Moderate) | 10486586 | |
acc3252 | STAT3 | P52631 | Stat3 | phosphorylation | Ser727 | rat | Alcoholic Liver Disease | Ethanol | Associated | 4.0 (Moderate) | 10486586 | |
acc3253 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Vascular Injury | VSMCs | Bradykinin | Associated | 4.0 (Moderate) | 10775566 |
acc3254 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr187 | rat | Vascular Injury | VSMCs | Bradykinin | Associated | 4.0 (Moderate) | 10775566 |
acc3255 | Bcl-2 | P10415 | BCL2 | phosphorylation | ser70 | human | Pancreatic Cancer | AsPC–1 | Medroxyprogesterone acetate | Associated | 4.0 (Moderate) | 10813710 |
acc3256 | Bcl-2 | P10415 | BCL2 | phosphorylation | ser70 | human | Pancreatic Cancer | Capan–2 | Medroxyprogesterone acetate | Associated | 4.0 (Moderate) | 10813710 |
acc3257 | Bcl-2 | P10415 | BCL2 | phosphorylation | ser70 | human | Pancreatic Cancer | MiaPaCa–2 | Medroxyprogesterone acetate | Associated | 4.0 (Moderate) | 10813710 |
acc3258 | pRb | P06400 | RB1 | phosphorylation | Ser249 | human | Leukemia | MV4-11 | TGF-beta | Associated | 4.0 (Moderate) | 11027571 |
acc3259 | pRb | P06400 | RB1 | phosphorylation | Thr252 | human | Leukemia | MV4-11 | TGF-beta | Associated | 4.0 (Moderate) | 11027571 |
acc3260 | pRb | P06400 | RB1 | phosphorylation | Thr373 | human | Leukemia | MV4-11 | TGF-beta | Associated | 4.0 (Moderate) | 11027571 |
acc3261 | pRb | P06400 | RB1 | phosphorylation | Ser780 | human | Leukemia | MV4-11 | TGF-beta | Associated | 4.0 (Moderate) | 11027571 |
acc3262 | pRb | P06400 | RB1 | phosphorylation | Ser807 | human | Leukemia | MV4-11 | TGF-beta | Associated | 4.0 (Moderate) | 11027571 |
acc3263 | pRb | P06400 | RB1 | phosphorylation | Ser811 | human | Leukemia | MV4-11 | TGF-beta | Associated | 4.0 (Moderate) | 11027571 |
acc3264 | Rhodopsin | P51489 | Rho | phosphorylation | unclear | rat | Retinal Dysfunction | Nilvadipine | Associated | 4.0 (Moderate) | 11581204 | |
acc3272 | MSH2 | P43246 | MSH2 | phosphorylation | unclear | human | Repair of DNA Damage | HeLa-MR | Quercetin | Associated | 4.0 (Moderate) | 11972333 |
acc3273 | MSH6 | P52701 | MSH6 | phosphorylation | unclear | human | Repair of DNA Damage | HeLa-MR | Quercetin | Associated | 4.0 (Moderate) | 11972333 |
acc3274 | Akt | P47196 | Akt1 | phosphorylation | Thr308 | rat | Obese | Rosiglitazone | Associated | 4.0 (Moderate) | 12145152 | |
acc3275 | Akt | P47196 | Akt1 | phosphorylation | Thr308 | rat | Obese | PPARgamma agonist | Associated | 4.0 (Moderate) | 12145152 | |
acc3277 | BCL-XL | Q07817 | BCL2L1 | phosphorylation | Tyr | human | Apoptosis | H1-A | Associated | 4.0 (Moderate) | 12518171 | |
acc3278 | Bcl-2 | P10415 | BCL2 | phosphorylation | Tyr | human | Apoptosis | H1-A | Associated | 4.0 (Moderate) | 12518171 | |
acc3279 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Epidermoid Carcinoma | A431/CDDP2 | Paclitaxel + Cisplatin | Associated | 4.0 (Moderate) | 12709826 |
acc3282 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Hyperalgesia | U0126 | Associated | 4.0 (Moderate) | 12941468 | |
acc3283 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Hyperalgesia | U0126 | Associated | 4.0 (Moderate) | 12941468 | |
acc3284 | Bcl-2 | P49950 | Bcl2 | phosphorylation | Ser87 | rat | Neuronal Death | Kainic acid | Associated | 4.0 (Moderate) | 12956712 | |
acc3285 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Obese | Losartan | Associated | 4.0 (Moderate) | 12960006 | |
acc3286 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Neuronal Damage | Cilostazol | Associated | 4.0 (Moderate) | 14634032 | |
acc3287 | CK2 | P19139 | Csnk2a1 | phosphorylation | unclear | rat | Neuronal Damage | Cilostazol | Associated | 4.0 (Moderate) | 14634032 | |
acc3288 | CREB | P15337 | Creb1 | phosphorylation | Ser133 | rat | Neuronal Damage | Cilostazol | Associated | 4.0 (Moderate) | 14634032 | |
acc3289 | PTEN | O54857 | Pten | phosphorylation | Ser380 | rat | Neuronal Damage | Cilostazol | Associated | 4.0 (Moderate) | 14634032 | |
acc3290 | PTEN | O54857 | Pten | phosphorylation | Thr382 | rat | Neuronal Damage | Cilostazol | Associated | 4.0 (Moderate) | 14634032 | |
acc3291 | PTEN | O54857 | Pten | phosphorylation | Thr383 | rat | Neuronal Damage | Cilostazol | Associated | 4.0 (Moderate) | 14634032 | |
acc3292 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | SMMC-7721 | TGF-beta1 | Associated | 4.0 (Moderate) | 14637150 |
acc3293 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Hepatocellular Carcinoma | SMMC-7721 | TGF-beta1 | Associated | 4.0 (Moderate) | 14637150 |
acc3294 | FAK | Q05397 | PTK2 | phosphorylation | Tyr | human | Hepatocellular Carcinoma | SMMC-7721 | TGF-beta1 | Associated | 4.0 (Moderate) | 14637150 |
acc3295 | NOS3 | Q62600 | Nos3 | phosphorylation | Ser1179 | rat | Hypertension | DOCA–salt | Associated | 4.0 (Moderate) | 14993198 | |
acc3296 | NOS3 | Q62600 | Nos3 | phosphorylation | Ser635 | rat | Hypertension | DOCA–salt | Associated | 4.0 (Moderate) | 14993198 | |
acc3297 | AKT2 | P31751 | AKT2 | phosphorylation | Ser474 | human | Obese | Insulin | Associated | 4.0 (Moderate) | 15010337 | |
acc3298 | ERK | P21708 | Mapk1 | phosphorylation | Thr202 | rat | Cardiac Hypertrophy | Pertussis toxin (PTX) | Associated | 4.0 (Moderate) | 15081308 | |
acc3299 | ERK | P21708 | Mapk1 | phosphorylation | Tyr204 | rat | Cardiac Hypertrophy | Pertussis toxin (PTX) | Associated | 4.0 (Moderate) | 15081308 | |
acc3300 | Mdm2 | P23804 | Mdm2 | phosphorylation | Ser166 | mouse | Tumorigenesis | mouse embryonic fibroblasts | PKB | Associated | 4.0 (Moderate) | 15169778 |
acc3301 | Mdm2 | P23804 | Mdm2 | phosphorylation | Ser188 | mouse | Tumorigenesis | mouse embryonic fibroblasts | PKB | Associated | 4.0 (Moderate) | 15169778 |
acc3302 | Mdm2 | P23804 | Mdm2 | ubiquitination | unclear | mouse | Tumorigenesis | mouse embryonic fibroblasts | PKB | Associated | 4.0 (Moderate) | 15169778 |
acc3305 | p38 MAPK | Q16539 | MAPK14 | phosphorylation | unclear | human | Airway Smooth Muscle Hyperplasia | SB203580 | Associated | 4.0 (Moderate) | 15249425 | |
acc3306 | pRb | P06400 | RB1 | phosphorylation | Ser780 | human | Airway Smooth Muscle Hyperplasia | SB203580 | Associated | 4.0 (Moderate) | 15249425 | |
acc3307 | FAK | P34152 | Ptk2 | phosphorylation | Tyr397 | mouse | Hyperosmotic Stress | Swiss 3T3 | Sucrose | Associated | 4.0 (Moderate) | 15302877 |
acc3308 | FAK | P34152 | Ptk2 | phosphorylation | Tyr397 | mouse | Hyperosmotic Stress | Swiss 3T3 | Sorbitol | Associated | 4.0 (Moderate) | 15302877 |
acc3309 | FAK | P34152 | Ptk2 | phosphorylation | Tyr577 | mouse | Hyperosmotic Stress | Swiss 3T3 | Sucrose | Associated | 4.0 (Moderate) | 15302877 |
acc3310 | FAK | P34152 | Ptk2 | phosphorylation | Tyr577 | mouse | Hyperosmotic Stress | Swiss 3T3 | Sorbitol | Associated | 4.0 (Moderate) | 15302877 |
acc3311 | ERK1 | Q63844 | Mapk3 | phosphorylation | unclear | mouse | Polycystic Kidney Disease | OPC31260 | Associated | 4.0 (Moderate) | 15361692 | |
acc3312 | ERK1 | P21708 | Mapk3 | phosphorylation | unclear | rat | Polycystic Kidney Disease | OPC31260 | Associated | 4.0 (Moderate) | 15361692 | |
acc3313 | Akt | P47196 | Akt1 | phosphorylation | rat | Myocardial Ischemic Injury | DHA | Associated | 4.0 (Moderate) | 15454281 | ||
acc3314 | Jak2 | Q62689 | Jak2 | phosphorylation | unclear | rat | Myocardial Ischemic Injury | DHA | Associated | 4.0 (Moderate) | 15454281 | |
acc3315 | STAT1 | Q6P6Q7 | Stat1 | phosphorylation | unclear | rat | Myocardial Ischemic Injury | DHA | Associated | 4.0 (Moderate) | 15454281 | |
acc3316 | STAT3 | P52631 | Stat3 | phosphorylation | unclear | rat | Myocardial Ischemic Injury | DHA | Associated | 4.0 (Moderate) | 15454281 | |
acc3317 | STAT5b | P52632 | Stat5b | phosphorylation | unclear | rat | Myocardial Ischemic Injury | DHA | Associated | 4.0 (Moderate) | 15454281 | |
acc3318 | p38 MAP kinase | P70618 | Mapk14 | phosphorylation | Thr180 | rat | Cardiac Myocyte Dysfunction | SB203580 | Associated | 4.0 (Moderate) | 15465893 | |
acc3319 | p38 MAP kinase | P70618 | Mapk14 | phosphorylation | Tyr182 | rat | Cardiac Myocyte Dysfunction | SB203580 | Associated | 4.0 (Moderate) | 15465893 | |
acc3320 | MLC20 | P02600 | Myl1 | phosphorylation | unclear | rat | Laryngeal Cancer | smooth muscle cell | Nicotinamide | Associated | 4.0 (Moderate) | 15559762 |
acc3321 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Cell Death | H9c2 | Rottlerin | Associated | 4.0 (Moderate) | 15631696 |
acc3322 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Cell Death | H9c2 | Rottlerin | Associated | 4.0 (Moderate) | 15631696 |
acc3323 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Cell Death | H9c2 | Rottlerin | Associated | 4.0 (Moderate) | 15631696 |
acc3324 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Cell Death | H9c2 | Rottlerin | Associated | 4.0 (Moderate) | 15631696 |
acc3325 | p38 MAPK | P70618 | Mapk14 | phosphorylation | Thr180 | rat | Cell Death | H9c2 | Rottlerin | Associated | 4.0 (Moderate) | 15631696 |
acc3326 | p38 MAPK | P70618 | Mapk14 | phosphorylation | Tyr182 | rat | Cell Death | H9c2 | Rottlerin | Associated | 4.0 (Moderate) | 15631696 |
acc3327 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Diabetes Mellitus | Zucker diabetic Fatty rat | Cardiac insulin | Associated | 4.0 (Moderate) | 15677515 |
acc3328 | eIF2alpha | A0A1U7Q8G2 | Eif2s1 | phosphorylation | Ser51 | hamster | Viral Infection | BHK | Thapsigargin | Associated | 4.0 (Moderate) | 15705563 |
acc3329 | eIF2alpha | Q8BJW6 | Eif2a | phosphorylation | Ser51 | mouse | Viral Infection | MEF | Thapsigargin | Associated | 4.0 (Moderate) | 15705563 |
acc3330 | nNOS | Q9Z0J4 | Nos1 | phosphorylation | Ser847 | mouse | Obese | MPTP | Associated | 4.0 (Moderate) | 15721991 | |
acc3332 | BAD | Q92934 | BAD | phosphorylation | Ser112 | human | Ovarian Cancer | IGROV-1 | ST1926+ZD1839 | Associated | 4.0 (Moderate) | 15781651 |
acc3333 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Ovarian Cancer | IGROV-1 | ST1926+ZD1839 | Associated | 4.0 (Moderate) | 15781651 |
acc3334 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Ovarian Cancer | IGROV-1 | ST1926+ZD1839 | Associated | 4.0 (Moderate) | 15781651 |
acc3335 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Ovarian Cancer | IGROV-1 | ST1926+ZD1839 | Associated | 4.0 (Moderate) | 15781651 |
acc3336 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Ovarian Cancer | IGROV-1 | ST1926+ZD1839 | Associated | 4.0 (Moderate) | 15781651 |
acc3337 | IRS1 | P35570 | Irs1 | phosphorylation | Ser307 | rat | Obese | Rosiglitazone | Associated | 4.0 (Moderate) | 15787606 | |
acc3338 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Pancreatic Cancer | PK - 1 | PD98059 | Associated | 4.0 (Moderate) | 15896303 |
acc3339 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Pancreatic Cancer | PK - 1 | U0126 | Associated | 4.0 (Moderate) | 15896303 |
acc3340 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Pancreatic Cancer | PK - 1 | PD98059 | Associated | 4.0 (Moderate) | 15896303 |
acc3341 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Pancreatic Cancer | PK - 1 | U0126 | Associated | 4.0 (Moderate) | 15896303 |
acc3342 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreatic Cancer | PK - 1 | PD98059 | Associated | 4.0 (Moderate) | 15896303 |
acc3343 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Pancreatic Cancer | PK - 1 | U0126 | Associated | 4.0 (Moderate) | 15896303 |
acc3344 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreatic Cancer | PK - 1 | PD98059 | Associated | 4.0 (Moderate) | 15896303 |
acc3345 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Pancreatic Cancer | PK - 1 | U0126 | Associated | 4.0 (Moderate) | 15896303 |
acc3346 | EGFR | P00533 | EGFR | phosphorylation | unclear | human | Diabetes Mellitus | PKI166 | Associated | 4.0 (Moderate) | 16105029 | |
acc3347 | EGFR | A8IP97 | Egfr | phosphorylation | unclear | rat | Diabetes Mellitus | PKI166 | Associated | 4.0 (Moderate) | 16105029 | |
acc3348 | MYPT1 | Q10728 | Ppp1r12a | phosphorylation | Thr696 | rat | Pulmonary Hypertension | Sildenafil | Associated | 4.0 (Moderate) | 16205723 | |
acc3349 | MYPT1 | Q10728 | Ppp1r12a | phosphorylation | Thr696 | rat | Pulmonary Hypertension | Fasudil | Associated | 4.0 (Moderate) | 16205723 | |
acc3350 | Rac | P63000 | RAC1 | prenylation | unclear | human | Diabetes Mellitus | Minodronate | Associated | 4.0 (Moderate) | 16216433 | |
acc3351 | EGFR | A8IP97 | Egfr | phosphorylation | unclear | rat | Diabetes Mellitus | ABT-627 | Associated | 4.0 (Moderate) | 16239374 | |
acc3352 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Morphine Dependence and Naloxone-Induced Withdrawal | U0126 | Associated | 4.0 (Moderate) | 16289800 | |
acc3353 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Morphine Dependence and Naloxone-Induced Withdrawal | U0126 | Associated | 4.0 (Moderate) | 16289800 | |
acc3354 | p38 MAPK | - | - | phosphorylation | Thr180 | bovine | Vascular Calcification | 牛血管钙化细胞系CVCs | DHA | Associated | 4.0 (Moderate) | 16514067 |
acc3355 | p38 MAPK | - | - | phosphorylation | Tyr182 | bovine | Vascular Calcification | 牛血管钙化细胞系CVCs | DHA | Associated | 4.0 (Moderate) | 16514067 |
acc3356 | CREB | P15337 | Creb1 | phosphorylation | Ser133 | rat | Cognitive Abnormalities | Cilostazol | Associated | 4.0 (Moderate) | 16645134 | |
acc3357 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Cognitive Abnormalities | Huperzine A | Associated | 4.0 (Moderate) | 16687166 | |
acc3358 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Cognitive Abnormalities | Huperzine A | Associated | 4.0 (Moderate) | 16687166 | |
acc3649 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Cardiac Hypertrophy | KS370 | Associated | 4.0 (Moderate) | 22484506 | |
acc3650 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Cardiac Hypertrophy | KS370 | Associated | 4.0 (Moderate) | 22484506 | |
acc3651 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Cardiac Hypertrophy | KS370 | Associated | 4.0 (Moderate) | 22484506 | |
acc3652 | GSK3beta | Q9WV60 | Gsk3b | phosphorylation | Ser9 | mouse | Cardiac Hypertrophy | KS370 | Associated | 4.0 (Moderate) | 22484506 | |
acc3653 | MnSOD | P09671 | Sod2 | nitration | unclear | mouse | Refractory Wounds | Ganoderma lucidum polysaccharide (Gl-PS) | Associated | 4.0 (Moderate) | 22508065 | |
acc3654 | p66Shc | P98083 | Shc1 | phosphorylation | Ser36 | mouse | Refractory Wounds | Ganoderma lucidum polysaccharide (Gl-PS) | Associated | 4.0 (Moderate) | 22508065 | |
acc3655 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Painful Diabetic Neuropathy | MK801 | Associated | 4.0 (Moderate) | 22573263 | |
acc3656 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Painful Diabetic Neuropathy | MK801 | Associated | 4.0 (Moderate) | 22573263 | |
acc3657 | NR1 | Q3UNH4 | Gprin1 | phosphorylation | Ser890 | mouse | Painful Diabetic Neuropathy | MK801 | Associated | 4.0 (Moderate) | 22573263 | |
acc3658 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Diabetes Mellitus | GW501516ruboxistaurin | Associated | 4.0 (Moderate) | 22586590 | |
acc3659 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Diabetes Mellitus | Ruboxistaurin | Associated | 4.0 (Moderate) | 22586590 | |
acc3660 | FOXO3a | Q9WVH4 | Foxo3 | phosphorylation | Thr32 | mouse | Diabetes Mellitus | GW501516ruboxistaurin | Associated | 4.0 (Moderate) | 22586590 | |
acc3661 | FOXO3a | Q9WVH4 | Foxo3 | phosphorylation | Thr32 | mouse | Diabetes Mellitus | Ruboxistaurin | Associated | 4.0 (Moderate) | 22586590 | |
acc3662 | ERK1 | P21708 | Mapk3 | phosphorylation | unclear | rat | Myocardial Fibrosis | Aliskiren | Associated | 4.0 (Moderate) | 22642589 | |
acc3663 | ERK2 | P63086 | Mapk1 | phosphorylation | unclear | rat | Myocardial Fibrosis | Aliskiren | Associated | 4.0 (Moderate) | 22642589 | |
acc3668 | PLN | P61016 | Pln | phosphorylation | Ser16 | rat | Cardiac Diastolic Dysfunction | cardiomyocytes | EGb761 | Associated | 4.0 (Moderate) | 22693651 |
acc3669 | PLN | P61016 | Pln | phosphorylation | Thr17 | rat | Cardiac Diastolic Dysfunction | cardiomyocytes | EGb761 | Associated | 4.0 (Moderate) | 22693651 |
acc3670 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Diabetes Mellitus | EGF | Associated | 4.0 (Moderate) | 22720029 | |
acc3671 | EGFR | A8IP97 | Egfr | phosphorylation | Tyr992 | rat | Diabetes Mellitus | Losartan | Associated | 4.0 (Moderate) | 22720029 | |
acc3672 | EGFR | A8IP97 | Egfr | phosphorylation | Tyr1068 | rat | Diabetes Mellitus | Losartan | Associated | 4.0 (Moderate) | 22720029 | |
acc3673 | EGFR | A8IP97 | Egfr | phosphorylation | Tyr1086 | rat | Diabetes Mellitus | Losartan | Associated | 4.0 (Moderate) | 22720029 | |
acc3674 | EGFR | A8IP97 | Egfr | phosphorylation | Tyr1148 | rat | Diabetes Mellitus | Losartan | Associated | 4.0 (Moderate) | 22720029 | |
acc3675 | EGFR | A8IP97 | Egfr | phosphorylation | Tyr992 | rat | Diabetes Mellitus | EGF | Associated | 4.0 (Moderate) | 22720029 | |
acc3676 | EGFR | A8IP97 | Egfr | phosphorylation | Tyr1068 | rat | Diabetes Mellitus | EGF | Associated | 4.0 (Moderate) | 22720029 | |
acc3677 | EGFR | A8IP97 | Egfr | phosphorylation | Tyr1086 | rat | Diabetes Mellitus | EGF | Associated | 4.0 (Moderate) | 22720029 | |
acc3678 | EGFR | A8IP97 | Egfr | phosphorylation | Tyr1148 | rat | Diabetes Mellitus | EGF | Associated | 4.0 (Moderate) | 22720029 | |
acc3679 | ErbB2 | P06494 | Erbb2 | phosphorylation | Tyr877 | rat | Diabetes Mellitus | EGF | Associated | 4.0 (Moderate) | 22720029 | |
acc3680 | ERK | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Diabetes Mellitus | EGF | Associated | 4.0 (Moderate) | 22720029 | |
acc3681 | ERK | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Diabetes Mellitus | EGF | Associated | 4.0 (Moderate) | 22720029 | |
acc3682 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Diabetes Mellitus | EGF | Associated | 4.0 (Moderate) | 22720029 | |
acc3683 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Diabetes Mellitus | EGF | Associated | 4.0 (Moderate) | 22720029 | |
acc3684 | FOXO3a | D3ZBQ1 | Foxo3 | phosphorylation | Ser253 | rat | Diabetes Mellitus | EGF | Associated | 4.0 (Moderate) | 22720029 | |
acc3685 | p38 | P70618 | Mapk14 | phosphorylation | Tyr1148 | rat | Diabetes Mellitus | EGF | Associated | 4.0 (Moderate) | 22720029 | |
acc3686 | CREB | P15337 | Creb1 | phosphorylation | Ser133 | rat | Chronic Hyperlipidemia | INS-1E | Kaempferol | Associated | 4.0 (Moderate) | 22819546 |
acc3687 | IkappaBalpha | Q8CEC5 | Nkiras1 | phosphorylation | Ser32 | mouse | Cardiac Dysfunction | Rhynchophylline | Associated | 4.0 (Moderate) | 22841535 | |
acc3688 | AMPK | P54645 | Prkaa1 | phosphorylation | Thr183 | rat | Diabetes Mellitus | Curcumin | Associated | 4.0 (Moderate) | 22898567 | |
acc3689 | AMPK | Q09137 | Prkaa2 | phosphorylation | Thr172 | rat | Diabetes Mellitus | Curcumin | Associated | 4.0 (Moderate) | 22898567 | |
acc3690 | MAPK | P63086 | Mapk1 | phosphorylation | unclear | rat | Neuropathic Allodynia | JWH015 | Associated | 4.0 (Moderate) | 22901764 | |
acc3691 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Pancreatitis | Sulindac | Associated | 4.0 (Moderate) | 22920325 | |
acc3692 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Pancreatitis | Sulindac | Associated | 4.0 (Moderate) | 22920325 | |
acc3693 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Pancreatitis | Sulindac | Associated | 4.0 (Moderate) | 22920325 | |
acc3694 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Pancreatitis | Sulindac | Associated | 4.0 (Moderate) | 22920325 | |
acc3695 | MEK | P31938 | MAP2K1 | phosphorylation | Ser217 | mouse | Pancreatitis | Sulindac | Associated | 4.0 (Moderate) | 22920325 | |
acc3696 | MEK | P31938 | MAP2K1 | phosphorylation | Ser221 | mouse | Pancreatitis | Sulindac | Associated | 4.0 (Moderate) | 22920325 | |
acc3697 | ERK | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Diabetes Mellitus | Resveratrol + SP600125 | Associated | 4.0 (Moderate) | 22933112 | |
acc3698 | ERK | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Diabetes Mellitus | Resveratrol + SB203580 | Associated | 4.0 (Moderate) | 22933112 | |
acc3699 | JNK | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Diabetes Mellitus | Resveratrol + SP600125 | Associated | 4.0 (Moderate) | 22933112 | |
acc3700 | JNK | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Diabetes Mellitus | Resveratrol + SP600125 | Associated | 4.0 (Moderate) | 22933112 | |
acc3701 | JNK | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Diabetes Mellitus | Resveratrol + SB203580 | Associated | 4.0 (Moderate) | 22933112 | |
acc3702 | JNK | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Diabetes Mellitus | Resveratrol + SB203580 | Associated | 4.0 (Moderate) | 22933112 | |
acc3703 | JNK1 | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Cerebral Ischemia | Rosiglitazone | Associated | 4.0 (Moderate) | 23032483 | |
acc3704 | JNK1 | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Cerebral Ischemia | Rosiglitazone | Associated | 4.0 (Moderate) | 23032483 | |
acc3705 | NR2B | Q01097 | Grin2b | phosphorylation | Ser1303 | mouse | Neuronal Death | NMDA | Associated | 4.0 (Moderate) | 23085545 | |
acc3706 | eNOS | P70313 | Nos3 | phosphorylation | Ser1177 | mouse | Diabetes Mellitus | Stromal vascular fraction | Associated | 4.0 (Moderate) | 23088258 | |
acc3709 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Myocardial I/R Injury | Danshensu | Associated | 4.0 (Moderate) | 23200898 | |
acc3710 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Myocardial I/R Injury | Danshensu | Associated | 4.0 (Moderate) | 23200898 | |
acc3711 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Myocardial I/R Injury | Danshensu | Associated | 4.0 (Moderate) | 23200898 | |
acc3712 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Myocardial I/R Injury | Danshensu | Associated | 4.0 (Moderate) | 23200898 | |
acc3713 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Myocardial I/R Injury | Danshensu | Associated | 4.0 (Moderate) | 23200898 | |
acc3716 | CaMKIV | P13234 | Camk4 | phosphorylation | unclear | rat | Infarction | Tat-NR2B9c | Associated | 4.0 (Moderate) | 23363435 | |
acc3717 | CREB | P15337 | Creb1 | phosphorylation | Ser133 | rat | Infarction | Tat-NR2B9c | Associated | 4.0 (Moderate) | 23363435 | |
acc3718 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Vascular Diseases | HUVEC | Sphingosine-1-phosphate | Associated | 4.0 (Moderate) | 23381659 |
acc3719 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Vascular Diseases | HUVEC | Sphingosine-1-phosphate | Associated | 4.0 (Moderate) | 23381659 |
acc3720 | PPARgamma | P37238 | Pparg | phosphorylation | Ser273 | mouse | Diabetes Mellitus | C333H | Associated | 4.0 (Moderate) | 23563593 | |
acc3721 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Allergic | HMC-1 | [6]-Shogaol | Associated | 4.0 (Moderate) | 23590633 |
acc3722 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Allergic | HMC-1 | [6]-Shogaol | Associated | 4.0 (Moderate) | 23590633 |
acc3723 | NF-kappaB p65 | Q04206 | RELA | phosphorylation | Ser536 | human | Allergic | HMC-1 | [6]-Shogaol | Associated | 4.0 (Moderate) | 23590633 |
acc3724 | kras | P32883 | Kras | prenylation | unclear | mouse | Pancreatic Cancer | P03 | Sulindac | Associated | 4.0 (Moderate) | 23689354 |
acc3725 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Colitis | Flavonoid myricitrin | Associated | 4.0 (Moderate) | 23861337 | |
acc3726 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Colitis | Flavonoid myricitrin | Associated | 4.0 (Moderate) | 23861337 | |
acc3727 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Colitis | Flavonoid myricitrin | Associated | 4.0 (Moderate) | 23861337 | |
acc3728 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Colitis | Flavonoid myricitrin | Associated | 4.0 (Moderate) | 23861337 | |
acc3729 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Colitis | Flavonoid myricitrin | Associated | 4.0 (Moderate) | 23861337 | |
acc3730 | JNK | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Colitis | Flavonoid myricitrin | Associated | 4.0 (Moderate) | 23861337 | |
acc3731 | JNK | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Colitis | Flavonoid myricitrin | Associated | 4.0 (Moderate) | 23861337 | |
acc3732 | NF-kappaB p65 | Q04207 | Rela | phosphorylation | Ser536 | mouse | Colitis | Flavonoid myricitrin | Associated | 4.0 (Moderate) | 23861337 | |
acc3733 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | Colitis | Flavonoid myricitrin | Associated | 4.0 (Moderate) | 23861337 | |
acc3734 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | Colitis | Flavonoid myricitrin | Associated | 4.0 (Moderate) | 23861337 | |
acc3735 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Axonal Degeneration | Axonal degeneration | Brimonidine | Associated | 4.0 (Moderate) | 23928702 |
acc3736 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Axonal Degeneration | Brimonidine | Associated | 4.0 (Moderate) | 23928702 | |
acc3737 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Axonal Degeneration | Brimonidine | Associated | 4.0 (Moderate) | 23928702 | |
acc3738 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Axonal Degeneration | Brimonidine | Associated | 4.0 (Moderate) | 23928702 | |
acc3739 | IkappaBalpha | Q63746 | Nfkbia | phosphorylation | Ser32 | rat | Acute Lung Injury | Rosiglitazone | Associated | 4.0 (Moderate) | 23933652 | |
acc3740 | eNOS | P70313 | Nos3 | phosphorylation | Ser1177 | mouse | Erectile Dysfunction | angiopoietin-4 | Associated | 4.0 (Moderate) | 23937122 | |
acc3744 | TH | P04177 | Th | phosphorylation | Ser40 | rat | Fatigue | Rg3 | Associated | 4.0 (Moderate) | 23994341 | |
acc3745 | eNOS | P70313 | Nos3 | phosphorylation | Ser1177 | mouse | Diabetes Mellitus | angiopoietin-1 | Associated | 4.0 (Moderate) | 24009238 | |
acc3746 | Tie-2 | Q02858 | Tek | phosphorylation | Tyr1100 | mouse | Diabetes Mellitus | angiopoietin-1 | Associated | 4.0 (Moderate) | 24009238 | |
acc3747 | VEGFR2 | P35918 | Kdr | phosphorylation | Tyr951 | mouse | Diabetes Mellitus | angiopoietin-1 | Associated | 4.0 (Moderate) | 24009238 | |
acc3748 | STAT3 | P42227 | Stat3 | phosphorylation | unclear | mouse | Inflammatory | HO–1 | Associated | 4.0 (Moderate) | 24095726 | |
acc3749 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Diabetes Mellitus | Schwann cell | "cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate (CDC)" | Associated | 4.0 (Moderate) | 24175152 |
acc3750 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Diabetes Mellitus | Schwann cell | "cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate (CDC)" | Associated | 4.0 (Moderate) | 24175152 |
acc3751 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Diabetes Mellitus | "cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate (CDC)" | Associated | 4.0 (Moderate) | 24175152 | |
acc3752 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Diabetes Mellitus | "cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate (CDC)" | Associated | 4.0 (Moderate) | 24175152 | |
acc3753 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Diabetes Mellitus | Schwann cell | "cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate (CDC)" | Associated | 4.0 (Moderate) | 24175152 |
acc3754 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Diabetes Mellitus | Schwann cell | "cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate (CDC)" | Associated | 4.0 (Moderate) | 24175152 |
acc3755 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Diabetes Mellitus | "cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate (CDC)" | Associated | 4.0 (Moderate) | 24175152 | |
acc3756 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Diabetes Mellitus | "cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate (CDC)" | Associated | 4.0 (Moderate) | 24175152 | |
acc3757 | p38 MAPK | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Diabetes Mellitus | Schwann cell | "cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate (CDC)" | Associated | 4.0 (Moderate) | 24175152 |
acc3758 | p38 MAPK | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Diabetes Mellitus | Schwann cell | "cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate (CDC)" | Associated | 4.0 (Moderate) | 24175152 |
acc3759 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | Diabetes Mellitus | "cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate (CDC)" | Associated | 4.0 (Moderate) | 24175152 | |
acc3760 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | Diabetes Mellitus | "cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate (CDC)" | Associated | 4.0 (Moderate) | 24175152 | |
acc3761 | p38 | P47811 | Mapk14 | phosphorylation | unclear | mouse | Cerebral Ischemia | Shikonin | Associated | 4.0 (Moderate) | 24248858 | |
acc3762 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | cardiac dysfunction | Norepinephrine | Associated | 4.0 (Moderate) | 24304472 | |
acc3763 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | cardiac dysfunction | Norepinephrine | Associated | 4.0 (Moderate) | 24304472 | |
acc3764 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | cardiac dysfunction | Norepinephrine | Associated | 4.0 (Moderate) | 24304472 | |
acc3765 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | cardiac dysfunction | Norepinephrine | Associated | 4.0 (Moderate) | 24304472 | |
acc3766 | IkappaBalpha | Q9Z1E3 | Nfkbia | phosphorylation | Ser32 | mouse | cardiac dysfunction | Norepinephrine | Associated | 4.0 (Moderate) | 24304472 | |
acc3767 | JNK1 | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | cardiac dysfunction | Norepinephrine | Associated | 4.0 (Moderate) | 24304472 | |
acc3768 | JNK1 | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | cardiac dysfunction | Norepinephrine | Associated | 4.0 (Moderate) | 24304472 | |
acc3769 | p38 | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | cardiac dysfunction | Norepinephrine | Associated | 4.0 (Moderate) | 24304472 | |
acc3770 | p38 | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | cardiac dysfunction | Norepinephrine | Associated | 4.0 (Moderate) | 24304472 | |
acc3771 | IRS1 | P35569 | Irs1 | phosphorylation | Ser636 | mouse | Diabetes Mellitus | Evodiamine | Associated | 4.0 (Moderate) | 24391749 | |
acc3772 | IRS1 | P35569 | Irs1 | phosphorylation | Ser639 | mouse | Diabetes Mellitus | Evodiamine | Associated | 4.0 (Moderate) | 24391749 | |
acc3773 | AMPK | P54645 | Prkaa1 | phosphorylation | Thr183 | rat | Obese | Rosiglitazone | Associated | 4.0 (Moderate) | 24424059 | |
acc3774 | AMPK | Q09137 | Prkaa2 | phosphorylation | Thr172 | rat | Obese | Rosiglitazone | Associated | 4.0 (Moderate) | 24424059 | |
acc3775 | Akt | P31750 | Akt1 | phosphorylation | unclear | mouse | Cardiac Contractile Dysfunction | H2S | Associated | 4.0 (Moderate) | 24622975 | |
acc3776 | GSK3beta | Q9WV60 | Gsk3b | phosphorylation | Ser9 | mouse | Cardiac Contractile Dysfunction | H2S | Associated | 4.0 (Moderate) | 24622975 | |
acc3777 | PTEN | O08586 | Pten | phosphorylation | unclear | mouse | Cardiac Contractile Dysfunction | H2S | Associated | 4.0 (Moderate) | 24622975 | |
acc3778 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Alzheimer's Disease | Rosiglitazone | Associated | 4.0 (Moderate) | 24623782 | |
acc3779 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Alzheimer's Disease | Rosiglitazone | Associated | 4.0 (Moderate) | 24623782 | |
acc3780 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Alzheimer's Disease | Rosiglitazone | Associated | 4.0 (Moderate) | 24623782 | |
acc3781 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Alzheimer's Disease | Rosiglitazone | Associated | 4.0 (Moderate) | 24623782 | |
acc3782 | S6K | Q8BSK8 | Rps6kb1 | phosphorylation | Thr389 | mouse | Cardiac Hypertrophy | Acsl1 (H-/-)mouse | Rapamycin | Associated | 4.0 (Moderate) | 24631848 |
acc3783 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Diabetes Mellitus | "VO(HB(3,5-Me2pz)3)(3,5-Me2pz)(SCN)(SCNH)2" | Associated | 4.0 (Moderate) | 24636761 | |
acc3784 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Diabetes Mellitus | "VO(HB(3,5-Me2pz)3)(3,5-Me2pz)(SCN)(SCNH)2" | Associated | 4.0 (Moderate) | 24636761 | |
acc3785 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Diabetes Mellitus | "VO(HB(3,5-Me2pz)3)(3,5-Me2pz)(SCN)(SCNH)2" | Associated | 4.0 (Moderate) | 24636761 | |
acc3786 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Diabetes Mellitus | "VO(HB(3,5-Me2pz)3)(3,5-Me2pz)(SCN)(SCNH)2" | Associated | 4.0 (Moderate) | 24636761 | |
acc3787 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Diabetes Mellitus | "VO(HB(3,5-Me2pz)3)(3,5-Me2pz)(SCN)(SCNH)2" | Associated | 4.0 (Moderate) | 24636761 | |
acc3790 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Diabetes Mellitus | Tadalafil | Associated | 4.0 (Moderate) | 24727492 | |
acc3791 | AMPKalpha | Q5EG47 | Prkaa1 | phosphorylation | Thr172 | mouse | Diabetes Mellitus | Tadalafil | Associated | 4.0 (Moderate) | 24727492 | |
acc3792 | eNOS | P70313 | Nos3 | phosphorylation | Ser1177 | mouse | Diabetes Mellitus | Tadalafil | Associated | 4.0 (Moderate) | 24727492 | |
acc3793 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | "Mechanical Allodynia, Anxiety-Like Behavior, and Cognitive Impairments" | U0126 | Associated | 4.0 (Moderate) | 24799176 | |
acc3794 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | "Mechanical Allodynia, Anxiety-Like Behavior, and Cognitive Impairments" | U0126 | Associated | 4.0 (Moderate) | 24799176 | |
acc3795 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | "Mechanical Allodynia, Anxiety-Like Behavior, and Cognitive Impairments" | U0126 | Associated | 4.0 (Moderate) | 24799176 | |
acc3796 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | "Mechanical Allodynia, Anxiety-Like Behavior, and Cognitive Impairments" | U0126 | Associated | 4.0 (Moderate) | 24799176 | |
acc3797 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Gastric Cancer | SGC-7901 | Rapamycin | Associated | 4.0 (Moderate) | 24799956 |
acc3798 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Gastric Cancer | SGC-7901 | Rapamycin | Associated | 4.0 (Moderate) | 24799956 |
acc3799 | p70S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Gastric Cancer | SGC-7901 | Rapamycin | Associated | 4.0 (Moderate) | 24799956 |
acc3800 | IP3R | Q14643 | ITPR1 | phosphorylation | Ser1756 | human | Allergic | HEK293 | Homoharringtonine | Associated | 4.0 (Moderate) | 24827904 |
acc3801 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Diabetes Mellitus | Insulin | Associated | 4.0 (Moderate) | 24855642 | |
acc3802 | IRS1 | P35569 | Irs1 | phosphorylation | Ser307 | mouse | Diabetes Mellitus | Insulin | Associated | 4.0 (Moderate) | 24855642 | |
acc3803 | Smad2 | Q62432 | Smad2 | phosphorylation | unclear | mouse | Cardiac Fibrosis | Serelaxin + Enalapril | Associated | 4.0 (Moderate) | 24866131 | |
acc3804 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Myocardial I/R Injury | Picroside II | Associated | 4.0 (Moderate) | 24868147 | |
acc3805 | eNOS | Q62600 | Nos3 | phosphorylation | Ser1177 | rat | Myocardial I/R Injury | Picroside II | Associated | 4.0 (Moderate) | 24868147 | |
acc3806 | Smad2 | Q62432 | Smad2 | acetylation | Ser465 | mouse | Diabetes Mellitus | H9c2 | p300 inhibitor | Associated | 4.0 (Moderate) | 24886336 |
acc3807 | Smad2 | Q62432 | Smad2 | acetylation | Ser467 | mouse | Diabetes Mellitus | H9c2 | p300 inhibitor | Associated | 4.0 (Moderate) | 24886336 |
acc3808 | Akt | P31750 | Akt1 | phosphorylation | unclear | mouse | Ovarian Cancer | Thioridazine | Associated | 4.0 (Moderate) | 24952635 | |
acc3809 | mTOR | Q9JLN9 | Mtor | phosphorylation | unclear | mouse | Ovarian Cancer | Thioridazine | Associated | 4.0 (Moderate) | 24952635 | |
acc3810 | PDK1 | Q8BFP9 | Pdk1 | phosphorylation | unclear | mouse | Ovarian Cancer | Thioridazine | Associated | 4.0 (Moderate) | 24952635 | |
acc3811 | VEGFR2 | P35918 | Kdr | phosphorylation | Tyr1175 | mouse | Ovarian Cancer | Thioridazine | Associated | 4.0 (Moderate) | 24952635 | |
acc3812 | Sort1 | Q99523 | SORT1 | phosphorylation | Ser793 | human | Obese | HepG2 | Palmitate | Associated | 4.0 (Moderate) | 24986865 |
acc3813 | CREB | Q01147 | Creb1 | phosphorylation | Ser133 | mouse | Cognitive Abnormalities | Lotus seedpod procyanidins | Associated | 4.0 (Moderate) | 25066354 | |
acc3814 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Cognitive Abnormalities | Lotus seedpod procyanidins | Associated | 4.0 (Moderate) | 25066354 | |
acc3815 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Cognitive Abnormalities | Lotus seedpod procyanidins | Associated | 4.0 (Moderate) | 25066354 | |
acc3816 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Cognitive Abnormalities | Lotus seedpod procyanidins | Associated | 4.0 (Moderate) | 25066354 | |
acc3817 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Cognitive Abnormalities | Lotus seedpod procyanidins | Associated | 4.0 (Moderate) | 25066354 | |
acc3818 | JNK | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Cognitive Abnormalities | Lotus seedpod procyanidins | Associated | 4.0 (Moderate) | 25066354 | |
acc3819 | JNK | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Cognitive Abnormalities | Lotus seedpod procyanidins | Associated | 4.0 (Moderate) | 25066354 | |
acc3820 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Acute Lung Injury | Rutin | Associated | 4.0 (Moderate) | 25091621 | |
acc3821 | Smad2 | O70436 | Smad2 | phosphorylation | Ser465 | rat | Cardiac Fibrosis | Cardiac fibroblasts | Curcumin | Associated | 4.0 (Moderate) | 25132338 |
acc3822 | Smad2 | O70436 | Smad2 | phosphorylation | Ser467 | rat | Cardiac Fibrosis | Cardiac fibroblasts | Curcumin | Associated | 4.0 (Moderate) | 25132338 |
acc3823 | Smad3 | P84025 | Smad3 | phosphorylation | Ser423 | rat | Cardiac Fibrosis | Cardiac fibroblasts | Curcumin | Associated | 4.0 (Moderate) | 25132338 |
acc3824 | Smad3 | P84025 | Smad3 | phosphorylation | Ser425 | rat | Cardiac Fibrosis | Cardiac fibroblasts | Curcumin | Associated | 4.0 (Moderate) | 25132338 |
acc3830 | Caveolin-1 | P41350 | Cav1 | phosphorylation | Tyr14 | rat | Diabetes Mellitus | Curcumin | Associated | 4.0 (Moderate) | 25196431 | |
acc3831 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Diabetes Mellitus | Lycopene | Associated | 4.0 (Moderate) | 25197372 | |
acc3832 | AMPKalpha | Q5EG47 | Prkaa1 | phosphorylation | Thr172 | mouse | Diabetes Mellitus | "9H-xanthene-9-carboxylic acid {2,2,2-trichloro-1-[3-(3-nitro-phenyl)-thioureido]-ethyl}-amide (Xn)" | Associated | 4.0 (Moderate) | 25250787 | |
acc3833 | AMPKalpha | Q5EG47 | Prkaa1 | phosphorylation | Thr172 | mouse | Diabetes Mellitus | "9H-xanthene-9-carboxylic acid {2,2,2-trichloro-1-[3-(3-cyano-phenyl)-thioureido]-ethyl}-amide (Xc)" | Associated | 4.0 (Moderate) | 25250787 | |
acc3834 | SMAD1 | P70340 | Smad1 | phosphorylation | Ser463 | mouse | Heterotopic Ossification | LDN-193189 | Associated | 4.0 (Moderate) | 25253675 | |
acc3835 | SMAD1 | P70340 | Smad1 | phosphorylation | Ser465 | mouse | Heterotopic Ossification | LDN-193189 | Associated | 4.0 (Moderate) | 25253675 | |
acc3836 | SMAD5 | P97454 | Smad5 | phosphorylation | Ser463 | mouse | Heterotopic Ossification | LDN-193189 | Associated | 4.0 (Moderate) | 25253675 | |
acc3837 | SMAD5 | P97454 | Smad5 | phosphorylation | Ser465 | mouse | Heterotopic Ossification | LDN-193189 | Associated | 4.0 (Moderate) | 25253675 | |
acc3838 | SMAD8 | Q9JIW5 | Smad9 | phosphorylation | Ser465 | mouse | Heterotopic Ossification | LDN-193189 | Associated | 4.0 (Moderate) | 25253675 | |
acc3839 | SMAD8 | Q9JIW5 | Smad9 | phosphorylation | Ser467 | mouse | Heterotopic Ossification | LDN-193189 | Associated | 4.0 (Moderate) | 25253675 | |
acc3840 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Diabetes Mellitus | Gallic acid | Associated | 4.0 (Moderate) | 25445038 | |
acc3841 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | H522、H23、H226 | "5,3'-Dihydroxy-6,7,4'-trimethoxyflavanone (DHTMF)" | Associated | 4.0 (Moderate) | 25446852 |
acc3842 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Lung Cancer | H522、H23、H226 | "5,3'-Dihydroxy-6,7,4'-trimethoxyflavanone (DHTMF)" | Associated | 4.0 (Moderate) | 25446852 |
acc3843 | p70S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Lung Cancer | H522、H23、H226 | "5,3'-Dihydroxy-6,7,4'-trimethoxyflavanone (DHTMF)" | Associated | 4.0 (Moderate) | 25446852 |
acc3844 | TRPV1 | O35433 | Trpv1 | phosphorylation | Ser800 | rat | Mechanical Hyperalgesia | DHPG | Associated | 4.0 (Moderate) | 25451626 | |
acc3846 | ATM | Q62388 | Atm | phosphorylation | Ser1981 | mouse | Fibrosis | UUO model | KU-55933 | Associated | 4.0 (Moderate) | 25480384 |
acc3848 | ATM | D4ACL8 | Atm | phosphorylation | Ser1981 | rat | Fibrosis | HK-2 | KU-55933 | Associated | 4.0 (Moderate) | 25480384 |
acc3850 | ATM | D4ACL8 | Atm | phosphorylation | Ser1981 | rat | Fibrosis | NRK-49F | KU-55933 | Associated | 4.0 (Moderate) | 25480384 |
acc3852 | p53 | P02340 | Tp53 | phosphorylation | Ser15 | mouse | Fibrosis | UUO model | KU-55933 | Associated | 4.0 (Moderate) | 25480384 |
acc3854 | p53 | P10361 | Tp53 | phosphorylation | Ser15 | rat | Fibrosis | HK-2 | KU-55933 | Associated | 4.0 (Moderate) | 25480384 |
acc3856 | p53 | P10361 | Tp53 | phosphorylation | Ser15 | rat | Fibrosis | NRK-49F | KU-55933 | Associated | 4.0 (Moderate) | 25480384 |
acc3859 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser423 | mouse | Fibrosis | UUO model | KU-55933 | Associated | 4.0 (Moderate) | 25480384 |
acc3860 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser425 | mouse | Fibrosis | UUO model | KU-55933 | Associated | 4.0 (Moderate) | 25480384 |
acc3863 | Smad3 | P84025 | Smad3 | phosphorylation | Ser423 | rat | Fibrosis | HK-2 | KU-55933 | Associated | 4.0 (Moderate) | 25480384 |
acc3864 | Smad3 | P84025 | Smad3 | phosphorylation | Ser425 | rat | Fibrosis | NRK-49F | KU-55933 | Associated | 4.0 (Moderate) | 25480384 |
acc3867 | Smad3 | P84025 | Smad3 | phosphorylation | Ser423 | rat | Fibrosis | NRK-49F | KU-55933 | Associated | 4.0 (Moderate) | 25480384 |
acc3868 | Smad3 | P84025 | Smad3 | phosphorylation | Ser425 | rat | Fibrosis | NRK-49F | KU-55933 | Associated | 4.0 (Moderate) | 25480384 |
acc3869 | IRS1 | P35570 | Irs1 | phosphorylation | unclear | rat | Diabetes Mellitus | Nymphayol | Associated | 4.0 (Moderate) | 25499137 | |
acc3870 | AMPKalpha | Q13131 | PRKAA1 | phosphorylation | Thr172 | human | Hepatocellular Carcinoma | HepG2 | Ursolic acid | Associated | 4.0 (Moderate) | 25547067 |
acc3871 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | beta-elemene | Associated | 4.0 (Moderate) | 25598321 | |
acc3872 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Lung Cancer | beta-elemene | Associated | 4.0 (Moderate) | 25598321 | |
acc3873 | AMPKalpha | Q13131 | PRKAA1 | phosphorylation | Thr172 | human | Lung Cancer | beta-elemene | Associated | 4.0 (Moderate) | 25598321 | |
acc3874 | AMPKalpha | Q13131 | PRKAA1 | phosphorylation | Thr172 | human | Lung Cancer | beta-elemene | Associated | 4.0 (Moderate) | 25598321 | |
acc3875 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | beta-elemene | Associated | 4.0 (Moderate) | 25598321 | |
acc3876 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | beta-elemene | Associated | 4.0 (Moderate) | 25598321 | |
acc3877 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Lung Cancer | beta-elemene | Associated | 4.0 (Moderate) | 25598321 | |
acc3878 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Lung Cancer | beta-elemene | Associated | 4.0 (Moderate) | 25598321 | |
acc3879 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | beta-elemene | Associated | 4.0 (Moderate) | 25598321 | |
acc3880 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | beta-elemene | Associated | 4.0 (Moderate) | 25598321 | |
acc3881 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Lung Cancer | beta-elemene | Associated | 4.0 (Moderate) | 25598321 | |
acc3882 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Lung Cancer | beta-elemene | Associated | 4.0 (Moderate) | 25598321 | |
acc3883 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Obesity | Monosodium l-glutamate (MSG) | Associated | 4.0 (Moderate) | 25683673 | |
acc3884 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Obesity | Monosodium l-glutamate (MSG) | Associated | 4.0 (Moderate) | 25683673 | |
acc3885 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr183 | rat | Obesity | Monosodium l-glutamate (MSG) | Associated | 4.0 (Moderate) | 25683673 | |
acc3886 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr185 | rat | Obesity | Monosodium l-glutamate (MSG) | Associated | 4.0 (Moderate) | 25683673 | |
acc3888 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Hypertension | Magnolol | Associated | 4.0 (Moderate) | 25793876 | |
acc3889 | eNOS | Q62600 | Nos3 | phosphorylation | Ser1179 | rat | Hypertension | Magnolol | Associated | 4.0 (Moderate) | 25793876 | |
acc3892 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Hypertension | "ARB, Tempol, PDTC" | Associated | 4.0 (Moderate) | 25928697 | |
acc3893 | IRS1 | P35570 | Irs1 | phosphorylation | Ser612 | rat | Hypertension | "ARB, Tempol, PDTC" | Associated | 4.0 (Moderate) | 25928697 | |
acc3894 | IkappaBalpha | Q63746 | Nfkbia | phosphorylation | Ser32 | rat | Hypertension | "ARB, Tempol, PDTC" | Associated | 4.0 (Moderate) | 25928697 | |
acc3895 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | HepG2 | Palmitate | Associated | 4.0 (Moderate) | 26039731 |
acc3896 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Vascular Dysfunction | Lapatinib | Associated | 4.0 (Moderate) | 26114862 | |
acc3897 | EGFR | A8IP97 | Egfr | phosphorylation | Tyr1068 | rat | Vascular Dysfunction | Lapatinib | Associated | 4.0 (Moderate) | 26114862 | |
acc3898 | eNOS | Q62600 | Nos3 | phosphorylation | Ser1177 | rat | Vascular Dysfunction | Lapatinib | Associated | 4.0 (Moderate) | 26114862 | |
acc3899 | ErbB2 | P06494 | Erbb2 | phosphorylation | Tyr1221 | rat | Vascular Dysfunction | Lapatinib | Associated | 4.0 (Moderate) | 26114862 | |
acc3900 | ErbB2 | P06494 | Erbb2 | phosphorylation | Tyr1222 | rat | Vascular Dysfunction | Lapatinib | Associated | 4.0 (Moderate) | 26114862 | |
acc3901 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Vascular Dysfunction | Lapatinib | Associated | 4.0 (Moderate) | 26114862 | |
acc3902 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Vascular Dysfunction | Lapatinib | Associated | 4.0 (Moderate) | 26114862 | |
acc3903 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Vascular Dysfunction | Lapatinib | Associated | 4.0 (Moderate) | 26114862 | |
acc3904 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Vascular Dysfunction | Lapatinib | Associated | 4.0 (Moderate) | 26114862 | |
acc3905 | FOXO3a | D3ZBQ1 | Foxo3 | phosphorylation | Ser253 | rat | Vascular Dysfunction | Lapatinib | Associated | 4.0 (Moderate) | 26114862 | |
acc3906 | IkappaBalpha | Q63746 | Nfkbia | phosphorylation | unclear | rat | Vascular Dysfunction | Lapatinib | Associated | 4.0 (Moderate) | 26114862 | |
acc3907 | ROCK2 | Q62868 | Rock2 | phosphorylation | Tyr256 | rat | Vascular Dysfunction | Lapatinib | Associated | 4.0 (Moderate) | 26114862 | |
acc3908 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Diabetes Mellitus | Irisin | Associated | 4.0 (Moderate) | 26201094 | |
acc3909 | GSK3 | Q2NL51 | Gsk3a | phosphorylation | Ser9 | mouse | Diabetes Mellitus | Irisin | Associated | 4.0 (Moderate) | 26201094 | |
acc3910 | GS | Q9Z1E4 | Gys1 | phosphorylation | Ser641 | mouse | Diabetes Mellitus | Irisin | Associated | 4.0 (Moderate) | 26201094 | |
acc3911 | eNOS | P70313 | Nos3 | phosphorylation | Ser1177 | mouse | Diabetes Mellitus | l-arginine | Associated | 4.0 (Moderate) | 26214584 | |
acc3912 | eNOS | P70313 | Nos3 | phosphorylation | Ser1177 | mouse | Diabetes Mellitus | Sepiapterin | Associated | 4.0 (Moderate) | 26214584 | |
acc3913 | eNOS | P70313 | Nos3 | phosphorylation | Ser1177 | mouse | Diabetes Mellitus | Salsalate | Associated | 4.0 (Moderate) | 26214584 | |
acc3914 | RIP3 | Q9Y572 | RIPK3 | S-nitrosylation | Cys119 | human | Neuronal Damage | SH-SY5Y | MK801 | Associated | 4.0 (Moderate) | 26319693 |
acc3915 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Haemorrhagic Shock | Huh7 | VPA | Associated | 4.0 (Moderate) | 26333042 |
acc3916 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Haemorrhagic Shock | Huh7 | VPA | Associated | 4.0 (Moderate) | 26333042 |
acc3917 | PTEN | P60484 | PTEN | phosphorylation | Ser380 | human | Haemorrhagic Shock | Huh7 | VPA | Associated | 4.0 (Moderate) | 26333042 |
acc3918 | PTEN | P60484 | PTEN | phosphorylation | Thr382 | human | Haemorrhagic Shock | Huh7 | VPA | Associated | 4.0 (Moderate) | 26333042 |
acc3919 | PTEN | P60484 | PTEN | phosphorylation | Ser383 | human | Haemorrhagic Shock | Huh7 | VPA | Associated | 4.0 (Moderate) | 26333042 |
acc3921 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Breast Cancer | MK-2206 | Associated | 4.0 (Moderate) | 26351323 | |
acc3922 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Breast Cancer | AZD5363 | Associated | 4.0 (Moderate) | 26351323 | |
acc3923 | GSK3beta | P18266 | Gsk3b | phosphorylation | Ser9 | rat | Myocardial I/R Injury | Remifentanil | Associated | 4.0 (Moderate) | 26468894 | |
acc3924 | STAT3 | P52631 | Stat3 | phosphorylation | Tyr705 | rat | Myocardial I/R Injury | Remifentanil | Associated | 4.0 (Moderate) | 26468894 | |
acc3925 | eNOS | Q62600 | Nos3 | phosphorylation | Ser1177 | rat | Ischemia | Ang-(1-7) | Associated | 4.0 (Moderate) | 26519026 | |
acc3926 | Drp1 | Q8K1M6 | Dnm1l | phosphorylation | Ser616 | mouse | Mitochondrial Dysfunction | Fasudil | Associated | 4.0 (Moderate) | 26602979 | |
acc3927 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Myocardial I/R Injury | BpV | Associated | 4.0 (Moderate) | 26666444 | |
acc3928 | GSK3beta | P18266 | Gsk3b | phosphorylation | Ser9 | rat | Myocardial I/R Injury | BpV | Associated | 4.0 (Moderate) | 26666444 | |
acc3929 | PTEN | O54857 | Pten | phosphorylation | Ser380 | rat | Myocardial I/R Injury | BpV | Associated | 4.0 (Moderate) | 26666444 | |
acc3930 | PTEN | O54857 | Pten | phosphorylation | Thr382 | rat | Myocardial I/R Injury | BpV | Associated | 4.0 (Moderate) | 26666444 | |
acc3931 | PTEN | O54857 | Pten | phosphorylation | Thr383 | rat | Myocardial I/R Injury | BpV | Associated | 4.0 (Moderate) | 26666444 | |
acc3932 | STAT3 | P52631 | Stat3 | phosphorylation | Tyr705 | rat | Myocardial I/R Injury | BpV | Associated | 4.0 (Moderate) | 26666444 | |
acc3933 | EGFR | A8IP97 | Egfr | phosphorylation | Tyr1068 | rat | Peritoneal Fibrosis | Gefitinib | Associated | 4.0 (Moderate) | 26677863 | |
acc3934 | Smad3 | P84025 | Smad3 | phosphorylation | Ser423 | rat | Peritoneal Fibrosis | Gefitinib | Associated | 4.0 (Moderate) | 26677863 | |
acc3935 | Smad3 | P84025 | Smad3 | phosphorylation | Ser425 | rat | Peritoneal Fibrosis | Gefitinib | Associated | 4.0 (Moderate) | 26677863 | |
acc3936 | STAT3 | P52631 | Stat3 | phosphorylation | Tyr705 | rat | Peritoneal Fibrosis | Gefitinib | Associated | 4.0 (Moderate) | 26677863 | |
acc3937 | STAT1 | P42225 | Stat1 | phosphorylation | Tyr701 | mouse | Corneal Stroma | Tofacitinib | Associated | 4.0 (Moderate) | 26689752 | |
acc3938 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Insulin Resistance | FAO | Rapamycin | Associated | 4.0 (Moderate) | 26733005 |
acc3939 | Akt | P47196 | Akt1 | phosphorylation | Thr308 | rat | Insulin Resistance | FAO | Rapamycin | Associated | 4.0 (Moderate) | 26733005 |
acc4252 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Hepatic Steatosis | HepG2 | PCW | Associated | 4.0 (Moderate) | 31569635 |
acc4253 | p70S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Hepatic Steatosis | HepG2 | PCW | Associated | 4.0 (Moderate) | 31569635 |
acc4254 | SREBP1c | P36956 | SREBF1 | phosphorylation | Ser372 | human | Hepatic Steatosis | HepG2 | PCW | Associated | 4.0 (Moderate) | 31569635 |
acc4255 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | Diabetes Mellitus | Betaine | Associated | 4.0 (Moderate) | 31585299 | |
acc4256 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | Diabetes Mellitus | Betaine | Associated | 4.0 (Moderate) | 31585299 | |
acc4257 | FAK | Q05397 | PTK2 | phosphorylation | Tyr397 | human | Mucosal Ulcer | Caco-2 | ZINC40099027 | Associated | 4.0 (Moderate) | 31604999 |
acc4258 | FAK | P34152 | Ptk2 | phosphorylation | Tyr397 | mouse | Mucosal Ulcer | ZINC40099027 | Associated | 4.0 (Moderate) | 31604999 | |
acc4259 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Pregnancy-Associated Cardiomyopathy | LCZ696 | Associated | 4.0 (Moderate) | 31649814 | |
acc4261 | GSK3alpha | Q2NL51 | Gsk3a | phosphorylation | Ser21 | mouse | Myopathic Conditions | C2C12 | Lithium | Associated | 4.0 (Moderate) | 31671858 |
acc4262 | GSK3beta | Q9WV60 | Gsk3b | phosphorylation | Ser9 | mouse | Myopathic Conditions | C2C12 | Lithium | Associated | 4.0 (Moderate) | 31671858 |
acc4263 | FOXO3a | O43524 | FOXO3 | phosphorylation | Ser253 | human | Polycystic Ovarian Syndrome | Berberine | Enhancing | 4.0 (Moderate) | 31706105 | |
acc4264 | SIRT3 | Q9NTG7 | SIRT3 | ubiquitination | unclear | human | Polycystic Ovarian Syndrome | Berberine | Enhancing | 4.0 (Moderate) | 31706105 | |
acc4265 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Diabetes Mellitus | RAPA | Associated | 4.0 (Moderate) | 31738412 | |
acc4267 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Cardiac Damage | H9c2 | Metformin+N-Acetyl Cysteine | Associated | 4.0 (Moderate) | 31766382 |
acc4268 | AMPK | P54645 | Prkaa1 | phosphorylation | Thr183 | rat | Cardiac Damage | H9c2 | Metformin+N-Acetyl Cysteine | Associated | 4.0 (Moderate) | 31766382 |
acc4269 | AMPK | Q09137 | Prkaa2 | phosphorylation | Thr172 | rat | Cardiac Damage | H9c2 | Metformin+N-Acetyl Cysteine | Associated | 4.0 (Moderate) | 31766382 |
acc4270 | Drp1 | Q8K1M6 | Dnm1l | phosphorylation | Ser616 | mouse | Obese | Quercetin | Associated | 4.0 (Moderate) | 31781748 | |
acc4272 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Atopic Dermatitis | HaCaT | "7,3',4'-trihydroxyisoflavone" | Associated | 4.0 (Moderate) | 31853913 |
acc4273 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Atopic Dermatitis | HaCaT | "7,3',4'-trihydroxyisoflavone" | Associated | 4.0 (Moderate) | 31853913 |
acc4274 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Atopic Dermatitis | HaCaT | "7,3',4'-trihydroxyisoflavone" | Associated | 4.0 (Moderate) | 31853913 |
acc4275 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Atopic Dermatitis | HaCaT | "7,3',4'-trihydroxyisoflavone" | Associated | 4.0 (Moderate) | 31853913 |
acc4276 | JNK1 | P45983 | MAPK8 | phosphorylation | Thr183 | human | Atopic Dermatitis | HaCaT | "7,3',4'-trihydroxyisoflavone" | Associated | 4.0 (Moderate) | 31853913 |
acc4277 | JNK1 | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Atopic Dermatitis | HaCaT | "7,3',4'-trihydroxyisoflavone" | Associated | 4.0 (Moderate) | 31853913 |
acc4278 | JNK2 | P45984 | MAPK9 | phosphorylation | Thr183 | human | Atopic Dermatitis | HaCaT | "7,3',4'-trihydroxyisoflavone" | Associated | 4.0 (Moderate) | 31853913 |
acc4279 | JNK2 | P45984 | MAPK9 | phosphorylation | Tyr185 | human | Atopic Dermatitis | HaCaT | "7,3',4'-trihydroxyisoflavone" | Associated | 4.0 (Moderate) | 31853913 |
acc4281 | GR | P06536 | Nr3c1 | phosphorylation | Ser246 | rat | Depression | SP600125 | Associated | 4.0 (Moderate) | 31901732 | |
acc4282 | JNK | P49185 | Mapk8 | phosphorylation | Thr183 | rat | Depression | SP600125 | Associated | 4.0 (Moderate) | 31901732 | |
acc4283 | JNK | P49185 | Mapk8 | phosphorylation | Tyr185 | rat | Depression | SP600125 | Associated | 4.0 (Moderate) | 31901732 | |
acc4288 | eIF2alpha | Q8BJW6 | Eif2a | phosphorylation | Ser51 | mouse | Prion Diseases | RML-ScCAD5 | Sephin1 | Associated | 4.0 (Moderate) | 31981074 |
acc4289 | eIF2alpha | Q8BJW6 | Eif2a | phosphorylation | Ser51 | mouse | Prion Diseases | N2a | Sephin1 | Associated | 4.0 (Moderate) | 31981074 |
acc4290 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Breast Cancer | MCF-7 | Brc-A | Associated | 4.0 (Moderate) | 32021288 |
acc4291 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Breast Cancer | MCF-7 | Brc-A | Associated | 4.0 (Moderate) | 32021288 |
acc4292 | Src | P12931 | SRC | phosphorylation | unclear | human | Breast Cancer | MCF-7 | Brc-A | Associated | 4.0 (Moderate) | 32021288 |
acc4293 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Melanoma | A375 | TM | Associated | 4.0 (Moderate) | 32085796 |
acc4294 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Melanoma | RPMI | TM | Associated | 4.0 (Moderate) | 32085796 |
acc4295 | S6 | P62753 | RPS6 | phosphorylation | Ser235 | human | Melanoma | SH4 | TM | Associated | 4.0 (Moderate) | 32085796 |
acc4296 | STAT3 | P52631 | Stat3 | phosphorylation | Tyr705 | rat | Acute Lung Injury | HSPH1 inhibitor(KNK437) | Associated | 4.0 (Moderate) | 32091104 | |
acc4297 | Akt | P31750 | Akt1 | phosphorylation | Thr308 | mouse | Alzheimer's Disease | Maslinic acid | Associated | 4.0 (Moderate) | 32133639 | |
acc4298 | CREB | Q01147 | Creb1 | phosphorylation | Ser133 | mouse | Alzheimer's Disease | Maslinic acid | Associated | 4.0 (Moderate) | 32133639 | |
acc4299 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Alzheimer's Disease | Maslinic acid | Associated | 4.0 (Moderate) | 32133639 | |
acc4300 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Alzheimer's Disease | Maslinic acid | Associated | 4.0 (Moderate) | 32133639 | |
acc4301 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Alzheimer's Disease | Maslinic acid | Associated | 4.0 (Moderate) | 32133639 | |
acc4302 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Alzheimer's Disease | Maslinic acid | Associated | 4.0 (Moderate) | 32133639 | |
acc4303 | PI3K | P42337 | Pik3ca | phosphorylation | Tyr199 | mouse | Alzheimer's Disease | Maslinic acid | Associated | 4.0 (Moderate) | 32133639 | |
acc4306 | JAK2 | G1TCI4 | JAK2 | phosphorylation | Tyr1007 | rabbit | Atherosclerosis | Ruxolitinib | Associated | 4.0 (Moderate) | 32169038 | |
acc4307 | JAK2 | G1TCI4 | JAK2 | phosphorylation | Tyr1008 | rabbit | Atherosclerosis | Ruxolitinib | Associated | 4.0 (Moderate) | 32169038 | |
acc4308 | STAT3 | G1T0H3 | STAT3 | phosphorylation | Tyr705 | rabbit | Atherosclerosis | Ruxolitinib | Associated | 4.0 (Moderate) | 32169038 | |
acc4309 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | High-Fat Diet | MC-IXC | Chloroform fraction from Actinidia arguta | Associated | 4.0 (Moderate) | 32238886 |
acc4310 | IRS1 | P35569 | Irs1 | phosphorylation | Ser307 | mouse | High-Fat Diet | MC-IXC | Chloroform fraction from Actinidia arguta | Associated | 4.0 (Moderate) | 32238886 |
acc4311 | JNK1 | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | High-Fat Diet | MC-IXC | Chloroform fraction from Actinidia arguta | Associated | 4.0 (Moderate) | 32238886 |
acc4312 | JNK1 | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | High-Fat Diet | MC-IXC | Chloroform fraction from Actinidia arguta | Associated | 4.0 (Moderate) | 32238886 |
acc4313 | Smad3 | P84025 | Smad3 | phosphorylation | Ser423 | rat | Diabetes Mellitus | HC067047 | Associated | 4.0 (Moderate) | 32274619 | |
acc4314 | Smad3 | P84025 | Smad3 | phosphorylation | Ser425 | rat | Diabetes Mellitus | HC067047 | Associated | 4.0 (Moderate) | 32274619 | |
acc4315 | eNOS | P70313 | Nos3 | phosphorylation | ser1177 | mouse | Atherosclerosis | Dihydromyricetin | Associated | 4.0 (Moderate) | 32301289 | |
acc4317 | SNAP-25 | P60880 | Snap25 | phosphorylation | Ser187 | mouse | Epilepsy | BRV | Associated | 4.0 (Moderate) | 32407277 | |
acc4318 | JNK | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Diabetes Mellitus | Melatonin | Associated | 4.0 (Moderate) | 32411318 | |
acc4319 | JNK | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Diabetes Mellitus | Melatonin | Associated | 4.0 (Moderate) | 32411318 | |
acc4320 | Titin | Q8WZ42 | TTN | phosphorylation | Ser4010 | human | Heart Failure | sGC stimulator | Associated | 4.0 (Moderate) | 32523538 | |
acc4321 | Titin | Q8WZ42 | TTN | phosphorylation | Ser4099 | human | Heart Failure | sGC stimulator | Associated | 4.0 (Moderate) | 32523538 | |
acc4322 | Titin | A0A8I5ZUN3 | Ttn | phosphorylation | Ser3991 | rat | Heart Failure | sGC stimulator | Associated | 4.0 (Moderate) | 32523538 | |
acc4323 | Titin | A0A8I5ZUN3 | Ttn | phosphorylation | Ser4043 | rat | Heart Failure | sGC stimulator | Associated | 4.0 (Moderate) | 32523538 | |
acc4324 | Titin | A0A8I5ZUN3 | Ttn | phosphorylation | Ser4080 | rat | Heart Failure | sGC stimulator | Associated | 4.0 (Moderate) | 32523538 | |
acc4325 | Titin | A0A8I5ZUN3 | Ttn | phosphorylation | Ser12742 | rat | Heart Failure | sGC stimulator | Associated | 4.0 (Moderate) | 32523538 | |
acc4326 | Titin | A0A8I5ZUN3 | Ttn | phosphorylation | Ser12884 | rat | Heart Failure | sGC stimulator | Associated | 4.0 (Moderate) | 32523538 | |
acc4327 | STAT5 | P42230 | "Stat5a," | phosphorylation | unclear | mouse | Myeloproliferative Disease | Fedratinib | Associated | 4.0 (Moderate) | 32647323 | |
acc4328 | eNOS | P29474 | NOS3 | phosphorylation | Tyr81 | human | Diabetes Mellitus | AKB-9778 | Associated | 4.0 (Moderate) | 32653904 | |
acc4329 | eNOS | P29474 | NOS3 | phosphorylation | Ser1177 | human | Diabetes Mellitus | AKB-9778 | Associated | 4.0 (Moderate) | 32653904 | |
acc4330 | eNOS | P70313 | Nos3 | phosphorylation | Tyr80 | mouse | Diabetes Mellitus | AKB-9778 | Associated | 4.0 (Moderate) | 32653904 | |
acc4331 | eNOS | P70313 | Nos3 | phosphorylation | Ser1176 | mouse | Diabetes Mellitus | AKB-9778 | Associated | 4.0 (Moderate) | 32653904 | |
acc4332 | eNOS | P70313 | Nos3 | phosphorylation | Ser1177 | mouse | Diabetes Mellitus | Metoprolol | Associated | 4.0 (Moderate) | 32704438 | |
acc4333 | JAK2 | Q62120 | Jak2 | phosphorylation | unclear | mouse | Colitis | TAK-242 | Associated | 4.0 (Moderate) | 32762699 | |
acc4334 | STAT3 | P42227 | Stat3 | phosphorylation | unclear | mouse | Colitis | TAK-242 | Associated | 4.0 (Moderate) | 32762699 | |
acc4335 | PRDX3 | P30048 | PRDX3 | acetylation | unclear | human | Beta-Cell Dysfunction | human beta cells (1.1B4) | Glucose | Associated | 4.0 (Moderate) | 32763411 |
acc4336 | PRDX3 | Q9Z0V6 | Prdx3 | acetylation | unclear | rat | Beta-Cell Dysfunction | rat insulinoma INS-1 cells | Glucose | Associated | 4.0 (Moderate) | 32763411 |
acc4337 | Bcl-2 | P10415 | BCL2 | phosphorylation | Ser70 | human | Lung Cancer | NCI-H460 | Vinorelbine + YL-9 | Associated | 4.0 (Moderate) | 32764382 |
acc4338 | Smad2 | Q15796 | SMAD2 | phosphorylation | unclear | human | Pulmonary Fibrosis | NHLF、DHLF、LL29 | Biochanin-A(BCA) | Impairing | 4.0 (Moderate) | 32781391 |
acc4339 | Smad3 | P84022 | SMAD3 | phosphorylation | unclear | human | Pulmonary Fibrosis | NHLF、DHLF、LL29 | Biochanin-A(BCA) | Impairing | 4.0 (Moderate) | 32781391 |
acc4340 | TGF-beta | P01137 | TGFB1 | phosphorylation | unclear | human | Pulmonary Fibrosis | NHLF、DHLF、LL29 | Biochanin-A(BCA) | Impairing | 4.0 (Moderate) | 32781391 |
acc4341 | Connexin43 | P08050 | Gja1 | phosphorylation | Ser368 | rat | Acute Myocardial Ischaemia and Reperfusion (I-R) | Ursodeoxycholic acid | Associated | 4.0 (Moderate) | 32943714 | |
acc4342 | ERK | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Anxiety | AE-PG | Associated | 4.0 (Moderate) | 33049337 | |
acc4343 | ERK | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Anxiety | AE-PG | Associated | 4.0 (Moderate) | 33049337 | |
acc4344 | ERK | P21708 | Mapk1 | phosphorylation | Thr185 | rat | Anxiety | AE-PG | Associated | 4.0 (Moderate) | 33049337 | |
acc4345 | ERK | P21708 | Mapk1 | phosphorylation | Tyr187 | rat | Anxiety | AE-PG | Associated | 4.0 (Moderate) | 33049337 | |
acc4346 | PPAR-gamma | O88275 | Pparg | phosphorylation | Ser112 | rat | Anxiety | AE-PG | Associated | 4.0 (Moderate) | 33049337 | |
acc4347 | eNOS | P29474 | NOS3 | phosphorylation | Ser1177 | human | Endothelial Dysfunction | HUVECs | Angiotensin II | Associated | 4.0 (Moderate) | 33162896 |
acc4348 | PP2A | Q15257 | PTPA | phosphorylation | Tyr307 | human | Endothelial Dysfunction | HUVECs | Angiotensin II | Associated | 4.0 (Moderate) | 33162896 |
acc4349 | eNOS | P70313 | Nos3 | phosphorylation | Ser1177 | mouse | Endothelial Dysfunction | Sprague–Dawley rat | Angiotensin II | Associated | 4.0 (Moderate) | 33162896 |
acc4350 | PP2A | P58389 | Ptpa | phosphorylation | Tyr307 | mouse | Endothelial Dysfunction | Sprague–Dawley rat | Angiotensin II | Associated | 4.0 (Moderate) | 33162896 |
acc4351 | Rac1 | P63001 | Rac1 | nitration | Tyr32 | mouse | Acute Lung Injury | NipR2 (nitration inhibitor peptide for the Rho GTPases 2) | Associated | 4.0 (Moderate) | 33248422 | |
acc4352 | Akt | P31750 | Akt1 | phosphorylation | unclear | mouse | Obesity | CTFV | Associated | 4.0 (Moderate) | 33273564 | |
acc4353 | ERK | Q63844 | Mapk3 | phosphorylation | unclear | mouse | Obesity | CTFV | Associated | 4.0 (Moderate) | 33273564 | |
acc4354 | IRS1 | P35569 | Irs1 | phosphorylation | unclear | mouse | Obesity | CTFV | Associated | 4.0 (Moderate) | 33273564 | |
acc4355 | JNK | Q91Y86 | Mapk8 | phosphorylation | unclear | mouse | Obesity | CTFV | Associated | 4.0 (Moderate) | 33273564 | |
acc4356 | MAPK | P63085 | Mapk1 | phosphorylation | unclear | mouse | Obesity | CTFV | Associated | 4.0 (Moderate) | 33273564 | |
acc4357 | p38 MAPK | P47811 | Mapk14 | phosphorylation | unclear | mouse | Obesity | CTFV | Associated | 4.0 (Moderate) | 33273564 | |
acc4358 | PI3K | P42337 | Pik3ca | phosphorylation | unclear | mouse | Obesity | CTFV | Associated | 4.0 (Moderate) | 33273564 | |
acc4361 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Cervical Cancer | HeLa | SP-FA | Associated | 4.0 (Moderate) | 33357846 |
acc4362 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Cervical Cancer | HeLa | SP-FA | Associated | 4.0 (Moderate) | 33357846 |
acc4363 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Cervical Cancer | HeLa | SP-FA | Associated | 4.0 (Moderate) | 33357846 |
acc4364 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Cervical Cancer | HeLa | SP-FA | Associated | 4.0 (Moderate) | 33357846 |
acc4365 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Cervical Cancer | HeLa | SP-FA | Associated | 4.0 (Moderate) | 33357846 |
acc4366 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Cervical Cancer | HeLa | SP-FA | Associated | 4.0 (Moderate) | 33357846 |
acc4367 | ERK | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Colonic Hypersensitivity | Linaclotide | Associated | 4.0 (Moderate) | 33373484 | |
acc4368 | ERK | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Colonic Hypersensitivity | Linaclotide | Associated | 4.0 (Moderate) | 33373484 | |
acc4369 | ERK | P21708 | Mapk1 | phosphorylation | Thr185 | rat | Colonic Hypersensitivity | Linaclotide | Associated | 4.0 (Moderate) | 33373484 | |
acc4370 | ERK | P21708 | Mapk1 | phosphorylation | Tyr187 | rat | Colonic Hypersensitivity | Linaclotide | Associated | 4.0 (Moderate) | 33373484 | |
acc4378 | PGC1alpha | Q9QYK2 | Ppargc1a | acetylation | Lys | rat | Cardiac and Neurological Injuries | H9c2 | Ginsenoside Rc | Associated | 4.0 (Moderate) | 33439015 |
acc4379 | PGC1alpha | Q9QYK2 | Ppargc1a | acetylation | Lys | rat | Cardiac and Neurological Injuries | PC12 | Ginsenoside Rc | Associated | 4.0 (Moderate) | 33439015 |
acc4380 | IkappaBalpha | Q9Z1E3 | Nfkbia | phosphorylation | Ser32 | mouse | Colitis | Coptisine | Associated | 4.0 (Moderate) | 33508280 | |
acc4381 | IkappaBalpha | Q9Z1E3 | Nfkbia | phosphorylation | Ser36 | mouse | Colitis | Coptisine | Associated | 4.0 (Moderate) | 33508280 | |
acc4382 | HSP27 | P42930 | Hspb1 | phosphorylation | Ser85 | rat | Cerebral Ischemia | Wistar rat | Geranylgeranylacetone | Associated | 4.0 (Moderate) | 33557752 |
acc4383 | HMGB1 | P63159 | Hmgb1 | acetylation | Lys12 | rat | Hyperoxic Lung Injury | KYC | Associated | 4.0 (Moderate) | 33607217 | |
acc4384 | MPO | D3ZGE2 | Mpo | oxidation | unclear | rat | Hyperoxic Lung Injury | KYC | Associated | 4.0 (Moderate) | 33607217 | |
acc4385 | Keap1 | P57790 | Keap1 | S-glutathionylation | unclear | rat | Hyperoxic Lung Injury | KYC | Associated | 4.0 (Moderate) | 33607217 | |
acc4386 | HMGB1 | P63159 | Hmgb1 | thiylation | unclear | rat | Hyperoxic Lung Injury | KYC | Associated | 4.0 (Moderate) | 33607217 | |
acc4387 | Keap1 | P57790 | Keap1 | thiylation | unclear | rat | Hyperoxic Lung Injury | KYC | Associated | 4.0 (Moderate) | 33607217 | |
acc4388 | EGFR | Q01279 | Egfr | phosphorylation | Tyr1173 | mouse | Renal Fibrosis | Nintedanib + Gefitinib | Associated | 4.0 (Moderate) | 33614732 | |
acc4389 | EGFR | A8IP97 | Egfr | phosphorylation | Tyr1173 | rat | Renal Fibrosis | NRK-44F | Nintedanib + Gefitinib | Associated | 4.0 (Moderate) | 33614732 |
acc4390 | NF-kappaB p65 | Q04207 | Rela | phosphorylation | Ser536 | mouse | Renal Fibrosis | Nintedanib + Gefitinib | Associated | 4.0 (Moderate) | 33614732 | |
acc4391 | NF-kappaB p65 | Q7TQN4 | Rela | phosphorylation | Ser536 | rat | Renal Fibrosis | NRK-49F | Nintedanib + Gefitinib | Associated | 4.0 (Moderate) | 33614732 |
acc4392 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser423 | mouse | Renal Fibrosis | Nintedanib + Gefitinib | Associated | 4.0 (Moderate) | 33614732 | |
acc4393 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser425 | mouse | Renal Fibrosis | Nintedanib + Gefitinib | Associated | 4.0 (Moderate) | 33614732 | |
acc4394 | Smad3 | P84025 | Smad3 | phosphorylation | Ser423 | rat | Renal Fibrosis | NRK-46F | Nintedanib + Gefitinib | Associated | 4.0 (Moderate) | 33614732 |
acc4395 | Smad3 | P84025 | Smad3 | phosphorylation | Ser425 | rat | Renal Fibrosis | NRK-47F | Nintedanib + Gefitinib | Associated | 4.0 (Moderate) | 33614732 |
acc4396 | Src | P05480 | Src | phosphorylation | Tyr416 | mouse | Renal Fibrosis | Nintedanib + Gefitinib | Associated | 4.0 (Moderate) | 33614732 | |
acc4397 | Src | Q9WUD9 | Src | phosphorylation | Tyr416 | rat | Renal Fibrosis | NRK-45F | Nintedanib + Gefitinib | Associated | 4.0 (Moderate) | 33614732 |
acc4398 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Renal Fibrosis | Nintedanib + Gefitinib | Associated | 4.0 (Moderate) | 33614732 | |
acc4399 | STAT3 | P52631 | Stat3 | phosphorylation | Tyr705 | rat | Renal Fibrosis | NRK-48F | Nintedanib + Gefitinib | Associated | 4.0 (Moderate) | 33614732 |
acc4400 | STAT3 | P52631 | Stat3 | acetylation | Lys685 | rat | Ocular Hypertension | SNC-121 | Associated | 4.0 (Moderate) | 33628191 | |
acc4401 | STAT3 | P52631 | Stat3 | acetylation | Lys686 | rat | Glaucomatous Injury | SNC-121 | Associated | 4.0 (Moderate) | 33628191 | |
acc4402 | STAT3 | P52631 | Stat3 | phosphorylation | Tyr705 | rat | Ocular Hypertension | SNC-121 | Associated | 4.0 (Moderate) | 33628191 | |
acc4403 | STAT3 | P52631 | Stat3 | phosphorylation | Tyr705 | rat | Glaucomatous Injury | SNC-121 | Associated | 4.0 (Moderate) | 33628191 | |
acc4404 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Colitis | 15d-PGJ2 | Associated | 4.0 (Moderate) | 33633749 | |
acc4405 | Smad3 | Q8BUN5 | Smad3 | acetylation | Lys | mouse | Cardiac Fibrosis | Isoproterenol | Associated | 4.0 (Moderate) | 33675899 | |
acc4407 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | Bel-7402 | CYH33 + AL3810 | Associated | 4.0 (Moderate) | 33785733 |
acc4408 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | Huh7 | CYH33 + AL3810 | Associated | 4.0 (Moderate) | 33785733 |
acc4409 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | JHH7 | CYH33 + AL3810 | Associated | 4.0 (Moderate) | 33785733 |
acc4410 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hepatocellular Carcinoma | SMMC-7721 | CYH33 + AL3810 | Associated | 4.0 (Moderate) | 33785733 |
acc4411 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Fatty Liver Disease | OBB | Associated | 4.0 (Moderate) | 33831691 | |
acc4412 | Akt | P31750 | Akt1 | phosphorylation | Thr308 | mouse | Fatty Liver Disease | OBB | Associated | 4.0 (Moderate) | 33831691 | |
acc4413 | GSK3beta | Q9WV60 | Gsk3b | phosphorylation | Ser9 | mouse | Fatty Liver Disease | OBB | Associated | 4.0 (Moderate) | 33831691 | |
acc4414 | IRS1 | P35569 | Irs1 | phosphorylation | Ser1101 | mouse | Fatty Liver Disease | OBB | Associated | 4.0 (Moderate) | 33831691 | |
acc4415 | Creb1 | Q01147 | Creb1 | phosphorylation | Ser133 | mouse | Hypoglycemia | Glucose | Associated | 4.0 (Moderate) | 33883213 | |
acc4416 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Cognitive Abnormalities | IGF-1 | Associated | 4.0 (Moderate) | 33949883 | |
acc4417 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser204 | mouse | Diabetes Mellitus | Dapagliflozin | Associated | 4.0 (Moderate) | 34003249 | |
acc4418 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Subarachnoid Hemorrhage | Hydrogen gas | Associated | 4.0 (Moderate) | 34149882 | |
acc4419 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Subarachnoid Hemorrhage | Hydrogen gas | Associated | 4.0 (Moderate) | 34149882 | |
acc4420 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Subarachnoid Hemorrhage | Hydrogen gas | Associated | 4.0 (Moderate) | 34149882 | |
acc4421 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Subarachnoid Hemorrhage | Hydrogen gas | Associated | 4.0 (Moderate) | 34149882 | |
acc4422 | p38 | P70618 | Mapk14 | phosphorylation | Thr180 | rat | Subarachnoid Hemorrhage | Hydrogen gas | Associated | 4.0 (Moderate) | 34149882 | |
acc4423 | p38 | P70618 | Mapk14 | phosphorylation | Tyr182 | rat | Subarachnoid Hemorrhage | Hydrogen gas | Associated | 4.0 (Moderate) | 34149882 | |
acc4426 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Plasmalogen Deficiency | TDG | Associated | 4.0 (Moderate) | 34302896 | |
acc4427 | Akt | P31750 | Akt1 | phosphorylation | Thr308 | mouse | Plasmalogen Deficiency | TDG | Associated | 4.0 (Moderate) | 34302896 | |
acc4428 | VGLL4 | Q14135 | VGLL4 | acetylation | unclear | mouse | Pulmonary Hypertension | PASMCs | Resveratrol | Associated | 4.0 (Moderate) | 34314061 |
acc4429 | p65 | Q04207 | Rela | phosphorylation | Ser536 | mouse | Atopic Dermatitis | Gomisin M2 | Associated | 4.0 (Moderate) | 34361560 | |
acc4430 | STAT1 | P42225 | Stat1 | phosphorylation | Tyr701 | mouse | Atopic Dermatitis | Gomisin M2 | Associated | 4.0 (Moderate) | 34361560 | |
acc4431 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Atopic Dermatitis | HaCaT | Rosa davurica Pall. | Associated | 4.0 (Moderate) | 34455178 |
acc4432 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Atopic Dermatitis | HaCaT | Rosa davurica Pall. | Associated | 4.0 (Moderate) | 34455178 |
acc4433 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Atopic Dermatitis | HaCaT | Rosa davurica Pall. | Associated | 4.0 (Moderate) | 34455178 |
acc4434 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Atopic Dermatitis | HaCaT | Rosa davurica Pall. | Associated | 4.0 (Moderate) | 34455178 |
acc4435 | IkappaB | P25963 | NFKBIA | phosphorylation | unclear | human | Atopic Dermatitis | HaCaT | Rosa davurica Pall. | Associated | 4.0 (Moderate) | 34455178 |
acc4436 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Atopic Dermatitis | HaCaT | Rosa davurica Pall. | Associated | 4.0 (Moderate) | 34455178 |
acc4437 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Atopic Dermatitis | HaCaT | Rosa davurica Pall. | Associated | 4.0 (Moderate) | 34455178 |
acc4438 | NF-kappaB p65 | Q04206 | RELA | phosphorylation | unclear | human | Atopic Dermatitis | HaCaT | Rosa davurica Pall. | Associated | 4.0 (Moderate) | 34455178 |
acc4439 | p38 MAPK | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Atopic Dermatitis | HaCaT | Rosa davurica Pall. | Associated | 4.0 (Moderate) | 34455178 |
acc4440 | p38 MAPK | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Atopic Dermatitis | HaCaT | Rosa davurica Pall. | Associated | 4.0 (Moderate) | 34455178 |
acc4441 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Acute Lung Injury | Chalcone derivatives 7w and(or) 7x | Associated | 4.0 (Moderate) | 34480112 | |
acc4442 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Acute Lung Injury | Chalcone derivatives 7w and(or) 7x | Associated | 4.0 (Moderate) | 34480112 | |
acc4443 | JNK1 | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Acute Lung Injury | Chalcone derivatives 7w and(or) 7x | Associated | 4.0 (Moderate) | 34480112 | |
acc4444 | JNK1 | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Acute Lung Injury | Chalcone derivatives 7w and(or) 7x | Associated | 4.0 (Moderate) | 34480112 | |
acc4445 | p38 | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | Acute Lung Injury | Chalcone derivatives 7w and(or) 7x | Associated | 4.0 (Moderate) | 34480112 | |
acc4446 | p38 | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | Acute Lung Injury | Chalcone derivatives 7w and(or) 7x | Associated | 4.0 (Moderate) | 34480112 | |
acc4447 | IL-33 | Q8BVZ5 | Il33 | ubiquitination | unclear | mouse | Asthma | MG149 | Associated | 4.0 (Moderate) | 34493712 | |
acc4448 | IL-33 | Q8BVZ5 | Il33 | acetylation | unclear | mouse | Asthma | MG149 | Associated | 4.0 (Moderate) | 34493712 | |
acc4449 | NF-kappaB p65 | Q04207 | Rela | phosphorylation | Ser468 | mouse | Intestinal Barrier Injury | Morchella importuna Flavones | Associated | 4.0 (Moderate) | 34552579 | |
acc4450 | Nrf2 | Q60795 | Nfe2l2 | phosphorylation | Ser40 | mouse | Intestinal Barrier Injury | Morchella importuna Flavones | Associated | 4.0 (Moderate) | 34552579 | |
acc4451 | ACC | Q5SWU9 | Acaca | phosphorylation | Ser79 | mouse | Metabolic Disease | 18:0 Lyso PC | Associated | 4.0 (Moderate) | 34607170 | |
acc4452 | AMPKalpha | Q5EG47 | Prkaa1 | phosphorylation | Thr172 | mouse | Metabolic Disease | 18:0 Lyso PC | Associated | 4.0 (Moderate) | 34607170 | |
acc4453 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Diabetes Mellitus | Novel Triterpenoids from Cassia fistula | Associated | 4.0 (Moderate) | 34833905 | |
acc4454 | IRS1 | P35570 | Irs1 | phosphorylation | Tyr612 | rat | Diabetes Mellitus | Novel Triterpenoids from Cassia fistula | Associated | 4.0 (Moderate) | 34833905 | |
acc4455 | CypD | Q08752 | PPID | acetylation | unclear | human | Damage In Chondrocytes | Rg3 | Associated | 4.0 (Moderate) | 34943075 | |
acc4456 | Drp1 | Q8K1M6 | Dnm1l | phosphorylation | Tyr628 | mouse | Aortic Valve Calcificatio | VICs | Folic acid | Associated | 4.0 (Moderate) | 35139535 |
acc4457 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Cardiomyopathy | Sunitinib | Associated | 4.0 (Moderate) | 35157045 | |
acc4458 | IkappaBalpha | Q63746 | Nfkbia | phosphorylation | Ser32 | rat | Allergic | "3,4-dihydroxybenzaldehyde (DHB)" | Associated | 4.0 (Moderate) | 35200662 | |
acc4460 | CREB | Q01147 | Creb1 | phosphorylation | Ser133 | mouse | Depression | Naringin | Associated | 4.0 (Moderate) | 35478969 | |
acc4461 | PPAR-gamma | P37238 | Pparg?? | phosphorylation | Ser112 | mouse | Acute Lung Injury | Forsythiae Fructuse | Associated | 4.0 (Moderate) | 35483561 | |
acc4462 | RXR-alpha | P28700 | Rxra | phosphorylation | Ser260 | mouse | Acute Lung Injury | Forsythiae Fructuse | Associated | 4.0 (Moderate) | 35483561 | |
acc4463 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Diabetes Mellitus | P-Cymene | Associated | 4.0 (Moderate) | 35528246 | |
acc4464 | AMPK | P54646 | PRKAA2 | phosphorylation | Thr172 | human | Diabetes Mellitus | Metformin | Associated | 4.0 (Moderate) | 35605453 | |
acc4465 | AMPK | Q13131 | PRKAA1 | phosphorylation | Thr183 | human | Diabetes Mellitus | Metformin | Associated | 4.0 (Moderate) | 35605453 | |
acc4466 | Eralpha | P03372 | ESR1 | phosphorylation | Ser118 | human | Ovarian Endometriosis | Ishikawa cells | E2 | Associated | 4.0 (Moderate) | 35654737 |
acc4467 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Colorectal Cancer | MC38 | Gallic acid | Associated | 4.0 (Moderate) | 35817479 |
acc4468 | Drp1 | Q8K1M6 | Dnm1l | phosphorylation | Ser616 | mouse | Cardiac Dysfunction | Fasudil | Associated | 4.0 (Moderate) | 35865967 | |
acc4470 | albumin | P02768 | ALB | glycosylation | unclear | human | Diabetes Mellitus | HEK–293T | Glucose | Associated | 4.0 (Moderate) | 35987363 |
acc4471 | AMPK | P54646 | PRKAA2 | phosphorylation | Thr172 | human | Endothelial Cell Angiogenic Damage | HUVECs | CoCl2 | Associated | 4.0 (Moderate) | 35994824 |
acc4472 | AMPK | Q13131 | PRKAA1 | phosphorylation | Thr183 | human | Endothelial Cell Angiogenic Damage | HUVECs | CoCl2 | Associated | 4.0 (Moderate) | 35994824 |
acc4473 | PLN | P26678 | PLN | phosphorylation | Ser16 | human | Endothelial Cell Angiogenic Damage | HUVECs | CoCl2 | Associated | 4.0 (Moderate) | 35994824 |
acc4474 | PLN | P26678 | PLN | phosphorylation | Thr17 | human | Endothelial Cell Angiogenic Damage | HUVECs | CoCl2 | Associated | 4.0 (Moderate) | 35994824 |
acc4475 | Smad3 | P84025 | Smad3 | phosphorylation | Ser423 | rat | Cardiac Inflammation and Fibrosis | T2DM rat | Gentiopicroside | Associated | 4.0 (Moderate) | 36037771 |
acc4476 | Smad3 | P84025 | Smad3 | phosphorylation | Ser425 | rat | Cardiac Inflammation and Fibrosis | T2DM rat | Gentiopicroside | Associated | 4.0 (Moderate) | 36037771 |
acc4477 | alpha-synuclein | P37840 | SNCA | phosphorylation | Ser129 | human | Parkinson's Disease | PFE-360 | Associated | 4.0 (Moderate) | 36179692 | |
acc4478 | alpha-synuclein | P37840 | SNCA | phosphorylation | Ser129 | human | Parkinson's Disease | MLi-2 | Associated | 4.0 (Moderate) | 36179692 | |
acc4481 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Metabolic Disease | CHM-273S | Associated | 4.0 (Moderate) | 36297523 | |
acc4482 | Akt | P47196 | Akt1 | phosphorylation | Thr308 | rat | Metabolic Disease | CHM-273S | Associated | 4.0 (Moderate) | 36297523 | |
acc4483 | STAT1 | P42225 | Stat1 | phosphorylation | Tyr701 | mouse | Asthma | PQQ | Associated | 4.0 (Moderate) | 36345503 | |
acc4484 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Asthma | PQQ | Associated | 4.0 (Moderate) | 36345503 | |
acc4485 | STAT4 | P42228 | Stat4 | phosphorylation | Tyr693 | mouse | Asthma | PQQ | Associated | 4.0 (Moderate) | 36345503 | |
acc4486 | STAT6 | P52633 | Stat6 | phosphorylation | Tyr641 | mouse | Asthma | PQQ | Associated | 4.0 (Moderate) | 36345503 | |
acc4487 | p53 | P04637 | TP53 | phosphorylation | Ser46 | human | Cerebral Ischemia-Reperfusion Injury | SH-SY5Y | DhHP-3 | Associated | 4.0 (Moderate) | 36442518 |
acc4488 | p53 | P10361 | Tp53 | phosphorylation | Ser46 | rat | Cerebral Ischemia-Reperfusion Injury | DhHP-3 | Associated | 4.0 (Moderate) | 36442518 | |
acc4489 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Mitochondrial Dysfunction | SH-SY5Y | Gallic acid | Associated | 4.0 (Moderate) | 36563952 |
acc4490 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Mitochondrial Dysfunction | SH-SY5Y | Gallic acid | Associated | 4.0 (Moderate) | 36563952 |
acc4491 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Mitochondrial Dysfunction | SH-SY5Y | Gallic acid | Associated | 4.0 (Moderate) | 36563952 |
acc4492 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Mitochondrial Dysfunction | SH-SY5Y | Gallic acid | Associated | 4.0 (Moderate) | 36563952 |
acc4493 | CaMKII | P11798 | Camk2a | phosphorylation | Thr287 | mouse | Diabetes Mellitus | EMPA | Associated | 4.0 (Moderate) | 36607794 | |
acc4494 | RyR2 | E9Q401 | Ryr2 | phosphorylation | Ser2814 | mouse | Diabetes Mellitus | EMPA | Associated | 4.0 (Moderate) | 36607794 | |
acc4495 | IRS1 | P35569 | Irs1 | phosphorylation | Ser307 | mouse | Metabolic Disease | Platycodon grandiflorus root extract | Associated | 4.0 (Moderate) | 36610135 | |
acc4496 | WNK1 | P83741 | Wnk1 | phosphorylation | Thr58 | mouse | Clostridioides Difficile Infection | c57BL/6J mouse | Genistein | Associated | 4.0 (Moderate) | 36628948 |
acc4497 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Myocardial Injury | Diazoxide | Associated | 4.0 (Moderate) | 36747448 | |
acc4498 | mTOR | P42346 | Mtor | phosphorylation | Ser2448 | rat | Myocardial Injury | Diazoxide | Associated | 4.0 (Moderate) | 36747448 | |
acc4499 | JNK | Q91Y86 | Mapk8 | phosphorylation | unclear | mouse | Cardiac Inflammation | C66 | Associated | 4.0 (Moderate) | 36868294 | |
acc4500 | JNK | P49185 | Mapk8 | phosphorylation | unclear | rat | Cardiac Inflammation | H9C2 | C66 | Associated | 4.0 (Moderate) | 36868294 |
acc4501 | Cav3 | P51637 | Cav3 | nitration | Tyr73 | mouse | Diabetes Mellitus | SIN-1 | Associated | 4.0 (Moderate) | 36883479 | |
acc4502 | ACC | Q5SWU9 | Acaca | phosphorylation | Ser79 | mouse | Hepatic Lipid Accumulation | FL83B | EF-2001 | Associated | 4.0 (Moderate) | 36901915 |
acc4503 | AMPK | Q5EG47 | Prkaa1 | phosphorylation | unclear | mouse | Hepatic Lipid Accumulation | FL83B | EF-2001 | Associated | 4.0 (Moderate) | 36901915 |
acc4504 | p70S6K | P67999 | Rps6kb1 | phosphorylation | Ser389 | rat | Cardiac Hypertrophy | NNVMs | Rapamycin | Associated | 4.0 (Moderate) | 36988388 |
acc4505 | STAT3 | P52631 | Stat3 | phosphorylation | Tyr705 | rat | Neurological Damage | HNK | Associated | 4.0 (Moderate) | 36997099 | |
acc4506 | PPARgamma | P37238 | Pparg | ubiquitination | unclear | mouse | Cardiac Hypertrophy | Luteolin | Associated | 4.0 (Moderate) | 36998980 | |
acc4508 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Diabetes Mellitus | Methylene blue | Associated | 4.0 (Moderate) | 37248837 | |
acc4509 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Diabetes Mellitus | Methylene blue | Associated | 4.0 (Moderate) | 37248837 | |
acc4510 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Diabetes Mellitus | Methylene blue | Associated | 4.0 (Moderate) | 37248837 | |
acc4511 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Diabetes Mellitus | Methylene blue | Associated | 4.0 (Moderate) | 37248837 | |
acc4512 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Diabetes Mellitus | Methylene blue | Associated | 4.0 (Moderate) | 37248837 | |
acc4513 | EGFR | A8IP97 | Egfr | phosphorylation | Tyr1086 | rat | Colitis | Eicosapentaenoic acid (EPA) | Associated | 4.0 (Moderate) | 37263490 | |
acc4514 | p53 | P02340 | Tp53 | acetylation | Lys382 | mouse | Acute Kidney Injury | Baicalein | Associated | 4.0 (Moderate) | 37354967 | |
acc4515 | eIF2alpha | P68101 | Eif2s1 | phosphorylation | Ser51 | rat | Neuronal Injury | ISRIB | Associated | 4.0 (Moderate) | 37410333 | |
acc4516 | NF-kappaB p65 | Q04207 | Rela | phosphorylation | Ser536 | mouse | Colitis | RAW 264.7 | Loganic acid | Associated | 4.0 (Moderate) | 37421777 |
acc4517 | NF-kappaB p65 | Q04207 | Rela | phosphorylation | Ser536 | mouse | Colitis | Caco-2 | Loganic acid | Associated | 4.0 (Moderate) | 37421777 |
acc4518 | eNOS | P29474 | NOS3 | phosphorylation | Ser1177 | human | High Glucose | HUVECs | TEPP-46 | Associated | 4.0 (Moderate) | 37539568 |
acc4519 | eNOS | P70313 | Nos3 | phosphorylation | Ser1177 | mouse | Diabetes Mellitus | TEPP-46 | Associated | 4.0 (Moderate) | 37539568 | |
acc4520 | PKM2 | P14618 | PKM | phosphorylation | Tyr105 | human | High Glucose | HUVECs | TEPP-46 | Associated | 4.0 (Moderate) | 37539568 |
acc4521 | PKM2 | P52480 | Pkm | phosphorylation | Tyr105 | mouse | Diabetes Mellitus | TEPP-46 | Associated | 4.0 (Moderate) | 37539568 | |
acc4522 | PLB | P61014 | Pln | phosphorylation | Thr17 | mouse | Cardiac Dysfunction | Vidarabine | Associated | 4.0 (Moderate) | 37558983 | |
acc4523 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Head-Twitch Response | HEK293T | M100907 + Gallein | Associated | 4.0 (Moderate) | 37657742 |
acc4524 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Head-Twitch Response | HEK293T | M100907 + Gallein | Associated | 4.0 (Moderate) | 37657742 |
acc4525 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Head-Twitch Response | HEK293T | M100907 + Gallein | Associated | 4.0 (Moderate) | 37657742 |
acc4526 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Head-Twitch Response | HEK293T | M100907 + Gallein | Associated | 4.0 (Moderate) | 37657742 |
acc4527 | PLCbeta3 | P51432 | Plcb3 | phosphorylation | Ser537 | mouse | Head-Twitch Response | HEK293T | M100907 + Gallein | Associated | 4.0 (Moderate) | 37657742 |
acc4528 | STAT3 | P42227 | Stat3 | phosphorylation | Ser727 | mouse | Diabetes Mellitus | Melatonin | Associated | 4.0 (Moderate) | 37739161 | |
acc4533 | GSK3beta | Q9WV60 | Gsk3b | phosphorylation | Ser9 | mouse | Melioidosis | Chloroquine+ doxycycline | Associated | 4.0 (Moderate) | 33612800 | |
acc4535 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Psoriasis | Tofacitinib | Associated | 4.0 (Moderate) | 34626614 | |
acc4536 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Psoriasis | Curcumin | Associated | 4.0 (Moderate) | 32114280 | |
acc4537 | STAT3 | P40763 | STAT3 | phosphorylation | Ser727 | human | Psoriasis | Curcumin | Associated | 4.0 (Moderate) | 32114280 | |
acc4538 | STAT3 | P42227 | Stat3 | phosphorylation | unclear | mouse | Psoriasis | A-770041 | Associated | 4.0 (Moderate) | 35576719 | |
acc4539 | GSK3beta | P18266 | Gsk3b | phosphorylation | Ser9 | rat | Psychiatric Disorders | Lithium | Associated | 4.0 (Moderate) | 29449801 | |
acc4540 | beta-catenin | Q9WU82 | Ctnnb1 | phosphorylation | Ser33 | rat | Psychiatric Disorders | Lithium | Associated | 4.0 (Moderate) | 29449801 | |
acc4541 | beta-catenin | Q9WU82 | Ctnnb1 | phosphorylation | Ser37 | rat | Psychiatric Disorders | Lithium | Associated | 4.0 (Moderate) | 29449801 | |
acc4542 | beta-catenin | Q9WU82 | Ctnnb1 | phosphorylation | Thr41 | rat | Psychiatric Disorders | Lithium | Associated | 4.0 (Moderate) | 29449801 | |
acc4543 | eNOS | Q62600 | Nos3 | phosphorylation | Thr495 | rat | Pulmonary Thromboembolism | Geldanamycin | Associated | 4.0 (Moderate) | 18852069 | |
acc4544 | Tau | P19332 | Mapt | phosphorylation | Ser202 | rat | Cognitive Abnormalities | BPV (pic) | Associated | 4.0 (Moderate) | 27836791 | |
acc4545 | Tau | P19332 | Mapt | phosphorylation | Thr205 | rat | Cognitive Abnormalities | BPV (pic) | Associated | 4.0 (Moderate) | 27836791 | |
acc4546 | Tau | P19332 | Mapt | phosphorylation | Ser396 | rat | Cognitive Abnormalities | BPV (pic) | Associated | 4.0 (Moderate) | 27836791 | |
acc4547 | NR2B | Q00960 | Grin2b | phosphorylation | Tyr1472 | rat | Cognitive Abnormalities | BPV (pic) | Associated | 4.0 (Moderate) | 27836791 | |
acc4548 | Akt | P47196 | Akt1 | phosphorylation | Thr308 | rat | Cognitive Abnormalities | BPV (pic) | Associated | 4.0 (Moderate) | 27836791 | |
acc4549 | PTEN | O54857 | Pten | phosphorylation | Ser380 | rat | Cognitive Abnormalities | BPV (pic) | Associated | 4.0 (Moderate) | 27836791 | |
acc4550 | PTEN | O54857 | Pten | phosphorylation | Thr382 | rat | Cognitive Abnormalities | BPV (pic) | Associated | 4.0 (Moderate) | 27836791 | |
acc4551 | PTEN | O54857 | Pten | phosphorylation | Thr383 | rat | Cognitive Abnormalities | BPV (pic) | Associated | 4.0 (Moderate) | 27836791 | |
acc4556 | Akt | P47196 | Akt1 | phosphorylation | Thr308 | rat | Pulmonary Artery Proliferation | KMUP-1 | Associated | 4.0 (Moderate) | 20870034 | |
acc4557 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Pulmonary Artery Proliferation | KMUP-1 | Associated | 4.0 (Moderate) | 20870034 | |
acc4558 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Pulmonary Artery Proliferation | KMUP-1 | Associated | 4.0 (Moderate) | 20870034 | |
acc4559 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Pulmonary Artery Proliferation | KMUP-1 | Associated | 4.0 (Moderate) | 20870034 | |
acc4560 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Pulmonary Artery Proliferation | KMUP-1 | Associated | 4.0 (Moderate) | 20870034 | |
acc4561 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Lung Cancer | U0126 | Associated | 4.0 (Moderate) | 24947959 | |
acc4562 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Lung Cancer | U0126 | Associated | 4.0 (Moderate) | 24947959 | |
acc4563 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Lung Cancer | U0126 | Associated | 4.0 (Moderate) | 24947959 | |
acc4564 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Lung Cancer | U0126 | Associated | 4.0 (Moderate) | 24947959 | |
acc4565 | MERTK | Q12866 | MERTK | phosphorylation | Tyr749 | human | Thrombosis | UNC2025 | Associated | 4.0 (Moderate) | 29045015 | |
acc4566 | MERTK | Q12866 | MERTK | phosphorylation | Tyr753 | human | Thrombosis | UNC2025 | Associated | 4.0 (Moderate) | 29045015 | |
acc4567 | MERTK | Q12866 | MERTK | phosphorylation | Tyr754 | human | Thrombosis | UNC2025 | Associated | 4.0 (Moderate) | 29045015 | |
acc4568 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Thrombosis | UNC2025 | Associated | 4.0 (Moderate) | 29045015 | |
acc4569 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Thrombosis | UNC2025 | Associated | 4.0 (Moderate) | 29045015 | |
acc4570 | Smad2 | Q62432 | Smad2 | phosphorylation | Ser465 | mouse | Pulmonary Hypertension | Fasudil | Associated | 4.0 (Moderate) | 23928001 | |
acc4571 | Smad2 | Q62432 | Smad2 | phosphorylation | Ser467 | mouse | Pulmonary Hypertension | Fasudil | Associated | 4.0 (Moderate) | 23928001 | |
acc4572 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser423 | mouse | Pulmonary Hypertension | Fasudil | Associated | 4.0 (Moderate) | 23928001 | |
acc4573 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser425 | mouse | Pulmonary Hypertension | Fasudil | Associated | 4.0 (Moderate) | 23928001 | |
acc4574 | Smad2 | Q62432 | Smad2 | phosphorylation | Ser465 | mouse | Pulmonary Fibrosis | Fasudil | Associated | 4.0 (Moderate) | 23928001 | |
acc4575 | Smad2 | Q62432 | Smad2 | phosphorylation | Ser467 | mouse | Pulmonary Fibrosis | Fasudil | Associated | 4.0 (Moderate) | 23928001 | |
acc4576 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser423 | mouse | Pulmonary Fibrosis | Fasudil | Associated | 4.0 (Moderate) | 23928001 | |
acc4577 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser425 | mouse | Pulmonary Fibrosis | Fasudil | Associated | 4.0 (Moderate) | 23928001 | |
acc4578 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Pulmonary Hypertension | 17beta-oestradiol | Associated | 4.0 (Moderate) | 22936708 | |
acc4579 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Pulmonary Hypertension | delta-aminolevulinic acid (ALA) | Associated | 4.0 (Moderate) | 25659899 | |
acc4580 | VASP | P70460 | Vasp | phosphorylation | unclear | mouse | Pulmonary Hypertension | delta-aminolevulinic acid (ALA) | Associated | 4.0 (Moderate) | 24920729 | |
acc4581 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Chronic Obstructive Pulmonary Disease | Mahuang-Tang water extract | Associated | 4.0 (Moderate) | 31004880 | |
acc4582 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Chronic Obstructive Pulmonary Disease | Mahuang-Tang water extract | Associated | 4.0 (Moderate) | 31004880 | |
acc4583 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Chronic Obstructive Pulmonary Disease | Mahuang-Tang water extract | Associated | 4.0 (Moderate) | 31004880 | |
acc4584 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Chronic Obstructive Pulmonary Disease | Mahuang-Tang water extract | Associated | 4.0 (Moderate) | 31004880 | |
acc4585 | p70s6k | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Rheumatoid Arthritis | Metformin | Associated | 4.0 (Moderate) | 31028998 | |
acc4586 | 4E-BP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr37 | human | Rheumatoid Arthritis | Metformin | Associated | 4.0 (Moderate) | 31028998 | |
acc4587 | 4E-BP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr46 | human | Rheumatoid Arthritis | Metformin | Associated | 4.0 (Moderate) | 31028998 | |
acc4588 | EGFR | P00533 | EGFR | oxidation | Cys797 | human | Retinoblastoma | Y-79 | Tubeimoside II (TBMS II) | Associated | 4.0 (Moderate) | 33412154 |
acc4589 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Retinoblastoma | Y-79 | Tubeimoside II (TBMS II) | Associated | 4.0 (Moderate) | 33412154 |
acc4590 | VAV2 | P52735 | VAV2 | phosphorylation | Tyr | human | Retinoblastoma | Y-79 | Tubeimoside II (TBMS II) | Associated | 4.0 (Moderate) | 33412154 |
acc4591 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Retinoblastoma | Y-79 | Tubeimoside II (TBMS II) | Associated | 4.0 (Moderate) | 33412154 |
acc4592 | EGFR | P00533 | EGFR | oxidation | Cys797 | human | Retinoblastoma | WERI-Rb-1 | Tubeimoside II (TBMS II) | Associated | 4.0 (Moderate) | 33412154 |
acc4593 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Retinoblastoma | WERI-Rb-1 | Tubeimoside II (TBMS II) | Associated | 4.0 (Moderate) | 33412154 |
acc4594 | VAV2 | P52735 | VAV2 | phosphorylation | Tyr | human | Retinoblastoma | WERI-Rb-1 | Tubeimoside II (TBMS II) | Associated | 4.0 (Moderate) | 33412154 |
acc4595 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Retinoblastoma | WERI-Rb-1 | Tubeimoside II (TBMS II) | Associated | 4.0 (Moderate) | 33412154 |
acc4619 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Nonseptic Shock | Tyrphostin AG-490 | Associated | 4.0 (Moderate) | 18656556 | |
acc4620 | STAT1 | P42225 | Stat1 | phosphorylation | Tyr701 | mouse | Nonseptic Shock | Tyrphostin AG-490 | Associated | 4.0 (Moderate) | 18656556 | |
acc4621 | DDR1 | Q03146 | Ddr1 | phosphorylation | Tyr | mouse | Renal Fibrosis | compound2.45 | Associated | 4.0 (Moderate) | 30452219 | |
acc4622 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Renal Fibrosis | HK-2 | GW4064 | Associated | 4.0 (Moderate) | 31298930 |
acc4623 | YAP | P46937 | YAP1 | phosphorylation | Ser127 | human | Renal Fibrosis | HK-2 | GW4064 | Associated | 4.0 (Moderate) | 31298930 |
acc4624 | Lats1 | O95835 | LATS1 | phosphorylation | Ser909 | human | Renal Fibrosis | HK-2 | GW4064 | Associated | 4.0 (Moderate) | 31298930 |
acc4625 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Renal Fibrosis | HK-2 | PP2 | Associated | 4.0 (Moderate) | 31298930 |
acc4626 | EGFR | P00533 | EGFR | phosphorylation | Tyr845 | human | Renal Fibrosis | HK-2 | PP2 | Associated | 4.0 (Moderate) | 31298930 |
acc4627 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | Renal Fibrosis | Telmisartan | Associated | 4.0 (Moderate) | 21381899 | |
acc4628 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | Renal Fibrosis | Telmisartan | Associated | 4.0 (Moderate) | 21381899 | |
acc4629 | MAPKAPK-2 | P49138 | Mapkapk2 | phosphorylation | unclear | mouse | Renal Fibrosis | Telmisartan | Associated | 4.0 (Moderate) | 21381899 | |
acc4630 | Akt | P31750 | Akt1 | phosphorylation | unclear | mouse | Renal Fibrosis | Telmisartan | Associated | 4.0 (Moderate) | 21381899 | |
acc4631 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser423 | mouse | Renal Fibrosis | BT173 | Associated | 4.0 (Moderate) | 28220029 | |
acc4632 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser425 | mouse | Renal Fibrosis | BT173 | Associated | 4.0 (Moderate) | 28220029 | |
acc4633 | AMPK | Q5EG47 | Prkaa1 | phosphorylation | Thr183 | mouse | Renal Injury | 14(15)-EET | Associated | 4.0 (Moderate) | 30804206 | |
acc4634 | AMPK | Q8BRK8 | Prkaa2 | phosphorylation | Thr172 | mouse | Renal Injury | 14(15)-EET | Associated | 4.0 (Moderate) | 30804206 | |
acc4635 | AMPK | Q5EG47 | Prkaa1 | phosphorylation | Thr183 | mouse | Renal Injury | 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea | Associated | 4.0 (Moderate) | 30804206 | |
acc4636 | AMPK | Q8BRK8 | Prkaa2 | phosphorylation | Thr172 | mouse | Renal Injury | 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea | Associated | 4.0 (Moderate) | 30804206 | |
acc4637 | Pax2 | P32114 | Pax2 | phosphorylation | Ser393 | mouse | Renal Injury | 14(15)-EET | Associated | 4.0 (Moderate) | 30804206 | |
acc4638 | Pax2 | P32114 | Pax2 | phosphorylation | Ser393 | mouse | Renal Injury | 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea | Associated | 4.0 (Moderate) | 30804206 | |
acc4639 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Renal Fibrosis | Resveratrol | Associated | 4.0 (Moderate) | 24976155 | |
acc4640 | STAT3 | P42227 | Stat3 | acetylation | Lys685 | mouse | Renal Fibrosis | Resveratrol | Associated | 4.0 (Moderate) | 24976155 | |
acc4641 | STAT3 | P52631 | Stat3 | phosphorylation | Tyr705 | rat | Renal Fibrosis | NRK-52E | Resveratrol | Associated | 4.0 (Moderate) | 24976155 |
acc4642 | STAT3 | P52631 | Stat3 | acetylation | Lys685 | rat | Renal Fibrosis | NRK-52E | Resveratrol | Associated | 4.0 (Moderate) | 24976155 |
acc4643 | Smad2 | O70436 | Smad2 | phosphorylation | unclear | rat | Cardiorenal Syndrome | G226 | Associated | 4.0 (Moderate) | 32305147 | |
acc4644 | NF-kappaB p65 | Q7TQN4 | Rela | phosphorylation | Ser536 | rat | Renal Injury | Benazepril | Associated | 4.0 (Moderate) | 19018797 | |
acc4645 | VEGFR2 | P35968 | KDR | phosphorylation | Tyr1175 | human | Neovascular Eye Disease | HUVECs | Curcumolide | Associated | 4.0 (Moderate) | 31450226 |
acc4646 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Neovascular Eye Disease | HUVECs | Curcumolide | Associated | 4.0 (Moderate) | 31450226 |
acc4647 | FAK | Q05397 | PTK2 | phosphorylation | Tyr576 | human | Neovascular Eye Disease | HUVECs | Curcumolide | Associated | 4.0 (Moderate) | 31450226 |
acc4648 | FAK | Q05397 | PTK2 | phosphorylation | Tyr577 | human | Neovascular Eye Disease | HUVECs | Curcumolide | Associated | 4.0 (Moderate) | 31450226 |
acc4649 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Neovascular Eye Disease | HUVECs | Curcumolide | Associated | 4.0 (Moderate) | 31450226 |
acc4650 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Neovascular Eye Disease | HUVECs | Curcumolide | Associated | 4.0 (Moderate) | 31450226 |
acc4651 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Neovascular Eye Disease | HUVECs | Curcumolide | Associated | 4.0 (Moderate) | 31450226 |
acc4652 | ERK2 | P28482 | MAPK1 | phosphorylation | Try187 | human | Neovascular Eye Disease | HUVECs | Curcumolide | Associated | 4.0 (Moderate) | 31450226 |
acc4653 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Neovascular Eye Disease | HUVECs | Curcumolide | Associated | 4.0 (Moderate) | 31450226 |
acc4654 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Neovascular Eye Disease | HUVECs | Curcumolide | Associated | 4.0 (Moderate) | 31450226 |
acc4655 | p70S6K | P23443 | RPS6KB1 | phosphorylation | Thr389 | human | Neovascular Eye Disease | HUVECs | Curcumolide | Associated | 4.0 (Moderate) | 31450226 |
acc4659 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Rheumatoid Arthritis | KD025 | Associated | 4.0 (Moderate) | 25385601 | |
acc4660 | STAT5 | P42229 | STAT5A | phosphorylation | Tyr694 | human | Rheumatoid Arthritis | KD025 | Associated | 4.0 (Moderate) | 25385601 | |
acc4661 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Rheumatoid Arthritis | KD025 | Associated | 4.0 (Moderate) | 25385601 | |
acc4662 | STAT5 | P42230 | Stat5a | phosphorylation | Tyr694 | mouse | Rheumatoid Arthritis | KD025 | Associated | 4.0 (Moderate) | 25385601 | |
acc4663 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Rheumatoid Arthritis | Bradykinin | Associated | 4.0 (Moderate) | 28288820 | |
acc4664 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Rheumatoid Arthritis | Bradykinin | Associated | 4.0 (Moderate) | 28288820 | |
acc4665 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Rheumatoid Arthritis | Bradykinin | Associated | 4.0 (Moderate) | 28288820 | |
acc4666 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Rheumatoid Arthritis | Bradykinin | Associated | 4.0 (Moderate) | 28288820 | |
acc4667 | p38 MAPK | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Rheumatoid Arthritis | Bradykinin | Associated | 4.0 (Moderate) | 28288820 | |
acc4668 | p38 MAPK | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Rheumatoid Arthritis | Bradykinin | Associated | 4.0 (Moderate) | 28288820 | |
acc4669 | JNK1 | P45983 | MAPK8 | phosphorylation | Thr183 | human | Rheumatoid Arthritis | Bradykinin | Associated | 4.0 (Moderate) | 28288820 | |
acc4670 | JNK1 | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Rheumatoid Arthritis | Bradykinin | Associated | 4.0 (Moderate) | 28288820 | |
acc4671 | JNK2 | P45984 | MAPK9 | phosphorylation | Thr183 | human | Rheumatoid Arthritis | Bradykinin | Associated | 4.0 (Moderate) | 28288820 | |
acc4672 | JNK2 | P45984 | MAPK9 | phosphorylation | Tyr185 | human | Rheumatoid Arthritis | Bradykinin | Associated | 4.0 (Moderate) | 28288820 | |
acc4673 | PKCmiu | Q15139 | PRKD1 | phosphorylation | Ser744 | human | Rheumatoid Arthritis | Bradykinin | Associated | 4.0 (Moderate) | 28288820 | |
acc4674 | PKCmiu | Q15139 | PRKD1 | phosphorylation | Ser748 | human | Rheumatoid Arthritis | Bradykinin | Associated | 4.0 (Moderate) | 28288820 | |
acc4675 | IkappaBalpha | P25963 | NFKBIA | phosphorylation | Ser32 | human | Rheumatoid Arthritis | Bradykinin | Associated | 4.0 (Moderate) | 28288820 | |
acc4676 | NF-kappaB p65 | Q04206 | RELA | phosphorylation | Ser536 | human | Rheumatoid Arthritis | Bradykinin | Associated | 4.0 (Moderate) | 28288820 | |
acc4677 | c-Jun | P05412 | JUN | phosphorylation | Ser63 | human | Rheumatoid Arthritis | Bradykinin | Associated | 4.0 (Moderate) | 28288820 | |
acc4678 | c-Fos | P01100 | FOS | phosphorylation | unclear | human | Rheumatoid Arthritis | Bradykinin | Associated | 4.0 (Moderate) | 28288820 | |
acc4679 | c-Jun | P05412 | JUN | acetylation | unclear | human | Rheumatoid Arthritis | Resveratrol | Associated | 4.0 (Moderate) | 28288820 | |
acc4680 | c-Fos | P01100 | FOS | acetylation | unclear | human | Rheumatoid Arthritis | Resveratrol | Associated | 4.0 (Moderate) | 28288820 | |
acc4681 | NF-kappaB p65 | Q04206 | RELA | phosphorylation | Ser536 | human | Rheumatoid Arthritis | Resveratrol | Associated | 4.0 (Moderate) | 28288820 | |
acc4682 | c-Jun | P05412 | JUN | phosphorylation | Ser63 | human | Rheumatoid Arthritis | Resveratrol | Associated | 4.0 (Moderate) | 28288820 | |
acc4683 | c-Fos | P01100 | FOS | phosphorylation | unclear | human | Rheumatoid Arthritis | Resveratrol | Associated | 4.0 (Moderate) | 28288820 | |
acc4684 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr701 | human | Rheumatoid Arthritis | Tofacitinib | Associated | 4.0 (Moderate) | 25398374 | |
acc4685 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Rheumatoid Arthritis | Tofacitinib | Associated | 4.0 (Moderate) | 25398374 | |
acc4686 | MLC2 | P08733 | Myl2 | phosphorylation | Ser19 | rat | Subarachnoid Hemorrhage | SNX-482 | Associated | 4.0 (Moderate) | 20568961 | |
acc4687 | EGFR | P00533 | EGFR | phosphorylation | Tyr1068 | human | Salivary Adenoid Cystic Carcinoma | ACC3 | AEE788 | Associated | 4.0 (Moderate) | 17121916 |
acc4688 | VEGFR2 | P35968 | KDR | phosphorylation | Tyr1054 | human | Salivary Adenoid Cystic Carcinoma | ACC3 | AEE788 | Associated | 4.0 (Moderate) | 17121916 |
acc4689 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Salivary Adenoid Cystic Carcinoma | ACC3 | AEE788 | Associated | 4.0 (Moderate) | 17121916 |
acc4690 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Salivary Adenoid Cystic Carcinoma | ACC3 | AEE788 | Associated | 4.0 (Moderate) | 17121916 |
acc4691 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Salivary Adenoid Cystic Carcinoma | ACC3 | AEE788 | Associated | 4.0 (Moderate) | 17121916 |
acc4692 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr202 | human | Salivary Adenoid Cystic Carcinoma | ACC3 | AEE788 | Associated | 4.0 (Moderate) | 17121916 |
acc4693 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr204 | human | Salivary Adenoid Cystic Carcinoma | ACC3 | AEE788 | Associated | 4.0 (Moderate) | 17121916 |
acc4694 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Spinal Cord Injury | PD98059 | Associated | 4.0 (Moderate) | 16513110 | |
acc4695 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Spinal Cord Injury | PD98059 | Associated | 4.0 (Moderate) | 16513110 | |
acc4696 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Spinal Cord Injury | PD98059 | Associated | 4.0 (Moderate) | 16513110 | |
acc4697 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Spinal Cord Injury | PD98059 | Associated | 4.0 (Moderate) | 16513110 | |
acc4698 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Spinal Cord Injury | Ruxolitinib | Associated | 4.0 (Moderate) | 30899259 | |
acc4699 | JNK1 | P49185 | Mapk8 | phosphorylation | Thr183 | rat | Spinal Cord Injury | SP600125 | Associated | 4.0 (Moderate) | 27080425 | |
acc4700 | JNK1 | P49185 | Mapk8 | phosphorylation | Tyr185 | rat | Spinal Cord Injury | SP600125 | Associated | 4.0 (Moderate) | 27080425 | |
acc4701 | JNK2 | P49186 | Mapk9 | phosphorylation | Thr183 | rat | Spinal Cord Injury | SP600125 | Associated | 4.0 (Moderate) | 27080425 | |
acc4702 | JNK2 | P49186 | Mapk9 | phosphorylation | Tyr185 | rat | Spinal Cord Injury | SP600125 | Associated | 4.0 (Moderate) | 27080425 | |
acc4706 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Spinal Cord Injury | bisperoxovanadium (bpV) | Associated | 4.0 (Moderate) | 30672370 | |
acc4707 | Ribosomal protein S6 | P62755 | Rps6 | phosphorylation | Ser235 | rat | Spinal Cord Injury | bisperoxovanadium (bpV) | Associated | 4.0 (Moderate) | 30672370 | |
acc4708 | Ribosomal protein S6 | P62755 | Rps6 | phosphorylation | Ser236 | rat | Spinal Cord Injury | bisperoxovanadium (bpV) | Associated | 4.0 (Moderate) | 30672370 | |
acc4709 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Spinal Cord Injury | bisperoxovanadium (bpV) | Associated | 4.0 (Moderate) | 30672370 | |
acc4710 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Spinal Cord Injury | bisperoxovanadium (bpV) | Associated | 4.0 (Moderate) | 30672370 | |
acc4711 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Spinal Cord Injury | bisperoxovanadium (bpV) | Associated | 4.0 (Moderate) | 30672370 | |
acc4712 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Spinal Cord Injury | bisperoxovanadium (bpV) | Associated | 4.0 (Moderate) | 30672370 | |
acc4713 | PKA | P27791 | Prkaca | phosphorylation | Thr197 | rat | Status Epilepticus | Leptomycin B | Associated | 4.0 (Moderate) | 28601633 | |
acc4714 | PP2B | P63329 | Ppp3ca | phosphorylation | Ser197 | rat | Status Epilepticus | Leptomycin B | Associated | 4.0 (Moderate) | 28601633 | |
acc4715 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Status Epilepticus | Leptomycin B | Associated | 4.0 (Moderate) | 28601633 | |
acc4716 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Status Epilepticus | Leptomycin B | Associated | 4.0 (Moderate) | 28601633 | |
acc4717 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Status Epilepticus | Leptomycin B | Associated | 4.0 (Moderate) | 28601633 | |
acc4718 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Status Epilepticus | Leptomycin B | Associated | 4.0 (Moderate) | 28601633 | |
acc4719 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Status Epilepticus | Leptomycin B + Cyclosporin A | Associated | 4.0 (Moderate) | 28601633 | |
acc4720 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Status Epilepticus | Leptomycin B + Cyclosporin A | Associated | 4.0 (Moderate) | 28601633 | |
acc4721 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Status Epilepticus | Leptomycin B + Cyclosporin A | Associated | 4.0 (Moderate) | 28601633 | |
acc4722 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Status Epilepticus | Leptomycin B + Cyclosporin A | Associated | 4.0 (Moderate) | 28601633 | |
acc4723 | EGFR | Q9WTS1 | Egfr | phosphorylation | Tyr1068 | rat | Spinal Cord Injury | C225 | Associated | 4.0 (Moderate) | 22824323 | |
acc4724 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Spinal Cord Injury | C225 | Associated | 4.0 (Moderate) | 22824323 | |
acc4725 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Spinal Cord Injury | C225 | Associated | 4.0 (Moderate) | 22824323 | |
acc4726 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Spinal Cord Injury | C225 | Associated | 4.0 (Moderate) | 22824323 | |
acc4727 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Spinal Cord Injury | C225 | Associated | 4.0 (Moderate) | 22824323 | |
acc4728 | JNK1 | P49185 | Mapk8 | phosphorylation | Thr183 | rat | Spinal Cord Injury | C225 | Associated | 4.0 (Moderate) | 22824323 | |
acc4729 | JNK1 | P49185 | Mapk8 | phosphorylation | Tyr185 | rat | Spinal Cord Injury | C225 | Associated | 4.0 (Moderate) | 22824323 | |
acc4730 | JNK2 | P49186 | Mapk9 | phosphorylation | Thr183 | rat | Spinal Cord Injury | C225 | Associated | 4.0 (Moderate) | 22824323 | |
acc4731 | JNK2 | P49186 | Mapk9 | phosphorylation | Tyr185 | rat | Spinal Cord Injury | C225 | Associated | 4.0 (Moderate) | 22824323 | |
acc4732 | p38 MAPK | P70618 | Mapk14 | phosphorylation | Thr180 | rat | Spinal Cord Injury | C225 | Associated | 4.0 (Moderate) | 22824323 | |
acc4733 | p38 MAPK | P70618 | Mapk14 | phosphorylation | Tyr182 | rat | Spinal Cord Injury | C225 | Associated | 4.0 (Moderate) | 22824323 | |
acc4734 | EGFR | Q9WTS1 | Egfr | phosphorylation | Tyr1068 | rat | Spinal Cord Injury | AG1478 | Associated | 4.0 (Moderate) | 22824323 | |
acc4735 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Spinal Cord Injury | AG1478 | Associated | 4.0 (Moderate) | 22824323 | |
acc4736 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Spinal Cord Injury | AG1478 | Associated | 4.0 (Moderate) | 22824323 | |
acc4737 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Spinal Cord Injury | AG1478 | Associated | 4.0 (Moderate) | 22824323 | |
acc4738 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Spinal Cord Injury | AG1478 | Associated | 4.0 (Moderate) | 22824323 | |
acc4739 | JNK1 | P49185 | Mapk8 | phosphorylation | Thr183 | rat | Spinal Cord Injury | AG1478 | Associated | 4.0 (Moderate) | 22824323 | |
acc4740 | JNK1 | P49185 | Mapk8 | phosphorylation | Tyr185 | rat | Spinal Cord Injury | AG1478 | Associated | 4.0 (Moderate) | 22824323 | |
acc4741 | JNK2 | P49186 | Mapk9 | phosphorylation | Thr183 | rat | Spinal Cord Injury | AG1478 | Associated | 4.0 (Moderate) | 22824323 | |
acc4742 | JNK2 | P49186 | Mapk9 | phosphorylation | Tyr185 | rat | Spinal Cord Injury | AG1478 | Associated | 4.0 (Moderate) | 22824323 | |
acc4743 | p38 MAPK | P70618 | Mapk14 | phosphorylation | Thr180 | rat | Spinal Cord Injury | AG1478 | Associated | 4.0 (Moderate) | 22824323 | |
acc4744 | p38 MAPK | P70618 | Mapk14 | phosphorylation | Tyr182 | rat | Spinal Cord Injury | AG1478 | Associated | 4.0 (Moderate) | 22824323 | |
acc4745 | IRAK4 | Q8R4K2 | Irak4 | phosphorylation | Thr345 | mouse | Traumatic Brain Injury | PF-0665083 | Associated | 4.0 (Moderate) | 35149117 | |
acc4746 | TAK1 | Q62073 | Map3k7 | phosphorylation | unclear | mouse | Traumatic Brain Injury | PF-0665083 | Associated | 4.0 (Moderate) | 35149117 | |
acc4749 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Neuronal Damage | Silymarin | Associated | 4.0 (Moderate) | 33182349 | |
acc4750 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Neuronal Damage | Silymarin | Associated | 4.0 (Moderate) | 33182349 | |
acc4751 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Neuronal Damage | Silymarin | Associated | 4.0 (Moderate) | 33182349 | |
acc4752 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Neuronal Damage | Silymarin | Associated | 4.0 (Moderate) | 33182349 | |
acc4753 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Neuronal Damage | Silymarin | Associated | 4.0 (Moderate) | 33182349 | |
acc4754 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Seizures | Topiramate | Associated | 4.0 (Moderate) | 17868053 | |
acc4755 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Seizures | Topiramate | Associated | 4.0 (Moderate) | 17868053 | |
acc4756 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Seizures | Topiramate | Associated | 4.0 (Moderate) | 17868053 | |
acc4757 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Seizures | Topiramate | Associated | 4.0 (Moderate) | 17868053 | |
acc4758 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Acute Lung Injury | J774A.1 | Colchicine | Associated | 4.0 (Moderate) | 37115345 |
acc4761 | cTnI | P48787 | Tnni3 | phosphorylation | Ser23 | mouse | Cardiac Dysfunction | Cyclopentyladenosine | Associated | 4.0 (Moderate) | 19201758 | |
acc4762 | cTnI | P48787 | Tnni3 | phosphorylation | Ser24 | mouse | Cardiac Dysfunction | Cyclopentyladenosine | Associated | 4.0 (Moderate) | 19201758 | |
acc4764 | NF-kappaB p65 | Q04207 | Rela | phosphorylation | Ser536 | mouse | Acute Kidney Injury | Dimethyl fumarate | Associated | 4.0 (Moderate) | 34915410 | |
acc3940 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Insulin Resistance | FAO | PF-4708671 | Associated | 4.0 (Moderate) | 26733005 |
acc3941 | Akt | P47196 | Akt1 | phosphorylation | Thr308 | rat | Insulin Resistance | FAO | PF-4708671 | Associated | 4.0 (Moderate) | 26733005 |
acc3942 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Insulin Resistance | L6 | Rapamycin | Associated | 4.0 (Moderate) | 26733005 |
acc3943 | Akt | P47196 | Akt1 | phosphorylation | Thr308 | rat | Insulin Resistance | L6 | Rapamycin | Associated | 4.0 (Moderate) | 26733005 |
acc3944 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Insulin Resistance | L6 | PF-4708671 | Associated | 4.0 (Moderate) | 26733005 |
acc3945 | Akt | P47196 | Akt1 | phosphorylation | Thr308 | rat | Insulin Resistance | L6 | PF-4708671 | Associated | 4.0 (Moderate) | 26733005 |
acc3946 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Diabetes Mellitus | Phycocyanin | Associated | 4.0 (Moderate) | 26827782 | |
acc3947 | IRS1 | P35569 | Irs1 | phosphorylation | Tyr612 | mouse | Diabetes Mellitus | Phycocyanin | Associated | 4.0 (Moderate) | 26827782 | |
acc3948 | IRS1 | P35569 | Irs1 | phosphorylation | Ser307 | mouse | Diabetes Mellitus | Phycocyanin | Associated | 4.0 (Moderate) | 26827782 | |
acc3949 | Caveolin-1 | P49817 | Cav1 | phosphorylation | Tyr14 | mouse | Diabetes Mellitus | Curcumin | Associated | 4.0 (Moderate) | 26838071 | |
acc3950 | Caveolin-1 | P41350 | Cav1 | phosphorylation | Tyr14 | rat | Diabetes Mellitus | podocyte | Curcumin | Associated | 4.0 (Moderate) | 26838071 |
acc3951 | nephrin | Q9QZS7 | Nphs1 | phosphorylation | Tyr1176 | mouse | Diabetes Mellitus | MRE–269 | Associated | 4.0 (Moderate) | 26868296 | |
acc3952 | nephrin | Q9QZS7 | Nphs1 | phosphorylation | Tyr1193 | mouse | Diabetes Mellitus | MRE–269 | Associated | 4.0 (Moderate) | 26868296 | |
acc3953 | PPARgamma | P37238 | Pparg | sulfhydration | Cys139 | mouse | Obese | H2S | Associated | 4.0 (Moderate) | 26946260 | |
acc3954 | ERK | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Nociceptive Behaviors | l-alpha-aminoadipate | Associated | 4.0 (Moderate) | 26948958 | |
acc3955 | ERK | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Nociceptive Behaviors | l-alpha-aminoadipate | Associated | 4.0 (Moderate) | 26948958 | |
acc3956 | TRPA1 | O75762 | TRPA1 | hydroxylation | Pro394 | human | Dysesthesia | HEK293 | Dimethyloxalylglycine (DMOG) | Associated | 4.0 (Moderate) | 26983498 |
acc3957 | TRPA1 | Q8BLA8 | Trpa1 | hydroxylation | Pro394 | mouse | Dysesthesia | Dimethyloxalylglycine (DMOG) | Associated | 4.0 (Moderate) | 26983498 | |
acc3958 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Parkinson's Disease | Desferrioxamine | Associated | 4.0 (Moderate) | 26996132 | |
acc3959 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Parkinson's Disease | Desferrioxamine | Associated | 4.0 (Moderate) | 26996132 | |
acc3960 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Parkinson's Disease | Desferrioxamine | Associated | 4.0 (Moderate) | 26996132 | |
acc3961 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Parkinson's Disease | Desferrioxamine | Associated | 4.0 (Moderate) | 26996132 | |
acc3962 | JNK | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Parkinson's Disease | Desferrioxamine | Associated | 4.0 (Moderate) | 26996132 | |
acc3963 | JNK | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Parkinson's Disease | Desferrioxamine | Associated | 4.0 (Moderate) | 26996132 | |
acc3964 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | Parkinson's Disease | Desferrioxamine | Associated | 4.0 (Moderate) | 26996132 | |
acc3965 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | Parkinson's Disease | Desferrioxamine | Associated | 4.0 (Moderate) | 26996132 | |
acc3966 | AMPKalpha | Q5EG47 | Prkaa1 | phosphorylation | Thr172 | mouse | Iodine Deficiency | Metformin | Associated | 4.0 (Moderate) | 27035650 | |
acc3967 | p70S6K | Q8BSK8 | Rps6kb1 | phosphorylation | Thr389 | mouse | Iodine Deficiency | Rapamycin | Associated | 4.0 (Moderate) | 27035650 | |
acc3968 | occludin | Q61146 | Ocln | glycosylation | unclear | mouse | Diabetes Mellitus | N-acetylcysteine | Associated | 4.0 (Moderate) | 27083477 | |
acc3969 | eNOS | Q62600 | Nos3 | phosphorylation | Ser1177 | rat | Pulmonary Hypertension | Metformin | Associated | 4.0 (Moderate) | 27084848 | |
acc3970 | CREB | P16220 | CREB1 | phosphorylation | Ser133 | human | Atopic Dermatitis | Benzoxaborole Phosphodiesterase Inhibitors | Associated | 4.0 (Moderate) | 27353073 | |
acc3971 | CREB | Q01147 | Creb1 | phosphorylation | Ser133 | mouse | Atopic Dermatitis | Benzoxaborole Phosphodiesterase Inhibitors | Associated | 4.0 (Moderate) | 27353073 | |
acc3972 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Atopic Dermatitis | Benzoxaborole Phosphodiesterase Inhibitors | Associated | 4.0 (Moderate) | 27353073 | |
acc3973 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Atopic Dermatitis | Benzoxaborole Phosphodiesterase Inhibitors | Associated | 4.0 (Moderate) | 27353073 | |
acc3974 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Atopic Dermatitis | Benzoxaborole Phosphodiesterase Inhibitors | Associated | 4.0 (Moderate) | 27353073 | |
acc3975 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Atopic Dermatitis | Benzoxaborole Phosphodiesterase Inhibitors | Associated | 4.0 (Moderate) | 27353073 | |
acc3976 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Atopic Dermatitis | Benzoxaborole Phosphodiesterase Inhibitors | Associated | 4.0 (Moderate) | 27353073 | |
acc3977 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Atopic Dermatitis | Benzoxaborole Phosphodiesterase Inhibitors | Associated | 4.0 (Moderate) | 27353073 | |
acc3978 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Atopic Dermatitis | Benzoxaborole Phosphodiesterase Inhibitors | Associated | 4.0 (Moderate) | 27353073 | |
acc3979 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Atopic Dermatitis | Benzoxaborole Phosphodiesterase Inhibitors | Associated | 4.0 (Moderate) | 27353073 | |
acc3980 | Fyn | Q62844 | Fyn | S-nitrosylation | Cys498 | rat | Cerebral Ischemia | GSNO | Associated | 4.0 (Moderate) | 27420046 | |
acc3983 | NOS3 | Q62600 | Nos3 | phosphorylation | Ser1177 | rat | Diabetes Mellitus | Sal B | Associated | 4.0 (Moderate) | 27614127 | |
acc3984 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Diabetes Mellitus | PSEE | Associated | 4.0 (Moderate) | 27649243 | |
acc3985 | Akt | P47196 | Akt1 | phosphorylation | Thr308 | rat | Diabetes Mellitus | PSEE | Associated | 4.0 (Moderate) | 27649243 | |
acc3986 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Obese | Berberine | Associated | 4.0 (Moderate) | 27702567 | |
acc3987 | IKKbeta | O88351 | Ikbkb | phosphorylation | Ser177 | mouse | Obese | Berberine | Associated | 4.0 (Moderate) | 27702567 | |
acc3988 | IKKbeta | O88351 | Ikbkb | phosphorylation | Ser181 | mouse | Obese | Berberine | Associated | 4.0 (Moderate) | 27702567 | |
acc3989 | IRS1 | P35569 | Irs1 | phosphorylation | Ser307 | mouse | Obese | Berberine | Associated | 4.0 (Moderate) | 27702567 | |
acc3990 | JNK | Q91Y86 | Mapk8 | phosphorylation | unclear | mouse | Obese | Berberine | Associated | 4.0 (Moderate) | 27702567 | |
acc3991 | Titin | A0A8I5ZUN3 | Ttn | phosphorylation | Ser4080 | rat | Heart Failure | Spermidine | Associated | 4.0 (Moderate) | 27841876 | |
acc3992 | eNOS | P70313 | Nos3 | nitration | unclear | mouse | Hypertension | Tempol | Associated | 4.0 (Moderate) | 27861245 | |
acc3993 | eNOS | P70313 | Nos3 | phosphorylation | Ser1176 | mouse | Hypertension | Tempol | Associated | 4.0 (Moderate) | 27861245 | |
acc3994 | eNOS | P70313 | Nos3 | phosphorylation | Ser1179 | mouse | Hypertension | Tempol | Associated | 4.0 (Moderate) | 27861245 | |
acc3995 | eNOS | P70313 | Nos3 | S-glutathionylation | unclear | mouse | Hypertension | Tempol | Associated | 4.0 (Moderate) | 27861245 | |
acc3996 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Acute Liver Injury | Obeticholic acid | Associated | 4.0 (Moderate) | 27865854 | |
acc3997 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Acute Liver Injury | Obeticholic acid | Associated | 4.0 (Moderate) | 27865854 | |
acc3998 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Acute Liver Injury | Obeticholic acid | Associated | 4.0 (Moderate) | 27865854 | |
acc3999 | IkappaB | Q9Z1E3 | Nkfbia | phosphorylation | Ser32 | mouse | Acute Liver Injury | Obeticholic acid | Associated | 4.0 (Moderate) | 27865854 | |
acc4000 | p38 | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | Acute Liver Injury | Obeticholic acid | Associated | 4.0 (Moderate) | 27865854 | |
acc4001 | p38 | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | Acute Liver Injury | Obeticholic acid | Associated | 4.0 (Moderate) | 27865854 | |
acc4002 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Cerebral Ischemia | Wortmannin | Associated | 4.0 (Moderate) | 27866373 | |
acc4003 | GSK3beta | P18266 | Gsk3b | phosphorylation | Ser9 | rat | Cerebral Ischemia | Wortmannin | Associated | 4.0 (Moderate) | 27866373 | |
acc4004 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser423 | mouse | Renal Fibrosis | Dasatinib | Associated | 4.0 (Moderate) | 27927780 | |
acc4005 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser425 | mouse | Renal Fibrosis | Dasatinib | Associated | 4.0 (Moderate) | 27927780 | |
acc4008 | PLC-gamma1 | Q62077 | Plcg1 | phosphorylation | Tyr783 | mouse | Asthma | Linker for activation of T cells | Associated | 4.0 (Moderate) | 28063403 | |
acc4009 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Opioid Dependence | Morphine | Associated | 4.0 (Moderate) | 28082900 | |
acc4010 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Opioid Dependence | Morphine | Associated | 4.0 (Moderate) | 28082900 | |
acc4011 | RyR2 | B0LPN4 | Ryr2 | oxidation | unclear | rat | Arrhythmia | NS309 | Associated | 4.0 (Moderate) | 28096168 | |
acc4014 | mTOR | P42346 | Mtor | phosphorylation | Ser2448 | rat | Neuronal Damage | DXT | Associated | 4.0 (Moderate) | 28365975 | |
acc4015 | p70S6K | P67999 | Rps6kb1 | phosphorylation | Thr389 | rat | Neuronal Damage | DXT | Associated | 4.0 (Moderate) | 28365975 | |
acc4016 | PP2A | P63330 | Ppp2ca | methylation | unclear | mouse | Diabetes Mellitus | Folic acid | Associated | 4.0 (Moderate) | 28422052 | |
acc4017 | Tau | P10637 | Mapt | phosphorylation | Ser396 | mouse | Diabetes Mellitus | Folic acid | Associated | 4.0 (Moderate) | 28422052 | |
acc4018 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Hyperuricemic Nephropathy | U0126 | Associated | 4.0 (Moderate) | 28442634 | |
acc4019 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Hyperuricemic Nephropathy | U0126 | Associated | 4.0 (Moderate) | 28442634 | |
acc4020 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Hyperuricemic Nephropathy | U0126 | Associated | 4.0 (Moderate) | 28442634 | |
acc4021 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Hyperuricemic Nephropathy | U0126 | Associated | 4.0 (Moderate) | 28442634 | |
acc4022 | Smad3 | P84025 | Smad3 | phosphorylation | Ser423 | rat | Hyperuricemic Nephropathy | U0126 | Associated | 4.0 (Moderate) | 28442634 | |
acc4023 | Smad3 | P84025 | Smad3 | phosphorylation | Ser425 | rat | Hyperuricemic Nephropathy | U0126 | Associated | 4.0 (Moderate) | 28442634 | |
acc4024 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Diabetes Mellitus | Insulin | Associated | 4.0 (Moderate) | 28511140 | |
acc4025 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Diabetes Mellitus | Insulin glargine U100 (Gla) | Associated | 4.0 (Moderate) | 28511140 | |
acc4026 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Diabetes Mellitus | Insulin detemir (Det) | Associated | 4.0 (Moderate) | 28511140 | |
acc4027 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Diabetes Mellitus | Insulin detemir (Det) | Associated | 4.0 (Moderate) | 28511140 | |
acc4033 | CREB | Q01147 | Creb1 | phosphorylation | Ser133 | mouse | Alzheimer's Disease | KH032 | Associated | 4.0 (Moderate) | 28578486 | |
acc4034 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Alzheimer's Disease | KH032 | Associated | 4.0 (Moderate) | 28578486 | |
acc4035 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Alzheimer's Disease | KH032 | Associated | 4.0 (Moderate) | 28578486 | |
acc4036 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Alzheimer's Disease | KH032 | Associated | 4.0 (Moderate) | 28578486 | |
acc4037 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Alzheimer's Disease | KH032 | Associated | 4.0 (Moderate) | 28578486 | |
acc4038 | Nrf2 | Q16236 | NFE2L2 | phosphorylation | unclear | human | Multiple Sclerosis | Medical ozone | Associated | 4.0 (Moderate) | 28623000 | |
acc4039 | FOXO3a | Q9WVH4 | Foxo3 | phosphorylation | Ser253 | mouse | Ovarian Damage | Melatonin + Ghrelin | Associated | 4.0 (Moderate) | 28658519 | |
acc4040 | FOXO3a | Q9WVH4 | Foxo3 | phosphorylation | Ser253 | mouse | Ovarian Damage | Cisplatin | Associated | 4.0 (Moderate) | 28658519 | |
acc4041 | PTEN | O08586 | Pten | phosphorylation | Ser380 | mouse | Ovarian Damage | Melatonin + Ghrelin | Associated | 4.0 (Moderate) | 28658519 | |
acc4042 | PTEN | O08586 | Pten | phosphorylation | Ser380 | mouse | Ovarian Damage | Cisplatin | Associated | 4.0 (Moderate) | 28658519 | |
acc4043 | STAT3 | P52631 | Stat3 | phosphorylation | Tyr705 | rat | Mechanical Allodynia and Central Sensitization | Metformin | Associated | 4.0 (Moderate) | 28729113 | |
acc4044 | AMPK | Q09137 | Prkaa2 | phosphorylation | Thr172 | rat | Myocardial Infarction | H9c2 | A-769662 | Impairing | 4.0 (Moderate) | 28765969 |
acc4045 | AMPK | P54645 | Prkaa1 | phosphorylation | Thr183 | rat | Myocardial Infarction | H9c2 | A-769662 | Impairing | 4.0 (Moderate) | 28765969 |
acc4046 | mTOR | P42346 | Mtor | phosphorylation | Ser2448 | rat | Myocardial Infarction | H9c2 | A-769662 | Impairing | 4.0 (Moderate) | 28765969 |
acc4047 | Akt | P47196 | Akt1 | phosphorylation | Thr308 | rat | Obese | Everolimus | Associated | 4.0 (Moderate) | 28805979 | |
acc4048 | TRPV1 | O35433 | Trpv1 | phosphorylation | Ser502 | rat | Colitis | HEK293 | Curcumin | Associated | 4.0 (Moderate) | 28812431 |
acc4049 | 4EBP1 | Q13541 | EIF4EBP1 | phosphorylation | Thr70 | human | Cancer | HCT116 | Ascochlorin | Associated | 4.0 (Moderate) | 28833404 |
acc4050 | ERK | P27361 | MAPK3 | phosphorylation | unclear | human | Cancer | HCT116 | Ascochlorin | Associated | 4.0 (Moderate) | 28833404 |
acc4051 | p70S6K | P23443 | RPS6KB1 | phosphorylation | unclear | human | Cancer | HCT116 | Ascochlorin | Associated | 4.0 (Moderate) | 28833404 |
acc4052 | YAP | Q2EJA0 | Yap1 | phosphorylation | Ser127 | rat | Ventricular Cardiomyocytes | Verteporfin | Associated | 4.0 (Moderate) | 28834610 | |
acc4053 | PHLPP2 | Q8BXA7 | Phlpp2 | phosphorylation | Ser1119 | mouse | Obese | Glucagon | Associated | 4.0 (Moderate) | 28859855 | |
acc4054 | PHLPP2 | Q8BXA7 | Phlpp2 | phosphorylation | Ser1210 | mouse | Obese | Glucagon | Associated | 4.0 (Moderate) | 28859855 | |
acc4055 | AMPKalpha | Q13131 | PRKAA1 | phosphorylation | Thr172 | human | Diabetes Mellitus | HCF | Curcumin | Associated | 4.0 (Moderate) | 28905939 |
acc4056 | p38 MAPK | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Diabetes Mellitus | HCF | Curcumin | Associated | 4.0 (Moderate) | 28905939 |
acc4057 | p38 MAPK | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Diabetes Mellitus | HCF | Curcumin | Associated | 4.0 (Moderate) | 28905939 |
acc4058 | Smad2 | Q15796 | SMAD2 | phosphorylation | Ser465 | human | Diabetes Mellitus | HCF | Curcumin | Associated | 4.0 (Moderate) | 28905939 |
acc4059 | Smad2 | Q15796 | SMAD2 | phosphorylation | Ser467 | human | Diabetes Mellitus | HCF | Curcumin | Associated | 4.0 (Moderate) | 28905939 |
acc4060 | Smad3 | P84022 | SMAD3 | phosphorylation | Ser423 | human | Diabetes Mellitus | HCF | Curcumin | Associated | 4.0 (Moderate) | 28905939 |
acc4061 | Smad3 | P84022 | SMAD3 | phosphorylation | Ser425 | human | Diabetes Mellitus | HCF | Curcumin | Associated | 4.0 (Moderate) | 28905939 |
acc4062 | eNOS | Q62600 | Nos3 | phosphorylation | Ser1177 | rat | Peripheral Artery Disease | Low molecular weight fucoidan (LMWF) | Associated | 4.0 (Moderate) | 28917976 | |
acc4063 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Cardiac Fibrosis | Eplerenone | Associated | 4.0 (Moderate) | 28966243 | |
acc4064 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Cardiac Fibrosis | Eplerenone | Associated | 4.0 (Moderate) | 28966243 | |
acc4065 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Cardiac Fibrosis | Eplerenone | Associated | 4.0 (Moderate) | 28966243 | |
acc4066 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Cardiac Fibrosis | Eplerenone | Associated | 4.0 (Moderate) | 28966243 | |
acc4067 | Akt | P31750 | Akt1 | phosphorylation | Thr308 | mouse | Alcoholic Fatty Liver | HepG2(还有小鼠实验) | N-acetylcysteine | Associated | 4.0 (Moderate) | 28987868 |
acc4068 | Akt | P31750 | Akt1 | phosphorylation | Thr308 | mouse | Alcoholic Fatty Liver | HepG2(还有小鼠实验) | Insulin-like growth factor-1 (IGF-1) | Associated | 4.0 (Moderate) | 28987868 |
acc4069 | Drp1 | O35303 | Dnm1l | phosphorylation | Ser616 | rat | Myocardial Injury | Melatonin | Associated | 4.0 (Moderate) | 29024001 | |
acc4070 | CREB | Q01147 | Creb1 | phosphorylation | Ser133 | mouse | Alzheimer's Disease | 1w·Cit | Associated | 4.0 (Moderate) | 29068218 | |
acc4071 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Hyperoxia-Induced Inflammation | Fucoidan | Associated | 4.0 (Moderate) | 29138816 | |
acc4072 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Hyperoxia-Induced Inflammation | Fucoidan | Associated | 4.0 (Moderate) | 29138816 | |
acc4073 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Hyperoxia-Induced Inflammation | Fucoidan | Associated | 4.0 (Moderate) | 29138816 | |
acc4074 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Hyperoxia-Induced Inflammation | Fucoidan | Associated | 4.0 (Moderate) | 29138816 | |
acc4075 | IkappaBalpha | Q9Z1E3 | Nfkbia | phosphorylation | Ser32 | mouse | Fatty Liver Disease | Alpinetin | Associated | 4.0 (Moderate) | 29156529 | |
acc4076 | IkappaBalpha | Q60680 | Chuk | phosphorylation | Ser176 | mouse | Fatty Liver Disease | Alpinetin | Associated | 4.0 (Moderate) | 29156529 | |
acc4077 | IkappaBalpha | Q60680 | Chuk | phosphorylation | Ser180 | mouse | Fatty Liver Disease | Alpinetin | Associated | 4.0 (Moderate) | 29156529 | |
acc4078 | IRS1 | P35569 | Irs1 | phosphorylation | Ser307 | mouse | Fatty Liver Disease | Alpinetin | Associated | 4.0 (Moderate) | 29156529 | |
acc4079 | NF-kappaB p65 | Q04207 | Rela | phosphorylation | Ser536 | mouse | Fatty Liver Disease | Alpinetin | Associated | 4.0 (Moderate) | 29156529 | |
acc4080 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Allergic | RBL-2H3 | Davallia mariesii extract | Associated | 4.0 (Moderate) | 29200667 |
acc4081 | cPLA2 | P50393 | Pla2g4a | phosphorylation | Ser505 | rat | Allergic | RBL-2H3 | Davallia mariesii extract | Associated | 4.0 (Moderate) | 29200667 |
acc4082 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Allergic | RBL-2H3 | Davallia mariesii extract | Associated | 4.0 (Moderate) | 29200667 |
acc4083 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Allergic | RBL-2H3 | Davallia mariesii extract | Associated | 4.0 (Moderate) | 29200667 |
acc4084 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Allergic | RBL-2H3 | Davallia mariesii extract | Associated | 4.0 (Moderate) | 29200667 |
acc4085 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Allergic | RBL-2H3 | Davallia mariesii extract | Associated | 4.0 (Moderate) | 29200667 |
acc4086 | Lyn | Q07014 | Lyn | phosphorylation | Tyr507 | rat | Allergic | RBL-2H3 | Davallia mariesii extract | Associated | 4.0 (Moderate) | 29200667 |
acc4087 | PLC-gamma1 | P10686 | Plcg1 | phosphorylation | Tyr783 | rat | Allergic | RBL-2H3 | Davallia mariesii extract | Associated | 4.0 (Moderate) | 29200667 |
acc4088 | Syk | Q64725 | Syk | phosphorylation | Tyr525 | rat | Allergic | RBL-2H3 | Davallia mariesii extract | Associated | 4.0 (Moderate) | 29200667 |
acc4089 | Syk | Q64725 | Syk | phosphorylation | Tyr526 | rat | Allergic | RBL-2H3 | Davallia mariesii extract | Associated | 4.0 (Moderate) | 29200667 |
acc4090 | PPARgamma | P37238 | Pparg | phosphorylation | Ser273 | mouse | Diabetes Mellitus | 3T3–L1 | Dihydrosanguinarine | Associated | 4.0 (Moderate) | 29202114 |
acc4091 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Obese | Resveratrol | Associated | 4.0 (Moderate) | 29229986 | |
acc4092 | Akt | P31750 | Akt1 | phosphorylation | Tyr | mouse | Obese | Resveratrol | Associated | 4.0 (Moderate) | 29229986 | |
acc4093 | IRbeta | P15208 | Insr | phosphorylation | Tyr1162 | mouse | Obese | Resveratrol | Associated | 4.0 (Moderate) | 29229986 | |
acc4094 | IRbeta | P15208 | Insr | phosphorylation | Tyr1163 | mouse | Obese | Resveratrol | Associated | 4.0 (Moderate) | 29229986 | |
acc4095 | IRbeta | P15208 | Insr | phosphorylation | Tyr | mouse | Obese | Resveratrol | Associated | 4.0 (Moderate) | 29229986 | |
acc4096 | IRS1 | P35569 | Irs1 | phosphorylation | Tyr632 | mouse | Obese | Resveratrol | Associated | 4.0 (Moderate) | 29229986 | |
acc4097 | IRS1 | P35569 | Irs1 | phosphorylation | Tyr | mouse | Obese | Resveratrol | Associated | 4.0 (Moderate) | 29229986 | |
acc4098 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Lung Cancer | A549 | "8-Hydroxy-2-methoxy-1,4-naphthoquinone (HMNQ)" | Associated | 4.0 (Moderate) | 29245930 |
acc4099 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Colorectal Cancer | HCT116 | "8-Hydroxy-2-methoxy-1,4-naphthoquinone (HMNQ)" | Associated | 4.0 (Moderate) | 29245930 |
acc4100 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Lung Cancer | A549 | "8-Hydroxy-2-methoxy-1,4-naphthoquinone (HMNQ)" | Associated | 4.0 (Moderate) | 29245930 |
acc4101 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Colorectal Cancer | HCT116 | "8-Hydroxy-2-methoxy-1,4-naphthoquinone (HMNQ)" | Associated | 4.0 (Moderate) | 29245930 |
acc4102 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Breast Cancer | MCF7 | "8-Hydroxy-2-methoxy-1,4-naphthoquinone (HMNQ)" | Associated | 4.0 (Moderate) | 29245930 |
acc4103 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Breast Cancer | MCF7 | "8-Hydroxy-2-methoxy-1,4-naphthoquinone (HMNQ)" | Associated | 4.0 (Moderate) | 29245930 |
acc4106 | Akt | P47196 | Akt1 | phosphorylation | Thr308 | rat | Diabetes Mellitus | PTX | Associated | 4.0 (Moderate) | 29357512 | |
acc4107 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Diabetes Mellitus | PTX | Associated | 4.0 (Moderate) | 29357512 | |
acc4108 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Cardiac Hypertrophy | Anti-IL-22 (nAb) | Associated | 4.0 (Moderate) | 29358851 | |
acc4109 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Cardiac Hypertrophy | Anti-IL-22 (nAb) | Associated | 4.0 (Moderate) | 29358851 | |
acc4110 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Cardiac Hypertrophy | Anti-IL-22 (nAb) | Associated | 4.0 (Moderate) | 29358851 | |
acc4111 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Cardiac Hypertrophy | Anti-IL-22 (nAb) | Associated | 4.0 (Moderate) | 29358851 | |
acc4112 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Cardiac Hypertrophy | Anti-IL-22 (nAb) | Associated | 4.0 (Moderate) | 29358851 | |
acc4113 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser423 | mouse | Cardiac Fibrosis | Rosmarinic acid | Associated | 4.0 (Moderate) | 29367637 | |
acc4114 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser425 | mouse | Cardiac Fibrosis | Rosmarinic acid | Associated | 4.0 (Moderate) | 29367637 | |
acc4115 | Smad2 | O70436 | Smad2 | phosphorylation | Ser465 | rat | Unilateral Ureteral Obstruction | / | Dietary iron restriction | Associated | 4.0 (Moderate) | 29417224 |
acc4116 | Smad2 | O70436 | Smad2 | phosphorylation | Ser467 | rat | Unilateral Ureteral Obstruction | / | Dietary iron restriction | Associated | 4.0 (Moderate) | 29417224 |
acc4117 | HSP27 | P42930 | Hspb1 | phosphorylation | Ser85 | rat | Cerebral Ischemia | KU–55933 | Associated | 4.0 (Moderate) | 29510140 | |
acc4118 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Neurological Deficit | DGMI | Associated | 4.0 (Moderate) | 29542683 | |
acc4119 | CREB | P15337 | Creb1 | phosphorylation | Ser133 | rat | Neurological Deficit | DGMI | Associated | 4.0 (Moderate) | 29542683 | |
acc4120 | AMPK | P54646 | PRKAA2 | phosphorylation | Thr172 | human | Hepatic Steatosis | HepG2 | PDX | Associated | 4.0 (Moderate) | 29572342 |
acc4121 | AMPK | Q13131 | PRKAA1 | phosphorylation | Thr183 | human | Hepatic Steatosis | HepG2 | PDX | Associated | 4.0 (Moderate) | 29572342 |
acc4122 | AMPK | Q5EG47 | Prkaa1 | phosphorylation | Thr183 | mouse | Hepatic Steatosis | PDX | Associated | 4.0 (Moderate) | 29572342 | |
acc4123 | AMPK | Q8BRK8 | Prkaa2 | phosphorylation | Thr172 | mouse | Hepatic Steatosis | PDX | Associated | 4.0 (Moderate) | 29572342 | |
acc4124 | eIF2alpha | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Hepatic Steatosis | HepG2 | PDX | Associated | 4.0 (Moderate) | 29572342 |
acc4125 | eIF2alpha | Q8BJW6 | Eif2a | phosphorylation | Ser51 | mouse | Hepatic Steatosis | PDX | Associated | 4.0 (Moderate) | 29572342 | |
acc4126 | IRE1 | O75460 | ERN1 | phosphorylation | Ser274 | human | Hepatic Steatosis | HepG2 | PDX | Associated | 4.0 (Moderate) | 29572342 |
acc4127 | IRE1 | Q9EQY0 | Ern1 | phosphorylation | Ser274 | mouse | Hepatic Steatosis | PDX | Associated | 4.0 (Moderate) | 29572342 | |
acc4128 | CREB | Q01147 | Creb1 | phosphorylation | Ser133 | mouse | Alzheimer's Disease | 3c·cit | Associated | 4.0 (Moderate) | 29616790 | |
acc4129 | JNK | Q91Y86 | Mapk8 | phosphorylation | unclear | mouse | Myocardial I/R Injury | Butorphanol | Associated | 4.0 (Moderate) | 29630131 | |
acc4130 | p38 | P47811 | Mapk14 | phosphorylation | unclear | mouse | Myocardial I/R Injury | Butorphanol | Associated | 4.0 (Moderate) | 29630131 | |
acc4133 | TRAF6 | P70196 | Traf6 | ubiquitination | Lys63 | mouse | Acute Lung Injury | Tabersonine | Associated | 4.0 (Moderate) | 29746822 | |
acc4134 | AKT | P31749 | AKT1 | phosphorylation | unclear | human | Pancreatic Cancer | Apatinib | Associated | 4.0 (Moderate) | 29785118 | |
acc4135 | AKT | P31749 | AKT1 | phosphorylation | unclear | human | Pancreatic Cancer | Apatinib + APS | Associated | 4.0 (Moderate) | 29785118 | |
acc4136 | ERK1 | P27361 | MAPK3 | phosphorylation | unclear | human | Pancreatic Cancer | Apatinib | Associated | 4.0 (Moderate) | 29785118 | |
acc4137 | ERK1 | P27361 | MAPK3 | phosphorylation | unclear | human | Pancreatic Cancer | Apatinib + APS | Associated | 4.0 (Moderate) | 29785118 | |
acc4138 | AMPK | Q5EG47 | Prkaa1 | phosphorylation | Thr183 | mouse | Diabetes Mellitus | Chloroquine + amodiaquine | Associated | 4.0 (Moderate) | 29884802 | |
acc4139 | AMPK | Q8BRK8 | Prkaa2 | phosphorylation | Thr172 | mouse | Diabetes Mellitus | Chloroquine + amodiaquine | Associated | 4.0 (Moderate) | 29884802 | |
acc4140 | CaMKIIdelta | Q13557 | CAMK2D | phosphorylation | Thr287 | human | Diabetes Mellitus | KN93 | Associated | 4.0 (Moderate) | 29903013 | |
acc4141 | CaMKIIdelta | P15791 | Camk2d | phosphorylation | Thr287 | rat | Diabetes Mellitus | AIP | Associated | 4.0 (Moderate) | 29903013 | |
acc4142 | AMPK | P54645 | Prkaa1 | phosphorylation | Thr183 | rat | Cerebral Ischemia | Puerarin | Associated | 4.0 (Moderate) | 29926825 | |
acc4143 | AMPK | Q09137 | Prkaa2 | phosphorylation | Thr172 | rat | Cerebral Ischemia | Puerarin | Associated | 4.0 (Moderate) | 29926825 | |
acc4144 | mTOR | P42346 | Mtor | phosphorylation | Ser2448 | rat | Cerebral Ischemia | Puerarin | Associated | 4.0 (Moderate) | 29926825 | |
acc4145 | ULK1 | A6J290 | Ulk1 | phosphorylation | Ser317 | rat | Cerebral Ischemia | Puerarin | Associated | 4.0 (Moderate) | 29926825 | |
acc4146 | Smad3 | P84025 | Smad3 | phosphorylation | Ser423 | rat | Hepatic Fibrosis | hepatic stellate cells | TF-SC | Associated | 4.0 (Moderate) | 29990830 |
acc4147 | RyR2 | A0A5G2R1W3 | RYR2 | oxidation | unclear | pig | Arrhythmogenesis | Flecainide | Associated | 4.0 (Moderate) | 30028197 | |
acc4149 | eNOS | Q62600 | Nos3 | phosphorylation | Ser1177 | rat | Hypertension | Hemin | Associated | 4.0 (Moderate) | 30048241 | |
acc4150 | ATM | Q13315 | ATM | phosphorylation | Ser1981 | human | Glioblastoma | U87-MG | Temozolomide + Caffeine | Associated | 4.0 (Moderate) | 30050935 |
acc4151 | p53 | P04637 | TP53 | phosphorylation | unclear | human | Glioblastoma | U87-MG | Temozolomide + Caffeine | Associated | 4.0 (Moderate) | 30050935 |
acc4152 | p38 | P70618 | Mapk14 | phosphorylation | unclear | rat | Myocardial Infarction | Atorvastatin | Associated | 4.0 (Moderate) | 30116330 | |
acc4153 | NR2B | Q62923 | Grin2b | phosphorylation | Tyr1472 | rat | Dyskinetic | Tat-Src | Associated | 4.0 (Moderate) | 30130562 | |
acc4154 | Src | Q9WUD9 | Src | phosphorylation | Tyr416 | rat | Dyskinetic | Tat-Src | Associated | 4.0 (Moderate) | 30130562 | |
acc4155 | Src | Q9WUD9 | Src | prenylation | Cys | rat | Dyskinetic | Tat-Src | Associated | 4.0 (Moderate) | 30130562 | |
acc4156 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Hepatic Steatosis | FO | Associated | 4.0 (Moderate) | 30145885 | |
acc4157 | IRS1 | P35569 | Irs1 | phosphorylation | Tyr632 | mouse | Hepatic Steatosis | FO | Associated | 4.0 (Moderate) | 30145885 | |
acc4158 | ERK | P21708 | Mapk1 | phosphorylation | unclear | rat | Neuropathic Pain | Dexmedetomidine | Associated | 4.0 (Moderate) | 30181689 | |
acc4159 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Peripheral Artery Disease | IL-22 antagonism | Associated | 4.0 (Moderate) | 30236983 | |
acc4160 | ERK | Q63844 | Mapk3 | phosphorylation | unclear | mouse | Inflammatory | RAW264.7 | Prethanol extract of Trifolium pratense | Associated | 4.0 (Moderate) | 30320514 |
acc4161 | ERK | P21708 | Mapk3 | phosphorylation | unclear | rat | Inflammatory | RAW264.7 | Prethanol extract of Trifolium pratense | Associated | 4.0 (Moderate) | 30320514 |
acc4162 | IkappaBalpha | Q9Z1E3 | Nfkbia | phosphorylation | unclear | mouse | Inflammatory | RAW264.7 | Prethanol extract of Trifolium pratense | Associated | 4.0 (Moderate) | 30320514 |
acc4163 | IkappaBalpha | Q63746 | Nfkbia | phosphorylation | unclear | rat | Inflammatory | RAW264.7 | Prethanol extract of Trifolium pratense | Associated | 4.0 (Moderate) | 30320514 |
acc4164 | JNK | Q91Y86 | Mapk8 | phosphorylation | unclear | mouse | Inflammatory | Prethanol extract of Trifolium pratense | Associated | 4.0 (Moderate) | 30320514 | |
acc4165 | JNK | P49185 | Mapk8 | phosphorylation | unclear | rat | Inflammatory | Prethanol extract of Trifolium pratense | Associated | 4.0 (Moderate) | 30320514 | |
acc4166 | NF-kappaB p65 | Q04207 | Rela | phosphorylation | unclear | mouse | Inflammatory | Prethanol extract of Trifolium pratense | Associated | 4.0 (Moderate) | 30320514 | |
acc4167 | NF-kappaB p65 | Q7TQN4 | Rela | phosphorylation | unclear | rat | Inflammatory | Prethanol extract of Trifolium pratense | Associated | 4.0 (Moderate) | 30320514 | |
acc4168 | p38 | P47811 | Mapk14 | phosphorylation | unclear | mouse | Inflammatory | RAW264.7 | Prethanol extract of Trifolium pratense | Associated | 4.0 (Moderate) | 30320514 |
acc4169 | p38 MAPK | P70618 | Mapk14 | phosphorylation | unclear | rat | Inflammatory | Prethanol extract of Trifolium pratense | Associated | 4.0 (Moderate) | 30320514 | |
acc4170 | p65 | Q04207 | Rela | phosphorylation | unclear | mouse | Inflammatory | RAW264.7 | Prethanol extract of Trifolium pratense | Associated | 4.0 (Moderate) | 30320514 |
acc4171 | p65 | Q7TQN4 | Rela | phosphorylation | unclear | rat | Inflammatory | RAW264.7 | Prethanol extract of Trifolium pratense | Associated | 4.0 (Moderate) | 30320514 |
acc4172 | AMPK | P54645 | Prkaa1 | phosphorylation | Thr183 | rat | Diabetes Mellitus | Rimonabant | Associated | 4.0 (Moderate) | 30365523 | |
acc4173 | AMPK | Q09137 | Prkaa2 | phosphorylation | Thr172 | rat | Diabetes Mellitus | Rimonabant | Associated | 4.0 (Moderate) | 30365523 | |
acc4175 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Hypertension | CoQ10 | Associated | 4.0 (Moderate) | 30668894 | |
acc4176 | nNOS | P29476 | Nos1 | phosphorylation | Ser1416 | rat | Hypertension | CoQ10 | Associated | 4.0 (Moderate) | 30668894 | |
acc4177 | p38 MAP kinase | P70618 | Mapk14 | phosphorylation | Thr180 | rat | Hypertension | CoQ10 | Associated | 4.0 (Moderate) | 30668894 | |
acc4178 | p38 MAP kinase | P70618 | Mapk14 | phosphorylation | Tyr182 | rat | Hypertension | CoQ10 | Associated | 4.0 (Moderate) | 30668894 | |
acc4179 | JNK | P45983 | MAPK8 | phosphorylation | Thr183 | human | Alzheimer's Disease | SH-SY5Y | VB-037 | Associated | 4.0 (Moderate) | 30707915 |
acc4180 | JNK | P45983 | MAPK8 | phosphorylation | Tyr185 | human | Alzheimer's Disease | SH-SY5Y | VB-037 | Associated | 4.0 (Moderate) | 30707915 |
acc4181 | JUN | P05412 | JUN | phosphorylation | Ser63 | human | Alzheimer's Disease | SH-SY5Y | VB-037 | Associated | 4.0 (Moderate) | 30707915 |
acc4182 | p38 | Q16539 | MAPK14 | phosphorylation | Thr180 | human | Alzheimer's Disease | SH-SY5Y | VB-037 | Associated | 4.0 (Moderate) | 30707915 |
acc4183 | p38 | Q16539 | MAPK14 | phosphorylation | Tyr182 | human | Alzheimer's Disease | SH-SY5Y | VB-037 | Associated | 4.0 (Moderate) | 30707915 |
acc4184 | ERK | P27361 | MAPK3 | phosphorylation | unclear | human | Atopic Dermatitis | HMC-1 | JC3 | Associated | 4.0 (Moderate) | 30729380 |
acc4185 | JNK | P45983 | MAPK8 | phosphorylation | unclear | human | Atopic Dermatitis | HMC-1 | JC3 | Associated | 4.0 (Moderate) | 30729380 |
acc4186 | p38 | Q16539 | MAPK14 | phosphorylation | unclear | human | Atopic Dermatitis | HMC-1 | JC3 | Associated | 4.0 (Moderate) | 30729380 |
acc4187 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Diabetes Mellitus | AM095 | Associated | 4.0 (Moderate) | 30763641 | |
acc4188 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Diabetes Mellitus | AM095 | Associated | 4.0 (Moderate) | 30763641 | |
acc4189 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Diabetes Mellitus | AM095 | Associated | 4.0 (Moderate) | 30763641 | |
acc4190 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Diabetes Mellitus | AM095 | Associated | 4.0 (Moderate) | 30763641 | |
acc4191 | JNK | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Diabetes Mellitus | AM095 | Associated | 4.0 (Moderate) | 30763641 | |
acc4192 | JNK | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Diabetes Mellitus | AM095 | Associated | 4.0 (Moderate) | 30763641 | |
acc4193 | NF-kappaB p65 | Q04207 | Rela | phosphorylation | Ser536 | mouse | Diabetes Mellitus | AM095 | Associated | 4.0 (Moderate) | 30763641 | |
acc4194 | PLN | P61016 | Pln | phosphorylation | Ser16 | rat | Cardiac Hypertrophy | H9c2 | Lithocholic acid | Associated | 4.0 (Moderate) | 30842472 |
acc4195 | AMPK | P54645 | Prkaa1 | phosphorylation | Thr183 | rat | Central Nervous System Inflammation | PC12 | Salidroside | Associated | 4.0 (Moderate) | 30848530 |
acc4196 | AMPK | Q09137 | Prkaa2 | phosphorylation | Thr172 | rat | Central Nervous System Inflammation | PC12 | Salidroside | Associated | 4.0 (Moderate) | 30848530 |
acc4197 | IkappaBalpha | Q63746 | Nfkbia | phosphorylation | Ser32 | rat | Central Nervous System Inflammation | PC12 | Salidroside | Associated | 4.0 (Moderate) | 30848530 |
acc4198 | NF-kappaB p65 | Q7TQN4 | Rela | phosphorylation | Ser536 | rat | Central Nervous System Inflammation | PC12 | Salidroside | Associated | 4.0 (Moderate) | 30848530 |
acc4199 | JNK | Q91Y86 | Mapk8 | phosphorylation | unclear | mouse | Mitochondrial Dysfunction | Farrerol | Associated | 4.0 (Moderate) | 30906210 | |
acc4200 | alpha-tubulin | P05213 | Tuba1b | acetylation | Lys40 | mouse | Bacterial Infection | J774A.1 | Evodiamine | Associated | 4.0 (Moderate) | 30971927 |
acc4201 | AMPK | Q5EG47 | Prkaa1 | phosphorylation | Thr183 | mouse | Acute Liver Injury | Thymoquinone | Associated | 4.0 (Moderate) | 30974967 | |
acc4202 | AMPK | Q8BRK8 | Prkaa2 | phosphorylation | Thr172 | mouse | Acute Liver Injury | Thymoquinone | Associated | 4.0 (Moderate) | 30974967 | |
acc4203 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Acute Liver Injury | Thymoquinone | Associated | 4.0 (Moderate) | 30974967 | |
acc4204 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Acute Liver Injury | Thymoquinone | Associated | 4.0 (Moderate) | 30974967 | |
acc4205 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Acute Liver Injury | Thymoquinone | Associated | 4.0 (Moderate) | 30974967 | |
acc4206 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Acute Liver Injury | Thymoquinone | Associated | 4.0 (Moderate) | 30974967 | |
acc4207 | JNK | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Acute Liver Injury | Thymoquinone | Associated | 4.0 (Moderate) | 30974967 | |
acc4208 | JNK | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Acute Liver Injury | Thymoquinone | Associated | 4.0 (Moderate) | 30974967 | |
acc4209 | p38 | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | Acute Liver Injury | Thymoquinone | Associated | 4.0 (Moderate) | 30974967 | |
acc4210 | p38 | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | Acute Liver Injury | Thymoquinone | Associated | 4.0 (Moderate) | 30974967 | |
acc4211 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Acute Liver Injury | Thymoquinone | Associated | 4.0 (Moderate) | 30974967 | |
acc4212 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Myocardial Hypertrophy | Tempol | Associated | 4.0 (Moderate) | 31047988 | |
acc4213 | p65 | Q04207 | Rela | phosphorylation | Ser536 | mouse | Neuronal Damage | BV-2 | FTY720 | Associated | 4.0 (Moderate) | 31069623 |
acc4214 | GSK3beta | Q9WV60 | Gsk3b | phosphorylation | Ser9 | mouse | Acute Liver Injury | CAY10594 | Associated | 4.0 (Moderate) | 31076618 | |
acc4215 | JNK | Q61831 | Mapk10 | phosphorylation | unclear | mouse | Acute Liver Injury | CAY10594 | Associated | 4.0 (Moderate) | 31076618 | |
acc4217 | AMPKalpha | Q5EG47 | Prkaa1 | phosphorylation | Thr172 | mouse | Diabetes Mellitus | Metformin | Associated | 4.0 (Moderate) | 31105845 | |
acc4218 | Chk1 | O14757 | CHEK1 | phosphorylation | Ser345 | human | Excessive Mitotic Abnormalities | AG11395 | Camptothecin | Associated | 4.0 (Moderate) | 31114910 |
acc4219 | MUS81 | Q96NY9 | MUS81 | phosphorylation | Ser87 | human | Excessive Mitotic Abnormalities | AG11395 | Camptothecin | Associated | 4.0 (Moderate) | 31114910 |
acc4220 | p38 | P47811 | Mapk14 | phosphorylation | unclear | mouse | Neuronal Loss | LPS | Associated | 4.0 (Moderate) | 31124385 | |
acc4221 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Cleft Palate | Folic acid | Associated | 4.0 (Moderate) | 31171577 | |
acc4226 | GSK3beta | P18266 | Gsk3b | phosphorylation | Ser9 | rat | Diabetes Mellitus | H9C2 | Glucose | Associated | 4.0 (Moderate) | 31197456 |
acc4227 | Akt2 | Q60823 | Akt2 | phosphorylation | Ser474 | mouse | Obese | L02 | Pituitary adenylate cyclase-activating polypeptide (PACAP) | Associated | 4.0 (Moderate) | 31270932 |
acc4228 | CREB | Q01147 | Creb1 | phosphorylation | Ser133 | mouse | Cognitive Abnormalities | Levetiracetam | Associated | 4.0 (Moderate) | 31302262 | |
acc4229 | Rb | P13405 | Rb1 | phosphorylation | unclear | mouse | Diabetes Mellitus | Palbociclib | Associated | 4.0 (Moderate) | 31312360 | |
acc4230 | EGFR | P00533 | EGFR | phosphorylation | Tyr845 | human | Respiratory Syncytial Virus | A549 | PST2238 | Associated | 4.0 (Moderate) | 31381610 |
acc4231 | EGFR | P00533 | EGFR | phosphorylation | Tyr845 | human | Respiratory Syncytial Virus | HSAEC | PST2238 | Associated | 4.0 (Moderate) | 31381610 |
acc4233 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser204 | mouse | Asthma | Atrial natriuretic peptide (ANP) | Associated | 4.0 (Moderate) | 31496319 | |
acc4234 | cystathionine beta-synthase | Q91WT9 | Cbs | nitration | unclear | mouse | Pancreatitis | S-adenosylmethionine | Associated | 4.0 (Moderate) | 31539805 | |
acc4235 | JNK | P49185 | Mapk8 | phosphorylation | Thr183 | rat | Diabetes Mellitus | All-Trans Retinoic Acid | Associated | 4.0 (Moderate) | 31557800 | |
acc4236 | JNK | P49185 | Mapk8 | phosphorylation | Tyr185 | rat | Diabetes Mellitus | All-Trans Retinoic Acid | Associated | 4.0 (Moderate) | 31557800 | |
acc4237 | Smad3 | P84025 | Smad3 | phosphorylation | Ser423 | rat | Diabetes Mellitus | All-Trans Retinoic Acid | Associated | 4.0 (Moderate) | 31557800 | |
acc4238 | Smad3 | P84025 | Smad3 | phosphorylation | Ser425 | rat | Diabetes Mellitus | All-Trans Retinoic Acid | Associated | 4.0 (Moderate) | 31557800 | |
acc4239 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Diabetes Mellitus | CAF6 | Associated | 4.0 (Moderate) | 31566891 | |
acc4240 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Diabetes Mellitus | CAF12 | Associated | 4.0 (Moderate) | 31566891 | |
acc4241 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Diabetes Mellitus | CAF6 | Associated | 4.0 (Moderate) | 31566891 | |
acc4242 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Diabetes Mellitus | CAF6 | Associated | 4.0 (Moderate) | 31566891 | |
acc4243 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Diabetes Mellitus | CAF12 | Associated | 4.0 (Moderate) | 31566891 | |
acc4244 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Diabetes Mellitus | CAF12 | Associated | 4.0 (Moderate) | 31566891 | |
acc4245 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Diabetes Mellitus | CAF6 | Associated | 4.0 (Moderate) | 31566891 | |
acc4246 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Diabetes Mellitus | CAF6 | Associated | 4.0 (Moderate) | 31566891 | |
acc4247 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Diabetes Mellitus | CAF12 | Associated | 4.0 (Moderate) | 31566891 | |
acc4248 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Diabetes Mellitus | CAF12 | Associated | 4.0 (Moderate) | 31566891 | |
acc4249 | ACC | Q13085 | ACACA | phosphorylation | Ser79 | human | Hepatic Steatosis | HepG2 | PCW | Associated | 4.0 (Moderate) | 31569635 |
acc4250 | AMPK | P54646 | PRKAA2 | phosphorylation | Thr172 | human | Hepatic Steatosis | HepG2 | PCW | Associated | 4.0 (Moderate) | 31569635 |
acc4251 | AMPK | Q13131 | PRKAA1 | phosphorylation | Thr183 | human | Hepatic Steatosis | HepG2 | PCW | Associated | 4.0 (Moderate) | 31569635 |
acc3981 | Smad2 | Q62432 | Smad2 | phosphorylation | Ser465 | mouse | Hepatic Steatosis | Vaccination | Associated | 3.0 (Low) | 27562139 | |
acc3982 | Smad2 | Q62432 | Smad2 | phosphorylation | Ser467 | mouse | Hepatic Steatosis | Vaccination | Associated | 3.0 (Low) | 27562139 | |
acc4006 | Akt | P31750 | Akt1 | phosphorylation | unclear | mouse | Insulin Resistance | Calorie restriction | Associated | 3.0 (Low) | 28024145 | |
acc4007 | PTEN | O08586 | Pten | phosphorylation | Ser380 | mouse | Insulin Resistance | Calorie restriction | Associated | 3.0 (Low) | 28024145 | |
acc4012 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Neuronal Degeneration | CHIP OE | Associated | 3.0 (Low) | 28153090 | |
acc4013 | eIF2alpha | P68101 | Eif2s1 | phosphorylation | Ser51 | rat | Neuronal Degeneration | CHIP OE | Associated | 3.0 (Low) | 28153090 | |
acc4028 | Akt | P31750 | Akt1 | phosphorylation | Thr308 | mouse | Glucose Intolerance and Insulin Resistance | HCV infection | Associated | 3.0 (Low) | 28559285 | |
acc4029 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Glucose Intolerance and Insulin Resistance | HCV infection | Associated | 3.0 (Low) | 28559285 | |
acc4030 | FOXO1 | Q9R1E0 | Foxo1 | phosphorylation | Ser256 | mouse | Glucose Intolerance and Insulin Resistance | HCV infection | Associated | 3.0 (Low) | 28559285 | |
acc4031 | IRS2 | P81122 | Irs2 | phosphorylation | Tyr | mouse | Glucose Intolerance and Insulin Resistance | HCV infection | Associated | 3.0 (Low) | 28559285 | |
acc4032 | PDK1 | Q8BFP9 | Pdk1 | phosphorylation | Ser241 | mouse | Glucose Intolerance and Insulin Resistance | HCV infection | Associated | 3.0 (Low) | 28559285 | |
acc4104 | HSL | P54310 | Lipe | phosphorylation | Ser660 | mouse | Myocardial Infarction | Gipr KO | Associated | 3.0 (Low) | 29275960 | |
acc4105 | HSL | P54310 | Lipe | phosphorylation | Ser563 | mouse | Myocardial Infarction | Gipr KO | Associated | 3.0 (Low) | 29275960 | |
acc4174 | histone H3 | P84245 | H3-3b | acetylation | Lys9 | rat | Depression | Venlafaxine | Associated | 3.0 (Low) | 30640193 | |
acc4216 | CRMP2 | O08553 | Crmp2 | phosphorylation | Ser522 | mouse | Axonal Degeneration | CRMP2 KI | Associated | 3.0 (Low) | 31076621 | |
acc4224 | HDAC4 | Q6NZM9 | Hdac4 | O-GlcNAcylation | Ser642 | mouse | Heart Failure | HDAC4-KO | Associated | 3.0 (Low) | 31195810 | |
acc4225 | HDAC4 | Q6NZM9 | Hdac4 | phosphorylation | Ser632 | mouse | Heart Failure | HDAC4-KO | Associated | 3.0 (Low) | 31195810 | |
acc4232 | p53 | P04637 | TP53 | phosphorylation | unclear | human | "Endothelial Cell Injury, Apoptosis" | HUVEC | ACTN4 OE | Associated | 3.0 (Low) | 31399951 |
acc3664 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Bone Loss | MC3T3-E1 | Hydrogen water | Associated | 3.0 (Low) | 22648000 |
acc3665 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Bone Loss | MC3T3-E1 | Hydrogen water | Associated | 3.0 (Low) | 22648000 |
acc3666 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Bone Loss | MC3T3-E1 | Hydrogen water | Associated | 3.0 (Low) | 22648000 |
acc3667 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Bone Loss | MC3T3-E1 | Hydrogen water | Associated | 3.0 (Low) | 22648000 |
acc3788 | STAT3 | P52631 | Stat3 | phosphorylation | Tyr705 | rat | Diaphragm Wasting and Weakness | CMV | Associated | 3.0 (Low) | 24671708 | |
acc3789 | STAT3 | P52631 | Stat3 | phosphorylation | Ser727 | rat | Diaphragm Wasting and Weakness | CMV | Associated | 3.0 (Low) | 24671708 | |
acc3825 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Hypertrophic cardiomyopathy | YAP OE | Associated | 3.0 (Low) | 25168380 | |
acc3826 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Hypertrophic cardiomyopathy | YAP OE | Associated | 3.0 (Low) | 25168380 | |
acc3827 | FOXO3 | O43524 | FOXO3 | phosphorylation | Thr32 | human | Hypertrophic cardiomyopathy | YAP OE | Associated | 3.0 (Low) | 25168380 | |
acc3828 | YAP | P46937 | YAP1 | phosphorylation | Ser127 | human | Hypertrophic cardiomyopathy | YAP OE | Associated | 3.0 (Low) | 25168380 | |
acc3829 | YAP | P46938 | Yap1 | phosphorylation | Ser127 | mouse | Hypertrophic cardiomyopathy | YAP OE | Associated | 3.0 (Low) | 25168380 | |
acc3845 | ATM | Q62388 | Atm | phosphorylation | Ser1981 | mouse | Fibrosis | UUO model | ATM KO | Associated | 3.0 (Low) | 25480384 |
acc3847 | ATM | D4ACL8 | Atm | phosphorylation | Ser1981 | rat | Fibrosis | HK-2 | ATM KO | Associated | 3.0 (Low) | 25480384 |
acc3849 | ATM | D4ACL8 | Atm | phosphorylation | Ser1981 | rat | Fibrosis | NRK-49F | ATM KO | Associated | 3.0 (Low) | 25480384 |
acc3851 | p53 | P02340 | Tp53 | phosphorylation | Ser15 | mouse | Fibrosis | UUO model | ATM KO | Associated | 3.0 (Low) | 25480384 |
acc3853 | p53 | P10361 | Tp53 | phosphorylation | Ser15 | rat | Fibrosis | HK-2 | ATM KO | Associated | 3.0 (Low) | 25480384 |
acc3855 | p53 | P10361 | Tp53 | phosphorylation | Ser15 | rat | Fibrosis | NRK-49F | ATM KO | Associated | 3.0 (Low) | 25480384 |
acc3857 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser423 | mouse | Fibrosis | UUO model | ATM KO | Associated | 3.0 (Low) | 25480384 |
acc3858 | Smad3 | Q8BUN5 | Smad3 | phosphorylation | Ser425 | mouse | Fibrosis | UUO model | ATM KO | Associated | 3.0 (Low) | 25480384 |
acc3861 | Smad3 | P84025 | Smad3 | phosphorylation | Ser423 | rat | Fibrosis | HK-2 | ATM KO | Associated | 3.0 (Low) | 25480384 |
acc3862 | Smad3 | P84025 | Smad3 | phosphorylation | Ser425 | rat | Fibrosis | HK-2 | ATM KO | Associated | 3.0 (Low) | 25480384 |
acc3865 | Smad3 | P84025 | Smad3 | phosphorylation | Ser423 | rat | Fibrosis | NRK-49F | ATM KO | Associated | 3.0 (Low) | 25480384 |
acc3866 | Smad3 | P84025 | Smad3 | phosphorylation | Ser425 | rat | Fibrosis | NRK-49F | ATM KO | Associated | 3.0 (Low) | 25480384 |
acc3890 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Obese | Bariatric Surgery | Associated | 3.0 (Low) | 25876175 | |
acc3891 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Obese | Bariatric Surgery | Associated | 3.0 (Low) | 25876175 | |
acc4260 | MARCKS | P29966 | MARCKS | phosphorylation | Ser158 | human | IPF | MPS peptide | Associated | 3.0 (Low) | 31661644 | |
acc4271 | Akt | P47196 | Akt1 | phosphorylation | unclear | rat | Myocardial I/R Injury | Fibrauretine | Associated | 3.0 (Low) | 31796985 | |
acc4280 | Drp1 | Q8K1M6 | Dnm1l | phosphorylation | Ser616 | mouse | Mitochondrial Dysfunction | SN4741 | mutant A53T alpha-synuclein | Associated | 3.0 (Low) | 31881179 |
acc4284 | AMPK | Q5EG47 | Prkaa1 | phosphorylation | Thr183 | mouse | Colitis | Metrnl KO | Associated | 3.0 (Low) | 31949292 | |
acc4285 | AMPK | Q8BRK8 | Prkaa2 | phosphorylation | Thr172 | mouse | Colitis | Metrnl KO | Associated | 3.0 (Low) | 31949292 | |
acc4286 | mTOR | Q9JLN9 | Mtor | phosphorylation | Ser2448 | mouse | Colitis | Metrnl KO | Associated | 3.0 (Low) | 31949292 | |
acc4287 | p70S6K | Q8BSK8 | Rps6kb1 | phosphorylation | Ser371 | mouse | Colitis | Metrnl KO | Associated | 3.0 (Low) | 31949292 | |
acc4304 | PARP1 | P11103 | Parp1 | ubiquitination | Lys249 | mouse | Heart Failure | WWP2 KO | Associated | 3.0 (Low) | 32139900 | |
acc4305 | PARP1 | P11103 | Parp1 | ubiquitination | Lys418 | mouse | Heart Failure | WWP2 KO | Associated | 3.0 (Low) | 32139900 | |
acc4359 | GluR1 | P23818 | Gria1 | phosphorylation | unclear | mouse | Alzheimer's Disease | Photobiomodulation (PBM) | Associated | 3.0 (Low) | 33336891 | |
acc4360 | JNK3 | Q61831 | Mapk10 | phosphorylation | unclear | mouse | Alzheimer's Disease | Photobiomodulation (PBM) | Associated | 3.0 (Low) | 33336891 | |
acc4406 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Colitis | Nr3c1 KO | Associated | 3.0 (Low) | 33684964 | |
acc4424 | Akt | P31750 | Akt1 | phosphorylation | Ser473 | mouse | Obese | Short-term strength exercise (STSE) | Associated | 3.0 (Low) | 34203825 | |
acc4425 | IRS1 | P35569 | Irs1 | phosphorylation | Tyr612 | mouse | Obese | Short-term strength exercise (STSE) | Associated | 3.0 (Low) | 34203825 | |
acc4459 | ULK1 | O70405 | Ulk1 | ubiquitination | unclear | mouse | Cardiac Infarction | TRAF3 OE | Associated | 3.0 (Low) | 35318880 | |
acc4469 | eNOS | P70313 | Nos3 | phosphorylation | Ser1177 | mouse | Diabetes Mellitus | shIGFBP5 | Associated | 3.0 (Low) | 35866351 | |
acc4479 | Akt | P31750 | Akt1 | phosphorylation | Ser437 | mouse | Mitochondrial Dysfunction | Akap1 KO | Associated | 3.0 (Low) | 36263130 | |
acc4480 | Drp1 | Q8K1M6 | Dnm1l | phosphorylation | Ser637 | mouse | Mitochondrial Dysfunction | Akap1 KO | Associated | 3.0 (Low) | 36263130 | |
acc4507 | Jak1 | P52332 | Jak1 | ubiquitination | unclear | mouse | Cardiac Hypertrophy | Trim65 OE | Associated | 3.0 (Low) | 37080331 | |
acc4534 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Psoriasis | HaCaT | Acitretin-conjugated dextran nanoparticles (ACT-Dex NPs) | Associated | 3.0 (Low) | 35071218 |
acc4596 | EGFR | P00533 | EGFR | sulfenylation | Cys797 | human | Lung Cancer | H292 | DUOX1 KO | Associated | 3.0 (Low) | 30890751 |
acc4597 | EGFR | P00533 | EGFR | sulfenylation | Cys797 | human | Lung Cancer | H187 | DUOX1 KO | Associated | 3.0 (Low) | 30890751 |
acc4598 | EGFR | P00533 | EGFR | sulfenylation | Cys797 | human | Lung Cancer | A549 | DUOX1 KO | Associated | 3.0 (Low) | 30890751 |
acc4603 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Retinoblastoma | MA-10 | FGF9 | Associated | 3.0 (Low) | 30191630 |
acc4604 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Retinoblastoma | MA-10 | FGF9 | Associated | 3.0 (Low) | 30191630 |
acc4605 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Retinoblastoma | MA-10 | FGF9 | Associated | 3.0 (Low) | 30191630 |
acc4606 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Retinoblastoma | MA-10 | FGF9 | Associated | 3.0 (Low) | 30191630 |
acc4607 | Rb | P13405 | Rb1 | phosphorylation | Ser807 | mouse | Retinoblastoma | MA-10 | FGF9 | Associated | 3.0 (Low) | 30191630 |
acc4608 | Rb | P13405 | Rb1 | phosphorylation | Ser811 | mouse | Retinoblastoma | MA-10 | FGF9 | Associated | 3.0 (Low) | 30191630 |
acc4656 | retinoblastoma protein (Rb) | P13405 | Rb1 | phosphorylation | Ser807 | mouse | Diabetes Mellitus | PKG-OE | Associated | 3.0 (Low) | 19717728 | |
acc4657 | retinoblastoma protein (Rb) | P13405 | Rb1 | phosphorylation | Ser811 | mouse | Diabetes Mellitus | PKG-OE | Associated | 3.0 (Low) | 19717728 | |
acc4658 | VASP | P70460 | Vasp | phosphorylation | Ser239 | mouse | Diabetes Mellitus | PKG-OE | Associated | 3.0 (Low) | 19717728 | |
acc4703 | histone H3 | P68431 | H3C1 | acetylation | unclear | human | Lung Cancer | U1906 | TRAIL | Associated | 3.0 (Low) | 21771726 |
acc4704 | histone H3 | P68431 | H3C1 | acetylation | unclear | human | Lung Cancer | U1906 | Decitabine + VPA | Associated | 3.0 (Low) | 21771726 |
acc4705 | histone H3 | P68431 | H3C1 | acetylation | unclear | human | Lung Cancer | H2171 | Decitabine + VPA | Associated | 3.0 (Low) | 21771726 |
acc4747 | IRAK4 | Q8R4K2 | Irak4 | phosphorylation | Thr345 | mouse | Traumatic Brain Injury | IRAK4 KO | Associated | 3.0 (Low) | 35149117 | |
acc4748 | TAK1 | Q62073 | Map3k7 | phosphorylation | unclear | mouse | Traumatic Brain Injury | IRAK4 KO | Associated | 3.0 (Low) | 35149117 | |
acc4759 | Histone H3 | P68433 | H3c1 | acetylation | unclear | mouse | Acute Lung Injury | J774A.1 | Colchicine | Associated | 3.0 (Low) | 37115345 |
acc4760 | Histone H4 | P62806 | H4c1 | acetylation | unclear | mouse | Acute Lung Injury | J774A.1 | Colchicine | Associated | 3.0 (Low) | 37115345 |
acc4763 | PP2A | P63330 | Ppp2ca | methylation | Leu309 | mouse | Cardiac Dysfunction | LPS | Associated | 3.0 (Low) | 19201758 | |
acc4765 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Cardiomyopathy | Hydrogen therapy | Associated | 3.0 (Low) | 31440160 | |
acc4766 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Cardiomyopathy | Hydrogen therapy | Associated | 3.0 (Low) | 31440160 | |
acc4767 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Cardiomyopathy | Hydrogen therapy | Associated | 3.0 (Low) | 31440160 | |
acc4768 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Cardiomyopathy | Hydrogen therapy | Associated | 3.0 (Low) | 31440160 | |
acc4769 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Thr180 | mouse | Cardiomyopathy | Hydrogen therapy | Associated | 3.0 (Low) | 31440160 | |
acc4770 | p38 MAPK | P47811 | Mapk14 | phosphorylation | Tyr182 | mouse | Cardiomyopathy | Hydrogen therapy | Associated | 3.0 (Low) | 31440160 | |
acc4771 | JNK1 | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Cardiomyopathy | Hydrogen therapy | Associated | 3.0 (Low) | 31440160 | |
acc4772 | JNK1 | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Cardiomyopathy | Hydrogen therapy | Associated | 3.0 (Low) | 31440160 | |
acc4773 | JNK2 | Q9WTU6 | Mapk9 | phosphorylation | Thr183 | mouse | Cardiomyopathy | Hydrogen therapy | Associated | 3.0 (Low) | 31440160 | |
acc4774 | JNK2 | Q9WTU6 | Mapk9 | phosphorylation | Tyr185 | mouse | Cardiomyopathy | Hydrogen therapy | Associated | 3.0 (Low) | 31440160 | |
acc4775 | STAT3 | P42227 | Stat3 | phosphorylation | Tyr705 | mouse | Cardiomyopathy | Electroacupuncture (EA) | Associated | 3.0 (Low) | 36160853 | |
acc1341 | mTOR | P42345 | MTOR | phosphorylation | Ser2448 | human | Breast Cancer | MCF7 | Rapamycin | Associated | 3.0 (Low) | 30154572 |
acc1343 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MDA-MB-468 | IBP OE | Associated | 3.0 (Low) | 24113176 |
acc1344 | mTOR | P42345 | MTOR | phosphorylation | Ser2481 | human | Breast Cancer | MDA-MB-468 | IBP OE | Associated | 3.0 (Low) | 24113176 |
acc1345 | FOXO3a | O43524 | FOXO3 | phosphorylation | Thr32 | human | Breast Cancer | MDA-MB-468 | IBP OE | Associated | 3.0 (Low) | 24113176 |
acc1346 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MDA-MB-231 | IBP OE | Associated | 3.0 (Low) | 24113176 |
acc1347 | mTOR | P42345 | MTOR | phosphorylation | Ser2481 | human | Breast Cancer | MDA-MB-231 | IBP OE | Associated | 3.0 (Low) | 24113176 |
acc1348 | FOXO3a | O43524 | FOXO3 | phosphorylation | Thr32 | human | Breast Cancer | MDA-MB-231 | IBP OE | Associated | 3.0 (Low) | 24113176 |
acc1393 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Prostate Cancer | PC3 | Selenium | Associated | 3.0 (Low) | 16505097 |
acc1394 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Prostate Cancer | PC3 | Selenium | Associated | 3.0 (Low) | 16505097 |
acc1427 | HSP27 | P04792 | HSPB1 | phosphorylation | Ser82 | human | Lung Cancer | A549 | ZNF323A OE | Associated | 3.0 (Low) | 32576196 |
acc1428 | eIF2a | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Lung Cancer | A549 | ZNF323A OE | Associated | 3.0 (Low) | 32576196 |
acc1429 | IRS1 | P35568 | IRS1 | phosphorylation | Ser1101 | human | Lung Cancer | A549 | ZNF323A OE | Associated | 3.0 (Low) | 32576196 |
acc1430 | HSP27 | P04792 | HSPB1 | phosphorylation | Ser82 | human | Lung Cancer | H1299 | ZNF323A OE | Associated | 3.0 (Low) | 32576196 |
acc1431 | eIF2a | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Lung Cancer | H1299 | ZNF323A OE | Associated | 3.0 (Low) | 32576196 |
acc1432 | IRS1 | P35568 | IRS1 | phosphorylation | Ser1101 | human | Lung Cancer | H1299 | ZNF323A OE | Associated | 3.0 (Low) | 32576196 |
acc1528 | USP8 | P40818 | USP8 | phosphorylation | Thr907 | human | Breast Cancer | MCF7 | NRG1 OV | Associated | 3.0 (Low) | 17210635 |
acc1529 | ErbB3 | P21860 | ERBB3 | ubiquitination | unclear | human | Breast Cancer | MCF7 | NRG1 OV | Associated | 3.0 (Low) | 17210635 |
acc1532 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Breast Cancer | BT474 | anti-HER2 phage-based vaccine | Associated | 3.0 (Low) | 36011047 |
acc1533 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Breast Cancer | BT474 | anti-HER2 phage-based vaccine | Associated | 3.0 (Low) | 36011047 |
acc1534 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Breast Cancer | BT474 | anti-HER2 phage-based vaccine | Associated | 3.0 (Low) | 36011047 |
acc1535 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Breast Cancer | BT474 | anti-HER2 phage-based vaccine | Associated | 3.0 (Low) | 36011047 |
acc0350 | p27 | P46527 | CDKN1B | phosphorylation | Thr187 | human | Hepatocellular Carcinoma | HuH-7 | MIF4GD OV | Associated | 3.0 (Low) | 24336329 |
acc0570 | eIF2a | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Prostate Cancer | PC3 | EPHB4 KO | Associated | 3.0 (Low) | 31641103 |
acc0571 | eIF2a | Q9BY44 | EIF2A | phosphorylation | Ser51 | human | Prostate Cancer | 22Rv1 | EPHB4 KO | Associated | 3.0 (Low) | 31641103 |
acc0574 | EGFR | P00533 | EGFR | phosphorylation | Thr654 | human | Skin Cancer | A431 | AnxA6 expression | Associated | 3.0 (Low) | 31869496 |
acc0003 | EGFR | P00533 | EGFR | acetylation | Lys1037 | human | Colorectal Cancer | HT29 | Sulfiredoxin | Associated | 3.0 (Low) | 26290602 |
acc0010 | PVT1 H4 | P62805 | H4C1 | acetylation | unclear | human | Pancreas Cancer | PANC-1 | Gemcitabine | Associated | 3.0 (Low) | 34564701 |
acc0011 | PVT1 H4 | P62805 | H4C1 | acetylation | unclear | human | Pancreas Cancer | BxPC-3 | Gemcitabine | Associated | 3.0 (Low) | 34564701 |
acc0012 | PVT1 H4 | P62805 | H4C1 | acetylation | unclear | human | Pancreas Cancer | MIA PaCa-2 | Gemcitabine | Associated | 3.0 (Low) | 34564701 |
acc0024 | histone H3 | P68431 | H3C1 | methylation | Lys9 | human | Leukemia | AML-193 | 5-aza-2'-deoxycytidine | Associated | 3.0 (Low) | 19881540 |
acc0025 | histone H3 | P68431 | H3C1 | methylation | Lys9 | human | Leukemia | Kasumi | 5-aza-2'-deoxycytidine | Associated | 3.0 (Low) | 19881540 |
acc0026 | histone H3 | P68431 | H3C1 | methylation | Lys9 | human | Leukemia | KG1a | 5-aza-2'-deoxycytidine | Associated | 3.0 (Low) | 19881540 |
acc0027 | eIF4E histone H3 | P68431 | H3C1 | methylation | Arg3 | human | Colorectal Cancer | HCT116 | PRMT5 KO | Associated | 3.0 (Low) | 26078354 |
acc0028 | eIF4E histone H3 | P68431 | H3C1 | methylation | Arg3 | human | Colorectal Cancer | SW620 | PRMT5 KO | Associated | 3.0 (Low) | 26078354 |
acc0029 | FGFR3 hisone H4 | P62805 | H4C1 | methylation | Arg8 | human | Colorectal Cancer | SW620 | PRMT5 KO | Associated | 3.0 (Low) | 26078354 |
acc0030 | FGFR3 hisone H4 | P62805 | H4C1 | methylation | Arg8 | human | Colorectal Cancer | SW480 | PRMT5 KO | Associated | 3.0 (Low) | 26078354 |
acc0031 | eIF4E histone H3 | P68431 | H3C1 | methylation | Arg3 | human | Colorectal Cancer | SW480 | PRMT5 KO | Associated | 3.0 (Low) | 26078354 |
acc0032 | FGFR3 hisone H4 | P62805 | H4C1 | methylation | Arg3 | human | Colorectal Cancer | HCT116 | PRMT5 KO | Associated | 3.0 (Low) | 26078354 |
acc0033 | FGFR3 hisone H4 | P62805 | H4C1 | methylation | Arg3 | human | Colorectal Cancer | SW620 | PRMT5 KO | Associated | 3.0 (Low) | 26078354 |
acc0034 | FGFR3 hisone H4 | P62805 | H4C1 | methylation | Arg3 | human | Colorectal Cancer | SW480 | PRMT5 KO | Associated | 3.0 (Low) | 26078354 |
acc0035 | eIF4E histone H3 | P68431 | H3C1 | methylation | Arg8 | human | Colorectal Cancer | HCT116 | PRMT5 KO | Associated | 3.0 (Low) | 26078354 |
acc0036 | eIF4E histone H3 | P68431 | H3C1 | methylation | Arg8 | human | Colorectal Cancer | SW620 | PRMT5 KO | Associated | 3.0 (Low) | 26078354 |
acc0037 | eIF4E histone H3 | P68431 | H3C1 | methylation | Arg8 | human | Colorectal Cancer | SW480 | PRMT5 KO | Associated | 3.0 (Low) | 26078354 |
acc0038 | FGFR3 hisone H4 | P62805 | H4C1 | methylation | Arg8 | human | Colorectal Cancer | HCT116 | PRMT5 KO | Associated | 3.0 (Low) | 26078354 |
acc0164 | H2AX | P16104 | H2AX | phosphorylation | Ser139 | human | Leukemia | Doxorubicin | Associated | 3.0 (Low) | 19411853 | |
acc0166 | H2AX | P16104 | H2AX | phosphorylation | Ser139 | human | Leukemia | Daunomycin | Associated | 3.0 (Low) | 19411853 | |
acc0168 | H2AX | P16104 | H2AX | phosphorylation | Ser139 | human | Leukemia | Mitoxantrone | Associated | 3.0 (Low) | 19411853 | |
acc0170 | H2AX | P16104 | H2AX | phosphorylation | Ser139 | human | Leukemia | Idarubicin | Associated | 3.0 (Low) | 19411853 | |
acc0208 | IRF3 | Q14653 | IRF3 | phosphorylation | Ser396 | human | Medulloblastoma | TE671 | ISG15 OV | Associated | 3.0 (Low) | 20035788 |
acc0209 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1007 | human | Medulloblastoma | TE671 | ISG15 OV | Associated | 3.0 (Low) | 20035788 |
acc0210 | JAK2 | O60674 | JAK2 | phosphorylation | Tyr1008 | human | Medulloblastoma | TE671 | ISG15 OV | Associated | 3.0 (Low) | 20035788 |
acc0211 | STAT1 | P42224 | STAT1 | phosphorylation | Tyr727 | human | Medulloblastoma | TE671 | ISG15 OV | Associated | 3.0 (Low) | 20035788 |
acc0212 | JAK1 | P23458 | JAK1 | phosphorylation | Tyr701 | human | Medulloblastoma | TE671 | ISG15 OV | Associated | 3.0 (Low) | 20035788 |
acc0213 | Tyk2 | P29597 | TYK2 | phosphorylation | Tyr1054 | human | Medulloblastoma | TE671 | ISG15 OV | Associated | 3.0 (Low) | 20035788 |
acc0214 | Tyk2 | P29597 | TYK2 | phosphorylation | Tyr1055 | human | Medulloblastoma | TE671 | ISG15 OV | Associated | 3.0 (Low) | 20035788 |
acc0215 | STAT2 | P52630 | STAT2 | phosphorylation | Tyr690 | human | Medulloblastoma | TE671 | ISG15 OV | Associated | 3.0 (Low) | 20035788 |
acc0216 | STAT5 | P42229 | STAT5A | phosphorylation | Tyr694 | human | Medulloblastoma | TE671 | ISG15 OV | Associated | 3.0 (Low) | 20035788 |
acc1779 | EGFR | P00533 | EGFR | phosphorylation | Tyr845 | human | Lung Cancer | H1299 | GPNMB | Impairing | 3.0 (Low) | 33706413 |
acc1780 | GPNMB | Q14956 | GPNMB | glycosylation | Asn134 | human | Lung Cancer | H1299 | GPNMB | Impairing | 3.0 (Low) | 33706413 |
acc1789 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Neuroblastoma | SH-SY5Y | FK506 | Associated | 3.0 (Low) | 19659461 |
acc1790 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Neuroblastoma | SH-SY5Y | Cyclosporine A | Associated | 3.0 (Low) | 19659461 |
acc0657 | PI3K | P42336 | PIK3CA | phosphorylation | Tyr458 | human | Ovarian Cancer | SK-OV-3 | sh-TRAF4 | Associated | 3.0 (Low) | 36625999 |
acc0658 | PI3K | P42336 | PIK3CA | phosphorylation | Tyr199 | human | Ovarian Cancer | SK-OV-3 | sh-TRAF4 | Associated | 3.0 (Low) | 36625999 |
acc0663 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | CAOV3 | sh-TRAF4 | Associated | 3.0 (Low) | 36625999 |
acc0664 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Ovarian Cancer | SK-OV-3 | sh-TRAF4 | Associated | 3.0 (Low) | 36625999 |
acc0665 | PI3K | P42336 | PIK3CA | phosphorylation | Tyr458 | human | Ovarian Cancer | CAOV3 | sh-TRAF4 | Associated | 3.0 (Low) | 36625999 |
acc0666 | PI3K | P42336 | PIK3CA | phosphorylation | Tyr199 | human | Ovarian Cancer | CAOV3 | sh-TRAF4 | Associated | 3.0 (Low) | 36625999 |
acc1192 | CREB | Q01147 | Creb1 | phosphorylation | Ser133 | mouse | Hepatocellular Carcinoma | Hepa1-6 | Cav-1 | Associated | 3.0 (Low) | 31209283 |
acc1193 | Sp1 | O89090 | Sp1 | phosphorylation | Thr739 | mouse | Hepatocellular Carcinoma | Hepa1-6 | Cav-1 | Associated | 3.0 (Low) | 31209283 |
acc1194 | HNF4A | P49698 | Hnf4a | phosphorylation | Ser313 | mouse | Hepatocellular Carcinoma | Hepa1-6 | Cav-1 | Associated | 3.0 (Low) | 31209283 |
acc1195 | c-Myc | P01108 | Myc | phosphorylation | Ser62 | mouse | Hepatocellular Carcinoma | Hepa1-6 | Cav-1 | Associated | 3.0 (Low) | 31209283 |
acc1196 | CREB | Q01147 | Creb1 | phosphorylation | Ser133 | mouse | Hepatocellular Carcinoma | Hca-F | Cav-1 | Associated | 3.0 (Low) | 31209283 |
acc1197 | Sp1 | O89090 | Sp1 | phosphorylation | Thr739 | mouse | Hepatocellular Carcinoma | Hca-F | Cav-1 | Associated | 3.0 (Low) | 31209283 |
acc1198 | HNF4A | P49698 | Hnf4a | phosphorylation | Ser313 | mouse | Hepatocellular Carcinoma | Hca-F | Cav-1 | Associated | 3.0 (Low) | 31209283 |
acc1199 | c-Myc | P01108 | Myc | phosphorylation | Ser62 | mouse | Hepatocellular Carcinoma | Hca-F | Cav-1 | Associated | 3.0 (Low) | 31209283 |
acc1208 | AKT | P31749 | AKT1 | phosphorylation | unclear | human | Hepatocellular Carcinoma | HepG2 | PM2.5 | Associated | 3.0 (Low) | 28521450 |
acc1209 | AKT | P31749 | AKT1 | phosphorylation | unclear | human | Hepatocellular Carcinoma | HuH-7 | PM2.5 | Associated | 3.0 (Low) | 28521450 |
acc1249 | Arix | O14813 | PHOX2A | phosphorylation | unclear | human | Neuroblastoma | SH-SY5Y | UO126 | Associated | 3.0 (Low) | 16156742 |
acc1250 | Arix | O14813 | PHOX2A | phosphorylation | unclear | human | Neuroblastoma | SH-SY5Y | PD98059 | Associated | 3.0 (Low) | 16156742 |
acc1257 | cSrc | P12931 | SRC | phosphorylation | Tyr416 | human | Breast Cancer | MDA-MB-231 | pHe | Associated | 3.0 (Low) | 35538691 |
acc1258 | cSrc | P12931 | SRC | phosphorylation | Tyr416 | human | Breast Cancer | LM3 | pHe | Associated | 3.0 (Low) | 35538691 |
acc0919 | SAMHD1 | Q9Y3Z3 | SAMHD1 | phosphorylation | Thr592 | human | Leukemia | CD4+ T | Dasatinib | Associated | 3.0 (Low) | 32828803 |
acc0939 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Prostate Cancer | DU145 | PHLDA3 OV | Associated | 3.0 (Low) | 34303965 |
acc0940 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Prostate Cancer | PC3 | PHLDA3 OV | Associated | 3.0 (Low) | 34303965 |
acc0941 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Prostate Cancer | DU145 | PHLDA3 OV | Associated | 3.0 (Low) | 34303965 |
acc0942 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Prostate Cancer | PC3 | PHLDA3 OV | Associated | 3.0 (Low) | 34303965 |
acc1005 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Leukemia | HL-60 | Arachidonic acid(AA) + TPA | Associated | 3.0 (Low) | 23490067 |
acc1006 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Leukemia | HL-60 | Arachidonic acid(AA) + TPA | Associated | 3.0 (Low) | 23490067 |
acc1007 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Leukemia | HL-60 | Arachidonic acid(AA) + TPA | Associated | 3.0 (Low) | 23490067 |
acc1008 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Leukemia | HL-60 | Arachidonic acid(AA) + TPA | Associated | 3.0 (Low) | 23490067 |
acc1065 | histone H3 | P68431 | H3C1 | methylation | Lys9 | human | Prostate Cancer | LNCaP | Genistein | Associated | 3.0 (Low) | 18431742 |
acc1066 | histone H3 | P68431 | H3C1 | methylation | Lys9 | human | Prostate Cancer | PC3 | Genistein | Associated | 3.0 (Low) | 18431742 |
acc3111 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | BCap37 | miR-93 | Associated | 3.0 (Low) | 32796817 |
acc3157 | IRF3 | Q90643 | IRF3 | phosphorylation | Ser386 | chicken | RNA Virus Infection | DF-1 | VP3 protein | Associated | 3.0 (Low) | 33975961 |
acc3158 | IRF3 | Q14653 | IRF3 | phosphorylation | Ser386 | human | RNA Virus Infection | HEK293T | VP3 protein | Associated | 3.0 (Low) | 33975961 |
acc3159 | TBK1 | A0A8V0YQ76 | TBK1 | phosphorylation | Ser172 | chicken | RNA Virus Infection | DF-2 | VP3 protein | Associated | 3.0 (Low) | 33975961 |
acc3160 | TBK1 | Q9UHD2 | TBK1 | phosphorylation | Ser172 | human | RNA Virus Infection | HEK294T | VP3 protein | Associated | 3.0 (Low) | 33975961 |
acc3161 | TRAF3 | A0A3Q3AAA5 | TRAF3 | ubiquitination | Lys155 | chicken | RNA Virus Infection | DF-3 | VP3 protein | Associated | 3.0 (Low) | 33975961 |
acc3162 | TRAF3 | Q13114 | TRAF3 | ubiquitination | Lys155 | human | RNA Virus Infection | HEK295T | VP3 protein | Associated | 3.0 (Low) | 33975961 |
acc3171 | Drp1 | Q8K1M6 | Dnm1l | phosphorylation | Ser616 | mouse | Colorectal Cancer | MC38 | PD-1 Positive | Associated | 3.0 (Low) | 34535949 |
acc3185 | histone H3 | P68433 | H3c1 | acetylation | Lys27 | mouse | Osteosarcoma | "MG63,U2OS" | Levobupivacaine | Associated | 3.0 (Low) | 35333774 |
acc3266 | Akt | P47196 | Akt1 | phosphorylation | Thr308 | rat | Diabetes Mellitus | islet-transplanted | Associated | 3.0 (Low) | 11723053 | |
acc3267 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Diabetes Mellitus | islet-transplanted | Associated | 3.0 (Low) | 11723053 | |
acc3268 | GSK3alpha | P18265 | Gsk3a | phosphorylation | Ser21 | rat | Diabetes Mellitus | islet-transplanted | Associated | 3.0 (Low) | 11723053 | |
acc3269 | GSK3beta | P18266 | Gsk3b | phosphorylation | Ser9 | rat | Diabetes Mellitus | islet-transplanted | Associated | 3.0 (Low) | 11723053 | |
acc3270 | IRS2 | F1MAL5 | Irs2 | phosphorylation | Tyr | rat | Diabetes Mellitus | islet-transplanted | Associated | 3.0 (Low) | 11723053 | |
acc3271 | p52(Shc) | O70143 | Shc3 | phosphorylation | Tyr | rat | Diabetes Mellitus | islet-transplanted | Associated | 3.0 (Low) | 11723053 | |
acc3276 | CREB | Q01147 | Creb1 | phosphorylation | Ser133 | mouse | Embryonic Palatal Issue | MEPM cells | Forskolin | Associated | 3.0 (Low) | 12175701 |
acc3281 | IRS1 | P35568 | IRS1 | phosphorylation | Tyr612 | human | Diabetes Mellitus | Weight loss | Associated | 3.0 (Low) | 12882908 | |
acc3303 | PKC delta | P28867 | Prkcd | phosphorylation | Thr505 | mouse | Allergic | Lyn(-/-) BMMCs | Lyn KO | Associated | 3.0 (Low) | 15210764 |
acc3304 | SHIP | Q61131 | Inpp5d | phosphorylation | Tyr1020 | mouse | Allergic | Lyn(-/-) BMMCs | Lyn KO | Associated | 3.0 (Low) | 15210764 |
acc3331 | H2AX | P16104 | H2AX | phosphorylation | unclear | human | Ovarian Cancer | IGROV-1 | ST1926+ZD1839 | Associated | 3.0 (Low) | 15781651 |
acc3375 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Myocardial Infarction | Aerobic exercise (AE) | Associated | 3.0 (Low) | 17505785 | |
acc3392 | ERK1 | Q63844 | Mapk3 | phosphorylation | Thr202 | mouse | Insulin Resistance | MKP-4 OE | Associated | 3.0 (Low) | 18296638 | |
acc3393 | ERK1 | Q63844 | Mapk3 | phosphorylation | Tyr204 | mouse | Insulin Resistance | MKP-4 OE | Associated | 3.0 (Low) | 18296638 | |
acc3394 | ERK2 | P63085 | Mapk1 | phosphorylation | Thr185 | mouse | Insulin Resistance | MKP-4 OE | Associated | 3.0 (Low) | 18296638 | |
acc3395 | ERK2 | P63085 | Mapk1 | phosphorylation | Tyr187 | mouse | Insulin Resistance | MKP-4 OE | Associated | 3.0 (Low) | 18296638 | |
acc3396 | JNK | Q91Y86 | Mapk8 | phosphorylation | Thr183 | mouse | Insulin Resistance | MKP-4 OE | Associated | 3.0 (Low) | 18296638 | |
acc3397 | JNK | Q91Y86 | Mapk8 | phosphorylation | Tyr185 | mouse | Insulin Resistance | MKP-4 OE | Associated | 3.0 (Low) | 18296638 | |
acc3453 | ASK-1 | O35099 | Map3k5 | phosphorylation | Ser83 | mouse | Alcoholic Cardiomyopathy | ALDH2 transgene | Associated | 3.0 (Low) | 19332462 | |
acc3454 | CREB | Q01147 | Creb1 | phosphorylation | Ser133 | mouse | Alcoholic Cardiomyopathy | ALDH2 transgene | Associated | 3.0 (Low) | 19332462 | |
acc3455 | GATA3 | P23772 | Gata3 | phosphorylation | Ser105 | mouse | Alcoholic Cardiomyopathy | ALDH2 transgene | Associated | 3.0 (Low) | 19332462 | |
acc3456 | GSK3beta | Q9WV60 | Gsk3b | phosphorylation | Ser9 | mouse | Alcoholic Cardiomyopathy | ALDH2 transgene | Associated | 3.0 (Low) | 19332462 | |
acc3536 | histone H3 | P68431 | H3C1 | acetylation | Lys9 | human | Colorectal Cancer | SW620 | Vorinostat + Capecitabine | Associated | 3.0 (Low) | 21045833 |
acc3537 | histone H3 | P68431 | H3C1 | acetylation | Lys14 | human | Colorectal Cancer | SW620 | Vorinostat + Capecitabine | Associated | 3.0 (Low) | 21045833 |
acc3563 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MDA-MB-231 | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3564 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | MCF-7 | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3565 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Cervical Cancer | Hela | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3566 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Breast Cancer | MDA-MB-231 | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3567 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Breast Cancer | MCF-7 | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3568 | AKT | P31749 | AKT1 | phosphorylation | Thr308 | human | Cervical Cancer | Hela | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3569 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Breast Cancer | MDA-MB-231 | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3570 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Breast Cancer | MDA-MB-231 | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3571 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Breast Cancer | MCF-7 | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3572 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Breast Cancer | MCF-7 | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3573 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Cervical Cancer | Hela | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3574 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Cervical Cancer | Hela | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3575 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Breast Cancer | MDA-MB-231 | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3576 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Breast Cancer | MDA-MB-231 | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3577 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Breast Cancer | MCF-7 | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3578 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Breast Cancer | MCF-7 | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3579 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Cervical Cancer | Hela | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3580 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Cervical Cancer | Hela | Hypoxia | Associated | 3.0 (Low) | 21642357 |
acc3583 | GATA4 | Q08369 | Gata4 | phosphorylation | Ser105 | rat | Systolic Dysfunction | GATA-4 KO | Associated | 3.0 (Low) | 21702924 | |
acc2327 | Tau | P10636 | MAPT | phosphorylation | Thr205 | human | Neuroblastoma | SH-SY5Y | Ebselen | Associated | 3.0 (Low) | 22634399 |
acc2328 | Tau | P10636 | MAPT | phosphorylation | Ser396 | human | Neuroblastoma | SH-SY5Y | Ebselen | Associated | 3.0 (Low) | 22634399 |
acc2329 | Tau | P10636 | MAPT | phosphorylation | Thr231 | human | Neuroblastoma | SH-SY5Y | Ebselen | Associated | 3.0 (Low) | 22634399 |
acc2330 | Smad2 | Q15796 | SMAD2 | phosphorylation | Ser465 | human | Breast Cancer | MCF7 | SSA | Associated | 3.0 (Low) | 26769851 |
acc2331 | Smad2 | Q15796 | SMAD2 | phosphorylation | Ser467 | human | Breast Cancer | MCF7 | SSA | Associated | 3.0 (Low) | 26769851 |
acc2332 | Smad3 | P84022 | SMAD3 | phosphorylation | Ser423 | human | Breast Cancer | MCF7 | SSA | Associated | 3.0 (Low) | 26769851 |
acc2333 | Smad3 | P84022 | SMAD3 | phosphorylation | Ser425 | human | Breast Cancer | MCF7 | SSA | Associated | 3.0 (Low) | 26769851 |
acc2334 | Smad2 | Q15796 | SMAD2 | phosphorylation | Ser465 | human | Breast Cancer | MDA-MB-231 | SSA | Associated | 3.0 (Low) | 26769851 |
acc2335 | Smad2 | Q15796 | SMAD2 | phosphorylation | Ser467 | human | Breast Cancer | MDA-MB-231 | SSA | Associated | 3.0 (Low) | 26769851 |
acc2336 | Smad3 | P84022 | SMAD3 | phosphorylation | Ser423 | human | Breast Cancer | MDA-MB-231 | SSA | Associated | 3.0 (Low) | 26769851 |
acc2337 | Smad3 | P84022 | SMAD3 | phosphorylation | Ser425 | human | Breast Cancer | MDA-MB-231 | SSA | Associated | 3.0 (Low) | 26769851 |
acc2406 | H2AX | P16104 | H2AX | methylation | Lys134 | human | Breast Cancer | MDA-MB-231 | OTS193320 | Associated | 3.0 (Low) | 30159125 |
acc2407 | H2AX | P16104 | H2AX | phosphorylation | Ser139 | human | Breast Cancer | MDA-MB-231 | OTS193320 | Associated | 3.0 (Low) | 30159125 |
acc2408 | H2AX | P16104 | H2AX | methylation | Lys134 | human | Lung Cancer | A549 | OTS193320 | Associated | 3.0 (Low) | 30159125 |
acc2409 | H2AX | P16104 | H2AX | phosphorylation | Ser139 | human | Lung Cancer | A549 | OTS193320 | Associated | 3.0 (Low) | 30159125 |
acc2440 | H2AX | P16104 | H2AX | phosphorylation | Ser139 | human | Melanoma | RPMI7951 | arsenite | Associated | 3.0 (Low) | 17145805 |
acc2532 | AMPK | P54646 | PRKAA2 | phosphorylation | Thr172 | human | Hepatocellular Carcinoma | HepG2 | Berberine | Associated | 3.0 (Low) | 16508037 |
acc2533 | AMPK | Q13131 | PRKAA1 | phosphorylation | Thr183 | human | Hepatocellular Carcinoma | HepG2 | Berberine | Associated | 3.0 (Low) | 16508037 |
acc2554 | PKCzeta | Q05513 | PRKCZ | ubiquitination | Lys48 | human | Lung Cancer | HOIL-1L expression | Enhancing | 3.0 (Low) | 25118570 | |
acc2104 | histone H3 | P68431 | H3C1 | phosphorylation | Ser10 | human | Breast Cancer | MDA-MB-231 | BOS172722 | Associated | 3.0 (Low) | 31575759 |
acc2105 | histone H3 | P68431 | H3C1 | phosphorylation | Ser10 | human | Breast Cancer | MDA-MB-468 | BOS172722 | Associated | 3.0 (Low) | 31575759 |
acc2259 | PP2A | Q15257 | PTPA | phosphorylation | unclear | human | Sarcoma | Rh1 | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2260 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Sarcoma | Rh1 | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2261 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Sarcoma | Rh1 | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2262 | PP2A | Q15257 | PTPA | phosphorylation | unclear | human | Colorectal Cancer | HT29 | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2263 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Colorectal Cancer | HT29 | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2264 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Colorectal Cancer | HT29 | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2265 | PP2A | Q15257 | PTPA | phosphorylation | unclear | human | Cervical Cancer | HeLa | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2266 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Cervical Cancer | HeLa | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2267 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Cervical Cancer | HeLa | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2268 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Cervical Cancer | HeLa | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2269 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Cervical Cancer | HeLa | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2270 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Sarcoma | Rh1 | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2271 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Sarcoma | Rh1 | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2272 | PP2A | Q15257 | PTPA | phosphorylation | unclear | human | Sarcoma | Rh30 | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2273 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Sarcoma | Rh30 | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2274 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Sarcoma | Rh30 | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2275 | ERK2 | P28482 | MAPK1 | phosphorylation | Thr185 | human | Sarcoma | Rh30 | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2276 | ERK2 | P28482 | MAPK1 | phosphorylation | Tyr187 | human | Sarcoma | Rh30 | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2277 | ERK1 | P27361 | MAPK3 | phosphorylation | Thr202 | human | Colorectal Cancer | HT29 | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2278 | ERK1 | P27361 | MAPK3 | phosphorylation | Tyr204 | human | Colorectal Cancer | HT29 | Resveratrol | Associated | 3.0 (Low) | 30066962 |
acc2897 | STAT3 | P40763 | STAT3 | phosphorylation | unclear | human | Insulin Resistance | HUVEC | miR-492 | Associated | 3.0 (Low) | 24526524 |
acc2898 | STAT3 | P42227 | Stat3 | phosphorylation | unclear | mouse | Insulin Resistance | 3T3-L1 | miR-492 | Associated | 3.0 (Low) | 24526524 |
acc2909 | cortactin | Q14247 | CTTN | phosphorylation | Tyr421 | human | Hepatocellular Carcinoma | HUH-7 | MPZL1 OE | Associated | 3.0 (Low) | 24812600 |
acc2910 | cortactin | Q14247 | CTTN | phosphorylation | Tyr421 | human | Hepatocellular Carcinoma | Hep3B | MPZL1 OE | Associated | 3.0 (Low) | 24812600 |
acc2911 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Hepatocellular Carcinoma | HUH-7 | MPZL1 OE | Associated | 3.0 (Low) | 24812600 |
acc2912 | Src | P12931 | SRC | phosphorylation | Tyr416 | human | Hepatocellular Carcinoma | Hep3B | MPZL1 OE | Associated | 3.0 (Low) | 24812600 |
acc2918 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Colorectal Cancer | DLD-1 | cPLA2alpha OE | Associated | 3.0 (Low) | 25365190 |
acc2940 | Rab13 | P51153 | RAB13 | phosphorylation | Ser111 | human | Parkinson's Disease | HEK293 | PINK1 | Associated | 3.0 (Low) | 26471730 |
acc2941 | Rab8A | P61006 | RAB8A | phosphorylation | Ser111 | human | Parkinson's Disease | HEK293 | PINK1 | Associated | 3.0 (Low) | 26471730 |
acc2942 | Rab8B | Q92930 | RAB8B | phosphorylation | Ser111 | human | Parkinson's Disease | HEK293 | PINK1 | Associated | 3.0 (Low) | 26471730 |
acc2984 | H2AX | P16104 | H2AX | phosphorylation | Ser139 | human | Prostate Cancer | DU145 | Etoposide | Associated | 3.0 (Low) | 28387728 |
acc2998 | hnRNPA1 | P09651 | HNRNPA1 | phosphorylation | Ser6 | human | Colorectal Cancer | HCT116 | S6 kinase 2 (S6K2) | Associated | 3.0 (Low) | 29344170 |
acc3066 | AR | P10275 | AR | phosphorylation | Tyr534 | human | Prostate Cancer | LNCaP | DUSP22 | Associated | 3.0 (Low) | 31693867 |
acc3068 | XPF | Q92889 | ERCC4 | acetylation | Lys911 | human | Genome Instability | HeLa | UV irradiation | Associated | 3.0 (Low) | 32034146 |
acc1827 | histone H3 | P68431 | H3C1 | methylation | Lys27 | human | Leukemia | HL-60 | ATRA | Associated | 3.0 (Low) | 19578722 |
acc1828 | histone H4 | P62805 | H4C1 | acetylation | unclear | human | Leukemia | HL-60 | ATRA | Associated | 3.0 (Low) | 19578722 |
acc1856 | histone H3 | P68431 | H3C1 | methylation | Lys9 | human | Colorectal Cancer | SW480 | Mithramycin | Associated | 3.0 (Low) | 32473242 |
acc1857 | histone H3 | P68431 | H3C1 | methylation | Lys9 | human | Colorectal Cancer | LoVo | Mithramycin | Associated | 3.0 (Low) | 32473242 |
acc1925 | IRS1 | P35568 | IRS1 | phosphorylation | Ser312 | human | Breast Cancer | MCF7 | anisomycin | Associated | 3.0 (Low) | 15952059 |
acc1953 | IRS1 | P35568 | IRS1 | phosphorylation | Tyr | human | Hepatocellular Carcinoma | FOCUS | Ethanol | Associated | 3.0 (Low) | 9884156 |
acc1966 | ULK1 | O75385 | ULK1 | phosphorylation | Ser757 | human | Melanoma | A375 | p53 upregulated regulator of p53 levels (PURPL) | Associated | 3.0 (Low) | 34759263 |
acc1967 | ULK1 | O75385 | ULK1 | phosphorylation | Ser555 | human | Melanoma | A375 | p53 upregulated regulator of p53 levels (PURPL) | Associated | 3.0 (Low) | 34759263 |
acc1968 | ULK1 | O75385 | ULK1 | phosphorylation | Ser317 | human | Melanoma | A375 | p53 upregulated regulator of p53 levels (PURPL) | Associated | 3.0 (Low) | 34759263 |
acc1969 | ULK1 | O75385 | ULK1 | phosphorylation | Ser757 | human | Melanoma | SK-Mel-28 | p53 upregulated regulator of p53 levels (PURPL) | Associated | 3.0 (Low) | 34759263 |
acc1970 | ULK1 | O75385 | ULK1 | phosphorylation | Ser555 | human | Melanoma | SK-Mel-28 | p53 upregulated regulator of p53 levels (PURPL) | Associated | 3.0 (Low) | 34759263 |
acc1971 | ULK1 | O75385 | ULK1 | phosphorylation | Ser317 | human | Melanoma | SK-Mel-28 | p53 upregulated regulator of p53 levels (PURPL) | Associated | 3.0 (Low) | 34759263 |
acc1972 | ULK1 | O75385 | ULK1 | phosphorylation | Ser757 | human | Melanoma | SK-MEL-1 | p53 upregulated regulator of p53 levels (PURPL) | Associated | 3.0 (Low) | 34759263 |
acc1973 | ULK1 | O75385 | ULK1 | phosphorylation | Ser555 | human | Melanoma | SK-MEL-1 | p53 upregulated regulator of p53 levels (PURPL) | Associated | 3.0 (Low) | 34759263 |
acc1974 | ULK1 | O75385 | ULK1 | phosphorylation | Ser317 | human | Melanoma | SK-MEL-1 | p53 upregulated regulator of p53 levels (PURPL) | Associated | 3.0 (Low) | 34759263 |
acc1991 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Neuroblastoma | SH-SY5Y | Ethanol | Associated | 3.0 (Low) | 26206265 |
acc1992 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Neuroblastoma | IMR-32 | Ethanol | Associated | 3.0 (Low) | 26206265 |
acc1997 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Medulloblastoma | Daoy | SPARC OE | Associated | 3.0 (Low) | 21613407 |
acc1998 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Medulloblastoma | D283 | SPARC OE | Associated | 3.0 (Low) | 21613407 |
acc1999 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr727 | human | Medulloblastoma | H2405 | SPARC OE | Associated | 3.0 (Low) | 21613407 |
acc2000 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr727 | human | Medulloblastoma | H2411 | SPARC OE | Associated | 3.0 (Low) | 21613407 |
acc2001 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Medulloblastoma | UW228 | SPARC OE | Associated | 3.0 (Low) | 21613407 |
acc2002 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Medulloblastoma | D425 | SPARC OE | Associated | 3.0 (Low) | 21613407 |
acc2003 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Medulloblastoma | H2405 | SPARC OE | Associated | 3.0 (Low) | 21613407 |
acc2004 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr705 | human | Medulloblastoma | H2411 | SPARC OE | Associated | 3.0 (Low) | 21613407 |
acc2005 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr727 | human | Medulloblastoma | Daoy | SPARC OE | Associated | 3.0 (Low) | 21613407 |
acc2006 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr727 | human | Medulloblastoma | D283 | SPARC OE | Associated | 3.0 (Low) | 21613407 |
acc2007 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr727 | human | Medulloblastoma | UW228 | SPARC OE | Associated | 3.0 (Low) | 21613407 |
acc2008 | STAT3 | P40763 | STAT3 | phosphorylation | Tyr727 | human | Medulloblastoma | D425 | SPARC OE | Associated | 3.0 (Low) | 21613407 |
acc2021 | LASP1 | Q14847 | LASP1 | phosphorylation | Tyr171 | human | Leukemia | BV173 | Nilotinib | Associated | 3.0 (Low) | 24913448 |
acc2666 | histone H3 | P68431 | H3C1 | acetylation | unclear | human | Hepatocellular Carcinoma | HepG2 | TSA | Associated | 3.0 (Low) | 15955204 |
acc2667 | histone H3 | P68431 | H3C1 | acetylation | unclear | human | Hepatocellular Carcinoma | Huh-7 | TSA | Associated | 3.0 (Low) | 15955204 |
acc2668 | histone H4 | P62805 | H4C1 | acetylation | unclear | human | Hepatocellular Carcinoma | HepG2 | TSA | Associated | 3.0 (Low) | 15955204 |
acc2669 | histone H4 | P62805 | H4C1 | acetylation | unclear | human | Hepatocellular Carcinoma | Huh-7 | TSA | Associated | 3.0 (Low) | 15955204 |
acc2724 | histone H3 | P68431 | H3C1 | phosphorylation | Ser10 | human | Breast Cancer | MCF-7 | Doxorubicin | Associated | 3.0 (Low) | 17363502 |
acc2725 | histone H3 | P68431 | H3C1 | phosphorylation | Ser10 | human | Breast Cancer | MCF-7 | Cisplatin | Associated | 3.0 (Low) | 17363502 |
acc2726 | histone H4 | P62805 | H4C1 | trimethylation | Lys20 | human | Breast Cancer | MCF-7 | Doxorubicin | Associated | 3.0 (Low) | 17363502 |
acc2727 | histone H4 | P62805 | H4C1 | trimethylation | Lys20 | human | Breast Cancer | MCF-7 | Cisplatin | Associated | 3.0 (Low) | 17363502 |
acc2728 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Mast Cell Activation | hCBMC | anti-Fc epsilon RI alpha mAb designated 15/1 | Associated | 3.0 (Low) | 17368811 |
acc2735 | IPP5 | Q8WVI7 | PPP1R1C | phosphorylation | Thr40 | human | Colorectal Cancer | SW480 | IPP5 OE | Associated | 3.0 (Low) | 18310074 |
acc2736 | IPP5 | Q8WVI7 | PPP1R1C | phosphorylation | Thr40 | human | Colorectal Cancer | SW620 | IPP5 OE | Associated | 3.0 (Low) | 18310074 |
acc2769 | Smad1 | P70340 | Smad1 | phosphorylation | unclear | mouse | Fibrodysplasia Ossificans Progressiva | C2C12 | mutant ALK2-R206H receptor | Associated | 3.0 (Low) | 19929436 |
acc2770 | GSK3beta | P18266 | Gsk3b | phosphorylation | Ser9 | rat | Infarction | Ischemic post-conditioning | Associated | 3.0 (Low) | 20054613 | |
acc2839 | SRC-3 | Q99469 | STAC | phosphorylation | Ser857 | human | Lung Cancer | H1299 | ERK3 OE | Associated | 3.0 (Low) | 22505454 |
acc2840 | SRC-3 | Q99469 | STAC | phosphorylation | Ser857 | human | Lung Cancer | A549 | ERK3 OE | Associated | 3.0 (Low) | 22505454 |
acc2625 | PDGFR | P20033 | Pdgfa | phosphorylation | Tyr | mouse | Pi-Turnover | NIH 3T3 | Glucopiericidin A | Associated | 2.0 (Low) | 8653074 |
acc2626 | PLC-gamma1 | Q62077 | Plcg1 | phosphorylation | Tyr783 | mouse | Pi-Turnover | NIH 3T3 | Glucopiericidin A | Associated | 2.0 (Low) | 8653074 |
acc2627 | SNAP-25 | P60881 | Snap25 | phosphorylation | Ser187 | rat | Synaptic Plasticity | PC12 cells | PMA | Associated | 2.0 (Low) | 8662851 |
acc2689 | DARPP-32 | Q6J4I0 | Ppp1r1b | phosphorylation | Thr34 | rat | Cell Signaling | PC-12/rNPFF1 | PFR(Tic)amide + Forskolin | Associated | 2.0 (Low) | 16490283 |
acc2781 | p53 | P02340 | Tp53 | phosphorylation | Ser18 | mouse | Insulin Resistance | N-acetylcysteine | Associated | 2.0 (Low) | 20956556 | |
acc3200 | PPARgamma | P37238 | Pparg | phosphorylation | Ser273 | mouse | Diabetes Mellitus | Helical peptide segments from the LXXLL motif region | Associated | 2.0 (Low) | 36057906 | |
acc3368 | nNOS | P29475 | NOS1 | phosphorylation | Ser847 | human | Brain Nitric Oxide Regulation | HEK-293 | EGF | Associated | 2.0 (Low) | 16984226 |
acc3369 | nNOS | P29476 | Nos1 | phosphorylation | Ser847 | rat | Brain Nitric Oxide Regulation | GH3 | EGF | Associated | 2.0 (Low) | 16984226 |
acc3415 | ACC | P11497 | Acaca | phosphorylation | Ser79 | rat | Hypothyroidism | T3 | Associated | 2.0 (Low) | 18703632 | |
acc3416 | AMPK | P54645 | Prkaa1 | phosphorylation | Thr183 | rat | Hypothyroidism | T3 | Associated | 2.0 (Low) | 18703632 | |
acc3417 | AMPK | Q09137 | Prkaa2 | phosphorylation | Thr172 | rat | Hypothyroidism | T3 | Associated | 2.0 (Low) | 18703632 | |
acc3530 | Akt | P47196 | Akt1 | phosphorylation | Ser473 | rat | Myocardial Infarction | EPO | Associated | 2.0 (Low) | 20981553 | |
acc3531 | ERK1 | P21708 | Mapk3 | phosphorylation | Thr202 | rat | Myocardial Infarction | EPO | Associated | 2.0 (Low) | 20981553 | |
acc3532 | ERK1 | P21708 | Mapk3 | phosphorylation | Tyr204 | rat | Myocardial Infarction | EPO | Associated | 2.0 (Low) | 20981553 | |
acc3533 | ERK2 | P63086 | Mapk1 | phosphorylation | Thr185 | rat | Myocardial Infarction | EPO | Associated | 2.0 (Low) | 20981553 | |
acc3534 | ERK2 | P63086 | Mapk1 | phosphorylation | Tyr187 | rat | Myocardial Infarction | EPO | Associated | 2.0 (Low) | 20981553 | |
acc3535 | GSK3beta | P18266 | Gsk3b | phosphorylation | Ser9 | rat | Myocardial Infarction | EPO | Associated | 2.0 (Low) | 20981553 | |
acc2876 | GSK3beta | P49841 | GSK3B | phosphorylation | Ser9 | human | Neuroblastoma | SH-SY5Y | Curcumin | Associated | 2.0 (Low) | 24188406 |
acc2877 | Tau | P10636 | MAPT | phosphorylation | Thr231 | human | Neuroblastoma | SH-SY5Y | Curcumin | Associated | 2.0 (Low) | 24188406 |
acc2878 | Tau | P10636 | MAPT | phosphorylation | Ser396 | human | Neuroblastoma | SH-SY5Y | Curcumin | Associated | 2.0 (Low) | 24188406 |
acc2952 | RyR2 | E9Q401 | Ryr2 | phosphorylation | Ser2814 | mouse | Heart Failure | Dantrolene | Associated | 2.0 (Low) | 27318036 | |
acc2953 | RyR2 | P30957 | RYR2 | phosphorylation | Ser2814 | rabbit | Heart Failure | Dantrolene | Associated | 2.0 (Low) | 27318036 | |
acc2991 | IGFBP-1 | P08833 | IGFBP1 | phosphorylation | Ser98 | human | Hypoxia | HepG2 | Rapamycin + Hypoxia | Associated | 2.0 (Low) | 29037858 |
acc2992 | IGFBP-1 | P08833 | IGFBP1 | phosphorylation | Ser101 | human | Hypoxia | HepG2 | Rapamycin + Hypoxia | Associated | 2.0 (Low) | 29037858 |
acc2993 | IGFBP-1 | P08833 | IGFBP1 | phosphorylation | Ser119 | human | Hypoxia | HepG2 | Rapamycin + Hypoxia | Associated | 2.0 (Low) | 29037858 |
acc2994 | IGFBP-1 | P08833 | IGFBP1 | phosphorylation | Ser169 | human | Hypoxia | HepG2 | Rapamycin + Hypoxia | Associated | 2.0 (Low) | 29037858 |
acc2995 | IGFBP-1 | P08833 | IGFBP1 | phosphorylation | Ser174 | human | Hypoxia | HepG2 | Rapamycin + Hypoxia | Associated | 2.0 (Low) | 29037858 |
acc1147 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Myeloma | XG-6 | mAVE1642 | Associated | 2.0 (Low) | 16951388 |
acc0680 | p125FAK | P34152 | Ptk2 | phosphorylation | Tyr397 | mouse | Mouse Embryonic Fibroblast | Swiss 3T3 | Thapsigargin | Associated | 2.0 (Low) | 8314789 |
acc0768 | AKT | P31749 | AKT1 | phosphorylation | Ser473 | human | Breast Cancer | BC | anthracyclines | Associated | 2.0 (Low) | 17804473 |
acc4529 | FRS2 | Q8WU20 | FRS2 | phosphorylation | Ser | rat | Neuronal Differentiation | PC-12 | U0126 | Associated | 2.0 (Low) | 19652666 |
acc4530 | FRS2 | Q8WU20 | FRS2 | phosphorylation | Thr | rat | Neuronal Differentiation | PC-12 | U0126 | Associated | 2.0 (Low) | 19652666 |
acc4531 | FRS2 | Q8WU20 | FRS2 | phosphorylation | Ser | rat | Neuronal Differentiation | PC-12 | POV | Associated | 2.0 (Low) | 19652666 |
acc4532 | FRS2 | Q8WU20 | FRS2 | phosphorylation | Thr | rat | Neuronal Differentiation | PC-12 | POV | Associated | 2.0 (Low) | 19652666 |
acc3714 | ESR1 | P03372 | ESR1 | methylation | unclear | human | Colorectal Cancer | Folate | Associated | 2.0 (Low) | 23328702 | |
acc3715 | MLH1 | P40692 | MLH1 | methylation | unclear | human | Colorectal Cancer | Folate | Associated | 2.0 (Low) | 23328702 | |
acc3741 | ACC | P11497 | Acaca | phosphorylation | Ser79 | rat | Diabetes Mellitus | AICAR | Associated | 2.0 (Low) | 23967267 | |
acc3742 | AMPK | Q09137 | Prkaa2 | phosphorylation | Thr172 | rat | Diabetes Mellitus | AICAR | Associated | 2.0 (Low) | 23967267 | |
acc3743 | AMPK | P54645 | Prkaa1 | phosphorylation | Thr183 | rat | Diabetes Mellitus | AICAR | Associated | 2.0 (Low) | 23967267 |